UniprotAccessionA	ProteinNameA	GeneNameA	UniprotAccessionB	ProteinNameB	GeneNameB	JaccardCoefficient	CommonProjectsCount	CommonProjectNames	CommonAssayCount	IntActIds	BioGridIds	CorunIds	ReactomeIds	Go:BP	GO:CC	GO:MF
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	0.47	30	PXD000948;PRD000053;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PXD001328;PXD000997;PRD000092;PRD000154;PXD001422;PRD000668;PRD000711;PRD000597;PRD000407;PRD000594;PXD001323;PRD000607;PXD000426;PRD000032;PRD000565;PXD000218;PRD000146;PRD000444;PXD000593;PXD001572;PXD000164;PXD000533;PRD000738	115	EBI-2638686	1273202;740967;288851		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	0.47	34	PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PXD001328;PRD000154;PXD000593;PXD001422;PRD000465;PRD000733;PRD000407;PRD000711;PRD000597;PRD000565;PRD000594;PXD001323;PRD000607;PRD000032;PXD000997;PXD000426;PRD000092;PRD000151;PXD000218;PRD000146;PRD000444;PXD001572;PRD000671;PXD000164;PXD000533;PRD000269	140		1259726;920599;741527		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	0.51	29	PXD000948;PRD000443;PXD000529;PXD001310;PRD000053;PXD000387;PRD000345;PXD001328;PXD000997;PRD000154;PXD001422;PRD000668;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000032;PXD000426;PRD000092;PRD000565;PXD000218;PRD000146;PRD000444;PXD000593;PXD001572;PRD000671;PRD000738	118		2244802;1259800;920600;741531		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	0.5	32	PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PXD001328;PXD000997;PRD000154;PXD000593;PXD001422;PRD000733;PRD000711;PRD000597;PRD000565;PRD000594;PXD001323;PRD000607;PXD000426;PRD000032;PRD000092;PXD000218;PRD000146;PRD000444;PXD001572;PRD000671;PXD000164;PXD000533;PRD000738;PRD000407	131		1259760;920595;741528		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	0.44	32	PRD000345;PRD000668;PRD000443;PXD000948;PRD000053;PXD000529;PXD001310;PXD000387;PXD001328;PXD000997;PRD000092;PRD000154;PXD001422;PRD000733;PRD000711;PRD000597;PRD000407;PRD000594;PXD001323;PRD000607;PXD000426;PRD000032;PRD000565;PXD000218;PRD000146;PRD000444;PXD000593;PXD001572;PXD001447;PXD000164;PXD000533;PRD000738	131		1259811;920604;741532		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.49	30	PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PXD001328;PXD000997;PRD000154;PXD001422;PRD000465;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000032;PXD000218;PXD000426;PRD000092;PRD000565;PRD000146;PRD000444;PXD000593;PXD001572;PRD000671;PXD000533	119		1259774;741529		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P40227	T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20)	CCT6A	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.41	32	PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PXD001328;PXD000997;PRD000154;PXD001422;PRD000465;PRD000733;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD000426;PRD000092;PRD000565;PRD000146;PXD000218;PRD000444;PXD000593;PRD000032;PXD001572;PRD000671;PXD000533;PRD000738	122		2247302;1259741;920588;741530		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
Q58FF8	Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b) (Heat shock protein 90Bb)		Q58FF7	Putative heat shock protein HSP 90-beta-3 (Heat shock protein 90-beta c) (Heat shock protein 90Bc)		0.44	52	PRD000733;PXD000426;PRD000059;PXD000948;PRD000123;PRD000668;PRD000443;PRD000092;PRD000407;PRD000053;PRD000417;PXD000529;PRD000269;PRD000154;PXD000387;PRD000684;PXD001328;PRD000565;PXD000047;PXD001422;PRD000032;PRD000796;PRD000465;PRD000146;PXD001323;PRD000416;PRD000711;PRD000597;PXD000593;PRD000594;PRD000607;PRD000020;PXD000997;PXD000314;PXD000472;PRD000167;PXD000533;PRD000168;PXD000217;PXD000164;PXD000218;PRD000731;PRD000046;PRD000671;PRD000345;PXD001324;PRD000234;PRD000444;PRD000073;PXD001572;PRD000738;PXD000786	262					protein folding [GO:0006457];response to stress [GO:0006950]	cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
Q0VD83	Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R)	APOBR	P19878	Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox)	NCF2	0.51	4	PRD000053;PXD001422;PXD000164;PRD000118	10							
P84077	ADP-ribosylation factor 1	ARF1	P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	0.42	21	PRD000053;PXD000529;PRD000154;PRD000594;PRD000668;PXD001323;PRD000738;PRD000118;PXD000426;PXD000948;PRD000733;PRD000001;PXD001328;PXD001572;PXD000164;PXD001422;PRD000020;PRD000345;PRD000407;PRD000711;PRD000597	83		1268464			vesicle-mediated transport [GO:0016192]	perinuclear region of cytoplasm [GO:0048471];protein-containing complex [GO:0032991];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	0.42	30	PXD000948;PXD000426;PRD000733;PRD000668;PRD000443;PRD000738;PRD000053;PXD000387;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000032;PRD000020;PXD001403;PXD000164;PRD000565;PRD000068;PRD000001;PXD000218;PXD000529;PRD000671;PRD000345;PRD000118;PRD000600;PRD000407	109		1268480		R-HSA-6811434;R-HSA-6807878	vesicle-mediated transport [GO:0016192]	Golgi membrane [GO:0000139];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	Q9H0U4	Ras-related protein Rab-1B	RAB1B	0.43	29	PXD000948;PRD000733;PRD000668;PRD000443;PRD000738;PRD000053;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000020;PXD001403;PRD000565;PRD000068;PRD000001;PXD000218;PRD000671;PRD000032;PRD000345;PRD000118;PRD000600;PXD000164;PRD000407	107		1268505		R-HSA-6811434;R-HSA-6807878	protein transport [GO:0015031]	Golgi membrane [GO:0000139];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	P51149	Ras-related protein Rab-7a	RAB7A	0.4	23	PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000565;PRD000001;PRD000020;PXD000426;PRD000733;PRD000345;PRD000118;PXD001447;PXD000164;PRD000407	89				R-HSA-2132295	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];protein transport [GO:0015031]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.43	21	PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PRD000118;PRD000711;PRD000597;PXD001323;PXD000948;PRD000001;PRD000020;PRD000733;PRD000345;PXD000426;PRD000594;PXD000164;PRD000407;PXD001422	86		1268468				cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	O14950	Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)	MYL12B	0.41	26	PXD000948;PRD000053;PRD000668;PRD000738;PXD000529;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000594;PXD001323;PXD000218;PRD000068;PRD000001;PRD000731;PRD000671;PRD000733;PRD000180;PRD000345;PXD001447;PXD000164;PRD000118;PRD000407	105						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P84077	ADP-ribosylation factor 1	ARF1	P19105	Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)	MYL12A	0.41	26	PXD000948;PRD000053;PRD000668;PRD000738;PXD000529;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000594;PXD001323;PXD000218;PRD000068;PRD000001;PRD000731;PRD000671;PRD000733;PRD000180;PRD000345;PXD001447;PXD000164;PRD000118;PRD000407	105						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P84077	ADP-ribosylation factor 1	ARF1	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.45	28	PRD000733;PRD000668;PRD000443;PRD000738;PRD000053;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000020;PXD001403;PRD000565;PRD000068;PXD000218;PRD000671;PRD000032;PRD000345;PRD000118;PRD000600;PXD000164;PRD000407	103					protein transport [GO:0015031]	Golgi membrane [GO:0000139]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.43	22	PRD000053;PXD000529;PXD000948;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000565;PXD000426;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000068;PRD000020;PXD001447;PRD000711;PRD000733;PRD000118	83						plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84077	ADP-ribosylation factor 1	ARF1	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.4	22	PRD000053;PRD000668;PXD000529;PXD000387;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000032;PXD000426;PXD000218;PXD001403;PRD000731;PXD000948;PRD000733;PRD000345;PXD000164;PRD000738;PRD000407	86						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P84077	ADP-ribosylation factor 1	ARF1	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.44	24	PRD000053;PRD000668;PRD000738;PXD000948;PXD000529;PXD000387;PXD001328;PXD001572;PRD000154;PRD000118;PRD000796;PRD000711;PRD000594;PXD001323;PRD000020;PRD000068;PRD000001;PRD000565;PRD000733;PXD000218;PXD000426;PXD001447;PXD000164;PXD001422	86						focal adhesion [GO:0005925];plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];protein domain specific binding [GO:0019904];GTP binding [GO:0005525]
Q9BUF5	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	0.5	60	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000364;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000426;PXD000997;PRD000068;PRD000168;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000600;PRD000671;PXD001324;PRD000234;PRD000444;PXD000383;PRD000523;PXD000786;PRD000407;PRD000118;PXD001447;PXD000164;PXD000533;PXD000226;PRD000108	297				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BUF5	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	0.41	61	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000364;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000426;PXD000472;PRD000068;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PXD000383;PRD000731;PRD000168;PRD000600;PRD000671;PXD001324;PRD000234;PRD000118;PXD000226;PRD000444;PRD000523;PXD000786;PRD000407;PXD001447;PXD000164;PXD000533;PRD000108	334	EBI-11139064	1456803;744926		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BUF5	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	0.49	59	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PRD000154;PXD000529;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000364;PXD000593;PRD000594;PRD000046;PRD000607;PRD000680;PXD000426;PRD000068;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000383;PRD000731;PRD000168;PRD000600;PRD000671;PXD001324;PRD000234;PRD000118;PXD000226;PRD000444;PRD000523;PRD000535;PRD000407;PXD001447;PXD000164;PXD000533;PRD000108	308				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BUF5	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	0.48	60	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000426;PRD000269;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000364;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PRD000068;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PXD000383;PRD000731;PRD000168;PRD000600;PRD000671;PXD001324;PRD000234;PRD000444;PXD000226;PRD000523;PXD000786;PRD000407;PRD000118;PXD001447;PXD000164;PXD000533;PRD000108	311		926274		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BUF5	Tubulin beta-6 chain (Tubulin beta class V)	TUBB6	Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	0.41	61	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000364;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000426;PXD000472;PRD000068;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PXD000383;PRD000731;PRD000168;PRD000600;PRD000671;PXD001324;PRD000234;PRD000118;PXD000226;PRD000444;PRD000523;PXD000786;PRD000407;PXD001447;PXD000164;PXD000533;PRD000108	330	EBI-16799786	926301;744879		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];enzyme binding [GO:0019899];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.48	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140						nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S8	Histone H2A type 1 (H2A.1) (Histone H2A/ptl)	HIST1H2AK;HIST1H2AL;HIST1H2AI;HIST1H2AG;HIST1H2AM	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P0C0S5	Histone H2A.Z (H2A/z)	H2AFZ	Q96A08	Histone H2B type 1-A (Histone H2B, testis) (TSH2B.1) (hTSH2B) (Testis-specific histone H2B)	HIST1H2BA	0.47	31	PRD000733;PXD000786;PRD000565;PRD000345;PXD000529;PRD000684;PXD000218;PRD000796;PRD000020;PRD000444;PXD000743;PRD000594;PRD000123;PXD000746;PRD000680;PXD001572;PXD001324;PRD000269;PRD000234;PXD000997;PXD000387;PXD000314;PRD000600;PXD000047;PXD001422;PRD000118;PXD001403;PXD000164;PRD000407;PRD000711;PRD000597	85		2245614;1197167		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982]
P02549	Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)	SPTA1	P11277	Spectrin beta chain, erythrocytic (Beta-I spectrin)	SPTB	0.4	8	PRD000092;PRD000154;PRD000477;PRD000053;PXD001324;PRD000020;PRD000684;PRD000738	51	EBI-9675000;EBI-9546817;EBI-9544836;EBI-1178954	305620		R-HSA-6807878;R-HSA-5673001;R-HSA-445095;R-HSA-375165	actin filament capping [GO:0051693];MAPK cascade [GO:0000165];axon guidance [GO:0007411];ER to Golgi vesicle-mediated transport [GO:0006888]	spectrin [GO:0008091];intrinsic component of the cytoplasmic side of the plasma membrane [GO:0031235];spectrin-associated cytoskeleton [GO:0014731];actin cytoskeleton [GO:0015629];cytosol [GO:0005829]	actin filament binding [GO:0051015];Ras guanyl-nucleotide exchange factor activity [GO:0005088];structural constituent of cytoskeleton [GO:0005200]
P40429	60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13)	RPL13A	P84098	60S ribosomal protein L19 (Large ribosomal subunit protein eL19)	RPL19	0.45	18	PXD001310;PRD000053;PRD000444;PRD000594;PRD000123;PRD000443;PRD000565;PRD000146;PXD000997;PXD000529;PRD000671;PXD001572;PXD000533;PXD000593;PXD001323;PRD000711;PRD000597;PXD001422	43		1269220	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P04259	Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)	KRT6B	P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	0.55	53	PRD000073;PRD000733;PRD000164;PRD000069;PXD000743;PRD000123;PRD000092;PRD000443;PRD000417;PXD000226;PRD000345;PXD000529;PRD000373;PXD000387;PXD001328;PXD001572;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PXD000593;PRD000172;PRD000416;PRD000407;PXD001323;PRD000059;PRD000607;PRD000680;PXD000997;PRD000212;PXD000746;PRD000551;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PRD000234;PRD000146;PRD000444;PRD000113;PRD000594;PRD000053;PRD000362;PXD000218;PXD000383;PXD001447;PRD000364	185				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P04259	Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)	KRT6B	P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	0.47	49	PRD000073;PRD000154;PRD000345;PRD000069;PXD000743;PRD000092;PRD000443;PRD000059;PXD000226;PXD000383;PRD000733;PRD000373;PXD000387;PXD000593;PXD001328;PXD001572;PXD001422;PXD000529;PXD000047;PRD000123;PRD000364;PRD000172;PRD000407;PXD001323;PRD000607;PRD000680;PXD000997;PXD000746;PRD000417;PXD000412;PRD000151;PXD001403;PXD001402;PXD000164;PRD000212;PXD001174;PXD001324;PRD000600;PRD000551;PRD000565;PRD000146;PRD000234;PRD000362;PRD000113;PRD000671;PXD001447;PRD000019;PXD000964;PRD000269	212				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P04259	Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)	KRT6B	P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	0.42	57	PRD000733;PRD000073;PRD000154;PRD000345;PXD000746;PRD000069;PRD000417;PXD000743;PRD000092;PRD000443;PRD000059;PXD000226;PRD000269;PXD000383;PRD000444;PRD000373;PXD000387;PXD000593;PXD001328;PXD001572;PXD001422;PRD000796;PXD000047;PRD000416;PRD000364;PRD000172;PRD000407;PRD000594;PXD001323;PRD000607;PRD000680;PRD000020;PXD000997;PRD000212;PXD001403;PRD000164;PXD000164;PXD000412;PRD000151;PXD001402;PXD000948;PXD001174;PXD001324;PRD000600;PRD000551;PRD000565;PRD000146;PRD000234;PRD000362;PRD000113;PRD000597;PRD000053;PXD000218;PRD000671;PXD001447;PRD000019;PXD000964	255				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P04259	Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)	KRT6B	P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	0.5	40	PRD000073;PXD000746;PRD000069;PRD000733;PXD000743;PXD001328;PXD001572;PXD001422;PRD000154;PRD000345;PXD000164;PRD000092;PRD000364;PRD000416;PRD000407;PXD000593;PXD001323;PRD000164;PRD000059;PRD000607;PRD000594;PXD001174;PRD000212;PXD001403;PRD000417;PRD000151;PXD001402;PRD000443;PRD000172;PRD000146;PXD001324;PRD000234;PXD000997;PRD000444;PXD000383;PRD000113;PRD000671;PRD000362;PRD000053;PXD001447	140				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P04259	Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)	KRT6B	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.6	56	PRD000073;PRD000733;PRD000164;PRD000069;PXD000743;PRD000123;PRD000092;PRD000059;PRD000443;PXD000226;PRD000345;PXD000383;PXD000529;PRD000444;PRD000373;PXD000387;PXD001328;PXD001572;PRD000154;PXD001422;PRD000796;PRD000417;PXD000047;PRD000711;PRD000597;PRD000364;PRD000172;PRD000416;PRD000407;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000746;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PXD000593;PRD000551;PRD000053;PRD000234;PRD000146;PRD000113;PRD000594;PRD000671;PRD000362;PXD000218;PXD001447;PXD000964	200				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P02760	Protein AMBP [Cleaved into: Alpha-1-microglobulin (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin]	AMBP	P02749	Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)	APOH	0.41	17	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD001174;PRD000416;PXD000164;PXD001403;PXD000743;PRD000631;PRD000172;PXD001324;PRD000158;PRD000019;PRD000364;PXD000746	102						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];cell surface [GO:0009986];collagen-containing extracellular matrix [GO:0062023]	
P02760	Protein AMBP [Cleaved into: Alpha-1-microglobulin (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin]	AMBP	P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	0.46	18	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PXD001403;PXD000743;PRD000631;PXD001174;PRD000172;PXD001324;PRD000551;PRD000158;PRD000269;PRD000364;PRD000417	136						extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	
P02760	Protein AMBP [Cleaved into: Alpha-1-microglobulin (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin]	AMBP	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.4	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD001174;PXD000164;PRD000172;PXD001403;PRD000631;PXD001324;PXD000765;PRD000551;PRD000158	126						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023]	
P05388	60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)	RPLP0	P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	0.44	33	PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PRD000269;PXD000387;PRD000345;PXD000997;PXD001572;PXD001422;PRD000796;PXD000050;PXD000426;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PRD000565;PRD000020;PXD000218;PXD000593;PRD000671;PRD000146;PRD000444;PRD000032;PXD001447;PRD000600;PXD000533;PXD000964	124		1271187;741660	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];cytoplasmic ribonucleoprotein granule [GO:0036464];focal adhesion [GO:0005925];membrane [GO:0016020];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P05388	60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)	RPLP0	P08865	40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2)	RPSA	0.4	32	PXD000948;PRD000053;PRD000668;PRD000443;PRD000417;PRD000416;PRD000146;PXD000529;PXD001310;PRD000269;PXD000387;PXD001572;PXD001422;PRD000154;PRD000796;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000020;PXD000997;PXD000218;PXD000426;PRD000565;PRD000671;PXD001324;PRD000444;PRD000345;PXD000786;PXD000533	137		1270370;741781	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P05388	60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)	RPLP0	P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	0.41	31	PXD000948;PRD000020;PRD000053;PRD000345;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD000997;PXD001572;PXD000593;PRD000154;PRD000796;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PXD000426;PRD000565;PRD000671;PRD000146;PXD000218;PRD000444;PXD000786;PXD000533;PXD001422	104		1270850;742964	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P05388	60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10)	RPLP0	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.41	34	PRD000020;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PRD000345;PXD001572;PXD001422;PRD000154;PRD000796;PRD000146;PXD000050;PXD000047;PXD000426;PRD000711;PRD000597;PXD000593;PRD000594;PRD000416;PXD001323;PRD000607;PRD000680;PXD000997;PRD000565;PXD000218;PXD000314;PRD000671;PRD000444;PXD001447;PRD000600;PXD000533;PXD000964	134		1270369;741661	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];endoplasmic reticulum [GO:0005783];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P02765	Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]	AHSG	P02652	Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]	APOA2	0.4	12	PRD000073;PRD000631;PRD000172;PXD001174;PXD000383;PRD000551;PRD000158;PRD000364;PXD001403;PRD000053;PXD000743;PXD000164	66				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02765	Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]	AHSG	P02656	Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)	APOC3	0.45	16	PRD000172;PXD000383;PRD000073;PRD000631;PRD000551;PXD001174;PRD000059;PRD000185;PRD000158;PXD001403;PRD000053;PRD000364;PXD000743;PXD000164;PRD000108;PRD000711	62						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];collagen-containing extracellular matrix [GO:0062023]	
P02765	Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B]	AHSG	P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	0.4	17	PRD000073;PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000711;PXD001174;PXD001403;PXD000412;PRD000172;PRD000551;PRD000158;PRD000362;PRD000364;PXD000743	95				R-HSA-8957275;R-HSA-381426;R-HSA-114608	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687];platelet degranulation [GO:0002576]	endoplasmic reticulum lumen [GO:0005788];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093]	cysteine-type endopeptidase inhibitor activity [GO:0004869]
P02766	Transthyretin (ATTR) (Prealbumin) (TBPA)	TTR	P02652	Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]	APOA2	0.45	15	PRD000631;PXD000383;PRD000551;PRD000073;PRD000416;PXD001174;PXD000743;PRD000158;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PXD000164;PRD000269	61				R-HSA-975634	cellular protein metabolic process [GO:0044267];retinoid metabolic process [GO:0001523]	extracellular region [GO:0005576];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982]
P02766	Transthyretin (ATTR) (Prealbumin) (TBPA)	TTR	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.42	16	PRD000185;PXD000383;PRD000158;PRD000631;PRD000551;PRD000073;PXD001174;PXD000765;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PXD000164;PRD000477;PRD000711	73						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	0.53	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	35					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	0.48	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PRD000059;PRD000053;PXD001422;PRD000416;PXD001403;PXD001174;PRD000019	32					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	0.53	15	PRD000417;PXD000743;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	43					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	0.44	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	22					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.51	4	PXD000383;PRD000671;PXD001422;PXD001403	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.52	17	PRD000417;PXD000743;PRD000551;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	50					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	0.41	12	PRD000019;PRD000551;PRD000671;PRD000631;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403	40							antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.45	17	PRD000417;PXD000743;PRD000345;PRD000671;PRD000631;PRD000551;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	45					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	0.42	12	PRD000019;PRD000551;PRD000671;PRD000631;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403	40							antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.54	15	PRD000417;PXD000743;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	43					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.49	5	PXD000383;PRD000671;PRD000345;PXD001422;PXD001403	16					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.44	7	PXD000383;PRD000671;PRD000019;PRD000345;PXD001403;PXD001422;PRD000212	18							antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	0.4	16	PRD000417;PXD000743;PRD000345;PRD000671;PRD000631;PRD000551;PXD000383;PRD000019;PRD000416;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	42					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.56	17	PRD000417;PXD000743;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	50					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.47	16	PRD000417;PXD000743;PRD000345;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403;PXD001174	45					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.45	12	PXD001324;PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PXD000743	36					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.48	9	PRD000417;PXD000383;PRD000671;PRD000416;PXD001403;PXD000164;PXD001422;PRD000345;PRD000019	23					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.55	12	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PRD000059;PXD000164;PXD001422;PRD000345;PXD001403	36					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.51	18	PRD000417;PXD000743;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PRD000059;PXD000164;PXD001422;PRD000345;PXD001403;PRD000269;PXD001174	50					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.56	15	PRD000417;PXD000743;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PRD000053;PXD000164;PRD000631;PRD000345;PXD001403;PXD001174;PRD000019	42					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.6	3	PXD000383;PXD001403;PXD001422	14					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.41	8	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PXD001174	25					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.55	14	PRD000417;PXD000743;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000164;PXD001422;PXD001403;PXD001174	43					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S5	Immunoglobulin kappa variable 1-27	IGKV1-27	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.56	14	PRD000417;PXD000743;PRD000671;PRD000631;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD001422;PXD001403;PXD001174;PRD000019	35					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P52272	Heterogeneous nuclear ribonucleoprotein M (hnRNP M)	HNRNPM	Q08211	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9	0.44	24	PRD000733;PXD000426;PRD000345;PXD000529;PRD000444;PXD000593;PXD000218;PXD000533;PRD000597;PXD000680;PRD000565;PRD000607;PXD000948;PXD001572;PRD000146;PXD000997;PRD000594;PXD001422;PRD000796;PXD000217;PXD000047;PRD000020;PRD000407;PRD000711	79		921941	3055	R-HSA-72163	mRNA splicing, via spliceosome [GO:0000398];alternative mRNA splicing, via spliceosome [GO:0000380]	nucleolus [GO:0005730];nucleoplasm [GO:0005654];membrane [GO:0016020]	RNA binding [GO:0003723]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	0.54	6	PRD000417;PRD000416;PXD000383;PRD000212;PXD001422;PRD000269	26				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01701	Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)	IGLV1-51	0.4	7	PXD000383;PRD000417;PRD000416;PXD001422;PXD000743;PRD000212;PXD001403	20				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	0.49	8	PRD000417;PXD000383;PRD000212;PXD001403;PRD000671;PXD001422;PRD000113;PRD000416	23				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	0.47	1	PXD000383	11						extracellular region [GO:0005576]	
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	0.41	1	PXD000383	11				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01699	Immunoglobulin lambda variable 1-44 (Ig lambda chain V-I region MEM) (Ig lambda chain V-I region VOR)	IGLV1-44	0.49	7	PRD000417;PRD000416;PXD000383;PRD000212;PXD001422;PXD000047;PRD000269	26				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.42	7	PRD000417;PRD000416;PXD000383;PRD000212;PXD001403;PRD000671;PXD001422	23				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.43	5	PXD000383;PRD000671;PXD001422;PRD000212;PXD001403	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.58	3	PXD000383;PRD000212;PXD001403	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.41	2	PXD000383;PRD000671	12					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.53	2	PXD000383;PXD001403	12					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.41	6	PXD000383;PRD000417;PRD000416;PXD001422;PRD000113;PXD001403	17					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.45	6	PXD000383;PRD000417;PRD000416;PXD001422;PRD000671;PXD001403	20				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.4	6	PRD000417;PRD000416;PXD000383;PRD000212;PXD001403;PRD000671	22				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.47	4	PXD000383;PXD001422;PRD000212;PXD001403	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.54	7	PXD000383;PRD000417;PRD000416;PRD000269;PXD001422;PRD000671;PXD001403	21					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01703	Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM)	IGLV1-40	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.42	8	PRD000417;PXD000383;PRD000416;PRD000212;PXD001403;PRD000671;PXD001422;PRD000113	25					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	0.45	9	PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	0.51	8	PRD000417;PXD000383;PRD000671;PRD000212;PXD001403;PXD000164;PXD001422;PRD000416	25				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	0.45	10	PRD000417;PRD000416;PXD000746;PXD000383;PRD000671;PXD000743;PRD000212;PXD001403;PXD000164;PXD001422	35					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	0.45	1	PXD000383	11						extracellular region [GO:0005576]	
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	0.49	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	22					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.53	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	0.44	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	0.43	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	0.44	5	PXD000383;PRD000551;PXD000164;PXD001403;PXD000743	20					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.5	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.43	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000551;PRD000416;PRD000212;PXD001403;PXD000164;PXD001422	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.46	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269	41				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.44	10	PRD000417;PRD000416;PXD000746;PXD000383;PRD000671;PXD000743;PRD000212;PXD001403;PXD000164;PXD001422	35				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	0.43	9	PRD000417;PXD000383;PRD000671;PXD000743;PRD000551;PRD000212;PXD001403;PXD000164;PRD000416	27				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.5	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	0.42	10	PRD000416;PXD000746;PXD000383;PRD000019;PRD000212;PXD001403;PRD000671;PXD000164;PXD001422;PXD000743	26					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.48	7	PXD000383;PRD000671;PXD000164;PRD000019;PXD001403;PXD001422;PRD000212	18					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.49	3	PXD000383;PXD001403;PRD000212	15					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	0.45	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269	39					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.43	12	PRD000417;PRD000416;PXD000746;PXD000383;PRD000671;PXD000743;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269	37				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.48	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269	38				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.5	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.53	9	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422	24					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.57	9	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000551;PXD001403;PXD000164;PXD001422	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.46	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269	39				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.54	9	PRD000417;PRD000416;PXD000383;PXD000743;PRD000551;PRD000212;PXD001403;PRD000671;PXD000164	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.53	11	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000019;PRD000551;PRD000212;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.54	7	PRD000417;PRD000416;PXD000383;PRD000671;PXD001403;PXD001422;PRD000269	24					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.55	10	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000551;PXD001403;PXD000164;PXD001422;PRD000269	36					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01700	Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH)	IGLV1-47	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.49	9	PRD000417;PXD000383;PRD000671;PRD000416;PRD000212;PXD001403;PXD000164;PXD001422;PXD000743	28					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01701	Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)	IGLV1-51	A0A0A0MT36	Immunoglobulin kappa variable 6D-21	IGKV6D-21	0.42	4	PXD001403;PRD000416;PXD000383;PRD000417	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01701	Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)	IGLV1-51	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.42	4	PXD000383;PXD001403;PXD001422;PRD000212	15					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01701	Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)	IGLV1-51	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.4	3	PXD000383;PXD001403;PRD000212	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01701	Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64)	IGLV1-51	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.43	4	PXD000383;PXD001403;PXD001422;PRD000212	15					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q15366	Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2)	PCBP2	Q15365	Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3)	PCBP1	0.42	29	PRD000345;PRD000053;PRD000032;PRD000123;PRD000668;PRD000443;PXD000529;PXD001328;PRD000154;PXD001422;PXD000047;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000607;PXD000948;PXD000472;PRD000565;PRD000733;PXD001324;PRD000146;PXD000218;PXD000997;PRD000444;PRD000407;PXD001572;PRD000671	115	EBI-946668;EBI-953278	1266261;1113139;721237;721103		R-HSA-72203;R-HSA-72163	mRNA splicing, via spliceosome [GO:0000398];RNA metabolic process [GO:0016070];viral RNA genome replication [GO:0039694]	membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P39023	60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)	RPL3	P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	0.41	24	PRD000053;PRD000565;PXD000593;PXD000426;PXD001310;PXD000529;PXD000948;PRD000733;PRD000594;PXD001323;PRD000443;PRD000680;PRD000146;PXD000997;PXD000387;PXD001328;PRD000671;PRD000180;PXD001572;PXD001422;PXD000047;PRD000711;PRD000597;PXD000218	76		1269707;742091	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P39023	60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)	RPL3	Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	0.4	26	PXD000948;PRD000565;PRD000443;PXD001328;PRD000053;PRD000733;PXD000593;PRD000594;PRD000123;PXD001323;PRD000020;PRD000680;PXD000529;PXD001310;PXD000218;PRD000146;PXD000997;PRD000671;PXD000426;PXD001572;PXD001422;PXD000050;PXD000047;PRD000597;PRD000711;PXD000964	75		1270175;742640	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P39023	60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3)	RPL3	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.44	25	PRD000443;PXD000948;PXD000529;PRD000053;PXD001328;PXD001572;PXD000593;PXD001422;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000997;PRD000565;PXD000218;PXD001310;PRD000733;PRD000146;PXD000426;PXD000533;PXD000964	86		1269706;742030	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q9NVP1	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb)	DDX18	Q9H0A0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	NAT10	0.46	7	PXD000047;PRD000565;PXD001572;PXD000529;PXD000533;PXD000426;PXD000593	11		1265239				nucleolus [GO:0005730];membrane [GO:0016020]	ATP binding [GO:0005524];RNA binding [GO:0003723]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	0.4	46	PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PXD000050;PXD000746;PRD000711;PRD000597;PXD001323;PRD000680;PRD000594;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD000217;PXD001402;PXD000164;PRD000053;PXD000426;PXD000218;PXD000314;PRD000600;PXD000948;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000269;PXD001447;PRD000407	146				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138	EBI-19920141;EBI-19920155			R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q8IUE6	Histone H2A type 2-B	HIST2H2AB	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.47	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139		1427394		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];antibacterial humoral response [GO:0019731];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334]	cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular space [GO:0005615];nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139		479437		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q7L7L0	Histone H2A type 3	HIST3H2A	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62807	Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l)	HIST1H2BE;HIST1H2BI;HIST1H2BC;HIST1H2BG;HIST1H2BF	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.44	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];protein ubiquitination [GO:0016567];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334];antibacterial humoral response [GO:0019731]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular space [GO:0005615];cytosol [GO:0005829];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	0.4	46	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000269;PXD001447;PRD000407	146				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	0.4	46	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000269;PXD001447;PRD000407	146				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.4	47	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000059;PRD000073;PRD000269;PXD001447;PRD000407	147				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062];protein-containing complex [GO:0032991]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.4	46	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000600;PRD000269;PXD001447;PRD000407	145				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.4	47	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000059;PRD000073;PRD000269;PXD001447;PRD000407	147				R-HSA-3214847;R-HSA-3214815	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.4	46	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000269;PXD001447;PRD000407	146			1227	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62805	Histone H4	HIST1H4F;HIST2H4B;HIST1H4L;HIST1H4B;HIST1H4A;HIST1H4C;HIST1H4K;HIST2H4A;HIST1H4J;HIST1H4H;HIST1H4I;HIST1H4D;HIST1H4E;HIST4H4	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.4	46	PRD000164;PXD000743;PRD000668;PRD000443;PRD000684;PXD000529;PXD000680;PXD000387;PRD000020;PXD000047;PXD001422;PRD000796;PRD000465;PXD000164;PXD000050;PXD000217;PRD000711;PRD000597;PXD000746;PRD000594;PXD001323;PRD000680;PXD000997;PXD000786;PXD001403;PXD000472;PRD000565;PRD000151;PXD001402;PRD000053;PRD000733;PXD000218;PXD000314;PRD000600;PXD000948;PXD000426;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000073;PRD000269;PXD001447;PRD000407	146				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9UKL0	REST corepressor 1 (Protein CoREST)	RCOR1	Q92769	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	0.4	5	PRD000345;PXD000680;PXD000533;PRD000407;PXD000426	40	EBI-6597828;EBI-3505059;EBI-926742	871963;832429;511199;511193;483646;261606;261598;244119	1233;871;642;636;633;632;620	R-HSA-983231;R-HSA-8943724;R-HSA-3214815	blood coagulation [GO:0007596];transcription, DNA-templated [GO:0006351];histone H4 deacetylation [GO:0070933];negative regulation of transcription, DNA-templated [GO:0045892]	nucleus [GO:0005634];nucleoplasm [GO:0005654]	transcription factor binding [GO:0008134];histone deacetylase activity [GO:0004407]
Q9UKL0	REST corepressor 1 (Protein CoREST)	RCOR1	Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	0.41	4	PRD000345;PXD000680;PXD000533;PRD000407	39	EBI-15785761;EBI-15667529;EBI-15665758;EBI-15665691;EBI-15665737;EBI-11132348;EBI-6597549;EBI-3505028;EBI-2461759;EBI-926742	2230792;1451932;871904;832402;520125;511192;511187;511168;505057;503270;483642;341164;261601;261597;244097	5614;871;649;648;646;642;636;633;632;626;620	R-HSA-983231;R-HSA-8943724;R-HSA-3214815	blood coagulation [GO:0007596];transcription, DNA-templated [GO:0006351];histone H4 deacetylation [GO:0070933];negative regulation of transcription, DNA-templated [GO:0045892]	nucleus [GO:0005634];nucleoplasm [GO:0005654]	transcription regulatory region DNA binding [GO:0044212];transcription factor binding [GO:0008134];transcription corepressor activity [GO:0003714];histone deacetylase activity [GO:0004407]
Q9UKL0	REST corepressor 1 (Protein CoREST)	RCOR1	Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	0.45	1	PRD000345	32	EBI-11938183;EBI-11087905	2450495;2329523;2228015;1451933	626		transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]
Q9UKL0	REST corepressor 1 (Protein CoREST)	RCOR1	Q9P2K3	REST corepressor 3	RCOR3	0.41	2	PRD000345;PXD000533	22			626;642		transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634];transcription factor complex [GO:0005667];transcriptional repressor complex [GO:0017053]	transcription regulatory region DNA binding [GO:0044212];transcription corepressor activity [GO:0003714];RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981];transcription factor binding [GO:0008134]
Q9UKL0	REST corepressor 1 (Protein CoREST)	RCOR1	Q14687	Genetic suppressor element 1	GSE1	0.55	2	PRD000345;PRD000407	31			632;633				
Q58FF7	Putative heat shock protein HSP 90-beta-3 (Heat shock protein 90-beta c) (Heat shock protein 90Bc)		Q14568	Heat shock protein HSP 90-alpha A2 (Heat shock 90 kDa protein 1 alpha-like 3) (Heat shock protein HSP 90-alpha A2 pseudogene)		0.42	54	PRD000733;PRD000092;PRD000059;PXD000948;PRD000053;PRD000269;PRD000123;PRD000668;PRD000443;PRD000417;PXD000529;PXD000387;PRD000684;PXD001328;PRD000565;PRD000154;PXD001422;PRD000796;PRD000032;PRD000465;PRD000146;PXD001323;PXD000047;PRD000711;PRD000597;PRD000594;PRD000477;PXD000593;PXD000426;PRD000046;PRD000416;PRD000607;PRD000020;PXD000997;PXD000472;PRD000167;PXD000533;PRD000168;PXD000217;PXD000218;PRD000731;PRD000671;PRD000345;PXD001324;PRD000234;PRD000444;PXD000314;PXD000164;PRD000073;PXD001572;PRD000738;PRD000108;PRD000407;PXD000786	262					protein folding [GO:0006457];response to stress [GO:0006950]	cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	0.47	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	0.45	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	0.47	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.44	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000314;PRD000020;PRD000796;PXD001422;PRD000345;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q8IUE6	Histone H2A type 2-B	HIST2H2AB	0.45	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.45	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000314;PRD000020;PRD000796;PXD001422;PRD000345;PXD000050;PXD000217;PXD000948;PRD000597	53				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.44	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000314;PRD000020;PRD000796;PXD001422;PRD000345;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.47	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q7L7L0	Histone H2A type 3	HIST3H2A	0.47	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.4	21	PRD000345;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PXD000529;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	53				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99880	Histone H2B type 1-L (Histone H2B.c) (H2B/c)	HIST1H2BL	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.42	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000314;PRD000020;PRD000796;PXD001422;PRD000345;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P01031	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5	0.46	14	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PRD000172;PXD001403;PRD000551;PRD000158;PRD000362;PRD000364;PXD000743	105				R-HSA-418594;R-HSA-375276	cell surface receptor signaling pathway [GO:0007166];G-protein coupled receptor signaling pathway [GO:0007186]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	0.43	12	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000551;PRD000158;PXD000743	103					negative regulation of cell growth [GO:0030308];negative regulation of angiogenesis [GO:0016525]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P08697	Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)	SERPINF2	0.42	14	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PRD000172;PXD001403;PXD001174;PRD000551;PRD000158;PRD000362;PXD000743	98					regulation of blood vessel diameter by renin-angiotensin [GO:0002034]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P43652	Afamin (Alpha-albumin) (Alpha-Alb)	AFM	0.41	13	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PRD000172;PXD001403;PXD001174;PRD000551;PRD000158;PRD000362	98						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.47	16	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000050;PXD000164;PRD000172;PXD001403;PXD001174;PRD000551;PRD000113;PRD000158;PRD000362;PXD000743	109					aging [GO:0007568]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01019	Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4]	AGT	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.44	13	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD001174;PRD000551;PRD000158;PRD000362	113						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	0.47	22	PRD000073;PRD000059;PRD000185;PXD000383;PRD000269;PRD000416;PXD000164;PXD001403;PRD000172;PXD000765;PXD000743;PRD000053;PRD000417;PRD000631;PXD000412;PXD001324;PRD000551;PRD000146;PRD000113;PRD000158;PXD001174;PRD000362	136						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	0.43	21	PRD000073;PRD000059;PRD000417;PRD000185;PRD000269;PXD000383;PRD000053;PXD001422;PXD000164;PXD001403;PRD000416;PRD000172;PXD000743;PRD000631;PXD001174;PXD001324;PXD000765;PRD000551;PRD000113;PRD000158;PRD000362	146						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.41	18	PRD000073;PRD000059;PRD000417;PRD000185;PRD000269;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000172;PXD001403;PRD000631;PXD000412;PXD001324;PRD000551;PRD000158;PRD000362	135						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	0.53	15	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PXD000164;PXD001403;PRD000416;PRD000172;PXD000743;PRD000631;PXD001324;PRD000551;PRD000158	128						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	0.5	17	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PXD000164;PXD001403;PRD000416;PRD000172;PXD000743;PRD000053;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362	128						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01011	Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less]	SERPINA3	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.62	17	PRD000073;PRD000059;PRD000417;PRD000185;PRD000269;PXD000383;PRD000416;PXD000164;PXD001403;PRD000172;PXD000743;PRD000631;PXD001174;PRD000551;PRD000146;PRD000158;PRD000362	150				R-HSA-114608	acute-phase response [GO:0006953];platelet degranulation [GO:0002576]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
Q5TDH0	Protein DDI1 homolog 2 (EC 3.4.23.-)	DDI2	Q9Y3I1	F-box only protein 7	FBXO7	0.41	3	PRD000154;PXD001422;PRD000092	10						cytosol [GO:0005829]	ubiquitin binding [GO:0043130]
Q5TDH0	Protein DDI1 homolog 2 (EC 3.4.23.-)	DDI2	Q16401	26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B)	PSMD5	0.42	4	PRD000154;PXD001422;PRD000092;PRD000146	10						nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q5TDH0	Protein DDI1 homolog 2 (EC 3.4.23.-)	DDI2	Q13098	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1	0.42	5	PRD000154;PXD001422;PXD001572;PXD000533;PXD000314	12						nucleoplasm [GO:0005654];cytosol [GO:0005829]	
O75947	ATP synthase subunit d, mitochondrial (ATPase subunit d)	ATP5PD	P48047	ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)	ATP5PO	0.47	13	PRD000053;PRD000345;PRD000168;PRD000668;PXD001323;PXD000218;PRD000146;PXD000387;PXD001572;PXD000529;PXD001422;PRD000738;PRD000711	60		1259183;744096	563	R-HSA-8949613;R-HSA-163210	ATP biosynthetic process [GO:0006754];mitochondrial ATP synthesis coupled proton transport [GO:0042776];cristae formation [GO:0042407]	mitochondrial inner membrane [GO:0005743];mitochondrial proton-transporting ATP synthase complex [GO:0005753];mitochondrion [GO:0005739]	transmembrane transporter activity [GO:0022857]
O75947	ATP synthase subunit d, mitochondrial (ATPase subunit d)	ATP5PD	P61019	Ras-related protein Rab-2A	RAB2A	0.4	14	PRD000020;PRD000053;PXD001323;PRD000668;PXD001324;PRD000146;PXD000218;PXD000529;PXD000164;PXD001422;PRD000738;PXD001572;PRD000711;PRD000597	45							
P17844	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)	DDX5	Q92841	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	0.41	17	PRD000733;PRD000565;PXD000426;PRD000594;PRD000345;PXD000593;PRD000597;PRD000607;PXD000529;PXD000218;PXD000948;PRD000146;PXD001572;PXD001422;PXD000533;PXD000047;PRD000711	40	EBI-9521695;EBI-9521683;EBI-6114112;EBI-7749531	2259094;920918;828180;828173;741788;695808;695807	3082;1332;351	R-HSA-3899300	RNA secondary structure unwinding [GO:0010501];intracellular estrogen receptor signaling pathway [GO:0030520];epithelial to mesenchymal transition [GO:0001837];myoblast differentiation [GO:0045445];regulation of transcription by RNA polymerase II [GO:0006357];alternative mRNA splicing, via spliceosome [GO:0000380];regulation of alternative mRNA splicing, via spliceosome [GO:0000381];androgen receptor signaling pathway [GO:0030521];regulation of skeletal muscle cell differentiation [GO:2001014]	nucleus [GO:0005634];nucleolus [GO:0005730];cytoplasm [GO:0005737];nucleoplasm [GO:0005654];membrane [GO:0016020]	ATP binding [GO:0005524];RNA binding [GO:0003723];RNA helicase activity [GO:0003724];ATP-dependent RNA helicase activity [GO:0004004]
P17844	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68)	DDX5	Q08211	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9	0.42	21	PXD000426;PRD000345;PXD000529;PRD000444;PRD000594;PXD000218;PRD000711;PXD000593;PXD000533;PRD000565;PRD000607;PXD000948;PRD000146;PXD000997;PXD001572;PXD001422;PXD000047;PXD000217;PRD000597;PRD000407;PXD000964	67	EBI-7750031	1260971;828264;828182	3082;351	R-HSA-72163	mRNA splicing, via spliceosome [GO:0000398];RNA secondary structure unwinding [GO:0010501];alternative mRNA splicing, via spliceosome [GO:0000380];regulation of transcription by RNA polymerase II [GO:0006357];rhythmic process [GO:0048511]	ribonucleoprotein complex [GO:1990904];nucleolus [GO:0005730];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];membrane [GO:0016020];nucleus [GO:0005634]	RNA helicase activity [GO:0003724];ATP binding [GO:0005524];promoter-specific chromatin binding [GO:1990841];RNA binding [GO:0003723];ATP-dependent RNA helicase activity [GO:0004004]
Q562R1	Beta-actin-like protein 2 (Kappa-actin)	ACTBL2	P0CG39	POTE ankyrin domain family member J	POTEJ	0.44	72	PXD000948;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000059;PRD000594;PRD000680;PRD000417;PRD000345;PRD000068;PRD000212;PRD000032;PRD000168;PRD000416;PRD000733;PRD000234;PRD000151;PXD000997;PRD000113;PRD000092;PXD001323;PXD000786;PRD000600;PXD000593;PXD000218;PRD000001;PRD000364;PXD000426;PRD000443;PXD001572;PRD000738;PRD000167;PRD000146;PXD000164;PXD001422;PRD000073;PRD000607;PRD000118;PXD000314;PRD000103;PXD000529;PRD000523;PRD000535;PRD000362;PXD000226;PRD000209;PXD001328;PRD000154;PRD000796;PRD000172;PRD000164;PXD000217;PRD000565;PRD000444;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PRD000532;PRD000731;PXD001324;PXD000964	358						extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
Q562R1	Beta-actin-like protein 2 (Kappa-actin)	ACTBL2	P0CG38	POTE ankyrin domain family member I	POTEI	0.44	75	PXD000948;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PXD000383;PRD000269;PXD000593;PRD000020;PRD000668;PRD000465;PXD000047;PRD000059;PRD000594;PRD000680;PRD000417;PRD000345;PRD000068;PRD000212;PRD000032;PXD001310;PRD000168;PRD000416;PRD000733;PRD000234;PRD000151;PXD000997;PRD000113;PRD000092;PXD001323;PXD000786;PRD000600;PRD000154;PRD000001;PRD000364;PXD000426;PRD000443;PRD000073;PXD001572;PRD000738;PRD000167;PRD000146;PXD000164;PXD001422;PRD000164;PRD000607;PRD000118;PRD000565;PXD000218;PXD000314;PRD000103;PXD000529;PRD000523;PRD000535;PRD000362;PXD000226;PRD000209;PXD001328;PRD000796;PRD000172;PXD000217;PRD000444;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PRD000410;PRD000532;PRD000731;PXD001324;PRD000407;PXD000964	381						extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133		2375671		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133	EBI-15936172;EBI-15936153;EBI-15936134;EBI-15936115;EBI-15936096;EBI-15856546;EBI-15856528;EBI-15856458;EBI-15856422			R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P04908	Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m)	HIST1H2AE;HIST1H2AB	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P16152	Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)	CBR1	P30086	Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]	PEBP1	0.4	17	PXD000948;PXD001323;PRD000053;PXD000529;PRD000059;PRD000594;PRD000668;PRD000443;PRD000046;PXD001324;PXD000164;PXD001572;PXD000533;PXD001422;PRD000796;PRD000020;PRD000711	78						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q9UNX3	60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1)	RPL26L1	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.4	19	PXD000948;PXD001310;PRD000053;PRD000020;PRD000444;PXD001323;PRD000123;PRD000565;PRD000733;PRD000146;PXD000997;PXD001572;PXD001422;PRD000796;PXD000593;PRD000269;PRD000711;PRD000597;PXD000218	44				R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	cytoplasmic translation [GO:0002181]	cytosolic large ribosomal subunit [GO:0022625];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P16157	Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin)	ANK1	P11277	Spectrin beta chain, erythrocytic (Beta-I spectrin)	SPTB	0.47	6	PRD000092;PRD000154;PRD000053;PRD000684;PRD000020;PRD000738	57		278878		R-HSA-6807878;R-HSA-445095	ER to Golgi vesicle-mediated transport [GO:0006888]	spectrin-associated cytoskeleton [GO:0014731];cytosol [GO:0005829]	structural constituent of cytoskeleton [GO:0005200]
Q9UNX4	WD repeat-containing protein 3	WDR3	Q14684	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B	0.47	7	PXD000529;PXD001572;PXD000426;PXD000533;PXD000964;PXD000680;PXD000314	14	EBI-16686997				rRNA processing [GO:0006364]	nucleus [GO:0005634];nucleoplasm [GO:0005654];nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q9UNX4	WD repeat-containing protein 3	WDR3	Q9Y5J1	U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)	UTP18	0.48	5	PXD000529;PXD001572;PXD000533;PXD000964;PXD000314	12				R-HSA-6790901;R-HSA-6791226	rRNA processing [GO:0006364]	nuclear membrane [GO:0031965];nucleolus [GO:0005730];nucleoplasm [GO:0005654];Pwp2p-containing subcomplex of 90S preribosome [GO:0034388];small-subunit processome [GO:0032040];nucleus [GO:0005634]	RNA binding [GO:0003723]
Q13233	Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1)	MAP3K1	P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	0.41	1	PRD000032	71						cytoplasm [GO:0005737]	ATP binding [GO:0005524]
Q13231	Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1)	CHIT1	P49913	Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]		0.43	4	PXD000164;PRD000684;PRD000118;PRD000053	10				R-HSA-6798695	neutrophil degranulation [GO:0043312]	specific granule lumen [GO:0035580];extracellular region [GO:0005576];extracellular space [GO:0005615];tertiary granule lumen [GO:1904724]	
Q14031	Collagen alpha-6(IV) chain	COL4A6	P35625	Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3)	TIMP3	0.46	2	PXD000743;PXD000746	11						extracellular region [GO:0005576]	
Q9BQG0	Myb-binding protein 1A	MYBBP1A	Q9NR30	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)	DDX21	0.42	12	PXD000680;PRD000594;PXD000593;PRD000565;PXD000426;PXD000218;PRD000146;PXD000997;PXD000314;PXD001572;PRD000345;PRD000597	37			6302;6194;3055	R-HSA-5250924	positive regulation of gene expression, epigenetic [GO:0045815];osteoblast differentiation [GO:0001649]	nucleus [GO:0005634];nucleolus [GO:0005730];cytoplasm [GO:0005737];nucleoplasm [GO:0005654];membrane [GO:0016020]	RNA binding [GO:0003723]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	0.43	20	PRD000053;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PXD001323;PRD000668;PRD000001;PRD000733;PRD000600;PXD001324;PRD000146;PXD001572;PXD000164;PXD001422;PRD000345;PRD000407;PRD000597;PRD000269	65	EBI-16797971			R-HSA-8873719;R-HSA-8854214		trans-Golgi network [GO:0005802];cytoplasmic vesicle [GO:0031410];cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P18085	ADP-ribosylation factor 4	ARF4	0.43	22	PRD000053;PRD000600;PXD000529;PRD000154;PRD000594;PRD000668;PXD001323;PRD000738;PXD000948;PRD000733;PRD000001;PXD001328;PXD001572;PXD000164;PXD001422;PRD000345;PRD000020;PXD000426;PRD000407;PRD000711;PRD000597;PRD000269	79	EBI-16798159;EBI-16797971			R-HSA-5620916		cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	0.45	26	PRD000020;PRD000053;PRD000738;PRD000668;PXD001572;PRD000154;PXD001422;PXD000948;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000001;PXD000529;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PRD000118;PXD000164;PXD000533;PRD000407;PRD000269	88		1268466;746397		R-HSA-8873719	post-translational protein modification [GO:0043687];melanosome transport [GO:0032402];vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	Q9H0U4	Ras-related protein Rab-1B	RAB1B	0.44	27	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PRD000118;PXD000948;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000001;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PXD000426;PXD000164;PXD000533;PRD000407;PRD000269;PXD001422	89		746402		R-HSA-8873719	post-translational protein modification [GO:0043687]	transport vesicle [GO:0030133];cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	0.42	25	PRD000053;PXD001328;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PRD000118;PRD000146;PRD000565;PXD000529;PRD000733;PRD000600;PXD001324;PRD000001;PRD000684;PRD000345;PXD001572;PRD000594;PXD001422;PXD000533;PXD001323;PRD000020;PRD000597;PRD000269	81						perinuclear region of cytoplasm [GO:0048471];phagocytic vesicle [GO:0045335];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P04179	Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)	SOD2	0.4	16	PRD000053;PXD000529;PRD000738;PRD000668;PXD001323;PRD000711;PRD000118;PRD000269;PRD000733;PXD001324;PRD000345;PXD001572;PRD000594;PXD000164;PXD001422;PRD000020	72						extracellular exosome [GO:0070062]	
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	0.43	16	PRD000053;PXD000529;PRD000154;PRD000594;PRD000668;PXD001323;PXD000426;PRD000146;PXD001324;PXD001328;PXD001572;PXD001422;PXD000948;PRD000345;PRD000711;PRD000597	73					post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61019	Ras-related protein Rab-2A	RAB2A	0.45	20	PRD000733;PRD000053;PXD000529;PRD000711;PRD000092;PXD001323;PRD000668;PXD000426;PXD001324;PRD000001;PRD000146;PRD000154;PXD000164;PXD001422;PXD000533;PRD000738;PRD000410;PRD000020;PXD001572;PRD000597	56		1268467		R-HSA-8873719	post-translational protein modification [GO:0043687]	cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61204	ADP-ribosylation factor 3	ARF3	0.42	21	PRD000053;PXD000529;PRD000154;PRD000594;PRD000668;PXD001323;PRD000738;PRD000118;PXD000426;PXD000948;PRD000733;PRD000001;PXD001328;PXD001572;PXD000164;PXD001422;PRD000020;PRD000345;PRD000407;PRD000711;PRD000597	83						perinuclear region of cytoplasm [GO:0048471];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P51149	Ras-related protein Rab-7a	RAB7A	0.44	25	PRD000020;PRD000053;PRD000668;PRD000738;PRD000001;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PXD000948;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000733;PXD001324;PRD000146;PRD000345;PXD000426;PRD000118;PXD000164;PXD000533;PRD000407	89		1268587;746290		R-HSA-8873719;R-HSA-8854214		phagocytic vesicle [GO:0045335];cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	0.46	23	PRD000053;PXD000529;PRD000711;PRD000154;PRD000594;PRD000092;PRD000668;PXD001323;PRD000738;PRD000118;PRD000565;PXD000948;PRD000733;PXD001324;PXD001328;PXD001572;PXD000164;PXD000533;PXD001422;PRD000410;PRD000345;PRD000597;PRD000269	77				R-HSA-1445148		trans-Golgi network [GO:0005802];recycling endosome membrane [GO:0055038];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P84085	ADP-ribosylation factor 5	ARF5	0.41	20	PRD000053;PXD000529;PRD000154;PRD000594;PRD000668;PXD001323;PRD000738;PXD000948;PRD000733;PRD000001;PXD001328;PXD001572;PXD000164;PXD001422;PXD000426;PRD000020;PRD000345;PRD000407;PRD000711;PRD000597	78	EBI-15605371					perinuclear region of cytoplasm [GO:0048471];extracellular exosome [GO:0070062];Golgi apparatus [GO:0005794]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P30048	Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)	PRDX3	0.42	19	PRD000053;PRD000600;PRD000594;PRD000668;PXD001323;PRD000738;PRD000711;PRD000118;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001572;PXD000164;PXD001422;PRD000020;PRD000345;PRD000269	75						cytosol [GO:0005829];protein-containing complex [GO:0032991]	
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.47	25	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PRD000118;PXD000948;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PXD000426;PXD000164;PRD000407;PRD000269;PXD001422	87	EBI-16797971						GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.45	19	PRD000053;PXD000529;PRD000711;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000092;PXD000948;PRD000001;PXD001328;PXD001572;PXD000164;PRD000118;PXD000533;PXD001422;PRD000020;PRD000269	70						cytosol [GO:0005829];cleavage furrow [GO:0032154];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.5	22	PRD000053;PRD000600;PRD000711;PRD000154;PRD000594;PRD000092;PRD000668;PXD001323;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001328;PXD001572;PXD000164;PXD001422;PRD000738;PRD000001;PRD000345;PRD000407;PRD000269	72	EBI-16797971	1268561		R-HSA-8873719;R-HSA-8854214	plasma membrane to endosome transport [GO:0048227]	extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.41	16	PRD000053;PXD000529;PRD000154;PRD000594;PRD000668;PRD000738;PRD000711;PXD000426;PRD000733;PXD001324;PXD001323;PRD000345;PXD000164;PXD001422;PRD000020;PXD001572	66						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.42	19	PRD000053;PRD000154;PRD000594;PRD000668;PRD000711;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001323;PRD000345;PXD001572;PXD000164;PXD001422;PXD000533;PRD000738;PRD000407;PRD000597	74					post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.41	20	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PRD000668;PXD001323;PRD000738;PRD000118;PXD000948;PRD000733;PXD001324;PXD001328;PXD001572;PXD000164;PXD000533;PXD001422;PRD000410;PRD000345;PRD000269	78						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61006	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A	0.4	23	PRD000053;PRD000600;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PRD000118;PRD000565;PXD000948;PRD000733;PXD001324;PRD000146;PXD001323;PRD000345;PXD000529;PXD001572;PXD000164;PXD001422;PRD000407;PRD000597;PRD000269	79				R-HSA-8873719;R-HSA-8854214;R-HSA-5620916;R-HSA-5620912;R-HSA-1445148	regulation of long-term neuronal synaptic plasticity [GO:0048169];protein localization to plasma membrane [GO:0072659];post-translational protein modification [GO:0043687];regulation of protein transport [GO:0051223]	phagocytic vesicle [GO:0045335];recycling endosome membrane [GO:0055038];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61026	Ras-related protein Rab-10	RAB10	0.42	26	PRD000600;PRD000053;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PXD001323;PRD000118;PRD000565;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001328;PRD000345;PXD001572;PRD000594;PXD000164;PXD001422;PXD000533;PRD000407;PRD000597;PRD000269	82				R-HSA-8873719;R-HSA-1445148	protein localization to plasma membrane [GO:0072659];establishment of protein localization to membrane [GO:0090150];vesicle-mediated transport [GO:0016192]	cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062];cytoplasmic vesicle membrane [GO:0030659];trans-Golgi network [GO:0005802];recycling endosome membrane [GO:0055038];recycling endosome [GO:0055037]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61106	Ras-related protein Rab-14	RAB14	0.43	23	PRD000053;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PRD000001;PXD000529;PRD000733;PRD000600;PXD001324;PRD000146;PXD001572;PXD000164;PXD001422;PXD000533;PRD000345;PXD001323;PRD000407;PRD000597;PRD000269;PRD000118	66				R-HSA-8873719;R-HSA-1445148	vesicle-mediated transport [GO:0016192]	phagocytic vesicle [GO:0045335];extracellular exosome [GO:0070062];intracellular membrane-bounded organelle [GO:0043231];cytosol [GO:0005829];trans-Golgi network [GO:0005802];perinuclear region of cytoplasm [GO:0048471];recycling endosome membrane [GO:0055038];recycling endosome [GO:0055037]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P62491	Ras-related protein Rab-11A (Rab-11) (YL8)	RAB11A	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.43	20	PRD000053;PXD000529;PRD000711;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000092;PRD000733;PXD000948;PRD000001;PXD001328;PXD001572;PXD000164;PRD000118;PXD000533;PXD001422;PRD000020;PXD000426	72					mitotic spindle assembly [GO:0090307]	vesicle [GO:0031982];extracellular exosome [GO:0070062];cleavage furrow [GO:0032154];axon [GO:0030424];cytosol [GO:0005829]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P50395	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2	Q01518	Adenylyl cyclase-associated protein 1 (CAP 1)	CAP1	0.41	29	PXD000948;PRD000053;PRD000668;PXD000529;PRD000269;PXD000387;PXD001328;PXD000426;PXD001572;PXD001422;PRD000154;PRD000711;PRD000597;PRD000594;PXD001323;PRD000059;PRD000073;PRD000416;PXD000218;PXD000533;PRD000417;PRD000001;PXD000164;PRD000731;PRD000068;PXD001324;PRD000444;PRD000118;PRD000738	124				R-HSA-6798695	signal transduction [GO:0007165];neutrophil degranulation [GO:0043312]	focal adhesion [GO:0005925];extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	
P50395	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2	P06744	Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)	GPI	0.42	27	PXD000948;PRD000053;PRD000668;PRD000059;PXD000529;PRD000269;PXD001328;PXD000426;PXD001572;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000416;PRD000417;PRD000001;PXD000164;PRD000020;PRD000731;PXD001324;PXD000218;PRD000444;PRD000345;PRD000523;PXD000533	126				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];membrane [GO:0016020];secretory granule lumen [GO:0034774];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P50395	Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2)	GDI2	P22314	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1	0.4	24	PXD000948;PRD000053;PRD000668;PRD000059;PXD000529;PXD001328;PXD000426;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000218;PXD000533;PXD000164;PRD000020;PRD000731;PXD001324;PRD000444;PRD000073;PRD000738;PRD000118	123						cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P35625	Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3)	TIMP3	P29400	Collagen alpha-5(IV) chain	COL4A5	0.47	3	PXD000746;PRD000269;PXD000743	12						extracellular region [GO:0005576]	
Q96E09	Protein FAM122A	FAM122A	Q9P1Y6	PHD and RING finger domain-containing protein 1	PHRF1	0.4	3	PXD000948;PXD000218;PXD000314	13							
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	0.48	31	PRD000345;PRD000565;PXD000426;PRD000053;PRD000443;PXD000948;PXD000529;PRD000444;PXD000387;PRD000154;PXD001422;PRD000668;PRD000711;PRD000597;PRD000407;PRD000594;PXD001323;PRD000607;PRD000092;PRD000001;PXD000218;PXD001310;PXD001324;PRD000146;PXD000593;PXD000997;PXD001328;PXD001572;PRD000032;PXD000164;PXD000533	146	EBI-16727444;EBI-2638686;EBI-2296802	2338286;1259736;925965;740964;736733;288847	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];scaRNA localization to Cajal body [GO:0090666];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase activity [GO:0051973];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];ubiquitin protein ligase binding [GO:0031625];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	0.51	30	PXD000948;PRD000565;PXD000426;PRD000443;PXD000529;PRD000053;PXD000387;PRD000345;PRD000154;PXD000593;PRD000668;PRD000711;PRD000597;PRD000407;PXD001323;PRD000607;PRD000032;PRD000092;PXD000218;PXD001310;PXD000217;PRD000146;PXD000997;PRD000444;PRD000594;PXD001422;PXD001328;PRD000167;PXD001572;PRD000738	127	EBI-2638686	2257495;1259805;925967;740791;288852		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	0.5	35	PRD000733;PRD000345;PRD000565;PXD000948;PRD000053;PRD000443;PXD000529;PXD000387;PXD001328;PRD000154;PXD001422;PRD000711;PRD000597;PXD000426;PRD000407;PXD000593;PXD001323;PRD000607;PRD000594;PRD000032;PRD000092;PRD000001;PXD000217;PXD000218;PXD000314;PXD001310;PXD001324;PRD000146;PXD000997;PRD000444;PXD001572;PXD000164;PXD000533;PRD000738;PRD000068	147	EBI-2638686	1273200;925966;740965;288849	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];scaRNA localization to Cajal body [GO:0090666];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase activity [GO:0051973];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	0.47	34	PRD000733;PXD000426;PRD000443;PXD000948;PRD000053;PXD000529;PXD000387;PRD000345;PRD000092;PRD000154;PXD001422;PRD000668;PRD000711;PRD000597;PRD000407;PXD000593;PXD001323;PRD000607;PRD000032;PRD000001;PXD000217;PRD000565;PXD000218;PXD001310;PXD001324;PRD000146;PXD000997;PRD000444;PRD000594;PXD001328;PXD001572;PXD000164;PXD000533;PRD000738	149	EBI-2638686	1259820;740988;288853	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.47	29	PRD000345;PRD000032;PXD000426;PRD000053;PRD000443;PXD000948;PXD000529;PXD001310;PRD000092;PXD000387;PXD000593;PRD000154;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000001;PRD000565;PXD000218;PXD001324;PRD000444;PXD001422;PXD001328;PXD001572;PXD000533;PXD000997;PRD000407	126	EBI-2638686;EBI-2296802	1273201;740790;288850	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P17987	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)	TCP1	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.45	35	PRD000733;PRD000345;PXD000948;PRD000053;PRD000443;PXD000529;PXD001310;PRD000092;PRD000444;PXD000387;PXD000426;PRD000154;PXD001422;PRD000711;PRD000597;PRD000032;PRD000416;PRD000407;PXD000593;PRD000594;PXD001323;PRD000607;PRD000417;PXD000533;PRD000001;PRD000565;PXD001324;PRD000146;PXD000218;PXD000997;PRD000269;PRD000167;PXD001328;PXD001572;PRD000738	157	EBI-11567552;EBI-2638686	2245792;1273199;920593;740966;288848	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	O43353	Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)	RIPK2	0.4	2	PRD000032;PXD000533	75						cytoplasm [GO:0005737]	ATP binding [GO:0005524];non-membrane spanning protein tyrosine kinase activity [GO:0004715]
P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	Q05397	Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)	PTK2	0.4	2	PRD000032;PXD000533	80					establishment of cell polarity [GO:0030010];microtubule cytoskeleton organization [GO:0000226]	nucleus [GO:0005634];cytoplasm [GO:0005737]	ATP binding [GO:0005524];non-membrane spanning protein tyrosine kinase activity [GO:0004715];protein tyrosine kinase activity [GO:0004713]
P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	P45983	Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1)	MAPK8	0.4	2	PRD000032;PXD000533	86						nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737]	ATP binding [GO:0005524];kinase activity [GO:0016301]
P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	Q7KZI7	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)	MARK2	0.43	2	PRD000032;PXD000533	87					establishment of cell polarity [GO:0030010]	nucleoplasm [GO:0005654];cytoplasm [GO:0005737]	ATP binding [GO:0005524];magnesium ion binding [GO:0000287]
P30291	Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase)	WEE1	Q13554	Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17)	CAMK2B	0.4	1	PRD000032	88						nucleoplasm [GO:0005654];cytoplasm [GO:0005737]	ATP binding [GO:0005524]
Q96CN7	Isochorismatase domain-containing protein 1	ISOC1	Q96AB3	Isochorismatase domain-containing protein 2	ISOC2	0.53	5	PRD000345;PRD000443;PXD001324;PXD001422;PRD000053	52					metabolic process [GO:0008152]	cytoplasm [GO:0005737]	catalytic activity [GO:0003824]
Q96CN7	Isochorismatase domain-containing protein 1	ISOC1	Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	0.56	3	PRD000345;PRD000443;PXD001422	47						cytoplasm [GO:0005737]	
Q96CN7	Isochorismatase domain-containing protein 1	ISOC1	P30837	Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)	ALDH1B1	0.4	5	PRD000345;PRD000443;PXD001324;PXD001422;PRD000053	48							
Q96CN7	Isochorismatase domain-containing protein 1	ISOC1	Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	0.45	4	PRD000345;PXD000426;PXD001572;PXD001422	44							
Q96CN7	Isochorismatase domain-containing protein 1	ISOC1	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.4	4	PRD000345;PXD001324;PRD000020;PRD000053	39							
P01833	Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component]	PIGR	P98088	Mucin-5AC (MUC-5AC) (Gastric mucin) (Lewis B blood group antigen) (LeB) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)	MUC5AC	0.42	4	PXD000164;PRD000212;PRD000146;PRD000796	11						extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	
P01834	Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)		P01859	Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)	IGHG2	0.4	30	PRD000073;PRD000417;PXD000743;PRD000738;PXD000746;PXD000383;PRD000416;PRD000185;PRD000269;PRD000053;PXD001422;PRD000796;PRD000164;PXD000164;PRD000059;PRD000212;PXD001403;PXD000412;PRD000631;PRD000151;PXD001324;PXD000765;PRD000671;PRD000551;PRD000146;PRD000113;PRD000362;PRD000019;PXD001447;PRD000364	145				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01834	Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)		P01857	Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)	IGHG1	0.41	35	PRD000073;PXD000746;PXD000743;PRD000738;PRD000417;PXD000383;PRD000416;PRD000185;PRD000269;PRD000053;PXD000164;PXD001422;PRD000796;PRD000164;PXD000050;PXD000047;PRD000059;PRD000607;PRD000212;PXD001403;PXD000412;PRD000631;PRD000151;PXD001174;PXD001324;PXD000765;PRD000671;PRD000551;PRD000146;PRD000113;PRD000362;PRD000118;PRD000019;PXD001447;PRD000364	163	EBI-1222317;EBI-8592728;EBI-7491650			R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01834	Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)		P0CG04	Immunoglobulin lambda constant 1 (Ig lambda chain C region MGC) (Ig lambda-1 chain C region)		0.4	31	PRD000073;PXD000743;PRD000738;PRD000668;PXD000746;PRD000417;PXD000383;PRD000416;PRD000269;PRD000053;PRD000185;PXD000164;PXD001422;PRD000796;PXD000047;PRD000164;PRD000059;PRD000212;PXD001403;PXD000412;PRD000631;PRD000151;PXD001174;PXD001324;PXD000765;PRD000671;PRD000551;PRD000146;PRD000113;PRD000019;PRD000364	125				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];regulation of complement activation [GO:0030449];defense response to bacterium [GO:0042742];Fc-epsilon receptor signaling pathway [GO:0038095];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871];leukocyte migration [GO:0050900]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576];plasma membrane [GO:0005886]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01834	Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI)		B9A064	Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1)	IGLL5	0.42	31	PRD000073;PXD000743;PRD000738;PRD000668;PXD000746;PRD000417;PXD000383;PRD000416;PRD000269;PRD000053;PRD000185;PXD000164;PXD001422;PRD000796;PXD000047;PRD000164;PRD000059;PRD000212;PXD001403;PXD000412;PRD000631;PRD000151;PXD001174;PXD001324;PXD000765;PRD000671;PRD000551;PRD000146;PRD000113;PRD000019;PRD000364	125					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A6NNZ2	Tubulin beta-8 chain-like protein LOC260334	TUBB8P12	Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	0.48	58	PRD000020;PRD000345;PRD000032;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000167;PRD000443;PXD000948;PXD001310;PXD000593;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PXD000529;PRD000154;PRD000465;PRD000733;PRD000146;PXD000047;PRD000711;PRD000597;PRD000407;PRD000600;PRD000594;PXD001323;PRD000607;PRD000073;PXD000997;PXD000426;PRD000565;PRD000068;PRD000151;PRD000001;PXD000217;PXD000218;PRD000234;PRD000731;PRD000168;PRD000796;PRD000671;PXD001324;PRD000444;PRD000523;PRD000535;PRD000118;PXD001447;PRD000364;PXD000164;PXD000533;PRD000680;PXD000786;PXD000226;PRD000108	275				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
A6NNZ2	Tubulin beta-8 chain-like protein LOC260334	TUBB8P12	Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	0.42	57	PRD000020;PRD000345;PRD000032;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000167;PRD000443;PXD000948;PXD001310;PXD000593;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PXD000529;PRD000154;PRD000465;PRD000733;PRD000146;PXD000047;PXD001323;PRD000711;PXD001447;PRD000597;PRD000407;PRD000600;PRD000594;PRD000607;PXD000997;PXD000426;PRD000565;PRD000068;PRD000151;PRD000001;PXD000217;PRD000234;PRD000731;PRD000168;PRD000796;PRD000671;PRD000680;PXD001324;PXD000218;PXD000226;PRD000444;PRD000523;PRD000535;PRD000118;PRD000364;PXD000164;PXD000533;PRD000073;PRD000108	280				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q8NHW5	60S acidic ribosomal protein P0-like (Large ribosomal subunit protein uL10-like)		P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	0.4	33	PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PRD000269;PXD000387;PRD000345;PXD000997;PXD001572;PXD001422;PRD000796;PXD000050;PXD000426;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PRD000565;PRD000020;PXD000218;PXD000593;PRD000671;PRD000146;PRD000444;PRD000032;PXD001447;PRD000600;PXD000533;PXD000964	120						ribosome [GO:0005840]	
Q8TDI0	Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.12) (ATP-dependent helicase CHD5)	CHD5	Q13330	Metastasis-associated protein MTA1	MTA1	0.43	5	PRD000565;PRD000345;PXD000529;PXD000533;PXD001572	10		1264974;1241841			transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634];nucleoplasm [GO:0005654];cytosol [GO:0005829];NuRD complex [GO:0016581]	
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	0.42	10	PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000113	27				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.44	11	PRD000671;PRD000631;PXD000383;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	0.42	12	PRD000671;PRD000631;PXD000383;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PRD000185;PXD000164;PXD001422	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	0.51	8	PRD000671;PXD000383;PXD000743;PRD000551;PRD000019;PRD000053;PXD001403;PXD000164	26				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	0.48	11	PRD000671;PRD000631;PXD000383;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	0.41	6	PXD000743;PXD000383;PRD000551;PXD000164;PRD000631;PXD001403	23					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.49	11	PRD000671;PRD000631;PXD000383;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	0.57	8	PRD000671;PXD000383;PXD000743;PRD000551;PRD000212;PRD000053;PXD001403;PXD000164	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.42	5	PXD000383;PXD001403;PXD001422;PRD000212;PXD000743	17					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.4	3	PXD000383;PXD001403;PRD000212	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01624	Immunoglobulin kappa variable 3-15 (Ig kappa chain V-III region CLL) (Ig kappa chain V-III region POM)	IGKV3-15	0.4	10	PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001403;PXD001422;PRD000113;PXD000164;PRD000212	27				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.4	3	PXD000383;PXD001403;PXD000743	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.41	8	PRD000631;PXD000383;PXD000743;PRD000019;PRD000053;PXD001403;PRD000551;PXD000164	25				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.42	7	PXD000383;PRD000671;PXD000743;PRD000551;PXD001403;PXD001422;PXD000164	27				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.4	3	PXD000383;PXD001403;PRD000671	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.43	8	PXD000743;PRD000671;PXD000383;PRD000551;PRD000212;PXD001403;PXD000164;PRD000631	31				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.41	11	PRD000671;PRD000631;PXD000383;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.45	5	PXD000383;PXD001403;PXD001422;PRD000212;PXD000743	16					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.4	4	PXD000383;PRD000671;PXD001403;PXD001422	18					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.4	4	PXD000383;PXD000164;PRD000073;PXD000743	16					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01714	Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH)	IGLV3-19	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.41	11	PXD000743;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PRD000053;PXD001403;PRD000073;PXD000164;PXD001422	34					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	0.43	13	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000416;PRD000269;PXD001174	33					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	0.46	1	PXD000383	11						extracellular region [GO:0005576]	
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	0.42	6	PXD000383;PRD000417;PRD000671;PXD001403;PXD001422;PRD000416	18					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.49	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	0.44	14	PRD000417;PRD000631;PRD000671;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PRD000185;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	0.42	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.48	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.48	15	PRD000417;PRD000631;PRD000671;PXD000383;PRD000269;PRD000551;PRD000212;PXD001403;PRD000053;PRD000185;PXD000164;PXD001422;PRD000059;PRD000416;PXD001174	39				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	0.43	11	PRD000631;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000113;PRD000019	34					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.42	12	PRD000417;PRD000631;PRD000671;PXD000383;PRD000212;PXD001403;PXD000164;PXD001422;PRD000113;PRD000416;PRD000269;PXD001174	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	0.43	11	PRD000631;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000113;PRD000019	34					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.42	13	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000416;PRD000269;PXD001174	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.48	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	0.43	2	PXD000383;PRD000631	14						extracellular region [GO:0005576]	
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.48	6	PXD000383;PRD000671;PXD000164;PXD001403;PXD001422;PRD000212	17					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.51	3	PXD000383;PXD001403;PRD000212	16					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.44	16	PRD000417;PRD000631;PRD000671;PXD000383;PRD000269;PRD000551;PRD000212;PXD001403;PRD000053;PRD000185;PXD000164;PXD001422;PRD000059;PRD000113;PRD000416;PXD001174	38				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.41	12	PRD000417;PRD000631;PRD000671;PXD000383;PRD000212;PXD001403;PRD000053;PRD000185;PXD000164;PXD001422;PRD000416;PXD001174	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.41	3	PXD000383;PRD000631;PRD000053	14						extracellular region [GO:0005576]	
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.47	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.43	10	PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000113;PRD000019	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.48	8	PXD000383;PRD000417;PRD000671;PRD000019;PXD001403;PXD001422;PRD000416;PRD000113	19					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.47	10	PRD000417;PXD000383;PRD000671;PRD000631;PRD000551;PXD001403;PXD001422;PRD000059;PRD000416;PRD000019	23				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.45	14	PRD000417;PRD000631;PRD000671;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059;PRD000416;PRD000269;PXD001174	38				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.48	13	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PRD000416;PXD001174;PRD000019	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.47	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD001422;PRD000059;PRD000416;PXD001174;PRD000019	32				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.49	6	PXD000383;PRD000417;PRD000671;PXD001403;PXD001422;PXD001174	20					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01717	Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil)	IGLV3-25	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.49	11	PRD000417;PRD000631;PRD000671;PXD000383;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000416;PXD001174	30					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	0.45	26	PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD000387;PXD000593;PXD001328;PXD001572;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PXD000426;PRD000565;PXD000217;PXD000218;PRD000146;PRD000020;PRD000444;PRD000345;PRD000671	98		1271184;741495	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	0.44	27	PRD000020;PRD000733;PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD001328;PXD000426;PXD001572;PXD001422;PRD000146;PXD000047;PXD000948;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000680;PXD000997;PXD000217;PRD000565;PXD000218;PRD000444;PRD000671;PRD000345	94	EBI-776423	1270214;741470	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	focal adhesion [GO:0005925];nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	RNA binding [GO:0003723];structural constituent of ribosome [GO:0003735];DNA binding [GO:0003677]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	0.4	24	PRD000020;PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD001572;PXD001422;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PXD000217;PRD000565;PXD000218;PRD000444;PXD000593;PRD000345;PRD000671	92		1270776	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	0.43	25	PRD000020;PRD000668;PRD000443;PRD000053;PXD000948;PXD000529;PXD001310;PXD000387;PXD000593;PXD001328;PXD001572;PXD001422;PXD000047;PRD000711;PRD000597;PRD000671;PRD000594;PXD001323;PRD000680;PRD000565;PXD000218;PRD000146;PXD000997;PRD000444;PRD000345	93		1270225;742372	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];mRNA binding [GO:0003729];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	0.46	27	PRD000565;PRD000020;PRD000733;PRD000443;PRD000053;PXD000529;PXD001310;PXD000426;PXD001572;PXD001422;PRD000668;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PXD000217;PXD000218;PXD000593;PRD000180;PRD000444;PRD000345;PRD000671	98		1270230;742557	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P26373	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13	0.46	26	PRD000565;PRD000020;PRD000733;PXD000743;PRD000443;PRD000053;PXD001310;PXD001328;PXD001572;PXD001422;PRD000668;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PXD000218;PXD000593;PRD000444;PRD000345;PXD000047;PRD000410;PRD000407	90		1270200;742791	5380;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];nucleolus [GO:0005730];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.42	26	PRD000020;PRD000733;PRD000668;PRD000443;PRD000053;PXD001310;PXD001572;PXD001422;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PRD000565;PXD000217;PXD000426;PRD000146;PRD000444;PXD000593;PRD000671;PRD000410;PRD000345;PRD000407	92	EBI-8459929;EBI-8440340;EBI-8429350;EBI-8419242;EBI-8412660;EBI-8408168;EBI-8401905;EBI-8392519;EBI-8387620;EBI-8383997;EBI-8357768;EBI-8354201;EBI-8350757;EBI-8328780;EBI-8312518	1270201;742083	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	cytosol [GO:0005829];nucleolus [GO:0005730];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	0.45	24	PRD000565;PRD000733;PRD000053;PXD000529;PXD001310;PXD001328;PXD001572;PXD001422;PRD000668;PRD000146;PXD000948;PXD000047;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000680;PXD000997;PXD000218;PXD000426;PRD000180;PRD000444;PRD000671	88		1270254;741471	5380;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.4	25	PRD000053;PRD000565;PXD000426;PRD000345;PXD001310;PXD000529;PXD000948;PRD000444;PRD000594;PXD001323;PRD000668;PRD000443;PXD000593;PRD000597;PRD000680;PRD000146;PXD000997;PRD000410;PXD000387;PXD001328;PXD001572;PXD001422;PXD000218;PRD000407;PRD000711	81		1271131;741488	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];nucleus [GO:0005634]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P46777	60S ribosomal protein L5 (Large ribosomal subunit protein uL18)	RPL5	0.42	23	PRD000053;PXD000218;PRD000565;PXD000426;PRD000345;PXD001310;PRD000020;PRD000733;PRD000444;PRD000594;PXD001323;PRD000668;PXD000948;PXD000529;PRD000146;PXD000997;PXD000593;PXD001328;PXD001572;PXD001422;PXD000047;PRD000711;PRD000597	73		1270142;741469	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];ribosomal large subunit biogenesis [GO:0042273]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P62753	40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)	RPS6	0.41	24	PRD000053;PRD000565;PXD001323;PXD001310;PXD000529;PRD000733;PRD000444;PXD000593;PRD000594;PRD000443;PXD000948;PRD000146;PXD000997;PXD001328;PRD000671;PXD001572;PXD001422;PXD000218;PRD000345;PXD000217;PXD000047;PRD000711;PRD000597;PRD000668	74	EBI-16798663	1271281;741498	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];nucleolus [GO:0005730];ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.42	29	PRD000020;PXD000948;PXD000743;PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD000593;PXD001328;PXD001422;PRD000733;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000997;PRD000565;PXD000217;PXD000218;PRD000444;PRD000345;PXD000426;PXD001572;PRD000671;PRD000410	115		1270229;741553	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723];mRNA binding [GO:0003729];DNA binding [GO:0003677]
P18124	60S ribosomal protein L7 (Large ribosomal subunit protein uL30)	RPL7	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.4	24	PRD000020;PXD000948;PRD000443;PXD000529;PXD001310;PRD000053;PXD001328;PXD001572;PXD001422;PRD000146;PXD000047;PRD000711;PRD000597;PRD000407;PRD000594;PXD001323;PRD000680;PXD000997;PRD000565;PXD000217;PXD000218;PXD000593;PRD000733;PRD000444	90		1270213;741545	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.48	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99878	Histone H2A type 1-J (Histone H2A/e)	HIST1H2AJ	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96AB3	Isochorismatase domain-containing protein 2	ISOC2	Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	0.51	3	PRD000345;PRD000032;PRD000443	47						nucleus [GO:0005634];cytoplasm [GO:0005737]	
Q96AB3	Isochorismatase domain-containing protein 2	ISOC2	Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	0.41	3	PRD000345;PRD000711;PXD001323	42							
Q9UIA9	Exportin-7 (Exp7) (Ran-binding protein 16)	XPO7	P45974	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5	0.45	8	PXD000529;PRD000154;PRD000053;PXD000426;PXD001422;PXD001572;PRD000345;PXD000533	20							
Q9UIA9	Exportin-7 (Exp7) (Ran-binding protein 16)	XPO7	O14980	Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog)	XPO1	0.41	12	PRD000154;PRD000032;PRD000168;PRD000092;PRD000671;PXD000948;PXD000529;PXD000426;PXD001572;PXD001422;PXD000533;PRD000345	28		1274606;746834			protein export from nucleus [GO:0006611];mRNA transport [GO:0051028]	nucleus [GO:0005634];cytoplasm [GO:0005737]	nuclear export signal receptor activity [GO:0005049];Ran GTPase binding [GO:0008536]
P18669	Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)	PGAM1	P52565	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA	0.4	33	PXD000948;PRD000059;PRD000053;PRD000668;PRD000417;PXD000529;PXD000387;PXD000426;PXD000164;PXD001422;PRD000796;PRD000465;PRD000146;PRD000416;PRD000269;PRD000711;PRD000597;PRD000477;PRD000092;PRD000594;PXD001323;PRD000020;PXD001403;PXD000217;PXD000218;PRD000731;PXD001324;PRD000444;PXD001328;PRD000118;PXD001572;PXD000533;PRD000738	142						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P18669	Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B)	PGAM1	O00299	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)	CLIC1	0.44	33	PXD000948;PRD000059;PRD000053;PRD000668;PRD000417;PXD000529;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000269;PRD000465;PRD000146;PRD000597;PRD000416;PRD000594;PRD000711;PXD001323;PRD000046;PXD001403;PXD000217;PXD000314;PRD000731;PXD000426;PXD001324;PXD000218;PRD000020;PRD000345;PRD000118;PXD001572;PXD000533;PRD000738	144						nucleus [GO:0005634];cytoplasm [GO:0005737];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P61020	Ras-related protein Rab-5B	RAB5B	0.4	18	PRD000600;PRD000711;PRD000053;PRD000154;PRD000092;PXD001323;PRD000668;PXD001324;PRD000001;PXD000529;PXD001572;PRD000738;PRD000407;PXD000948;PRD000269;PRD000733;PXD001422;PRD000146	60				R-HSA-8876198;R-HSA-8873719;R-HSA-8854214;R-HSA-6798695	antigen processing and presentation [GO:0019882];protein transport [GO:0015031];neutrophil degranulation [GO:0043312]	secretory granule membrane [GO:0030667];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];membrane [GO:0016020]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P07203	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	0.41	11	PRD000053;PRD000154;PXD001323;PRD000668;PRD000738;PRD000092;PRD000733;PXD001324;PRD000001;PXD001572;PXD001422	44						cytosol [GO:0005829]	
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P61019	Ras-related protein Rab-2A	RAB2A	0.42	18	PRD000020;PRD000733;PRD000053;PRD000711;PRD000092;PXD001323;PRD000668;PXD001324;PRD000001;PRD000146;PXD000529;PRD000154;PXD000164;PRD000796;PRD000738;PXD001422;PXD001572;PRD000597	53		1268571		R-HSA-8873719	protein transport [GO:0015031]	Golgi apparatus [GO:0005794];Golgi membrane [GO:0000139];cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.43	21	PRD000600;PRD000053;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PXD001323;PRD000668;PRD000146;PXD001324;PRD000001;PXD000529;PXD001572;PXD000164;PRD000345;PRD000407;PRD000597;PRD000269;PRD000733;PXD001422	67		1268474		R-HSA-8873719;R-HSA-8854214		cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	0.41	21	PRD000053;PRD000711;PRD000154;PXD001323;PRD000092;PRD000668;PRD000738;PRD000607;PRD000733;PXD001324;PXD000529;PRD000600;PXD001572;PXD000164;PRD000796;PRD000068;PRD000345;PXD000948;PRD000597;PRD000269;PXD001422	65				R-HSA-6798695	neutrophil degranulation [GO:0043312]	cytosol [GO:0005829];trans-Golgi network [GO:0005802];endoplasmic reticulum membrane [GO:0005789];membrane [GO:0016020];secretory granule membrane [GO:0030667];Golgi membrane [GO:0000139];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.4	16	PRD000269;PRD000053;PRD000711;PRD000154;PXD001323;PRD000668;PRD000738;PRD000092;PRD000607;PRD000733;PRD000001;PXD001572;PXD000529;PXD000164;PXD001422;PRD000068	59						plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.4	22	PRD000020;PRD000600;PRD000053;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PRD000443;PRD000607;PXD001324;PXD000529;PXD001572;PXD000164;PRD000738;PRD000001;PRD000407;PXD000948;PRD000269;PRD000733;PXD001422;PRD000146	66				R-HSA-8876198;R-HSA-8873719;R-HSA-8854214;R-HSA-6798695	protein transport [GO:0015031];neutrophil degranulation [GO:0043312]	plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P20339	Ras-related protein Rab-5A	RAB5A	0.41	18	PRD000600;PRD000711;PRD000053;PRD000154;PRD000092;PXD001323;PRD000668;PXD001324;PXD000529;PXD001572;PRD000738;PRD000001;PRD000407;PXD000948;PRD000269;PRD000733;PXD001422;PRD000146	57				R-HSA-8876198;R-HSA-8873719;R-HSA-8854214	protein transport [GO:0015031]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.42	14	PRD000020;PRD000733;PRD000053;PRD000711;PRD000154;PXD001323;PRD000668;PRD000092;PXD001324;PRD000001;PXD000529;PRD000796;PXD001422;PXD001572	46				R-HSA-8873719	protein transport [GO:0015031]	Golgi membrane [GO:0000139];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];endoplasmic reticulum membrane [GO:0005789]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P20340	Ras-related protein Rab-6A (Rab-6)	RAB6A	P61106	Ras-related protein Rab-14	RAB14	0.4	14	PRD000053;PRD000154;PXD001323;PRD000711;PRD000738;PRD000733;PXD001324;PRD000001;PXD000529;PXD000164;PRD000668;PXD001572;PRD000407;PXD001422	43				R-HSA-8876198;R-HSA-8873719;R-HSA-6798695	protein transport [GO:0015031];neutrophil degranulation [GO:0043312]	trans-Golgi network [GO:0005802];Golgi membrane [GO:0000139];plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];myosin V binding [GO:0031489];GTP binding [GO:0005525]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	0.41	18	PRD000073;PRD000059;PXD000743;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001174;PXD001403;PRD000631;PXD001324;PXD000765;PRD000551;PRD000158;PRD000362;PRD000019;PRD000113	140				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	0.4	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD000412;PRD000551;PRD000158;PRD000019;PXD000743	117						extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	heparin binding [GO:0008201];serine-type endopeptidase inhibitor activity [GO:0004867]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	0.43	21	PRD000073;PRD000059;PXD000743;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PRD000711;PRD000172;PXD001174;PXD001403;PRD000417;PRD000631;PXD001324;PRD000269;PRD000551;PRD000146;PRD000158;PRD000362;PRD000113	146						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.51	16	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000711;PRD000172;PXD001403;PRD000631;PXD000412;PRD000417;PXD001324;PRD000551;PRD000158;PRD000362	134						extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	0.44	13	PRD000073;PRD000059;PRD000185;PXD000383;PXD000164;PXD001403;PRD000711;PRD000172;PXD000743;PRD000631;PXD001324;PRD000551;PRD000158	108						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	0.46	17	PRD000073;PRD000059;PXD000743;PRD000185;PXD000383;PXD000164;PRD000711;PRD000172;PXD001403;PRD000053;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362;PRD000108;PRD000019	121				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.43	19	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PRD000711;PRD000172;PXD001174;PXD000743;PRD000631;PXD001324;PRD000551;PRD000146;PRD000158;PRD000362;PRD000019;PRD000113	119				R-HSA-140837		extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.45	15	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001174;PXD001403;PRD000631;PXD001324;PXD000765;PRD000551;PRD000158;PRD000362	127						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P06727	Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)	APOA4	0.41	17	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PRD000172;PXD000743;PRD000631;PXD000412;PXD001324;PRD000551;PRD000113;PRD000158;PRD000362;PRD000019	126					cellular protein metabolic process [GO:0044267]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	identical protein binding [GO:0042802]
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.48	20	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PRD000711;PRD000172;PXD000765;PXD001174;PXD001403;PRD000417;PRD000631;PXD001324;PRD000269;PRD000551;PRD000146;PRD000158;PRD000362	142						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01008	Antithrombin-III (ATIII) (Serpin C1)	SERPINC1	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.43	17	PRD000073;PRD000059;PXD000743;PRD000185;PXD000383;PXD000164;PRD000711;PRD000172;PXD001403;PRD000417;PRD000631;PRD000269;PRD000416;PRD000551;PRD000146;PRD000158;PRD000362	126						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P08708	40S ribosomal protein S17 (Small ribosomal subunit protein eS17)	RPS17	P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	0.41	25	PXD000948;PXD000218;PRD000345;PXD001310;PRD000053;PRD000444;PRD000594;PXD001323;PRD000668;PRD000443;PXD000217;PRD000146;PRD000733;PXD000529;PXD000997;PRD000600;PXD001572;PRD000234;PXD000533;PRD000796;PXD000593;PRD000465;PRD000711;PRD000597;PXD001422	67		743374	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P08708	40S ribosomal protein S17 (Small ribosomal subunit protein eS17)	RPS17	P32969	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9	0.4	21	PXD000948;PRD000345;PXD001310;PRD000053;PRD000444;PRD000594;PXD001323;PRD000565;PXD000529;PRD000146;PXD000218;PXD000997;PXD000387;PRD000600;PRD000671;PXD001572;PXD000533;PXD000593;PRD000711;PRD000597;PXD001422	56	EBI-17171503	742859	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];ribosome [GO:0005840];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P02763	Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)	ORM1	P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	0.44	15	PRD000073;PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000118;PXD000164;PRD000212;PXD001403;PXD000412;PRD000417;PRD000551;PRD000158;PXD000743	105				R-HSA-114608	platelet degranulation [GO:0002576]	extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02763	Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)	ORM1	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.42	15	PRD000073;PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PXD001174;PRD000212;PXD001324;PXD000765;PRD000551;PRD000158;PRD000362	113				R-HSA-6798695;R-HSA-114608	platelet degranulation [GO:0002576];neutrophil degranulation [GO:0043312]	extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093]	
P02763	Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1)	ORM1	P19652	Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2)	ORM2	0.4	15	PXD000383;PRD000073;PRD000158;PRD000631;PRD000362;PXD000765;PRD000417;PRD000059;PRD000416;PRD000551;PRD000053;PRD000212;PXD001403;PXD001174;PXD000164	82		2218908		R-HSA-6798695;R-HSA-114608	positive regulation of interleukin-1 secretion [GO:0050716];acute-phase response [GO:0006953];positive regulation of tumor necrosis factor secretion [GO:1904469];positive regulation of interleukin-1 beta secretion [GO:0050718];platelet degranulation [GO:0002576];regulation of immune system process [GO:0002682];neutrophil degranulation [GO:0043312]	specific granule lumen [GO:0035580];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093]	
A0A0C4DH41	Immunoglobulin heavy variable 4-61	IGHV4-61	P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	0.41	5	PXD000383;PRD000417;PRD000416;PXD001403;PRD000146	19					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0C4DH41	Immunoglobulin heavy variable 4-61	IGHV4-61	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.42	10	PRD000417;PRD000059;PRD000631;PXD000383;PXD000743;PRD000019;PRD000146;PXD001403;PRD000053;PRD000416	27					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH41	Immunoglobulin heavy variable 4-61	IGHV4-61	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.42	4	PXD000383;PXD001403;PXD001422;PXD000743	15							antigen binding [GO:0003823]
Q92769	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	O60341	Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)	KDM1A	0.43	7	PRD000345;PRD000407;PRD000565;PXD000680;PXD000948;PXD000529;PXD000533	49	EBI-6597828;EBI-3505117;EBI-3505059;EBI-2461848;EBI-2461830;EBI-2461776	1262928;871952;832467;832428;676547;645070;569528;547241;511200;511196;483933;262274;260608;260603;260588;244103	1257;871;642;636;634;633;632;620;614	R-HSA-983231;R-HSA-8943724;R-HSA-3214815	negative regulation of DNA binding transcription factor activity [GO:0043433];negative regulation of transcription by RNA polymerase II [GO:0000122];positive regulation of transcription by RNA polymerase II [GO:0045944];negative regulation of DNA binding [GO:0043392];transcription, DNA-templated [GO:0006351];blood coagulation [GO:0007596];negative regulation of transcription, DNA-templated [GO:0045892]	nucleus [GO:0005634];nucleoplasm [GO:0005654];nuclear chromatin [GO:0000790];protein-containing complex [GO:0032991]	transcription factor binding [GO:0008134];chromatin binding [GO:0003682];enzyme binding [GO:0019899];histone deacetylase activity [GO:0004407]
Q92769	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	0.54	7	PRD000345;PRD000443;PXD000948;PXD000680;PXD000533;PXD001572;PRD000407	52	EBI-6260872;EBI-298035;EBI-630267;EBI-2461759;EBI-3505028;EBI-3505059;EBI-6593231;EBI-6597549;EBI-6597828;EBI-9006985;EBI-9006952;EBI-11132348;EBI-15667567	2230891;1504745;1444793;1262927;1035547;882688;882686;871947;871865;832438;244099;255647;255666;260591;260829;260844;260855;261565;261567;261744;262199;262275;262281;262335;262336;262445;263897;263900;467847;467849;485692;485693;485694;502888;511162;511468;511469;514073;516174;516194;534510;569432;569451;669516;669517;676512;740754;832406	6421;6373;3167;2851;2814;2721;1505;1257;888;871;778;749;743;739;738;732;714;696;685;642;636;634;633;632;620;614;282;61	R-HSA-983231;R-HSA-8943724;R-HSA-73762;R-HSA-6804758;R-HSA-4551638;R-HSA-427413;R-HSA-427389;R-HSA-3214815;R-HSA-2894862;R-HSA-2644606;R-HSA-2122947;R-HSA-193670	odontogenesis of dentin-containing tooth [GO:0042475];eyelid development in camera-type eye [GO:0061029];ATP-dependent chromatin remodeling [GO:0043044];negative regulation of transcription by RNA polymerase II [GO:0000122];negative regulation of apoptotic process [GO:0043066];positive regulation of transcription by RNA polymerase II [GO:0045944];circadian regulation of gene expression [GO:0032922];hair follicle placode formation [GO:0060789];chromatin remodeling [GO:0006338];positive regulation of transcription, DNA-templated [GO:0045893];histone H3 deacetylation [GO:0070932];transcription, DNA-templated [GO:0006351];positive regulation of cell proliferation [GO:0008284];blood coagulation [GO:0007596];positive regulation of receptor biosynthetic process [GO:0010870];histone H4 deacetylation [GO:0070933];negative regulation of transcription, DNA-templated [GO:0045892];embryonic digit morphogenesis [GO:0042733];epidermal cell differentiation [GO:0009913];fungiform papilla formation [GO:0061198];histone deacetylation [GO:0016575]	nucleoplasm [GO:0005654];cytoplasm [GO:0005737];protein-containing complex [GO:0032991];Sin3 complex [GO:0016580];NuRD complex [GO:0016581];nucleus [GO:0005634];nuclear chromatin [GO:0000790]	histone deacetylase binding [GO:0042826];enzyme binding [GO:0019899];protein deacetylase activity [GO:0033558];RNA polymerase II repressing transcription factor binding [GO:0001103];NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041];deacetylase activity [GO:0019213];histone deacetylase activity [GO:0004407];NF-kappaB binding [GO:0051059];transcription factor binding [GO:0008134]
Q92769	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	0.4	4	PRD000345;PRD000711;PRD000443;PXD000529	47						nucleus [GO:0005634];cytoplasm [GO:0005737]	
Q92769	Histone deacetylase 2 (HD2) (EC 3.5.1.98)	HDAC2	Q14687	Genetic suppressor element 1	GSE1	0.45	2	PRD000345;PRD000407	34	EBI-6597828;EBI-3505059	871945;832426;260586	632;633				
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	0.45	30	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD000997;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000426;PXD000217;PRD000565;PRD000020;PXD000218;PRD000731;PRD000671;PRD000146;PRD000444;PXD000593;PRD000345;PRD000600;PXD000533;PXD000964	106		1270797;925230;728336	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	small ribosomal subunit [GO:0015935];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	0.46	30	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PRD000796;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PRD000565;PRD000020;PXD000218;PXD000593;PRD000671;PRD000146;PRD000444;PRD000345;PRD000269;PXD000533	99		1271197;925181;742461;728337	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	0.45	29	PRD000053;PRD000123;PRD000443;PXD000529;PXD001310;PRD000269;PXD000997;PXD001572;PXD001422;PRD000668;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PXD000426;PXD000217;PRD000565;PRD000020;PXD000218;PRD000731;PXD000593;PRD000671;PRD000146;PRD000444;PRD000345;PXD000964	105		1271412;925338;742576;728324	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	0.43	31	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PXD001323;PRD000607;PRD000680;PXD000948;PXD000217;PRD000020;PXD000218;PRD000731;PRD000671;PRD000565;PRD000146;PXD000997;PRD000032;PRD000444;PXD000593;PRD000345;PXD001447;PRD000600;PRD000594;PXD000533	91		1271195;924992;742454;728326	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	small ribosomal subunit [GO:0015935];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.43	28	PXD000426;PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PRD000565;PRD000020;PXD000218;PRD000146;PRD000444;PXD000593;PRD000345;PRD000600;PXD000533;PXD000964	97		1271363;925311;742533;728323	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	0.45	23	PRD000565;PRD000123;PXD000948;PRD000053;PXD000529;PXD001310;PXD001328;PXD001572;PXD001422;PRD000668;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000680;PXD000997;PXD000218;PRD000731;PXD000593;PRD000146;PRD000444;PXD000533	90		1271185;742445	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.47	32	PRD000345;PRD000123;PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD000387;PXD001328;PXD001572;PXD001422;PXD000050;PRD000711;PRD000597;PRD000269;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PXD000997;PRD000565;PXD000218;PXD000217;PXD000593;PRD000671;PRD000146;PRD000444;PXD000426;PRD000032;PRD000600;PXD000533	91		1271205;925232;741552	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.47	35	PXD000426;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001328;PXD000997;PXD001572;PXD001422;PRD000796;PXD000050;PRD000711;PRD000597;PRD000269;PRD000594;PXD001323;PRD000607;PRD000680;PRD000565;PXD000217;PRD000020;PXD000218;PRD000731;PXD001310;PXD000593;PRD000671;PRD000146;PRD000032;PRD000444;PRD000345;PXD001447;PRD000600;PXD000533;PXD000964	124		1271204;925220;742462;728338	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];polysome [GO:0005844];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62701	40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)	RPS4X	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.4	27	PRD000565;PRD000053;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PXD000997;PXD000217;PXD000218;PRD000731;PRD000671;PRD000146;PRD000032;PRD000444;PXD000593;PRD000345;PXD001447;PRD000600;PXD000533;PXD000964	94		1271196;925026;742455;728328	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P17858	ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)	PFKL	P46459	Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF)	NSF	0.48	14	PXD001328;PRD000053;PRD000154;PXD000426;PRD000594;PXD001323;PRD000671;PXD001572;PXD000529;PXD001422;PXD000050;PXD000948;PRD000092;PRD000711	33						cytosol [GO:0005829]	metal ion binding [GO:0046872];ATP binding [GO:0005524]
Q9BTC8	Metastasis-associated protein MTA3	MTA3	Q12873	Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)	CHD3	0.45	5	PRD000565;PRD000345;PXD000529;PXD000533;PXD000314	10	EBI-16878902	1264996;482553		R-HSA-3214815;R-HSA-427389;R-HSA-73762;R-HSA-8943724		nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];NuRD complex [GO:0016581]	zinc ion binding [GO:0008270];histone deacetylase activity [GO:0004407]
Q9BTC8	Metastasis-associated protein MTA3	MTA3	Q14687	Genetic suppressor element 1	GSE1	0.42	1	PRD000345	18		832487					
Q96N67	Dedicator of cytokinesis protein 7	DOCK7	Q14676	Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1)	MDC1	0.4	6	PXD000529;PXD000680;PXD001572;PXD000948;PRD000118;PXD000314	12						focal adhesion [GO:0005925]	
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q8IUE6	Histone H2A type 2-B	HIST2H2AB	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.47	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139		2216866		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q7L7L0	Histone H2A type 3	HIST3H2A	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P58876	Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b)	HIST1H2BD	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.44	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O76021	Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1)	RSL1D1	Q8IY81	pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3	0.41	11	PRD000118;PXD000047;PXD000964;PXD001572;PXD000426;PXD000533;PRD000146;PXD000593;PXD000218;PRD000597;PXD000314	19						nucleolus [GO:0005730]	RNA binding [GO:0003723]
O76021	Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1)	RSL1D1	P46087	Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	NOP2	0.44	15	PXD000593;PXD000218;PXD000680;PRD000146;PXD000426;PXD000997;PXD000314;PXD001572;PXD000529;PXD000533;PRD000118;PRD000565;PXD000047;PRD000597;PXD000964	26		749318			maturation of LSU-rRNA [GO:0000470]	nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q13131	5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26)	PRKAA1	Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)	CAMK2G	0.41	5	PRD000032;PXD001328;PXD001572;PRD000168;PXD000529	100						nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829]	ATP binding [GO:0005524]
Q14137	Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein)	BOP1	Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	0.44	8	PRD000565;PXD000047;PXD000426;PXD001572;PXD000533;PXD000529;PRD000597;PXD000593	12						nucleolus [GO:0005730]	RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	0.4	22	PRD000053;PXD001310;PRD000444;PRD000594;PXD001323;PRD000668;PRD000146;PRD000565;PXD000997;PRD000269;PRD000671;PXD001572;PRD000154;PXD000529;PXD000593;PXD000218;PRD000020;PRD000407;PRD000711;PRD000597;PXD001422;PRD000234	63		1270542;924870	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal small subunit assembly [GO:0000028];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];nucleoplasm [GO:0005654];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	0.45	24	PRD000053;PRD000731;PRD000345;PXD001310;PXD000948;PRD000444;PRD000594;PXD001323;PRD000668;PRD000146;PRD000565;PRD000234;PXD000426;PXD000997;PXD000529;PXD001572;PXD000593;PXD001422;PXD000218;PRD000020;PRD000407;PRD000711;PRD000597;PRD000733	70	EBI-11571853;EBI-11568224;EBI-11566286	1270536;924857;742159	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	0.43	23	PRD000053;PRD000600;PRD000345;PXD001310;PXD000948;PRD000444;PRD000594;PXD001323;PRD000668;PRD000443;PRD000565;PRD000733;PRD000146;PXD000997;PXD000529;PXD001572;PXD000593;PXD001422;PXD000218;PRD000020;PRD000407;PRD000711;PRD000597	68	EBI-8383997;EBI-8354201	1270540;924864;743275	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribosome [GO:0005840];nucleolus [GO:0005730];cytosol [GO:0005829];nucleoplasm [GO:0005654];cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.4	21	PRD000053;PRD000345;PXD001310;PXD000948;PRD000444;PRD000594;PRD000668;PRD000443;PRD000146;PRD000565;PXD000997;PXD000529;PXD001572;PXD000593;PXD001422;PXD000218;PXD001323;PXD000047;PRD000020;PRD000711;PRD000597	71		1271348;925300;743168	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.4	23	PRD000053;PXD001310;PRD000444;PRD000671;PRD000594;PXD001323;PRD000668;PRD000443;PRD000565;PXD000948;PRD000146;PXD000997;PRD000269;PXD000529;PXD001572;PXD001422;PXD000593;PRD000154;PXD000047;PRD000020;PRD000407;PRD000711;PRD000597	66		1270523	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleolus [GO:0005730];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	0.4	18	PRD000053;PXD001310;PRD000444;PRD000594;PXD001323;PRD000668;PRD000443;PRD000146;PXD000997;PXD000529;PXD001572;PXD000593;PXD001422;PXD000218;PXD000047;PRD000020;PRD000711;PXD000948	46	EBI-8586548	1270524	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.45	23	PRD000053;PRD000731;PXD001310;PRD000444;PRD000594;PRD000668;PRD000565;PXD000426;PRD000146;PXD000997;PXD000529;PRD000671;PXD001572;PXD000593;PXD001422;PXD000218;PXD001323;PXD000047;PXD000948;PRD000020;PRD000711;PRD000597;PRD000733	67		1270528	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.41	24	PRD000053;PRD000600;PRD000731;PRD000345;PXD001310;PRD000444;PRD000671;PRD000594;PRD000668;PRD000443;PRD000146;PRD000565;PXD000047;PXD000997;PRD000269;PXD001323;PXD001572;PRD000154;PXD000593;PXD001422;PRD000020;PRD000711;PRD000597;PXD000218	79		1269112;743408	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleolus [GO:0005730];cytosol [GO:0005829];nucleoplasm [GO:0005654];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.4	20	PRD000053;PXD001310;PRD000444;PRD000594;PXD001323;PRD000668;PRD000565;PRD000733;PRD000146;PXD000997;PRD000269;PXD001572;PXD000593;PXD001422;PXD000948;PXD000047;PRD000407;PRD000711;PRD000597;PXD000218	59		1270529	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46783	40S ribosomal protein S10 (Small ribosomal subunit protein eS10)	RPS10	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.44	24	PRD000053;PRD000600;PRD000731;PRD000345;PXD001310;PRD000444;PRD000594;PRD000668;PRD000671;PRD000146;PRD000565;PRD000733;PXD000948;PXD000997;PXD000529;PXD001323;PXD001572;PRD000154;PXD000593;PXD001422;PRD000407;PRD000711;PRD000597;PXD000218	77		1270538;925019;743305	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal small subunit assembly [GO:0000028];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	0.4	24	PRD000565;PXD001310;PRD000053;PXD000218;PRD000444;PXD000217;PXD001323;PRD000668;PRD000443;PRD000607;PXD000529;PRD000146;PXD000997;PRD000269;PRD000671;PXD001572;PRD000154;PXD000593;PRD000345;PRD000020;PRD000711;PRD000597;PXD001422;PRD000234	60		1271453;925248	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	0.4	22	PXD001310;PRD000053;PRD000444;PXD000217;PXD001323;PRD000668;PRD000443;PRD000680;PRD000565;PXD000426;PXD000529;PRD000146;PRD000234;PXD000997;PXD001572;PXD000593;PRD000345;PRD000020;PRD000711;PRD000597;PXD000218;PXD001422	55		1271444;924928;743333	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P32969	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9	0.43	22	PRD000733;PXD001310;PRD000053;PRD000444;PXD001323;PRD000565;PRD000607;PXD000529;PRD000146;PRD000234;PXD000997;PRD000671;PXD000426;PXD001572;PXD000593;PRD000345;PRD000269;PRD000020;PRD000711;PRD000597;PXD000218;PXD001422	53		1271440	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];ribosome [GO:0005840];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.41	27	PRD000565;PXD001310;PRD000053;PRD000020;PRD000444;PXD000217;PXD001323;PRD000668;PRD000443;PRD000607;PRD000680;PRD000733;PRD000146;PXD000997;PRD000269;PXD000529;PRD000671;PRD000597;PXD001572;PXD000426;PXD000593;PRD000154;PRD000345;PRD000711;PXD000948;PXD000218;PXD001422	69		1271421;743231	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];nucleolus [GO:0005730];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.43	22	PRD000565;PXD001310;PRD000053;PRD000020;PRD000444;PXD001323;PRD000668;PRD000597;PRD000680;PXD000426;PXD000529;PRD000733;PRD000146;PXD000997;PRD000671;PXD001572;PXD000593;PXD001422;PRD000345;PRD000711;PRD000269;PXD000218	58		1269529;743378	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];nucleolus [GO:0005730];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.4	22	PRD000565;PXD001310;PRD000053;PRD000020;PRD000444;PXD001323;PRD000443;PRD000597;PXD000426;PXD000529;PRD000733;PRD000146;PXD000997;PXD001572;PXD000593;PRD000668;PRD000345;PRD000269;PRD000711;PXD000948;PXD000218;PXD001422	54	EBI-8459929;EBI-8419242;EBI-8412660;EBI-8401905;EBI-8372752;EBI-8357768;EBI-8338396;EBI-8328780;EBI-8312518	1269390	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46781	40S ribosomal protein S9 (Small ribosomal subunit protein uS4)	RPS9	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.4	25	PRD000565;PXD001310;PRD000053;PXD000218;PRD000444;PXD000217;PXD001323;PRD000668;PRD000443;PRD000607;PRD000680;PXD000529;PRD000733;PRD000146;PXD000997;PRD000345;PRD000269;PRD000671;PRD000597;PXD001572;PRD000154;PXD000593;PRD000020;PRD000711;PXD001422	69		1271419;743281	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];membrane [GO:0016020];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	0.42	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	23					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.5	15	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PXD001403;PXD001422;PRD000059;PXD000164;PRD000269;PXD001174	42					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	0.43	18	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000019;PXD001324;PRD000416;PRD000212;PXD000743;PRD000185;PXD001403;PXD001422;PRD000345;PXD000164;PXD000047;PRD000269;PXD001174	47					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	0.48	5	PRD000073;PRD000631;PXD000383;PXD000743;PRD000364	27							
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.54	19	PRD000417;PXD000743;PRD000073;PXD001403;PRD000631;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000269;PRD000212;PRD000059;PRD000185;PRD000364;PXD000164;PXD001422;PXD000047;PXD001174	53					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.45	16	PRD000417;PXD000743;PXD001174;PRD000631;PRD000671;PXD000383;PXD001324;PRD000416;PRD000269;PRD000212;PXD001403;PRD000185;PRD000364;PXD000164;PXD001422;PRD000345	50					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.55	16	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PXD001403;PXD001422;PRD000059;PRD000345;PXD000164;PRD000269;PXD001174	43					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0M8Q6	Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region)		0.4	19	PRD000417;PXD000743;PRD000073;PXD001403;PRD000631;PRD000671;PXD000383;PRD000416;PXD001324;PRD000269;PRD000212;PRD000059;PRD000185;PRD000364;PRD000019;PXD000164;PXD001422;PXD000047;PXD001174	58						plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.57	16	PRD000417;PXD000743;PXD001174;PRD000416;PXD000746;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PXD001403;PXD000164;PXD001422;PXD000047;PRD000269;PRD000212	48					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.47	16	PRD000417;PXD000743;PRD000073;PXD001174;PRD000362;PRD000631;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PXD001403;PRD000364;PXD000164;PXD001422	51					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.52	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422;PRD000345	26					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.46	10	PRD000417;PRD000416;PXD000383;PRD000671;PRD000059;PXD000743;PRD000019;PXD001403;PXD001422;PXD000164	30					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.47	16	PRD000417;PXD000743;PRD000073;PRD000631;PRD000671;PXD000383;PRD000416;PRD000019;PXD001324;PRD000212;PRD000059;PXD001403;PXD000164;PXD001422;PRD000269;PXD001174	47					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.46	12	PRD000417;PXD000743;PRD000362;PRD000416;PRD000671;PXD000383;PRD000212;PXD001403;PXD000164;PRD000059;PRD000631;PXD001174	36					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.56	15	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PXD001403;PXD001422;PRD000059;PXD000164;PRD000269;PXD001174	42					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.49	14	PRD000417;PXD000743;PXD001174;PRD000631;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PXD001403;PRD000364;PXD000164;PXD001422	43					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MRZ8	Immunoglobulin kappa variable 3D-11	IGKV3D-11	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.55	14	PRD000417;PXD000743;PRD000631;PRD000671;PXD000383;PRD000059;PRD000416;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000269;PXD001174	36					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q6P4A8	Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]	PLBD1	P04839	Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome)	CYBB	0.45	6	PRD000684;PRD000053;PXD001422;PXD000164;PRD000118;PRD000668	21							
Q6P4A8	Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]	PLBD1	P12724	Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)	RNASE3	0.47	5	PRD000684;PXD000164;PRD000053;PRD000118;PRD000668	20						extracellular space [GO:0005615]	
Q6P4A8	Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C]	PLBD1	O43451	Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]	MGAM	0.41	4	PXD000164;PRD000684;PRD000118;PRD000053	11							
Q8TD19	Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8)	NEK9	Q9UHD2	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	TBK1	0.4	4	PRD000032;PXD000529;PXD001422;PXD000533	100						cytosol [GO:0005829]	ATP binding [GO:0005524];protein serine/threonine kinase activity [GO:0004674]
Q8TD19	Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8)	NEK9	Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)	CAMK2G	0.4	1	PRD000032	98						cytosol [GO:0005829]	ATP binding [GO:0005524];protein serine/threonine kinase activity [GO:0004674]
P11215	Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b)	ITGAM	P05107	Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)	ITGB2	0.48	6	PRD000684;PRD000668;PRD000118;PRD000053;PXD001422;PXD000164	39			2153	R-HSA-166016;R-HSA-202733;R-HSA-216083;R-HSA-6785807;R-HSA-6798695	extracellular matrix organization [GO:0030198];neutrophil degranulation [GO:0043312];phagocytosis, engulfment [GO:0006911];positive regulation of microglial cell activation [GO:1903980];cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742];negative regulation of dopamine metabolic process [GO:0045963];positive regulation of neutrophil degranulation [GO:0043315];positive regulation of protein targeting to membrane [GO:0090314];amyloid-beta clearance [GO:0097242];cytokine-mediated signaling pathway [GO:0019221];positive regulation of prostaglandin-E synthase activity [GO:2000363];integrin-mediated signaling pathway [GO:0007229];cell adhesion [GO:0007155];positive regulation of superoxide anion generation [GO:0032930];microglial cell activation [GO:0001774];toll-like receptor 4 signaling pathway [GO:0034142];positive regulation of neuron death [GO:1901216];leukocyte migration [GO:0050900]	tertiary granule membrane [GO:0070821];extracellular exosome [GO:0070062];specific granule membrane [GO:0035579];plasma membrane raft [GO:0044853];integrin alphaM-beta2 complex [GO:0034688];cell surface [GO:0009986];external side of plasma membrane [GO:0009897];integrin complex [GO:0008305];plasma membrane [GO:0005886]	protein heterodimerization activity [GO:0046982];heat shock protein binding [GO:0031072];complement component C3b binding [GO:0001851];metal ion binding [GO:0046872]
O60341	Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)	KDM1A	Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	0.42	1	PRD000345	38	EBI-6597993	872032			transcription, DNA-templated [GO:0006351];negative regulation of transcription, DNA-templated [GO:0045892]	nucleus [GO:0005634];nucleoplasm [GO:0005654]	enzyme binding [GO:0019899];histone deacetylase activity [GO:0004407]
O60341	Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)	KDM1A	Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	0.45	8	PRD000345;PRD000407;PRD000565;PXD000680;PXD000948;PXD000529;PXD000426;PXD000533	51	EBI-15785761;EBI-15650664;EBI-11132348;EBI-6597549;EBI-3505117;EBI-3505028;EBI-2461848;EBI-2461830;EBI-2461776;EBI-2461759	2239148;2208183;1451726;1262915;871881;832468;832400;676546;676511;645069;616761;569527;558827;558826;544304;530453;530447;511195;511186;511166;483932;483487;261607;261605;260602;244093	1257;871;648;646;642;636;634;633;632;626;620;614	R-HSA-983231;R-HSA-9018519;R-HSA-8943724;R-HSA-3214815	blood coagulation [GO:0007596];transcription, DNA-templated [GO:0006351];negative regulation of transcription by RNA polymerase II [GO:0000122];positive regulation of transcription by RNA polymerase II [GO:0045944];negative regulation of transcription, DNA-templated [GO:0045892]	nucleus [GO:0005634];nucleoplasm [GO:0005654];nuclear chromatin [GO:0000790];protein-containing complex [GO:0032991]	transcription factor binding [GO:0008134];transcription regulatory region DNA binding [GO:0044212];p53 binding [GO:0002039];enzyme binding [GO:0019899];histone deacetylase activity [GO:0004407]
O60341	Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)	KDM1A	Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	0.4	6	PRD000345;PXD000529;PRD000565;PXD000426;PXD001572;PXD000533	45							
P17213	Bactericidal permeability-increasing protein (BPI) (CAP 57)	BPI	P80188	Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin LCN2) (p25)	LCN2	0.4	4	PRD000684;PRD000118;PXD000164;PRD000053	25				R-HSA-6798695	antimicrobial humoral response [GO:0019730];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];specific granule lumen [GO:0035580];extracellular exosome [GO:0070062]	
P17213	Bactericidal permeability-increasing protein (BPI) (CAP 57)	BPI	P13727	Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]	PRG2	0.41	3	PRD000684;PXD000164;PRD000053	20				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];extracellular exosome [GO:0070062]	
P17213	Bactericidal permeability-increasing protein (BPI) (CAP 57)	BPI	P20160	Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP)	AZU1	0.41	5	PRD000684;PRD000118;PXD000164;PXD000412;PRD000053	25				R-HSA-6798695	antimicrobial humoral response [GO:0019730];defense response to Gram-negative bacterium [GO:0050829];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	
P17213	Bactericidal permeability-increasing protein (BPI) (CAP 57)	BPI	P08246	Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)	ELANE	0.41	5	PRD000684;PRD000118;PXD000164;PXD000412;PRD000053	26				R-HSA-6798695;R-HSA-6803157	antimicrobial humoral response [GO:0019730];neutrophil degranulation [GO:0043312]	specific granule lumen [GO:0035580];extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	
P17213	Bactericidal permeability-increasing protein (BPI) (CAP 57)	BPI	P24158	Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)	PRTN3	0.47	5	PRD000684;PRD000118;PXD000164;PXD000412;PRD000053	26				R-HSA-6803157;R-HSA-6798695	antimicrobial humoral response [GO:0019730];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	
Q9Y2K2	Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK)	SIK3	P51451	Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk)	BLK	0.42	3	PRD000032;PRD000167;PRD000168	51							ATP binding [GO:0005524]
A5A3E0	POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein)	POTEF	P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	0.4	78	PXD000948;PRD000814;PRD000733;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PXD000426;PRD000059;PRD000680;PRD000417;PRD000416;PRD000212;PXD001310;PRD000234;PRD000032;PXD000997;PXD000218;PRD000113;PXD001323;PXD000786;PRD000600;PXD000680;PRD000001;PRD000019;PRD000364;PXD000533;PRD000443;PXD001572;PRD000738;PRD000146;PXD001422;PRD000164;PRD000607;PXD000314;PRD000092;PRD000103;PXD000529;PRD000477;PRD000523;PRD000535;PRD000594;PRD000108;PRD000118;PXD000226;PRD000209;PXD001328;PRD000154;PRD000796;PRD000073;PXD001403;PXD000217;PXD001402;PRD000565;PRD000068;PRD000345;PRD000444;PRD000631;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000410;PXD000472;PRD000151;PRD000532;PRD000731;PXD001324;PRD000407	465						extracellular exosome [GO:0070062]	
P48047	ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)	ATP5PO	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.4	21	PRD000600;PXD001323;PRD000053;PRD000032;PRD000444;PRD000594;PRD000668;PRD000738;PRD000711;PRD000269;PRD000607;PXD000948;PRD000146;PXD000218;PXD001572;PXD000529;PRD000565;PXD001422;PRD000345;PRD000796;PRD000523	80							
P48047	ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)	ATP5PO	Q99714	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)	HSD17B10	0.41	19	PRD000345;PXD001323;PRD000053;PRD000444;PRD000594;PRD000668;PRD000711;PRD000269;PXD000948;PXD000218;PRD000146;PRD000234;PXD000387;PXD001572;PRD000565;PXD000529;PXD001422;PXD000533;PRD000738	79						plasma membrane [GO:0005886];mitochondrion [GO:0005739]	
P18085	ADP-ribosylation factor 4	ARF4	Q9H0U4	Ras-related protein Rab-1B	RAB1B	0.4	28	PRD000053;PRD000668;PRD000443;PRD000738;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000020;PXD000948;PRD000565;PRD000068;PRD000001;PRD000671;PRD000032;PRD000733;PXD000218;PRD000345;PRD000600;PRD000269;PXD000164;PRD000407	98				R-HSA-6811434;R-HSA-6807878	retrograde vesicle-mediated transport, Golgi to ER [GO:0006890];protein transport [GO:0015031];ER to Golgi vesicle-mediated transport [GO:0006888]	cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P18085	ADP-ribosylation factor 4	ARF4	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.44	22	PRD000053;PRD000600;PXD000529;PRD000154;PRD000668;PXD001323;PRD000738;PXD000948;PRD000733;PRD000001;PRD000269;PXD001328;PXD001572;PRD000594;PXD000164;PXD001422;PRD000345;PRD000020;PXD000426;PRD000407;PRD000711;PRD000597	82						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P18085	ADP-ribosylation factor 4	ARF4	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.44	27	PRD000053;PRD000668;PRD000443;PRD000738;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000020;PXD000948;PRD000565;PRD000068;PRD000671;PRD000032;PRD000733;PXD000218;PRD000345;PRD000600;PRD000269;PXD000164;PRD000407	95					protein transport [GO:0015031];ER to Golgi vesicle-mediated transport [GO:0006888]		GTPase activity [GO:0003924];GTP binding [GO:0005525]
P18085	ADP-ribosylation factor 4	ARF4	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.45	22	PRD000053;PXD000529;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PXD000948;PRD000565;PXD000426;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000068;PXD001447;PRD000020;PRD000711;PRD000269;PRD000733	77						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P18085	ADP-ribosylation factor 4	ARF4	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.41	23	PXD000948;PRD000053;PRD000600;PXD001323;PRD000154;PRD000594;PRD000668;PRD000443;PRD000565;PXD000529;PRD000733;PXD001328;PXD001572;PXD000164;PRD000738;PXD001422;PXD001447;PRD000001;PRD000345;PRD000407;PRD000711;PRD000269;PXD000426	81					protein transport [GO:0015031]	extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P18085	ADP-ribosylation factor 4	ARF4	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.43	22	PRD000053;PXD000529;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PXD000948;PRD000565;PRD000733;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000796;PRD000068;PXD001447;PRD000020;PXD000426;PRD000711	79					cell migration [GO:0016477]	ruffle membrane [GO:0032587];extracellular exosome [GO:0070062];cytosol [GO:0005829];dendritic spine [GO:0043197]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P01825	Immunoglobulin heavy variable 4-59 (Ig heavy chain V-II region NEWM)	IGHV4-59	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.41	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	0.56	1	PXD000383	11						extracellular region [GO:0005576]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	0.4	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	0.44	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	0.55	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	0.48	1	PXD000383	11				R-HSA-114608;R-HSA-2404192;R-HSA-2428928;R-HSA-2428933;R-HSA-381426	cellular protein metabolic process [GO:0044267];positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731];skeletal system development [GO:0001501];positive regulation of transcription by RNA polymerase II [GO:0045944];positive regulation of MAPK cascade [GO:0043410];positive regulation of cell proliferation [GO:0008284];platelet degranulation [GO:0002576];positive regulation of activated T cell proliferation [GO:0042104];positive regulation of mitotic nuclear division [GO:0045840];positive regulation of glycogen biosynthetic process [GO:0045725]	platelet alpha granule lumen [GO:0031093];extracellular region [GO:0005576];extracellular space [GO:0005615]	growth factor activity [GO:0008083];insulin receptor binding [GO:0005158];integrin binding [GO:0005178];hormone activity [GO:0005179];insulin-like growth factor receptor binding [GO:0005159]
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.51	1	PXD000383	11							
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.69	1	PXD000383	11							
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.54	1	PXD000383	11						extracellular region [GO:0005576]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.53	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.67	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.43	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.41	1	PXD000383	11						extracellular region [GO:0005576];extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.4	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.45	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.51	1	PXD000383	11						extracellular space [GO:0005615]	
P05019	Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C)	IGF1	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.4	1	PXD000383	11						extracellular space [GO:0005615]	
Q9Y281	Cofilin-2 (Cofilin, muscle isoform)	CFL2	P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	0.41	19	PRD000154;PRD000053;PRD000668;PXD000529;PXD000948;PXD001572;PXD001422;PRD000073;PRD000711;PRD000597;PRD000594;PXD001323;PRD000020;PRD000565;PXD000218;PXD000314;PRD000731;PXD001324;PRD000146	94						extracellular exosome [GO:0070062]	
Q9Y281	Cofilin-2 (Cofilin, muscle isoform)	CFL2	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.4	19	PRD000154;PRD000053;PXD000529;PRD000594;PXD001323;PRD000668;PRD000738;PRD000711;PRD000607;PRD000565;PXD000948;PXD000218;PRD000269;PXD001572;PXD001422;PXD000164;PRD000733;PRD000020;PXD001447	82						extracellular exosome [GO:0070062]	
P11678	Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain]	EPX	P14780	Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]	MMP9	0.4	6	PRD000684;PRD000362;PRD000059;PRD000118;PXD000164;PRD000053	27				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P14618	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM	P13639	Elongation factor 2 (EF-2)	EEF2	0.4	50	PRD000733;PRD000269;PXD000426;PRD000345;PXD000948;PRD000417;PXD000743;PRD000123;PRD000668;PRD000059;PRD000053;PXD000529;PRD000154;PXD000387;PXD001328;PXD000047;PXD001422;PXD000050;PRD000796;PRD000465;PRD000146;PRD000416;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD000533;PRD000073;PRD000151;PXD000217;PXD000786;PXD000164;PRD000032;PXD000218;PRD000443;PRD000731;PRD000103;PRD000600;PXD001324;PRD000234;PRD000444;PRD000565;PRD000046;PXD001572;PXD001447;PRD000118;PRD000410;PXD000226;PRD000407	246				R-HSA-6798695	neutrophil degranulation [GO:0043312]	ficolin-1-rich granule lumen [GO:1904813];secretory granule lumen [GO:0034774];cytosol [GO:0005829];cytoplasm [GO:0005737];nucleus [GO:0005634];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296];RNA binding [GO:0003723]
P14618	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM	P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	0.43	66	PXD000948;PRD000053;PXD000426;PRD000164;PRD000733;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000059;PXD000529;PRD000269;PRD000410;PXD000387;PRD000684;PXD001328;PXD000047;PXD001422;PRD000032;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD001323;PXD000164;PRD000416;PRD000597;PRD000364;PRD000711;PRD000607;PRD000594;PXD000786;PRD000108;PXD000746;PRD000001;PXD000217;PXD001402;PXD000218;PXD000050;PRD000532;PRD000731;PRD000103;PRD000068;PRD000600;PRD000671;PRD000565;PRD000234;PRD000151;PXD000314;PRD000118;PXD000226;PRD000444;PRD000345;PRD000113;PRD000477;PRD000046;PXD001572;PRD000019;PXD001447;PRD000523;PXD000533;PXD001324;PRD000407	339		1266763;745044		R-HSA-70171	canonical glycolysis [GO:0061621]	vesicle [GO:0031982];nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P14618	Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58)	PKM	P06733	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)	ENO1	0.49	63	PXD000948;PRD000053;PXD000426;PRD000059;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PXD000529;PRD000269;PRD000410;PXD000387;PRD000684;PXD001328;PRD000154;PXD001422;PRD000416;PRD000796;PRD000465;PRD000733;PRD000146;PXD001323;PXD000164;PXD000047;PRD000597;PRD000364;PRD000118;PRD000164;PRD000711;PRD000607;PXD000786;PRD000073;PXD000746;PRD000151;PRD000001;PXD000217;PXD001402;PRD000032;PXD000218;PXD000050;PRD000532;PRD000731;PRD000068;PRD000046;PRD000671;PRD000565;PXD001324;PRD000234;PXD000314;PRD000345;PXD000226;PRD000444;PRD000594;PRD000113;PXD000593;PXD001572;PXD001447;PRD000523;PXD000533;PRD000108;PRD000407	312				R-HSA-70171	canonical glycolysis [GO:0061621]	nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	magnesium ion binding [GO:0000287];cadherin binding [GO:0045296];RNA binding [GO:0003723]
P60842	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	EIF4A1	P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	0.41	33	PRD000733;PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD000387;PXD000050;PXD000426;PRD000154;PXD001422;PRD000711;PRD000597;PRD000565;PRD000594;PXD001323;PRD000607;PXD000533;PRD000092;PXD000217;PXD000218;PRD000731;PRD000671;PRD000345;PXD001324;PRD000146;PXD000997;PRD000444;PXD000593;PXD001328;PXD001572;PRD000738;PRD000407	145						cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];RNA binding [GO:0003723]
P60842	Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1)	EIF4A1	Q14974	Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97)	KPNB1	0.4	29	PXD000948;PXD000426;PRD000053;PRD000668;PRD000443;PXD000529;PRD000154;PXD001422;PRD000465;PRD000146;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000565;PXD000533;PXD000218;PRD000738;PRD000731;PRD000671;PRD000345;PXD001324;PXD000997;PRD000444;PXD000593;PXD001328;PXD001572	144				R-HSA-1169408		membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
Q96C19	EF-hand domain-containing protein D2 (Swiprosin-1)	EFHD2	O15144	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)	ARPC2	0.41	14	PXD001328;PRD000053;PXD000529;PRD000668;PRD000711;PRD000118;PRD000059;PXD000948;PXD001324;PXD001323;PXD000426;PXD001422;PXD000164;PRD000416	64		1258879					
P13010	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining))	XRCC5	P12956	X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6)	XRCC6	0.48	24	PXD000948;PXD000426;PRD000668;PXD000529;PRD000053;PXD001328;PXD001572;PXD001422;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000269;PRD000594;PRD000565;PXD000218;PXD000593;PRD000733;PXD000997;PRD000444;PRD000345;PXD000533;PRD000118	99	EBI-707473;EBI-516722;EBI-7162081;EBI-7162105;EBI-1201176;EBI-1563979;EBI-1563986;EBI-1563993;EBI-1563999;EBI-8505439;EBI-4370616;EBI-11057566;EBI-11057764;EBI-18744603;EBI-18744590;EBI-15976169;EBI-15976240;EBI-16138058	2389091;2235620;1518122;1518121;1518118;1518117;1448159;1444579;1274619;1055115;926766;885370;885369;854709;9423;263868;276062;278812;280495;317003;317004;483738;483742;506482;506486;514363;564018;604468;604469;604585;606972;608608;608610;615986;615991;658301;674858;674861;676369;676374;676377;714752;715115;740727;795734;795736	6310;5251;5235;5231;5183;5179;5176;4082;3102;2918;2766;1571;1220;1193;1189;1092;355;328;95	R-HSA-6798695;R-HSA-5693571;R-HSA-3270619;R-HSA-1834949;R-HSA-164843	establishment of integrated proviral latency [GO:0075713];activation of innate immune response [GO:0002218];double-strand break repair via nonhomologous end joining [GO:0006303];DNA recombination [GO:0006310];cellular response to X-ray [GO:0071481];regulation of smooth muscle cell proliferation [GO:0048660];cellular hyperosmotic salinity response [GO:0071475];transcription, DNA-templated [GO:0006351];telomere maintenance [GO:0000723];brain development [GO:0007420];positive regulation of protein kinase activity [GO:0045860];negative regulation of transcription, DNA-templated [GO:0045892];positive regulation of type I interferon production [GO:0032481];neutrophil degranulation [GO:0043312];cellular response to gamma radiation [GO:0071480];innate immune response [GO:0045087]	protein-DNA complex [GO:0032993];secretory granule lumen [GO:0034774];cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];protein-containing complex [GO:0032991];nuclear chromosome, telomeric region [GO:0000784];nuclear telomere cap complex [GO:0000783];membrane [GO:0016020];nonhomologous end joining complex [GO:0070419];extracellular region [GO:0005576];nucleus [GO:0005634];Ku70:Ku80 complex [GO:0043564]	transcription regulatory region DNA binding [GO:0044212];double-stranded DNA binding [GO:0003690];telomeric DNA binding [GO:0042162];protein C-terminus binding [GO:0008022];damaged DNA binding [GO:0003684];protein-containing complex binding [GO:0044877];ATP binding [GO:0005524];ATP-dependent DNA helicase activity [GO:0004003];RNA binding [GO:0003723];DNA binding [GO:0003677]
Q9Y2W1	Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150)	THRAP3	Q9NYF8	Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1)	BCLAF1	0.46	14	PXD000314;PXD000948;PXD000680;PXD000964;PXD000218;PXD000593;PXD000529;PXD000997;PRD000146;PXD000472;PXD000426;PXD000533;PRD000118;PXD001572	57	EBI-8459929;EBI-8412660;EBI-8387620;EBI-8372752;EBI-8357768;EBI-8338396;EBI-11086629;EBI-6430466;EBI-6430459;EBI-6430355;EBI-6430333	1449997;1273249				nucleus [GO:0005634];nucleoplasm [GO:0005654];nuclear speck [GO:0016607]	RNA binding [GO:0003723]
O00469	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)	PLOD2	Q02809	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)	PLOD1	0.49	7	PXD001328;PXD001323;PRD000345;PXD000529;PRD000597;PXD000387;PRD000053	12		2270817		R-HSA-1650814	hydroxylysine biosynthetic process [GO:0046947];cellular protein modification process [GO:0006464];peptidyl-lysine hydroxylation [GO:0017185];response to hypoxia [GO:0001666]	rough endoplasmic reticulum membrane [GO:0030867];extracellular exosome [GO:0070062];endoplasmic reticulum membrane [GO:0005789]	procollagen-lysine 5-dioxygenase activity [GO:0008475];iron ion binding [GO:0005506];L-ascorbic acid binding [GO:0031418]
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	0.43	47	PRD000345;PRD000053;PRD000123;PRD000668;PRD000417;PRD000059;PXD000948;PXD000529;PRD000416;PXD000387;PXD000426;PXD001572;PXD001422;PRD000032;PRD000796;PRD000146;PRD000269;PRD000597;PRD000154;PRD000477;PRD000594;PRD000711;PXD001323;PRD000046;PRD000073;PXD000786;PXD001403;PRD000001;PXD000217;PXD001402;PXD000164;PRD000020;PXD000218;PXD000314;PRD000731;PRD000103;PXD001324;PRD000234;PRD000444;PRD000113;PXD001328;PRD000362;PRD000738;PXD001447;PRD000364;PRD000523;PRD000118	211		1273502				cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P63104	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	0.45	49	PRD000073;PXD000948;PRD000032;PRD000053;PXD000743;PRD000123;PRD000668;PRD000059;PRD000417;PXD000529;PRD000416;PXD000387;PXD001328;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000269;PXD000680;PRD000711;PRD000597;PRD000154;PRD000477;PXD001323;PRD000046;PRD000523;PRD000020;PXD000786;PXD001403;PXD000472;PXD000533;PRD000001;PXD000217;PXD000164;PXD000218;PRD000738;PRD000731;PXD001324;PRD000234;PXD000314;PRD000151;PRD000444;PRD000113;PRD000345;PRD000594;PRD000118;PXD001447;PRD000364	246	EBI-7194572					nucleus [GO:0005634];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ubiquitin protein ligase binding [GO:0031625]
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P62937	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA	0.43	47	PXD000948;PRD000032;PRD000345;PRD000053;PXD000743;PRD000123;PRD000668;PRD000417;PRD000059;PRD000738;PRD000416;PXD000387;PXD000426;PXD001572;PXD001422;PXD000529;PRD000796;PRD000073;PRD000146;PRD000269;PRD000711;PRD000597;PRD000154;PRD000477;PXD001323;PRD000046;PRD000020;PXD000218;PRD000212;PXD000786;PXD000472;PXD000533;PRD000151;PRD000001;PXD000217;PXD000164;PRD000731;PRD000103;PXD001324;PRD000234;PXD000314;PRD000444;PRD000523;PRD000594;PXD001447;PRD000364;PRD000118	231						nucleus [GO:0005634];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	0.46	42	PXD000948;PRD000345;PRD000053;PXD000743;PRD000123;PRD000668;PRD000417;PRD000738;PXD000529;PRD000416;PXD000387;PXD001328;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000711;PRD000597;PRD000269;PXD000680;PRD000154;PRD000594;PRD000059;PXD001323;PRD000046;PRD000073;PXD000786;PXD000472;PXD000533;PXD000217;PXD000164;PRD000020;PXD000218;PRD000532;PRD000731;PXD001324;PXD000314;PRD000444;PRD000523;PXD001447;PRD000364	191		314978				nucleus [GO:0005634];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	0.41	36	PXD000948;PRD000020;PRD000053;PRD000668;PRD000417;PRD000416;PRD000269;PXD000387;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000738;PXD000786;PRD000151;PXD000217;PXD000218;PRD000731;PRD000032;PXD001324;PRD000234;PXD000529;PRD000444;PRD000345;PRD000523;PXD000164;PXD001328;PRD000118;PRD000364;PXD000533	159				R-HSA-70263	gluconeogenesis [GO:0006094]	nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.47	48	PXD000948;PRD000345;PRD000020;PRD000053;PXD000743;PRD000123;PRD000668;PRD000417;PRD000059;PXD000529;PRD000416;PXD000387;PXD001328;PXD000426;PXD001572;PXD001422;PRD000796;PRD000073;PRD000146;PRD000269;PRD000597;PRD000154;PRD000477;PRD000594;PRD000711;PXD001323;PRD000046;PRD000738;PXD000786;PRD000001;PXD000217;PXD001402;PXD000164;PXD000218;PXD000314;PRD000731;PRD000103;PXD001324;PRD000234;PRD000151;PRD000444;PRD000362;PRD000019;PXD001447;PRD000364;PXD000533;PRD000118;PRD000410	220		1273499			glycolytic process [GO:0006096]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P08758	Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)	ANXA5	0.41	34	PRD000020;PRD000053;PXD000743;PRD000123;PRD000668;PRD000417;PRD000059;PXD000948;PXD000529;PRD000416;PRD000269;PXD000387;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000597;PRD000594;PRD000711;PXD001323;PRD000073;PRD000001;PXD000218;PRD000738;PXD000680;PRD000234;PRD000444;PRD000113;PXD000164;PXD001328;PXD001447;PRD000118;PXD001324	174						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60174	Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase)	TPI1	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.42	36	PRD000073;PRD000032;PRD000053;PRD000123;PRD000668;PRD000738;PRD000059;PXD000948;PXD000387;PXD000426;PXD001572;PXD001422;PXD000529;PRD000796;PRD000146;PRD000711;PRD000597;PXD001323;PRD000046;PRD000410;PRD000020;PXD000533;PRD000001;PXD000217;PXD000164;PXD000218;PRD000731;PRD000103;PXD001324;PRD000444;PRD000345;PXD000786;PRD000594;PRD000118;PRD000364;PXD000314	186						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	0.4	1	PXD000383	10						plasma membrane [GO:0005886]	
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	0.65	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	0.43	2	PXD000383;PRD000019	12				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.47	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.56	1	PXD000383	11					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	0.45	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.53	1	PXD000383	11						extracellular region [GO:0005576]	
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	0.55	1	PXD000383	10					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.41	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.65	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.63	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.41	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.47	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.44	3	PXD000383;PRD000671;PRD000019	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	P08493	Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)	MGP	0.41	1	PXD000383	11							
P01721	Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT)	IGLV6-57	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.53	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P28482	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)	MAPK1	Q16539	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)	MAPK14	0.44	10	PRD000032;PRD000053;PXD001422;PRD000345;PXD000948;PRD000711;PXD001323;PRD000168;PRD000565;PXD000529	112	EBI-6932414;EBI-6932389;EBI-8702570;EBI-7234344;EBI-7234300	2327660;662330;302752;259227		R-HSA-6798695;R-HSA-450341;R-HSA-2559580;R-HSA-198753	positive regulation of gene expression [GO:0010628];transcription, DNA-templated [GO:0006351];apoptotic process [GO:0006915];cellular response to tumor necrosis factor [GO:0071356];regulation of ossification [GO:0030278];lipopolysaccharide-mediated signaling pathway [GO:0031663];activation of MAPK activity [GO:0000187];signal transduction [GO:0007165];peptidyl-serine phosphorylation [GO:0018105];chemotaxis [GO:0006935];neutrophil degranulation [GO:0043312]	ficolin-1-rich granule lumen [GO:1904813];cytosol [GO:0005829];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];mitochondrion [GO:0005739];nucleus [GO:0005634];extracellular region [GO:0005576]	MAP kinase activity [GO:0004707];ATP binding [GO:0005524];MAP kinase kinase activity [GO:0004708];protein serine/threonine kinase activity [GO:0004674]
A0A087WSY4	Immunoglobulin heavy variable 4-30-2	AC234301.4;IGHV4-31	P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	0.42	5	PXD000383;PRD000417;PRD000416;PXD001403;PRD000146	19					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A087WSY4	Immunoglobulin heavy variable 4-30-2	AC234301.4;IGHV4-31	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.42	3	PXD000383;PXD001403;PXD001422	14							antigen binding [GO:0003823]
A0A087WSY4	Immunoglobulin heavy variable 4-30-2	AC234301.4;IGHV4-31	P01772	Immunoglobulin heavy variable 3-33 (Ig heavy chain V-III region HIL) (Ig heavy chain V-III region KOL)	IGHV3-33	0.41	6	PXD000383;PRD000417;PRD000416;PXD001403;PRD000146;PXD001422	20					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A087WSY4	Immunoglobulin heavy variable 4-30-2	AC234301.4;IGHV4-31	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.45	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	0.41	7	PXD000383;PRD000417;PRD000671;PXD000164;PXD001403;PXD001422;PRD000416	21					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.41	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	23					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.42	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PRD000416;PRD000345;PXD000164	22					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.49	4	PXD000383;PRD000671;PXD001403;PXD001422	15							antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.43	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.4	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	26					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.45	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.54	8	PXD000383;PRD000417;PXD001403;PXD000164;PXD001422;PRD000416;PXD000743;PRD000345	21					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.54	9	PRD000417;PXD000383;PRD000019;PXD001403;PRD000671;PXD001422;PRD000416;PXD000164;PXD000743	23					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.5	8	PRD000417;PXD000383;PRD000019;PXD001403;PRD000671;PXD000743;PRD000416;PXD000164	22					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.44	7	PXD000383;PRD000417;PRD000671;PXD000164;PXD001403;PXD001422;PRD000416	21					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.42	5	PXD000383;PRD000417;PRD000671;PXD001403;PXD001422	17					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.4	8	PRD000417;PXD000383;PXD001403;PRD000671;PXD001422;PXD000743;PRD000416;PXD000164	23					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSY6	Immunoglobulin kappa variable 3D-15	IGKV3D-15	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.45	7	PXD000383;PRD000417;PRD000671;PXD001403;PXD001422;PRD000416;PXD000743	19					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P62829	60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14)	RPL23	P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	0.4	22	PRD000053;PRD000565;PXD001310;PRD000407;PRD000444;PRD000594;PRD000123;PRD000668;PRD000443;PXD000948;PXD000218;PRD000269;PRD000146;PXD000997;PXD001323;PRD000597;PXD001572;PXD001422;PXD000593;PXD000217;PXD000047;PRD000711	70		1269632	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	Q9H0U4	Ras-related protein Rab-1B	RAB1B	0.45	18	PXD000948;PRD000053;PRD000154;PRD000594;PXD001323;PRD000668;PRD000443;PRD000118;PXD001324;PRD000146;PXD000529;PXD000533;PRD000738;PXD001422;PRD000068;PRD000407;PRD000711;PRD000597	47		2216522;2197825;2197799;1268514;1183141		R-HSA-8876198;R-HSA-8873719;R-HSA-6811434;R-HSA-6807878;R-HSA-204005;R-HSA-162658	positive regulation of glycoprotein metabolic process [GO:1903020];ER to Golgi vesicle-mediated transport [GO:0006888];COPII vesicle coating [GO:0048208];autophagy [GO:0006914];retrograde vesicle-mediated transport, Golgi to ER [GO:0006890];post-translational protein modification [GO:0043687];virion assembly [GO:0019068]	Golgi apparatus [GO:0005794];Golgi membrane [GO:0000139];cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	P61204	ADP-ribosylation factor 3	ARF3	0.41	30	PXD000948;PXD000426;PRD000733;PRD000668;PRD000443;PRD000738;PRD000053;PXD000387;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000032;PRD000020;PXD001403;PXD000164;PRD000068;PRD000001;PXD000218;PXD000529;PRD000671;PRD000565;PRD000345;PRD000118;PRD000600;PRD000407	109				R-HSA-6811434;R-HSA-6807878	retrograde vesicle-mediated transport, Golgi to ER [GO:0006890]	Golgi membrane [GO:0000139];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	P51149	Ras-related protein Rab-7a	RAB7A	0.45	27	PRD000020;PRD000053;PRD000668;PRD000738;PXD001572;PRD000154;PXD001422;PRD000146;PXD000948;PXD000164;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PXD000426;PRD000001;PRD000417;PRD000565;PRD000733;PXD001324;PRD000444;PRD000345;PRD000118;PXD000533;PRD000407	111		2448521;1268589;746177		R-HSA-8876198;R-HSA-8873719	autophagosome assembly [GO:0000045];endocytosis [GO:0006897]	cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.46	26	PRD000053;PRD000020;PRD000738;PRD000668;PXD001572;PRD000154;PXD000948;PRD000711;PRD000597;PRD000092;PXD001323;PRD000001;PXD000529;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PRD000118;PRD000594;PXD000164;PXD000533;PXD001422;PRD000407;PRD000269	90		1268471;746147		R-HSA-8873719	post-translational protein modification [GO:0043687];melanosome transport [GO:0032402]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];cadherin binding [GO:0045296];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	0.4	25	PRD000053;PRD000668;PRD000738;PXD001572;PRD000154;PXD001422;PRD000796;PXD000164;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000607;PXD000948;PRD000068;PXD000529;PRD000565;PRD000733;PXD001324;PRD000345;PRD000118;PRD000600;PXD000533;PRD000269	96					substrate adhesion-dependent cell spreading [GO:0034446]	melanosome [GO:0042470];Golgi membrane [GO:0000139];cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.45	25	PRD000020;PRD000053;PRD000668;PRD000443;PXD001572;PXD000529;PXD001422;PRD000711;PRD000154;PRD000092;PXD001323;PRD000607;PXD000948;PRD000001;PRD000565;PXD000164;PRD000733;PXD001324;PRD000146;PRD000594;PRD000600;PXD000533;PRD000738;PRD000407;PRD000269	94		1268494		R-HSA-8876198;R-HSA-8873719		melanosome [GO:0042470];early endosome [GO:0005769];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62820	Ras-related protein Rab-1A (YPT1-related protein)	RAB1A	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.41	27	PRD000053;PRD000668;PRD000738;PXD000387;PXD001572;PRD000154;PXD000529;PXD001422;PRD000796;PRD000711;PRD000092;PXD001323;PRD000607;PRD000020;PRD000068;PRD000001;PXD000164;PRD000565;PRD000733;PXD000948;PXD000218;PRD000597;PRD000269;PRD000594;PRD000364;PXD000533;PRD000118	96					cell migration [GO:0016477]	cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62826	GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)	RAN	P60900	Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6	0.41	25	PRD000154;PRD000053;PRD000668;PXD001328;PXD001572;PXD001422;PRD000146;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000565;PRD000032;PRD000731;PRD000733;PXD001324;PXD000529;PXD000997;PRD000444;PXD000426;PRD000738;PRD000345;PRD000407	109						nucleus [GO:0005634];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62826	GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)	RAN	P63244	Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]	RACK1	0.4	22	PXD000948;PRD000053;PRD000668;PXD000529;PXD001328;PXD001572;PXD001422;PXD000047;PRD000711;PRD000594;PXD001323;PRD000565;PXD000218;PRD000731;PRD000671;PXD001324;PRD000146;PRD000444;PRD000443;PRD000345;PXD000426;PXD000997	94					viral process [GO:0016032]	cytosol [GO:0005829];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];nucleus [GO:0005634];midbody [GO:0030496];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296];RNA binding [GO:0003723]
P62826	GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein)	RAN	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.41	27	PRD000154;PRD000053;PRD000668;PXD000529;PRD000269;PXD001572;PXD001422;PRD000465;PXD000050;PRD000407;PRD000711;PRD000597;PRD000092;PXD001323;PRD000032;PRD000565;PXD000218;PXD000948;PRD000731;PRD000671;PXD001324;PRD000146;PXD000997;PRD000594;PXD000426;PXD000533;PXD000786	109					viral process [GO:0016032]	nucleus [GO:0005634];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P06732	Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK)	CKM	P02144	Myoglobin	MB	0.41	4	PRD000073;PRD000234;PRD000544;PRD000373	13						cytosol [GO:0005829]	
O95983	Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3)	MBD3	O75182	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	SIN3B	0.4	1	PRD000345	10					negative regulation of transcription by RNA polymerase II [GO:0000122];transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654];cytoplasm [GO:0005737]	chromatin binding [GO:0003682]
P01031	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.41	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000417;PRD000362	123				R-HSA-977606;R-HSA-174577	complement activation, alternative pathway [GO:0006957];regulation of complement activation [GO:0030449]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P01031	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5	P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	0.42	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000417;PXD000164;PXD001403;PRD000416;PXD000743;PRD000631;PRD000172;PRD000551;PRD000158;PRD000364	117						extracellular region [GO:0005576];extracellular exosome [GO:0070062]	
P01031	Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain]	C5	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.42	15	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PXD000743;PRD000631;PRD000172;PRD000551;PRD000146;PRD000158;PRD000417;PRD000362	110				R-HSA-977606	regulation of complement activation [GO:0030449];complement activation, classical pathway [GO:0006958]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P02749	Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)	APOH	P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	0.45	18	PRD000073;PRD000059;PRD000416;PRD000185;PXD000383;PRD000269;PRD000053;PXD000164;PXD001403;PRD000711;PXD001174;PXD000743;PRD000631;PRD000172;PRD000417;PXD001324;PRD000158;PRD000364	114				R-HSA-114608	platelet degranulation [GO:0002576];blood coagulation, intrinsic pathway [GO:0007597];negative regulation of blood coagulation [GO:0030195]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];collagen-containing extracellular matrix [GO:0062023]	heparin binding [GO:0008201]
P02749	Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI)	APOH	P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	0.45	15	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PRD000416;PXD000164;PXD001403;PRD000711;PXD000743;PRD000417;PRD000631;PRD000172;PRD000158;PRD000364	96	EBI-9548365;EBI-9693663			R-HSA-114608	platelet degranulation [GO:0002576];negative regulation of fibrinolysis [GO:0051918]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];cell surface [GO:0009986]	
P01036	Cystatin-S (Cystatin-4) (Cystatin-SA-III) (Salivary acidic protein 1)	CST4	P23280	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)	CA6	0.43	2	PRD000164;PRD000212	10					detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P01036	Cystatin-S (Cystatin-4) (Cystatin-SA-III) (Salivary acidic protein 1)	CST4	Q6P5S2	Protein LEG1 homolog	C6orf58	0.4	3	PRD000164;PRD000212;PXD000412	12						extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P08514	Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]	ITGA2B	P05106	Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61)	ITGB3	0.55	8	PRD000364;PRD000001;PRD000053;PXD001422;PXD001324;PRD000118;PRD000738;PRD000068	20	EBI-16152447;EBI-16152524;EBI-15959536;EBI-15805670;EBI-8591167;EBI-8591111;EBI-8591139;EBI-8591055;EBI-8591083;EBI-8591027;EBI-8590999;EBI-8590972;EBI-1040341;EBI-703368;EBI-703283	2399116;2381463;2381000;2379680;2377286;2377284;2376830;2376829;1528291	3115;2896;2872;2382;2381;2379;2378;2377;2376;2370	R-HSA-114608;R-HSA-216083;R-HSA-3000178;R-HSA-354192;R-HSA-354194;R-HSA-372708;R-HSA-445144;R-HSA-5674135;R-HSA-6802946;R-HSA-6802948;R-HSA-6802949;R-HSA-6802952;R-HSA-6802955	extracellular matrix organization [GO:0030198];cell-matrix adhesion [GO:0007160];platelet aggregation [GO:0070527];integrin-mediated signaling pathway [GO:0007229];platelet degranulation [GO:0002576]	extracellular exosome [GO:0070062];cell surface [GO:0009986];focal adhesion [GO:0005925];integrin complex [GO:0008305];platelet alpha granule membrane [GO:0031092];plasma membrane [GO:0005886]	extracellular matrix binding [GO:0050840];identical protein binding [GO:0042802]
P06331	Immunoglobulin heavy variable 4-34 (Ig heavy chain V-II region ARH-77)	IGHV4-34	P01772	Immunoglobulin heavy variable 3-33 (Ig heavy chain V-III region HIL) (Ig heavy chain V-III region KOL)	IGHV3-33	0.42	6	PXD000383;PRD000417;PRD000416;PXD001403;PRD000146;PXD001422	20				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P06331	Immunoglobulin heavy variable 4-34 (Ig heavy chain V-II region ARH-77)	IGHV4-34	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.41	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6Q5	Immunoglobulin heavy variable 3-64	IGHV3-64	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.4	2	PXD000383;PXD001403	11							antigen binding [GO:0003823]
A0A075B6Q5	Immunoglobulin heavy variable 3-64	IGHV3-64	A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	0.61	2	PXD000383;PXD001403	10							antigen binding [GO:0003823]
A0A075B6Q5	Immunoglobulin heavy variable 3-64	IGHV3-64	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.45	2	PXD000383;PXD001403	11							antigen binding [GO:0003823]
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	0.4	21	PRD000073;PRD000059;PXD000743;PRD000185;PRD000269;PXD000383;PRD000053;PXD001422;PXD000164;PRD000417;PRD000212;PXD001403;PRD000631;PXD001174;PRD000172;PXD001324;PRD000551;PRD000113;PRD000158;PRD000362;PRD000416	157					cellular iron ion homeostasis [GO:0006879]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P02675	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	FGB	0.4	19	PRD000073;PRD000417;PXD000743;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000477;PRD000059;PRD000212;PXD001403;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362;PRD000019	155						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	chaperone binding [GO:0051087]
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.49	18	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000269;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000158;PRD000362	162						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P04114	Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]	APOB	0.45	15	PRD000073;PRD000059;PRD000185;PRD000053;PRD000417;PXD000164;PXD000383;PXD001403;PRD000416;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PXD000743	141				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P0C0L5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B;C4B_2	0.58	22	PRD000073;PRD000059;PRD000417;PXD000743;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000477;PRD000212;PXD001403;PRD000631;PRD000269;PXD001174;PRD000172;PXD001324;PRD000551;PRD000113;PRD000158;PRD000362	175						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	P0C0L4	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A	0.58	22	PRD000073;PRD000059;PRD000417;PXD000743;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000477;PRD000212;PXD001403;PRD000631;PRD000269;PXD001174;PRD000172;PXD001324;PRD000551;PRD000113;PRD000158;PRD000362	175				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00450	Ceruloplasmin (EC 1.16.3.1) (Ferroxidase)	CP	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.5	17	PRD000073;PRD000059;PRD000417;PXD000743;PRD000185;PXD000383;PXD000164;PRD000416;PRD000477;PRD000269;PXD001403;PRD000631;PXD001174;PRD000172;PRD000551;PRD000158;PRD000362	151						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	0.62	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	405	EBI-11139064	1450459;926292		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	0.43	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000059;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000383;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PXD000226;PRD000407;PXD000964	354				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	0.52	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD001447;PRD000671;PRD000108;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PRD000407;PXD000964	364		926273;744945		R-HSA-983189;R-HSA-8955332;R-HSA-8854518;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5620912;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-3371497;R-HSA-2565942;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	regulation of G2/M transition of mitotic cell cycle [GO:0010389];ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];microtubule-based process [GO:0007017]	extracellular region [GO:0005576];microtubule [GO:0005874];extracellular exosome [GO:0070062];cytoskeleton [GO:0005856];cytosol [GO:0005829]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	0.64	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	405		2449306;744867		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	myelin sheath [GO:0043209];microtubule [GO:0005874]	structural constituent of cytoskeleton [GO:0005200];GTPase activity [GO:0003924];double-stranded RNA binding [GO:0003725];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	0.45	66	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000032;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PXD000786;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PRD000684;PXD001422;PRD000118;PRD000073;PRD000607;PXD000529;PRD000444;PRD000523;PRD000535;PXD000164;PXD000226;PXD001328;PRD000146;PRD000172;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000164;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	372				R-HSA-6798695;R-HSA-3371497	neutrophil degranulation [GO:0043312]	myelin sheath [GO:0043209];extracellular region [GO:0005576];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	unfolded protein binding [GO:0051082]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	0.62	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	400		1273775;744872		R-HSA-983189;R-HSA-8955332;R-HSA-8854518;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5620912;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-3371497;R-HSA-2565942;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	regulation of G2/M transition of mitotic cell cycle [GO:0010389];ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];microtubule-based process [GO:0007017]	myelin sheath [GO:0043209];microtubule [GO:0005874];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P11021	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	HSPA5	0.4	60	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PXD001310;PXD000426;PXD000387;PXD001328;PXD000997;PXD001422;PRD000154;PRD000118;PRD000796;PRD000073;PRD000146;PXD000050;PXD000047;PRD000407;PRD000711;PRD000597;PRD000269;PXD000593;PRD000535;PRD000671;PRD000594;PXD001323;PRD000046;PRD000059;PRD000607;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000565;PRD000001;PXD000217;PXD000786;PXD000218;PXD000529;PRD000731;PRD000444;PXD001572;PXD001324;PRD000234;PXD000314;PRD000600;PXD001447;PRD000684;PXD000164;PXD000226;PRD000108;PXD000964	339						nucleus [GO:0005634];extracellular exosome [GO:0070062];myelin sheath [GO:0043209]	unfolded protein binding [GO:0051082]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	0.4	61	PRD000733;PXD000948;PRD000032;PRD000053;PRD000345;PXD000426;PXD000743;PRD000123;PRD000668;PRD000443;PXD000529;PXD000387;PRD000684;PXD001328;PRD000154;PRD000020;PXD001422;PXD000997;PRD000118;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000172;PXD000593;PRD000407;PRD000594;PXD001323;PRD000046;PRD000607;PXD000472;PXD000164;PXD000533;PRD000068;PRD000168;PRD000364;PRD000001;PXD000217;PRD000565;PXD000218;PRD000731;PRD000167;PRD000600;PRD000671;PXD001324;PRD000234;PRD000151;PRD000108;PRD000444;PRD000523;PRD000269;PRD000059;PXD001572;PXD001447;PXD000786;PRD000738;PXD000314;PXD000964	332				R-HSA-8852276;R-HSA-6798695;R-HSA-3371497	neutrophil degranulation [GO:0043312]	nucleus [GO:0005634];extracellular region [GO:0005576];cytosol [GO:0005829];extracellular exosome [GO:0070062]	double-stranded RNA binding [GO:0003725];unfolded protein binding [GO:0051082];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.49	49	PXD000426;PRD000020;PRD000053;PRD000565;PRD000668;PRD000443;PRD000167;PXD000948;PRD000345;PRD000032;PXD000593;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000733;PRD000146;PXD000047;PRD000523;PRD000711;PRD000597;PRD000671;PRD000172;PRD000594;PXD001323;PRD000046;PRD000059;PRD000607;PRD000680;PXD000997;PRD000068;PRD000168;PRD000151;PRD000001;PXD000529;PXD000217;PXD001324;PXD000218;PRD000444;PRD000364;PXD000164;PXD000533;PRD000738;PRD000073;PRD000108;PRD000407	203		926294;744905		R-HSA-8854518;R-HSA-6798695;R-HSA-5620912;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-2565942	ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];regulation of G2/M transition of mitotic cell cycle [GO:0010389];microtubule-based process [GO:0007017];natural killer cell mediated cytotoxicity [GO:0042267];neutrophil degranulation [GO:0043312]	cytoskeleton [GO:0005856];microtubule [GO:0005874];nucleus [GO:0005634];extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];MHC class I protein binding [GO:0042288];GTP binding [GO:0005525]
P68371	Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain)	TUBB4B	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.41	50	PRD000733;PXD000948;PXD000426;PRD000032;PRD000345;PRD000053;PXD000743;PRD000668;PRD000443;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000118;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PRD000597;PRD000073;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PRD000565;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000444;PRD000523;PRD000535;PRD000594;PRD000269;PXD001447;PXD000164;PXD000533;PRD000738;PXD000226;PRD000407	279		1273768				cytosol [GO:0005829];extracellular exosome [GO:0070062]	double-stranded RNA binding [GO:0003725];unfolded protein binding [GO:0051082]
Q9UHD2	Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1)	TBK1	Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)	CAMK2G	0.41	2	PRD000032;PRD000168	109					peptidyl-threonine phosphorylation [GO:0018107];peptidyl-serine phosphorylation [GO:0018105]	nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829]	ATP binding [GO:0005524];identical protein binding [GO:0042802];protein serine/threonine kinase activity [GO:0004674]
P78316	Nucleolar protein 14 (Nucleolar complex protein 14)	NOP14	Q14684	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B	0.4	7	PXD001572;PXD000472;PXD000533;PXD000964;PXD000593;PXD000314;PXD000680	11	EBI-16686997				rRNA processing [GO:0006364]	nucleus [GO:0005634];nucleoplasm [GO:0005654];nucleolus [GO:0005730]	RNA binding [GO:0003723]
P78316	Nucleolar protein 14 (Nucleolar complex protein 14)	NOP14	Q8N9T8	Protein KRI1 homolog	KRI1	0.43	6	PXD001572;PXD000472;PXD000533;PXD000680;PXD000593;PXD000314	11					endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]	90S preribosome [GO:0030686];nucleolus [GO:0005730]	RNA binding [GO:0003723]
P78316	Nucleolar protein 14 (Nucleolar complex protein 14)	NOP14	Q9Y5J1	U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50)	UTP18	0.4	6	PXD001572;PXD000426;PXD000533;PXD000680;PXD000964;PXD000314	10				R-HSA-6790901;R-HSA-6791226	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];rRNA processing [GO:0006364]	nucleus [GO:0005634];nucleoplasm [GO:0005654];small-subunit processome [GO:0032040];nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q9NY61	Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1)	AATF	Q8N9T8	Protein KRI1 homolog	KRI1	0.41	6	PXD000426;PXD001572;PXD000533;PXD000680;PXD000218;PXD000314	10		1263997				nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q05639	Elongation factor 1-alpha 2 (EF-1-alpha-2) (Eukaryotic elongation factor 1 A-2) (eEF1A-2) (Statin-S1)	EEF1A2	0.4	55	PRD000733;PRD000345;PRD000032;PXD000426;PRD000053;PXD000948;PRD000146;PRD000565;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000997;PRD000269;PXD000387;PXD001328;PXD000047;PXD001422;PRD000020;PRD000154;PRD000796;PRD000465;PRD000407;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000746;PXD000533;PRD000168;PRD000151;PXD001403;PXD000218;PXD000529;PRD000731;PXD000217;PRD000600;PRD000671;PXD001324;PRD000234;PRD000180;PRD000444;PRD000059;PXD000786;PXD001572;PXD001447;PXD000164;PRD000738;PRD000108	277						cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.44	56	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PRD000053;PRD000146;PRD000565;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000997;PRD000269;PXD000387;PXD001328;PXD001422;PRD000154;PRD000796;PRD000465;PXD000047;PRD000407;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000746;PRD000168;PRD000151;PXD001403;PXD000217;PXD000218;PXD000529;PRD000600;PXD000533;PRD000671;PXD001572;PXD001324;PRD000234;PRD000180;PRD000444;PRD000059;PXD000786;PRD000731;PXD001447;PXD000164;PRD000738;PXD000226;PRD000108	299						cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.46	61	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PRD000154;PXD001422;PXD000997;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000426;PXD001572;PXD000533;PRD000092;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000600;PRD000671;PXD001324;PRD000234;PRD000118;PXD000383;PRD000444;PRD000523;PXD000786;PRD000407;PXD001447;PXD000164;PXD000226;PRD000108	332				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.43	61	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD000426;PXD000593;PRD000269;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000671;PRD000535;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000997;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000600;PXD001324;PRD000234;PRD000118;PXD000383;PRD000444;PRD000523;PXD000786;PRD000407;PXD001572;PXD001447;PXD000164;PXD001310;PXD000226;PRD000108;PXD000964	327				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.44	56	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PRD000053;PRD000146;PRD000565;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000997;PRD000269;PXD000387;PXD001328;PXD001422;PRD000154;PRD000796;PRD000465;PXD000047;PRD000407;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000746;PRD000168;PRD000151;PXD001403;PXD000217;PXD000218;PXD000529;PRD000600;PXD000533;PRD000671;PXD001572;PXD001324;PRD000234;PRD000180;PRD000444;PRD000059;PXD000786;PRD000731;PXD001447;PXD000164;PRD000738;PXD000226;PRD000108	299						cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.49	60	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PRD000565;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000426;PRD000269;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000997;PXD000533;PRD000092;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PXD000218;PXD000529;PRD000731;PRD000600;PRD000671;PXD001324;PRD000234;PRD000444;PXD000383;PRD000523;PXD000786;PRD000407;PRD000118;PXD001572;PXD001447;PXD000164;PRD000108	326				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.43	61	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD000426;PXD000593;PRD000269;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000671;PRD000535;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000997;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000600;PXD001324;PRD000234;PRD000118;PXD000383;PRD000444;PRD000523;PXD000786;PRD000407;PXD001572;PXD001447;PXD000164;PXD001310;PXD000226;PRD000108;PXD000964	327				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule cytoskeleton [GO:0015630];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9NY65	Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2)	TUBA8	Q3ZCM7	Tubulin beta-8 chain (Tubulin beta 8 class VIII)	TUBB8	0.51	59	PRD000733;PRD000345;PRD000032;PRD000020;PXD000948;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000671;PRD000535;PXD000593;PRD000594;PXD001323;PRD000607;PRD000680;PXD000426;PRD000092;PRD000068;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000168;PRD000600;PXD001572;PXD001324;PRD000234;PRD000444;PRD000523;PXD000786;PRD000118;PXD001447;PXD000164;PXD000533;PXD000226;PRD000108;PRD000407	286				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148		cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
O75182	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)	SIN3B	Q9P0W2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (SMARCE1-related protein) (BRCA2-associated factor 35) (HMG box-containing protein 20B) (HMG domain-containing protein 2) (HMG domain-containing protein HMGX2) (Sox-like transcriptional factor) (Structural DNA-binding protein BRAF35)	HMG20B	0.5	1	PRD000345	14					transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]	
P63010	AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit)	AP2B1	O95782	AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit)	AP2A1	0.43	19	PRD000733;PRD000032;PXD000529;PRD000154;PXD000948;PRD000123;PXD000593;PRD000565;PRD000053;PXD001572;PXD000997;PXD001328;PRD000594;PXD001422;PXD000218;PXD000533;PRD000711;PXD001447;PXD000426	62		1258645		R-HSA-8964038;R-HSA-8866427;R-HSA-8856828;R-HSA-8856825;R-HSA-5140745;R-HSA-5099900;R-HSA-437239;R-HSA-416993;R-HSA-3928665;R-HSA-2132295;R-HSA-182218;R-HSA-177504;R-HSA-167590	low-density lipoprotein particle receptor catabolic process [GO:0032802];membrane organization [GO:0061024];low-density lipoprotein particle clearance [GO:0034383];clathrin-dependent endocytosis [GO:0072583];Wnt signaling pathway, planar cell polarity pathway [GO:0060071];intracellular protein transport [GO:0006886];regulation of defense response to virus by virus [GO:0050690];antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];ephrin receptor signaling pathway [GO:0048013]	cytosol [GO:0005829];clathrin-coated endocytic vesicle [GO:0045334];plasma membrane [GO:0005886];endolysosome membrane [GO:0036020];endocytic vesicle membrane [GO:0030666];membrane [GO:0016020];AP-2 adaptor complex [GO:0030122];clathrin-coated endocytic vesicle membrane [GO:0030669]	protein-containing complex binding [GO:0044877]
Q14019	Coactosin-like protein	COTL1	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.4	10	PRD000053;PXD001323;PRD000594;PRD000668;PRD000711;PXD000164;PXD001422;PRD000738;PXD000948;PXD000218	59				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];secretory granule lumen [GO:0034774];extracellular exosome [GO:0070062]	
Q14019	Coactosin-like protein	COTL1	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.43	9	PRD000053;PRD000668;PXD001323;PRD000711;PRD000118;PXD001328;PXD000164;PXD001422;PRD000738	63						extracellular exosome [GO:0070062]	
P60763	Ras-related C3 botulinum toxin substrate 3 (p21-Rac3)	RAC3	Q92930	Ras-related protein Rab-8B	RAB8B	0.41	22	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PRD000668;PXD001323;PRD000738;PRD000118;PRD000607;PRD000565;PXD000948;PRD000733;PXD001324;PRD000600;PXD001572;PXD001422;PXD000164;PRD000796;PRD000068;PRD000345;PRD000269	82						perinuclear region of cytoplasm [GO:0048471];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P60763	Ras-related C3 botulinum toxin substrate 3 (p21-Rac3)	RAC3	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.4	21	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PRD000594;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PRD000733;PXD001328;PXD001572;PXD001422;PXD000164;PXD000533;PRD000068;PXD001447;PRD000269;PXD000948	75		1268625		R-HSA-194840	regulation of small GTPase mediated signal transduction [GO:0051056];small GTPase mediated signal transduction [GO:0007264]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
O43353	Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)	RIPK2	P42684	Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG)	ABL2	0.4	3	PRD000032;PRD000168;PRD000118	84					signal transduction [GO:0007165];innate immune response [GO:0045087]	cytosol [GO:0005829]	ATP binding [GO:0005524];non-membrane spanning protein tyrosine kinase activity [GO:0004715];signaling receptor binding [GO:0005102]
O43353	Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2)	RIPK2	Q16539	Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)	MAPK14	0.41	3	PRD000032;PXD001422;PRD000168	81				R-HSA-450302;R-HSA-168638	positive regulation of transcription by RNA polymerase II [GO:0045944];activation of MAPK activity [GO:0000187];lipopolysaccharide-mediated signaling pathway [GO:0031663];signal transduction [GO:0007165];cellular response to lipoteichoic acid [GO:0071223];apoptotic process [GO:0006915]	cytoplasm [GO:0005737];cytosol [GO:0005829]	ATP binding [GO:0005524];protein serine/threonine kinase activity [GO:0004674]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	0.42	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000032;PRD000417;PRD000345;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PRD000416;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	402				R-HSA-3371497		nucleus [GO:0005634]	
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.43	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD001403;PXD000217;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	363						nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.63	66	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000383;PXD000314;PXD001447;PRD000671;PXD000387;PRD000711;PRD000597;PXD000472;PXD000786;PRD000731;PXD001324;PRD000407	391		1273731		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.64	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	384		926263		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.43	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD001403;PXD000217;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	363	EBI-11139064	1444281				nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	0.42	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000059;PRD000594;PRD000032;PRD000417;PRD000345;PRD000068;PRD000168;PRD000234;PXD000997;PXD001323;PRD000600;PXD000680;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000108;PRD000523;PRD000269;PRD000118;PXD000164;PXD001328;PRD000796;PRD000146;PRD000046;PXD000217;PRD000565;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PRD000416;PXD000472;PRD000151;PRD000731;PXD001324;PRD000407;PRD000167;PXD000964	368	EBI-11139064	1444988		R-HSA-8852276;R-HSA-3371497		nucleus [GO:0005634];cytoplasm [GO:0005737]	GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.61	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PXD000226;PRD000407;PRD000684	381	EBI-11139064	1450456;744989		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.64	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	384		1273730		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule cytoskeleton [GO:0015630];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.6	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	420	EBI-11139064	1457946;1273755;926311		R-HSA-380320	cell division [GO:0051301];microtubule-based process [GO:0007017];cytoskeleton-dependent intracellular transport [GO:0030705]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	structural molecule activity [GO:0005198];GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q9BQE3	Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain]	TUBA1C	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.42	50	PRD000733;PXD000948;PRD000345;PXD000426;PRD000032;PRD000053;PXD000743;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PXD000680;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PRD000444;PXD000472;PXD000164;PRD000001;PXD000217;PRD000565;PXD000218;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PRD000118;PRD000523;PRD000535;PRD000269;PXD001447;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	290	EBI-11139064	1445005				cytoplasm [GO:0005737]	
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.48	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140						nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96KK5	Histone H2A type 1-H (Histone H2A/s)	HIST1H2AH	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P68871	Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]	HBB	P69905	Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain)	HBA1;HBA2	0.51	55	PRD000020;PRD000053;PRD000154;PRD000269;PRD000032;PXD000743;PRD000738;PRD000668;PXD000746;PRD000417;PRD000684;PRD000416;PRD000631;PXD000948;PXD000383;PXD001174;PRD000373;PXD001328;PXD000164;PXD001422;PRD000796;PRD000073;PRD000092;PRD000477;PRD000594;PRD000059;PRD000680;PRD000551;PRD000212;PXD001403;PRD000544;PRD000001;PRD000565;PRD000532;PRD000600;PXD001324;PRD000234;PRD000733;PRD000108;PRD000180;PRD000362;PRD000118;PXD000226;PRD000597;PRD000523;PRD000535;PXD001323;PRD000345;PRD000731;PRD000019;PRD000364;PXD000387;PRD000711;PRD000407;PRD000146	334	EBI-20013037;EBI-20013051;EBI-9208308;EBI-1042156;EBI-1032489;EBI-1032478;EBI-1029816;EBI-1029806;EBI-1029796;EBI-1027836;EBI-1027513;EBI-1027502;EBI-1027413;EBI-1026804;EBI-1025887;EBI-1025877;EBI-1025867;EBI-1025857;EBI-1025847;EBI-1025836;EBI-1025826;EBI-732103	275234;270393		R-HSA-2168880;R-HSA-1247673;R-HSA-1237044	oxygen transport [GO:0015671];positive regulation of cell death [GO:0010942];hydrogen peroxide catabolic process [GO:0042744];cellular oxidant detoxification [GO:0098869];response to hydrogen peroxide [GO:0042542];bicarbonate transport [GO:0015701];protein heterooligomerization [GO:0051291];receptor-mediated endocytosis [GO:0006898]	cytosol [GO:0005829];endocytic vesicle lumen [GO:0071682];hemoglobin complex [GO:0005833];extracellular space [GO:0005615];haptoglobin-hemoglobin complex [GO:0031838];extracellular region [GO:0005576];blood microparticle [GO:0072562];extracellular exosome [GO:0070062]	heme binding [GO:0020037];oxygen binding [GO:0019825];oxygen carrier activity [GO:0005344]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	0.41	52	PRD000020;PRD000345;PRD000032;PRD000053;PRD000565;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD000948;PXD000529;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PRD000796;PRD000059;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000407;PXD000593;PRD000600;PRD000594;PRD000607;PRD000680;PXD000218;PXD000426;PRD000073;PRD000168;PRD000364;PRD000151;PXD000217;PRD000671;PXD001572;PXD001324;PRD000234;PRD000444;PXD000383;PRD000523;PXD001447;PXD000164;PXD000533;PRD000108;PXD000964	234				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule cytoskeleton [GO:0015630];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.47	58	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000417;PRD000053;PXD000529;PXD001310;PRD000269;PXD000387;PXD001328;PRD000565;PXD000997;PXD001422;PRD000154;PRD000796;PRD000073;PRD000416;PRD000465;PRD000146;PXD000047;PRD000594;PRD000711;PRD000597;PRD000407;PRD000671;PXD000593;PRD000600;PXD001323;PRD000046;PRD000059;PRD000607;PRD000680;PXD000218;PXD000746;PXD000164;PRD000168;PRD000151;PXD000217;PRD000731;PXD000533;PXD001572;PXD001324;PRD000234;PXD000314;PRD000180;PXD000226;PRD000444;PXD001447;PRD000738;PRD000108	328						nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.52	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000383;PXD001447;PRD000671;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PXD000226;PRD000407	347		1273733		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.49	62	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD000426;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PXD000529;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PXD000314;PXD000593;PRD000407;PRD000594;PRD000046;PRD000607;PRD000680;PXD001572;PXD000164;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000383;PRD000731;PRD000600;PRD000671;PXD001324;PRD000234;PRD000108;PRD000118;PXD000226;PRD000444;PRD000523;PRD000535;PXD000786;PXD001447;PXD000533;PXD001310;PXD000964	341				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.47	58	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000417;PRD000053;PXD000529;PXD001310;PRD000269;PXD000387;PXD001328;PRD000565;PXD000997;PXD001422;PRD000154;PRD000796;PRD000073;PRD000416;PRD000465;PRD000146;PXD000047;PRD000594;PRD000711;PRD000597;PRD000407;PRD000671;PXD000593;PRD000600;PXD001323;PRD000046;PRD000059;PRD000607;PRD000680;PXD000218;PXD000746;PXD000164;PRD000168;PRD000151;PXD000217;PRD000731;PXD000533;PXD001572;PXD001324;PRD000234;PXD000314;PRD000180;PXD000226;PRD000444;PXD001447;PRD000738;PRD000108	328						nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.54	62	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PRD000053;PXD001310;PXD000426;PRD000269;PXD000387;PXD001328;PRD000565;PXD000997;PRD000154;PXD001422;PXD000529;PRD000796;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000407;PRD000671;PXD000593;PRD000594;PRD000046;PRD000607;PRD000680;PXD000164;PRD000092;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PXD000218;PRD000731;PRD000600;PXD001324;PRD000234;PRD000108;PXD000226;PXD000383;PRD000444;PRD000523;PRD000535;PXD000314;PRD000118;PXD001572;PXD000786;PXD001447;PXD000533;PRD000073	339				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.49	62	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD000426;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PXD000529;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PXD000314;PXD000593;PRD000407;PRD000594;PRD000046;PRD000607;PRD000680;PXD001572;PXD000164;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000383;PRD000731;PRD000600;PRD000671;PXD001324;PRD000234;PRD000108;PRD000118;PXD000226;PRD000444;PRD000523;PRD000535;PXD000786;PXD001447;PXD000533;PXD001310;PXD000964	341		1273732		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule cytoskeleton [GO:0015630];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.4	65	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000059;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000383;PXD000314;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PRD000417;PXD001324;PXD000226;PRD000407;PXD000964	366				R-HSA-380320	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q6PEY2	Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain]	TUBA3E	Q3ZCM7	Tubulin beta-8 chain (Tubulin beta 8 class VIII)	TUBB8	0.46	59	PRD000733;PRD000345;PRD000032;PRD000020;PRD000053;PXD000948;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PXD000529;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000671;PRD000407;PXD000593;PRD000594;PRD000059;PRD000607;PRD000680;PXD000426;PRD000092;PRD000068;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PRD000731;PRD000168;PRD000600;PXD001572;PXD001324;PRD000234;PXD000226;PRD000444;PRD000523;PRD000535;PRD000118;PXD001447;PXD000164;PXD000533;PRD000108	292				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148		cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q14839	Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta)	CHD4	O94776	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2	0.54	6	PXD000529;PRD000565;PRD000345;PXD001572;PXD000533;PXD000948	15	EBI-16879171;EBI-16878920;EBI-16878886;EBI-16878833;EBI-8110190;EBI-8110166	1264986;1241827;741727;676525;569519;516198;255667;255650	888;778;685;632;61	R-HSA-3214815;R-HSA-427389;R-HSA-6804758;R-HSA-73762;R-HSA-8943724	ATP-dependent chromatin remodeling [GO:0043044]	NuRD complex [GO:0016581];nucleoplasm [GO:0005654];nuclear chromatin [GO:0000790];protein-containing complex [GO:0032991];membrane [GO:0016020]	histone deacetylase binding [GO:0042826];RNA polymerase II repressing transcription factor binding [GO:0001103];zinc ion binding [GO:0008270];histone deacetylase activity [GO:0004407]
P01859	Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)	IGHG2	P01857	Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)	IGHG1	0.57	28	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000053;PXD001403;PXD001422;PRD000796;PRD000164;PXD000164;PXD000743;PRD000364;PXD000765;PRD000059;PRD000212;PRD000151;PRD000185;PRD000068;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000345;PRD000362	236				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01859	Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)	IGHG2	P01876	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	0.47	28	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000185;PRD000053;PXD001422;PRD000796;PRD000164;PXD000164;PXD000743;PXD000765;PRD000059;PRD000212;PXD001403;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000345;PRD000362;PRD000364;PXD001447;PRD000113	205					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	extracellular region [GO:0005576];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01859	Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)	IGHG2	P01861	Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)	IGHG4	0.44	24	PRD000073;PRD000738;PXD000746;PXD000743;PRD000019;PXD000383;PRD000269;PRD000053;PXD001422;PRD000416;PRD000164;PXD000164;PRD000671;PRD000059;PRD000212;PXD001403;PRD000417;PRD000551;PRD000631;PRD000565;PRD000185;PXD001324;PRD000146;PRD000364	104				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01859	Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE)	IGHG2	P01860	Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)		0.54	28	PRD000164;PRD000073;PRD000417;PRD000738;PXD000746;PRD000416;PRD000185;PRD000019;PXD000383;PRD000269;PRD000053;PXD001422;PXD000164;PXD000743;PXD000765;PRD000059;PRD000212;PXD001403;PRD000551;PRD000151;PRD000565;PRD000631;PXD001324;PRD000671;PRD000146;PRD000345;PRD000362;PRD000364	198				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	0.41	17	PRD000053;PRD000444;PRD000594;PXD001323;PRD000668;PXD000948;PXD000529;PXD001324;PRD000146;PXD000218;PRD000345;PXD001572;PXD000164;PXD001422;PXD000387;PRD000020;PRD000711	71							
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P30044	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)	PRDX5	0.43	20	PRD000053;PXD000529;PRD000444;PXD001323;PRD000594;PRD000668;PXD000948;PXD001324;PRD000146;PRD000234;PXD000218;PXD000164;PXD001422;PXD000533;PRD000738;PXD000387;PRD000020;PXD001572;PRD000711;PRD000345	76						mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P48735	Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)	IDH2	0.4	18	PRD000053;PXD000529;PRD000594;PXD001323;PRD000668;PRD000671;PRD000443;PXD001324;PRD000234;PXD001328;PRD000345;PXD001572;PXD001422;PXD000164;PRD000738;PRD000073;PRD000711;PXD000426	69						mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P54819	Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]	AK2	0.41	19	PRD000053;PXD000426;PRD000444;PXD001323;PRD000594;PRD000668;PXD000948;PXD000529;PXD001324;PXD000218;PRD000345;PXD001422;PXD000164;PXD000533;PRD000738;PXD000387;PRD000146;PXD001572;PRD000711	76							
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.4	17	PRD000053;PXD000529;PXD001323;PRD000594;PRD000668;PXD000948;PXD001324;PRD000345;PRD000565;PXD001422;PXD000164;PXD000533;PRD000738;PRD000146;PRD000020;PXD001572;PRD000711	70							
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	P30084	Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)	ECHS1	0.41	17	PRD000053;PXD000529;PRD000444;PRD000594;PXD001323;PRD000668;PXD001324;PRD000234;PXD001572;PXD000218;PXD001422;PXD000387;PRD000146;PRD000020;PXD000426;PRD000711;PXD000948	63						mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P13804	Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)	ETFA	Q99714	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)	HSD17B10	0.43	22	PRD000053;PRD000565;PXD000529;PRD000444;PXD001323;PRD000594;PRD000668;PXD000948;PXD001324;PRD000146;PRD000234;PRD000671;PXD001572;PXD000164;PXD000533;PXD001422;PRD000738;PRD000345;PXD000387;PXD000218;PRD000020;PRD000711	76						mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P01857	Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)	IGHG1	P01876	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	0.43	31	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000185;PRD000053;PXD001422;PRD000796;PRD000164;PXD000050;PXD000164;PXD001403;PXD000743;PXD000765;PRD000059;PRD000607;PRD000212;PRD000631;PRD000532;PXD001324;PRD000671;PRD000551;PRD000146;PXD001447;PRD000345;PRD000362;PRD000364;PRD000113	215					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	extracellular region [GO:0005576];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01857	Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)	IGHG1	P01861	Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)	IGHG4	0.43	24	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000053;PXD001403;PXD001422;PRD000796;PXD000164;PXD000743;PXD000765;PRD000059;PRD000212;PRD000151;PRD000068;PRD000631;PXD001324;PRD000551;PRD000146;PRD000185;PRD000671	215				R-HSA-977606;R-HSA-6785807;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];cytokine-mediated signaling pathway [GO:0019221];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01857	Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE)	IGHG1	P01860	Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)		0.4	25	PRD000164;PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000053;PXD001422;PRD000796;PXD000164;PXD000743;PRD000364;PRD000059;PRD000212;PXD001403;PRD000151;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000185;PRD000345	186				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P15259	Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M)	PGAM2	Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	0.4	23	PRD000053;PRD000668;PRD000417;PXD000529;PXD001572;PXD001422;PRD000465;PRD000416;PRD000269;PRD000711;PRD000597;PRD000092;PRD000594;PXD001323;PXD000948;PXD001403;PRD000731;PXD001324;PRD000146;PXD000218;PXD000164;PRD000118;PRD000407	101						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	0.4	2	PRD000345;PRD000443	45				R-HSA-2894862;R-HSA-2644606;R-HSA-2122947	protein deacetylation [GO:0006476];positive regulation of receptor biosynthetic process [GO:0010870];histone deacetylation [GO:0016575];transcription, DNA-templated [GO:0006351];negative regulation of transcription, DNA-templated [GO:0045892]	histone deacetylase complex [GO:0000118];nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829]	histone deacetylase binding [GO:0042826];RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978];NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041];enzyme binding [GO:0019899];histone deacetylase activity [GO:0004407]
Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	0.46	2	PRD000345;PXD001422	38					intracellular protein transport [GO:0006886]	perinuclear region of cytoplasm [GO:0048471];cytosol [GO:0005829]	zinc ion binding [GO:0008270]
Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	P46109	Crk-like protein	CRKL	0.42	4	PRD000345;PRD000032;PRD000053;PXD001422	40						nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q9UBN7	Histone deacetylase 6 (HD6) (EC 3.5.1.98)	HDAC6	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.4	1	PRD000345	34						cytosol [GO:0005829]	
Q9UKU7	Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.99.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)	ACAD8	Q6PJ69	Tripartite motif-containing protein 65	TRIM65	0.42	2	PRD000345;PXD001422	15							
Q9UKU7	Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.99.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)	ACAD8	Q9BPZ7	Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) (mSIN1)	MAPKAP1	0.4	1	PRD000345	16							
P12429	Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)	ANXA3	P14780	Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9]	MMP9	0.42	7	PRD000684;PRD000477;PRD000059;PRD000118;PXD000164;PRD000113;PRD000053	29					neutrophil degranulation [GO:0043312]	extracellular exosome [GO:0070062]	
Q5JTH9	RRP12-like protein	RRP12	Q9H0A0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	NAT10	0.51	7	PXD000047;PXD001572;PXD000426;PXD000533;PRD000597;PXD000593;PXD000314	10						nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q7Z3Y7	Keratin, type I cytoskeletal 28 (Cytokeratin-28) (CK-28) (Keratin-25D) (K25D) (Keratin-28) (K28) (Type I inner root sheath-specific keratin-K25irs4)	KRT28	Q14CN4	Keratin, type II cytoskeletal 72 (Cytokeratin-72) (CK-72) (Keratin-72) (K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)	KRT72	0.41	42	PRD000069;PXD000743;PRD000092;PRD000373;PXD001328;PXD001572;PXD000593;PRD000154;PRD000796;PXD000164;PXD000047;PRD000711;PRD000671;PRD000172;PXD000746;PRD000407;PRD000059;PXD001174;PRD000607;PRD000680;PXD001323;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PRD000733;PXD001324;PRD000234;PXD000997;PRD000444;PRD000345;PRD000113;PRD000443;PRD000597;PRD000164;PRD000600;PXD001447;PRD000364;PRD000019;PXD001422;PRD000146	135				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y7	Keratin, type I cytoskeletal 28 (Cytokeratin-28) (CK-28) (Keratin-25D) (K25D) (Keratin-28) (K28) (Type I inner root sheath-specific keratin-K25irs4)	KRT28	Q86Y46	Keratin, type II cytoskeletal 73 (Cytokeratin-73) (CK-73) (Keratin-73) (K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)	KRT73	0.41	43	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PXD000387;PRD000373;PXD001328;PXD001572;PRD000154;PXD000593;PRD000345;PXD000164;PXD000047;PRD000711;PRD000671;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PXD001323;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001324;PRD000146;PRD000234;PXD000997;PRD000444;PRD000113;PRD000443;PRD000597;PRD000164;PRD000600;PRD000362;PXD001447;PRD000364;PRD000019;PXD001422;PRD000269	140				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y7	Keratin, type I cytoskeletal 28 (Cytokeratin-28) (CK-28) (Keratin-25D) (K25D) (Keratin-28) (K28) (Type I inner root sheath-specific keratin-K25irs4)	KRT28	Q7RTS7	Keratin, type II cytoskeletal 74 (Cytokeratin-74) (CK-74) (Keratin-5c) (K5C) (Keratin-74) (K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)	KRT74	0.41	43	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000373;PXD001328;PXD001572;PRD000154;PXD000593;PRD000345;PXD000164;PXD000047;PRD000711;PRD000671;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PRD000680;PXD001323;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001324;PRD000234;PXD000997;PRD000444;PRD000113;PRD000443;PRD000597;PRD000164;PRD000600;PRD000362;PXD001447;PRD000364;PRD000019;PXD001422;PRD000146;PRD000269	141				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y7	Keratin, type I cytoskeletal 28 (Cytokeratin-28) (CK-28) (Keratin-25D) (K25D) (Keratin-28) (K28) (Type I inner root sheath-specific keratin-K25irs4)	KRT28	Q3SY84	Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34)	KRT71	0.43	42	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000373;PXD001328;PXD001572;PRD000154;PXD000593;PXD000164;PXD000047;PRD000711;PRD000671;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PXD001323;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001324;PRD000146;PRD000234;PXD000997;PRD000345;PRD000113;PRD000443;PRD000597;PRD000444;PRD000164;PRD000600;PRD000362;PXD001447;PRD000364;PRD000019;PXD001422;PRD000269	136	EBI-19825170;EBI-19825183			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q15819	Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein)	UBE2V2	O15145	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	0.4	9	PRD000053;PRD000668;PRD000711;PRD000597;PXD000529;PXD001323;PXD000533;PXD001422;PRD000738	55						extracellular exosome [GO:0070062]	
Q15819	Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein)	UBE2V2	P30046	D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II)	DDT	0.41	13	PRD000053;PXD001323;PRD000668;PRD000059;PRD000711;PXD000529;PXD001324;PRD000269;PRD000594;PXD001422;PRD000417;PRD000020;PXD000948	52						cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q9HCE1	Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein)	MOV10	0.42	6	PXD000529;PXD000047;PXD001572;PXD000533;PXD000426;PXD000593	12							ATP binding [GO:0005524];RNA binding [GO:0003723]
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q9H0A0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	NAT10	0.41	9	PRD000565;PXD000047;PXD001572;PXD000529;PXD000426;PXD000533;PRD000146;PRD000597;PXD000593	15						nucleolus [GO:0005730];membrane [GO:0016020]	ATP binding [GO:0005524];RNA binding [GO:0003723]
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q8IY81	pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3	0.42	8	PXD000047;PXD000426;PXD001572;PXD000533;PRD000146;PXD000964;PXD000593;PRD000597	17						nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q96GQ7	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27	0.44	6	PXD000529;PXD000047;PXD001572;PXD000533;PRD000597;PXD000593	11					RNA secondary structure unwinding [GO:0010501]	cytoplasm [GO:0005737];nucleolus [GO:0005730]	ATP binding [GO:0005524];RNA binding [GO:0003723];ATP-dependent RNA helicase activity [GO:0004004]
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q9BZE4	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4	0.42	8	PXD000529;PXD000047;PXD000426;PXD001572;PRD000146;PXD000593;PXD000964;PRD000597	12						nucleolus [GO:0005730];cytoplasm [GO:0005737];membrane [GO:0016020]	RNA binding [GO:0003723]
Q9BQ39	ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2)	DDX50	Q9BVP2	Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47) (NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin)	GNL3	0.42	7	PXD000529;PXD001572;PRD000146;PXD000593;PXD000426;PXD000964;PRD000597	12						nucleolus [GO:0005730];membrane [GO:0016020]	RNA binding [GO:0003723]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.49	43	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	130		752989		R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nuclear chromosome, telomeric region [GO:0000784];nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135						nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.49	43	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	130				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.47	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.49	43	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	130				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	43	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	130				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.5	43	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	130				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q96QV6	Histone H2A type 1-A (Histone H2A/r)	HIST1H2AA	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.46	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	135				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	0.4	30	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000001;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PXD000164;PRD000600;PRD000118;PRD000364;PXD000533	105					protein transport [GO:0015031]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P61204	ADP-ribosylation factor 3	ARF3	0.43	29	PXD000948;PRD000053;PRD000668;PRD000443;PRD000738;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000733;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000020;PXD001403;PRD000068;PRD000001;PXD000218;PRD000671;PRD000032;PRD000565;PRD000345;PRD000118;PRD000600;PXD000164;PRD000407	107				R-HSA-6811434;R-HSA-6807878	retrograde vesicle-mediated transport, Golgi to ER [GO:0006890];protein transport [GO:0015031]	Golgi membrane [GO:0000139];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P51149	Ras-related protein Rab-7a	RAB7A	0.45	27	PRD000020;PRD000053;PRD000668;PRD000738;PXD000529;PRD000154;PXD001422;PRD000146;PXD000948;PXD000164;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PRD000001;PRD000417;PRD000565;PRD000733;PXD001324;PRD000444;PRD000345;PRD000118;PXD001572;PXD000533;PRD000407	109		1268590		R-HSA-8876198;R-HSA-8873719	protein transport [GO:0015031]	phagophore assembly site membrane [GO:0034045];cytosol [GO:0005829];Golgi apparatus [GO:0005794];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.46	27	PRD000053;PRD000020;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PRD000118;PXD000948;PRD000711;PRD000597;PXD000426;PRD000092;PXD001323;PRD000001;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PRD000594;PXD000164;PXD000533;PRD000407;PRD000269;PXD001422	92		1268472;746315		R-HSA-8873719	post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P61224	Ras-related protein Rap-1b (GTP-binding protein smg p21B)	RAP1B	0.4	30	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000001;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PXD000164;PRD000600;PRD000118;PRD000364;PXD000533	106						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.45	26	PRD000020;PRD000053;PRD000668;PRD000443;PXD000529;PXD001572;PXD001422;PRD000711;PRD000154;PRD000092;PXD001323;PRD000607;PXD000948;PRD000001;PRD000565;PRD000600;PRD000733;PXD001324;PRD000146;PXD000164;PRD000594;PXD000533;PRD000738;PRD000407;PRD000269;PXD000426	96	EBI-6879922;EBI-6880084;EBI-8020250	2396512;1268517		R-HSA-8876198;R-HSA-8873719	protein transport [GO:0015031]	extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9H0U4	Ras-related protein Rab-1B	RAB1B	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.4	26	PRD000053;PRD000668;PRD000738;PXD000529;PRD000154;PRD000118;PRD000796;PXD000164;PRD000711;PRD000092;PXD001323;PRD000607;PRD000020;PRD000068;PRD000001;PRD000565;PRD000733;PXD000948;PXD000218;PRD000597;PRD000269;PRD000594;PXD001572;PRD000364;PXD000533;PXD001422	92						cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q9UL46	Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta)	PSME2	Q06323	Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha)	PSME1	0.45	22	PRD000345;PRD000053;PRD000668;PRD000443;PXD000529;PXD000426;PRD000154;PXD001422;PRD000146;PRD000711;PRD000092;PXD001323;PXD000948;PRD000020;PXD000218;PRD000731;PXD000217;PXD001324;PRD000032;PRD000594;PXD001328;PRD000738	117	EBI-8375919;EBI-18782192;EBI-18750441;EBI-18782205;EBI-18750454;EBI-760252	940840;924345;740853;719227;719226;719223;675560;675559;301951;122103	193;192;30	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];regulation of proteasomal protein catabolic process [GO:0061136];positive regulation of endopeptidase activity [GO:0010950];protein deubiquitination [GO:0016579];regulation of G1/S transition of mitotic cell cycle [GO:2000045]	proteasome activator complex [GO:0008537];cytosol [GO:0005829];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	endopeptidase activator activity [GO:0061133]
Q12873	Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)	CHD3	Q13330	Metastasis-associated protein MTA1	MTA1	0.43	7	PXD001572;PRD000345;PRD000565;PXD000529;PXD000533;PXD000680;PXD000314	12	EBI-16878902;EBI-16878859	1264972;569445;520058;483508	632;614;282	R-HSA-3214815;R-HSA-427389;R-HSA-73762;R-HSA-8943724	transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];NuRD complex [GO:0016581]	zinc ion binding [GO:0008270];histone deacetylase activity [GO:0004407]
Q12873	Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH)	CHD3	Q8WXI9	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B	0.53	7	PXD000529;PXD001572;PRD000345;PXD000533;PXD000680;PRD000118;PXD000314	12	EBI-16878902;EBI-16878859	2222359;1259965;1192032		R-HSA-3214815;R-HSA-427389;R-HSA-6804758;R-HSA-73762;R-HSA-8943724	transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]	zinc ion binding [GO:0008270]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	P51149	Ras-related protein Rab-7a	RAB7A	0.41	26	PRD000020;PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000417;PRD000594;PXD001323;PRD000092;PRD000607;PXD000948;PRD000001;PXD000164;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000118;PXD000533	91		1268591		R-HSA-6798695	protein transport [GO:0015031];neutrophil degranulation [GO:0043312]	phagocytic vesicle [GO:0045335];late endosome [GO:0005770];plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.41	25	PRD000053;PXD001328;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PRD000118;PRD000001;PRD000565;PXD000529;PRD000733;PRD000600;PXD001324;PRD000146;PRD000684;PRD000345;PXD001572;PRD000594;PXD001422;PXD000533;PXD001323;PRD000020;PRD000597;PRD000269	80						phagocytic vesicle [GO:0045335];cell junction [GO:0030054];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	O14950	Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)	MYL12B	0.4	28	PRD000020;PRD000053;PRD000668;PRD000738;PXD000529;PXD000387;PRD000269;PRD000684;PRD000565;PXD001572;PRD000154;PXD001422;PRD000711;PRD000594;PXD001323;PRD000680;PXD000948;PRD000068;PRD000001;PXD000217;PXD000164;PRD000733;PRD000146;PRD000180;PRD000535;PRD000600;PRD000364;PRD000118	97						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.42	28	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PXD000164;PRD000600;PRD000118;PRD000364	102					protein transport [GO:0015031]		GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.41	15	PRD000053;PRD000154;PXD001323;PRD000594;PRD000668;PRD000738;PRD000711;PXD000948;PRD000733;PXD001324;PRD000345;PXD001422;PXD001572;PRD000020;PRD000565	73				R-HSA-6798695	neutrophil degranulation [GO:0043312]	cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.42	24	PRD000053;PRD000668;PRD000738;PXD000529;PRD000684;PXD001328;PXD001572;PRD000154;PXD001422;PRD000711;PRD000092;PXD001323;PRD000607;PRD000068;PRD000565;PXD000164;PRD000733;PXD001324;PRD000345;PXD000948;PRD000118;PRD000600;PXD000533;PRD000269	86					signal transduction [GO:0007165]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	P61006	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A	0.41	26	PRD000020;PRD000053;PRD000738;PRD000668;PXD001572;PXD001422;PRD000711;PRD000597;PRD000154;PRD000092;PXD001323;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000565;PXD000164;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PRD000600;PRD000118;PRD000364	95		1268601				phagocytic vesicle [GO:0045335];plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P62834	Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1)	RAP1A	P61026	Ras-related protein Rab-10	RAB10	0.42	30	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001328;PXD001572;PXD001422;PRD000711;PRD000597;PRD000154;PRD000092;PXD001323;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PXD000164;PRD000600;PRD000118;PRD000364;PRD000594;PXD000533	97				R-HSA-6798695	neutrophil degranulation [GO:0043312]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q8NBJ5	Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (ColGalT 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1)	COLGALT1	O60568	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3)	PLOD3	0.51	7	PXD001328;PRD000345;PXD001572;PXD001422;PXD000529;PXD000533;PXD001323	10	EBI-8429350;EBI-8419242;EBI-8412660;EBI-8392519;EBI-8362519;EBI-8333649;EBI-8312518	1266790		R-HSA-1650814			procollagen galactosyltransferase activity [GO:0050211]
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.4	13	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000212;PXD001403;PXD000412;PRD000631;PRD000172;PRD000551;PRD000158	123						extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P08697	Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)	SERPINF2	0.41	13	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PRD000172;PXD001403;PRD000551;PRD000158;PRD000019;PXD000743	101				R-HSA-75205;R-HSA-114608	platelet degranulation [GO:0002576];fibrinolysis [GO:0042730];negative regulation of fibrinolysis [GO:0051918]	extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];cell surface [GO:0009986];blood microparticle [GO:0072562];extracellular exosome [GO:0070062]	serine-type endopeptidase inhibitor activity [GO:0004867]
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P20742	Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)	PZP	0.4	11	PRD000073;PXD000383;PRD000059;PRD000185;PRD000053;PXD000164;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158	92						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P43652	Afamin (Alpha-albumin) (Alpha-Alb)	AFM	0.41	11	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158	105						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P05156	Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain]	CFI	0.4	12	PRD000631;PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PXD001403;PRD000172;PRD000417;PRD000551;PRD000158	98						extracellular region [GO:0005576];extracellular exosome [GO:0070062]	metal ion binding [GO:0046872]
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.49	14	PRD000059;PRD000185;PXD000383;PRD000053;PRD000073;PXD000164;PRD000477;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000019;PXD000743	109				R-HSA-114608	platelet degranulation [GO:0002576];fibrinolysis [GO:0042730]	extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.55	13	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000551;PRD000345;PRD000158;PRD000269	118				R-HSA-114608	platelet degranulation [GO:0002576]	extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P04196	Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG)	HRG	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.41	13	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000477;PRD000212;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158	126						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02647	Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]	APOA1	P01023	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M	0.4	26	PRD000032;PRD000073;PXD000383;PRD000668;PRD000417;PRD000185;PRD000053;PXD001422;PXD001323;PXD000164;PRD000711;PRD000416;PRD000059;PRD000158;PXD001403;PRD000631;PXD000412;PRD000020;PRD000172;PXD001324;PRD000551;PRD000362;PRD000364;PXD000533;PRD000738;PXD000743	131				R-HSA-8963896;R-HSA-114608	platelet degranulation [GO:0002576]	extracellular region [GO:0005576];cytosol [GO:0005829];blood microparticle [GO:0072562];extracellular exosome [GO:0070062]	enzyme binding [GO:0019899]
P02647	Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]	APOA1	P02675	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	FGB	0.43	21	PRD000073;PRD000738;PRD000668;PRD000417;PRD000416;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PRD000477;PRD000158;PRD000059;PRD000212;PXD000743;PRD000631;PXD001324;PRD000551;PRD000362;PRD000269;PRD000364	143				R-HSA-114608	platelet degranulation [GO:0002576];positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	extracellular vesicle [GO:1903561];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];cell surface [GO:0009986];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	
P02647	Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))]	APOA1	P02671	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	FGA	0.44	24	PRD000073;PRD000738;PRD000417;PRD000416;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PXD001403;PRD000269;PRD000477;PRD000158;PRD000059;PRD000212;PXD000743;PRD000631;PRD000020;PRD000172;PXD001324;PRD000551;PRD000032;PRD000362;PRD000364	146	EBI-6595065;EBI-1220621	1504528;825506		R-HSA-977225;R-HSA-8957275;R-HSA-381426;R-HSA-114608	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687];platelet degranulation [GO:0002576];positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]	endoplasmic reticulum lumen [GO:0005788];extracellular vesicle [GO:1903561];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];cell surface [GO:0009986];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	
A0A087WSX0	Immunoglobulin lambda variable 5-45	IGLV5-45	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.5	2	PXD000383;PXD001403	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSX0	Immunoglobulin lambda variable 5-45	IGLV5-45	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.42	2	PXD000383;PXD001403	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSX0	Immunoglobulin lambda variable 5-45	IGLV5-45	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.62	2	PXD000383;PXD001403	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P01591	Immunoglobulin J chain (Joining chain of multimeric IgA and IgM)	JCHAIN	0.41	15	PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD000743;PRD000053;PRD000416;PXD001422;PRD000059;PXD000164;PXD001403;PRD000269;PXD001174	41				R-HSA-2168880;R-HSA-202733	receptor-mediated endocytosis [GO:0006898];immune response [GO:0006955];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.51	17	PRD000417;PRD000551;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	0.41	12	PRD000019;PRD000551;PRD000671;PRD000631;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403	40					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.44	16	PRD000417;PRD000671;PRD000631;PRD000551;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	0.43	12	PRD000019;PRD000551;PRD000671;PRD000631;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403	40					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.51	15	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD000743;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.43	6	PXD000383;PRD000671;PRD000019;PXD001403;PXD001422;PRD000212	17					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.54	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.49	15	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	43				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.47	12	PXD001324;PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PXD000743	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.53	11	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PRD000059;PXD001422;PXD001403;PXD000164	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.54	16	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PRD000059;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	48				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.55	14	PRD000417;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PXD000743;PRD000053;PXD000164;PRD000631;PXD001403;PXD001174;PRD000019	40				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.47	3	PXD000383;PXD001422;PXD001403	13				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.43	8	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PXD001174	25					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.56	14	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	42					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01597	Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker)	IGKV1-39	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.48	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD001422;PXD001403;PXD001174;PRD000019	34					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01591	Immunoglobulin J chain (Joining chain of multimeric IgA and IgM)	JCHAIN	P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	0.43	16	PXD001324;PRD000631;PRD000671;PXD000383;PRD000551;PRD000212;PXD000743;PRD000053;PRD000185;PRD000416;PXD001422;PRD000059;PXD000164;PXD001403;PRD000269;PXD001174	44				R-HSA-2168880;R-HSA-202733	receptor-mediated endocytosis [GO:0006898];immune response [GO:0006955];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01591	Immunoglobulin J chain (Joining chain of multimeric IgA and IgM)	JCHAIN	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.4	15	PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD000743;PRD000053;PRD000416;PXD001422;PRD000059;PXD000164;PXD001403;PRD000269;PXD001174	41				R-HSA-2168880;R-HSA-202733	receptor-mediated endocytosis [GO:0006898];immune response [GO:0006955];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
Q969H8	Myeloid-derived growth factor (MYDGF) (Interleukin-25) (IL-25) (Stromal cell-derived growth factor SF20)	MYDGF	Q13404	Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)	UBE2V1	0.4	12	PRD000053;PXD000948;PRD000594;PXD001323;PRD000668;PRD000597;PRD000733;PXD001324;PXD001422;PRD000796;PXD001572;PRD000711	55							
P01024	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3	P01023	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M	0.52	28	PRD000073;PRD000032;PRD000631;PRD000417;PRD000059;PRD000185;PRD000416;PRD000269;PXD000383;PRD000053;PXD001422;PXD000164;PRD000711;PRD000158;PRD000597;PRD000212;PXD001403;PXD000533;PXD000412;PRD000172;PXD001324;PRD000551;PRD000146;PRD000113;PRD000362;PRD000364;PRD000738;PXD000743	202						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	signaling receptor binding [GO:0005102]
P01024	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3	P04114	Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]	APOB	0.46	20	PRD000073;PRD000059;PRD000185;PRD000053;PRD000417;PXD000164;PRD000711;PXD000383;PXD001403;PXD000533;PRD000416;PRD000631;PRD000068;PRD000172;PRD000551;PRD000032;PRD000158;PRD000362;PRD000364;PXD000743	147				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];positive regulation of lipid storage [GO:0010884];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	
P01024	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3	P0C0L5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B;C4B_2	0.46	30	PRD000073;PRD000417;PRD000059;PXD000746;PRD000416;PRD000185;PRD000269;PXD000383;PRD000053;PXD001572;PXD001422;PXD000050;PXD000164;PXD000047;PXD001447;PRD000477;PRD000711;PRD000158;PRD000212;PXD000743;PRD000631;PXD001403;PRD000172;PXD001324;PRD000551;PRD000146;PRD000113;PRD000362;PRD000364;PRD000092	215				R-HSA-977606;R-HSA-174577	inflammatory response [GO:0006954];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of apoptotic cell clearance [GO:2000427];complement activation, classical pathway [GO:0006958]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase activity [GO:0004252];endopeptidase inhibitor activity [GO:0004866]
P01024	Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2]	C3	P0C0L4	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A	0.46	32	PRD000073;PRD000417;PRD000059;PXD000746;PRD000416;PRD000185;PRD000269;PXD000383;PRD000053;PXD001572;PXD001422;PXD000050;PXD000164;PXD000047;PXD001447;PRD000477;PRD000711;PRD000158;PRD000212;PXD000743;PRD000631;PXD001403;PRD000172;PXD001324;PRD000551;PRD000146;PRD000113;PRD000345;PXD001328;PRD000362;PRD000364;PRD000092	217				R-HSA-977606;R-HSA-8957275;R-HSA-381426;R-HSA-174577	cellular protein metabolic process [GO:0044267];positive regulation of apoptotic cell clearance [GO:2000427];complement activation, classical pathway [GO:0006958];inflammatory response [GO:0006954];post-translational protein modification [GO:0043687];regulation of complement activation [GO:0030449];complement activation [GO:0006956]	endoplasmic reticulum lumen [GO:0005788];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	serine-type endopeptidase activity [GO:0004252];endopeptidase inhibitor activity [GO:0004866]
P01023	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M	P0C0L5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B;C4B_2	0.47	26	PRD000073;PRD000032;PRD000631;PRD000417;PRD000059;PRD000185;PRD000416;PXD000383;PRD000053;PXD001422;PXD000164;PRD000711;PRD000158;PRD000212;PXD001403;PRD000172;PXD001324;PRD000551;PRD000146;PRD000113;PRD000362;PRD000019;PRD000364;PXD000533;PXD000743;PRD000269	178						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01023	Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5)	A2M	P0C0L4	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A	0.47	26	PRD000073;PRD000032;PRD000631;PRD000417;PRD000059;PRD000185;PRD000416;PXD000383;PRD000053;PXD001422;PXD000164;PRD000711;PRD000158;PRD000212;PXD001403;PRD000172;PXD001324;PRD000551;PRD000146;PRD000113;PRD000362;PRD000019;PRD000364;PXD000533;PXD000743;PRD000269	178						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P61020	Ras-related protein Rab-5B	RAB5B	Q92930	Ras-related protein Rab-8B	RAB8B	0.4	19	PRD000600;PRD000711;PRD000053;PRD000154;PRD000092;PXD001323;PRD000668;PXD000948;PRD000733;PXD001324;PRD000146;PXD000529;PXD001572;PRD000738;PRD000565;PXD001422;PRD000407;PXD000164;PRD000269	70				R-HSA-8876198;R-HSA-8873719;R-HSA-8854214	antigen processing and presentation [GO:0019882]	plasma membrane [GO:0005886];endosome [GO:0005768];intracellular membrane-bounded organelle [GO:0043231];extracellular exosome [GO:0070062];secretory granule membrane [GO:0030667]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P61020	Ras-related protein Rab-5B	RAB5B	P20339	Ras-related protein Rab-5A	RAB5A	0.41	7	PRD000053;PXD001323;PRD000154;PXD001324;PRD000092;PRD000668;PXD001422	21				R-HSA-8876198;R-HSA-8873719;R-HSA-8856828;R-HSA-8854214	regulation of endocytosis [GO:0030100];protein transport [GO:0015031]	extracellular exosome [GO:0070062];endosome [GO:0005768];early endosome membrane [GO:0031901];early endosome [GO:0005769];melanosome [GO:0042470];endocytic vesicle [GO:0030139];plasma membrane [GO:0005886]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P61020	Ras-related protein Rab-5B	RAB5B	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.41	12	PRD000733;PRD000053;PRD000154;PXD001323;PRD000092;PXD001324;PRD000001;PXD000529;PRD000668;PXD001422;PXD001572;PRD000711	42		2225843		R-HSA-8873719	protein transport [GO:0015031]	plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P08729	Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)	KRT7	P08727	Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)	KRT19	0.43	45	PRD000069;PXD000743;PXD000746;PRD000345;PXD000529;PXD000387;PXD001328;PXD000997;PXD001572;PRD000154;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PRD000172;PRD000092;PRD000164;PRD000059;PXD001174;PRD000607;PXD000948;PXD000786;PXD000533;PRD000151;PXD001402;PRD000565;PRD000212;PXD000218;PXD000593;PXD001324;PRD000551;PRD000234;PRD000444;PRD000113;PRD000443;PXD000383;PXD001323;PRD000594;PRD000600;PXD001447;PXD000164;PRD000407;PXD000964	122				R-HSA-6809371;R-HSA-6805567	viral process [GO:0016032];cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08729	Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)	KRT7	P05783	Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)	KRT18	0.41	37	PRD000069;PXD000743;PRD000123;PXD000746;PXD000948;PXD000529;PXD001328;PXD001572;PRD000154;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PRD000092;PRD000594;PRD000059;PXD001323;PRD000607;PXD000786;PXD000533;PRD000151;PXD001402;PRD000565;PXD000218;PXD001174;PRD000671;PRD000234;PRD000444;PRD000113;PRD000443;PRD000345;PXD000593;PXD001447;PXD000164;PRD000407;PXD000964	99				R-HSA-6809371;R-HSA-6805567	viral process [GO:0016032];cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q04695	Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)	KRT17	Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	0.46	49	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PXD000387;PXD001328;PXD000047;PXD001422;PRD000154;PRD000345;PXD000164;PRD000711;PRD000364;PRD000172;PXD000746;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001403;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PXD000383;PRD000594;PRD000671;PRD000600;PRD000053;PRD000362;PXD001572;PXD001447;PRD000407;PXD000964	155				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q04695	Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)	KRT17	P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	0.46	45	PXD000746;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PXD001328;PXD000047;PXD001422;PRD000154;PRD000796;PRD000164;PXD000164;PRD000711;PRD000364;PRD000172;PRD000059;PXD001323;PRD000607;PXD000948;PXD000997;PRD000212;PXD000593;PRD000151;PXD001403;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000345;PRD000113;PRD000443;PRD000594;PRD000671;PRD000600;PXD001572;PXD001447;PRD000407	146				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q04695	Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)	KRT17	Q5XKE5	Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)	KRT79	0.46	48	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PRD000345;PXD000387;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000164;PXD000164;PRD000711;PRD000364;PRD000172;PXD000746;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001403;PXD001402;PRD000053;PRD000565;PRD000020;PXD000218;PXD001174;PRD000600;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PRD000594;PRD000671;PXD001572;PXD001447;PRD000407;PXD000964	161				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q04695	Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)	KRT17	O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	0.53	50	PRD000345;PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PXD000529;PXD000387;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000146;PXD000164;PRD000711;PRD000364;PRD000172;PXD000746;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001403;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PRD000600;PRD000053;PXD001324;PRD000551;PRD000234;PRD000444;PRD000113;PXD000383;PRD000594;PRD000671;PXD001572;PXD001447;PRD000407;PXD000964	170				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	0.47	29	PRD000565;PXD000948;PXD000426;PRD000053;PRD000443;PXD000529;PXD001310;PXD000387;PRD000345;PRD000154;PXD001422;PRD000668;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000032;PRD000092;PRD000068;PXD000218;PRD000146;PXD000593;PXD000997;PRD000444;PXD001328;PXD001572;PRD000671	147		2246024;1259728;920601;741587		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	0.51	32	PRD000345;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PXD000387;PXD001328;PXD000426;PRD000154;PXD001422;PRD000733;PRD000711;PRD000597;PRD000407;PXD001323;PRD000607;PRD000594;PXD000218;PRD000565;PXD000533;PRD000092;PRD000001;PXD001324;PRD000146;PXD000593;PXD000997;PRD000444;PXD001572;PRD000671;PXD000164	166	EBI-19386547;EBI-19386560	1259724;741518	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];scaRNA localization to Cajal body [GO:0090666];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase activity [GO:0051973];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	0.48	33	PXD000426;PRD000345;PRD000053;PRD000668;PRD000443;PXD000948;PXD000680;PXD000387;PRD000154;PXD001422;PXD000529;PRD000733;PRD000711;PRD000597;PXD001323;PRD000607;PXD000997;PRD000565;PRD000092;PRD000068;PRD000001;PXD000218;PXD001310;PXD001324;PRD000146;PXD000593;PRD000444;PRD000594;PXD001328;PXD001572;PXD000164;PXD000533;PRD000407	174		1259807;920585;741523	6247	R-HSA-6814122;R-HSA-6798695;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821];neutrophil degranulation [GO:0043312]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.51	32	PRD000345;PXD000426;PRD000053;PRD000668;PRD000443;PXD000948;PXD000387;PRD000154;PXD001422;PXD000529;PRD000465;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000032;PXD000218;PXD000533;PRD000565;PRD000092;PRD000001;PXD001310;PXD001324;PRD000146;PXD000593;PXD000997;PRD000444;PXD001328;PXD001572;PRD000671	160		1259725;920584;741519	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P78371	T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta)	CCT2	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.46	35	PRD000345;PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PRD000444;PXD000387;PXD000426;PRD000154;PRD000020;PXD001422;PRD000465;PRD000733;PRD000407;PRD000711;PRD000597;PXD001323;PRD000032;PRD000607;PRD000594;PXD000997;PXD000533;PRD000565;PRD000092;PRD000068;PRD000001;PXD001324;PRD000146;PXD000218;PXD000593;PXD001328;PXD001572;PRD000671	165		2232419;1259723;920586;741520	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	positive regulation of protein localization to Cajal body [GO:1904871];toxin transport [GO:1901998];protein folding [GO:0006457];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P08727	Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)	KRT19	P05787	Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)	KRT8	0.4	51	PRD000020;PRD000069;PXD000743;PXD000746;PRD000443;PRD000345;PXD000529;PXD000387;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PXD000948;PRD000172;PRD000092;PRD000600;PRD000594;PRD000059;PXD001323;PRD000164;PRD000607;PXD000997;PRD000212;PXD000786;PXD000472;PRD000565;PRD000151;PXD001402;PXD000218;PXD001174;PXD000593;PXD001324;PRD000551;PRD000234;PRD000444;PRD000113;PXD000383;PRD000053;PRD000362;PXD000680;PRD000073;PXD001447;PXD000164;PXD000533;PRD000407;PXD000964	150	EBI-18901217;EBI-18901230			R-HSA-6809371;R-HSA-6805567	cell differentiation involved in embryonic placenta development [GO:0060706];viral process [GO:0016032];sarcomere organization [GO:0045214];cornification [GO:0070268];keratinization [GO:0031424]	Z disc [GO:0030018];extracellular exosome [GO:0070062];costamere [GO:0043034];sarcolemma [GO:0042383];dystrophin-associated glycoprotein complex [GO:0016010];intermediate filament [GO:0005882];apicolateral plasma membrane [GO:0016327];cytosol [GO:0005829]	protein-containing complex binding [GO:0044877]
Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	0.52	31	PXD000948;PRD000565;PRD000443;PXD000529;PXD001310;PRD000053;PXD000387;PXD001328;PXD000426;PRD000154;PXD000593;PRD000345;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000032;PRD000092;PRD000020;PXD000218;PXD000217;PRD000146;PXD000997;PRD000444;PXD001422;PXD001572;PRD000671;PRD000738;PRD000407	135		2251353;1259798;920596;741557		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	0.41	32	PXD000426;PRD000053;PRD000443;PXD000948;PXD000529;PXD001310;PXD000387;PRD000154;PXD001422;PRD000345;PRD000668;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000565;PRD000032;PRD000407;PRD000092;PRD000068;PRD000020;PXD000218;PXD000217;PRD000146;PXD000593;PXD000997;PRD000444;PXD001328;PXD001572;PRD000738	135		1259813;920605;741526		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];cell body [GO:0044297];chaperonin-containing T-complex [GO:0005832];cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.48	29	PXD000948;PRD000565;PXD000426;PRD000053;PRD000443;PXD000529;PXD001310;PXD000387;PXD000997;PRD000154;PXD000593;PRD000345;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000032;PRD000092;PRD000020;PXD000218;PRD000146;PRD000444;PXD001422;PXD001328;PXD001572;PRD000671	128		2264032;1259799;920598;741610		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
Q99832	T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]	CCT7	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.45	32	PRD000565;PXD000948;PRD000053;PRD000443;PXD000529;PXD001310;PXD000387;PXD000426;PXD000997;PRD000154;PXD000593;PRD000345;PRD000407;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000046;PRD000607;PRD000068;PRD000020;PRD000146;PXD000218;PRD000444;PXD001328;PRD000167;PXD001572;PRD000032;PXD001422;PRD000671;PRD000738	133		2224415;1259797;920602;741522		R-HSA-6814122;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
Q9H8G2	Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP)	CAAP1	Q9NTI5	Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3)	PDS5B	0.42	4	PXD000218;PXD000680;PRD000118;PXD000314	11							
Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	0.43	49	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000226;PXD000383;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000345;PXD000047;PRD000711;PXD000593;PRD000172;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PRD000600;PRD000053;PRD000362;PXD001572;PXD001447;PRD000364;PRD000407;PXD000964	184	EBI-19794548;EBI-19794561			R-HSA-6809371;R-HSA-6805567	cytoskeleton organization [GO:0007010];cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	0.46	40	PRD000069;PRD000733;PXD000743;PRD000092;PRD000443;PRD000059;PXD000383;PXD000387;PRD000373;PRD000154;PXD001422;PRD000345;PXD000164;PXD000593;PRD000172;PXD000746;PXD001174;PRD000607;PRD000680;PRD000212;PRD000151;PXD001402;PRD000565;PRD000020;PXD001324;PRD000146;PRD000234;PXD000997;PRD000113;PXD001323;PRD000671;PRD000600;PRD000362;PXD000218;PXD001572;PXD001447;PRD000364;PRD000407;PRD000019;PXD000964	158	EBI-19890420;EBI-19890433			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	P13646	Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)	KRT13	0.45	45	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PRD000373;PXD001328;PXD000047;PXD001422;PRD000154;PRD000345;PXD000164;PRD000711;PRD000671;PRD000172;PXD000746;PRD000164;PRD000059;PXD001174;PRD000607;PRD000594;PRD000212;PXD000593;PRD000151;PXD001403;PXD001402;PRD000020;PXD000218;PXD001324;PRD000551;PRD000234;PRD000146;PXD000997;PRD000444;PRD000113;PRD000443;PXD000383;PXD001323;PRD000053;PRD000362;PXD001572;PXD001447;PRD000407;PXD000964	141				R-HSA-6809371;R-HSA-6805567	cytoskeleton organization [GO:0007010];cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.5	47	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PRD000373;PXD000387;PXD001328;PXD000047;PXD001422;PRD000154;PRD000345;PXD000164;PRD000711;PRD000172;PXD000746;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PXD000383;PRD000594;PRD000600;PRD000053;PRD000362;PXD001572;PXD001447;PRD000407;PXD000964	149				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q01546	Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)	KRT76	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.41	51	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000059;PRD000597;PXD000226;PXD000383;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000345;PXD000047;PRD000711;PRD000364;PRD000172;PRD000164;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD001324;PXD000593;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PRD000671;PRD000600;PRD000053;PRD000362;PXD001572;PXD001447;PRD000407;PXD000964	188				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
O15230	Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha)	LAMA5	P27658	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin]	COL8A1	0.4	2	PXD000746;PRD000269	14					extracellular matrix organization [GO:0030198];angiogenesis [GO:0001525]	extracellular region [GO:0005576];collagen-containing extracellular matrix [GO:0062023]	
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.45	58	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PRD000053;PRD000565;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000997;PRD000269;PXD000387;PXD001328;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PXD000593;PRD000600;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000746;PRD000168;PRD000151;PXD001403;PXD000217;PXD000218;PXD000529;PRD000671;PXD000533;PXD001572;PXD001324;PRD000234;PRD000180;PRD000444;PXD000226;PRD000059;PXD000786;PXD000314;PRD000407;PRD000731;PXD001447;PXD000164;PRD000738;PRD000108	315						extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.59	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000383;PRD000444;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000786;PRD000731;PXD001324;PRD000407	352		1273738		R-HSA-983189;R-HSA-8955332;R-HSA-8854518;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5620912;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-3371497;R-HSA-2565942;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	regulation of G2/M transition of mitotic cell cycle [GO:0010389];ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];microtubule-based process [GO:0007017]	microtubule [GO:0005874];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.57	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PXD000314;PRD000444;PXD001447;PRD000671;PRD000108;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PRD000407;PXD000964	350	EBI-8459929;EBI-8387620;EBI-8338396;EBI-8333649;EBI-8312518	1273758;926272;744372		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.45	58	PRD000733;PRD000345;PRD000032;PXD000426;PRD000020;PXD000948;PRD000053;PRD000565;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000997;PRD000269;PXD000387;PXD001328;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PXD000593;PRD000600;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000746;PRD000168;PRD000151;PXD001403;PXD000217;PXD000218;PXD000529;PRD000671;PXD000533;PXD001572;PXD001324;PRD000234;PRD000180;PRD000444;PXD000226;PRD000059;PXD000786;PXD000314;PRD000407;PRD000731;PXD001447;PXD000164;PRD000738;PRD000108	315		1261361				extracellular region [GO:0005576];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein kinase binding [GO:0019901];GTPase activity [GO:0003924];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.59	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PRD000444;PXD001447;PRD000671;PRD000108;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PXD000226;PRD000407	349		2448494;2257148;1273763;744881		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.57	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PXD000314;PRD000444;PXD001447;PRD000671;PRD000108;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PRD000407;PXD000964	350		1273760		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule cytoskeleton [GO:0015630];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.48	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000167;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000796;PXD001572;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PXD001447;PRD000671;PRD000108;PXD000786;PXD000387;PRD000711;PRD000597;PRD000731;PXD001324;PRD000407;PXD000964	372		1273756;926271;744092	1400	R-HSA-8854518;R-HSA-5620912;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-2565942	regulation of G2/M transition of mitotic cell cycle [GO:0010389];ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];microtubule-based process [GO:0007017]	extracellular region [GO:0005576];microtubule [GO:0005874];cytoskeleton [GO:0005856];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68366	Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain)	TUBA4A	Q3ZCM7	Tubulin beta-8 chain (Tubulin beta 8 class VIII)	TUBB8	0.42	59	PRD000733;PRD000345;PRD000032;PRD000020;PXD000948;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PXD000426;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000671;PRD000535;PXD000593;PRD000594;PXD001323;PRD000607;PRD000680;PRD000092;PRD000068;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PXD000529;PRD000731;PRD000168;PRD000600;PXD001572;PXD001324;PRD000234;PRD000444;PXD000226;PRD000523;PXD000786;PRD000118;PXD001447;PXD000164;PXD000533;PRD000108;PRD000407	296				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5617833;R-HSA-437239;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148		extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	0.43	64	PRD000733;PXD000948;PRD000814;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000032;PRD000417;PRD000345;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PRD000416;PXD000533;PRD000443;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000796;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	402				R-HSA-3371497		myelin sheath [GO:0043209]	ubiquitin protein ligase binding [GO:0031625]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.41	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD001403;PXD000217;PXD000680;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	366							GTPase activity [GO:0003924];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.62	66	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000383;PXD000314;PXD001447;PRD000671;PXD000387;PRD000711;PRD000597;PXD000472;PXD000786;PRD000731;PXD001324;PRD000407	391				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	myelin sheath [GO:0043209];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.64	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	384		744331		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.41	62	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD001403;PXD000217;PXD000680;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	366						myelin sheath [GO:0043209]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	0.42	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000059;PRD000594;PRD000032;PRD000417;PRD000345;PRD000068;PRD000168;PRD000234;PXD000997;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000108;PRD000523;PRD000269;PRD000118;PXD000164;PXD001328;PRD000796;PRD000146;PRD000046;PXD000217;PRD000565;PXD000680;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PRD000416;PXD000472;PRD000151;PRD000731;PXD001324;PRD000407;PRD000167;PXD000964	370				R-HSA-8852276;R-HSA-3371497	cellular response to interleukin-4 [GO:0071353]		ubiquitin protein ligase binding [GO:0031625];double-stranded RNA binding [GO:0003725];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.6	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PXD000226;PRD000407;PRD000684	381	EBI-8716403;EBI-8716372;EBI-8716172	1512286;1512283;744953		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.65	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	384		745095		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	microtubule cytoskeleton [GO:0015630];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.62	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	420		746135		R-HSA-380320	cell division [GO:0051301];microtubule-based process [GO:0007017];cytoskeleton-dependent intracellular transport [GO:0030705]	membrane raft [GO:0045121];microtubule [GO:0005874]	structural molecule activity [GO:0005198];GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];ubiquitin protein ligase binding [GO:0031625];GTP binding [GO:0005525]
P68363	Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain]	TUBA1B	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.42	50	PRD000733;PXD000948;PRD000345;PXD000426;PRD000032;PRD000053;PXD000743;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PXD000680;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PRD000444;PXD000472;PXD000164;PRD000001;PXD000217;PRD000565;PXD000218;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PRD000118;PRD000523;PRD000535;PRD000269;PXD001447;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	293							ubiquitin protein ligase binding [GO:0031625];double-stranded RNA binding [GO:0003725]
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	P48668	Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)	KRT6C	0.57	54	PRD000073;PRD000733;PRD000345;PRD000069;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PXD000593;PRD000172;PRD000416;PRD000407;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001402;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PRD000551;PRD000565;PRD000234;PRD000146;PRD000444;PRD000113;PXD000383;PRD000053;PRD000362;PXD000218;PXD001572;PXD001447;PRD000364;PXD000226;PXD000964	196	EBI-19794297;EBI-19794310			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];intermediate filament cytoskeleton organization [GO:0045104];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	0.41	45	PXD000746;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PRD000373;PXD001328;PRD000154;PXD001422;PRD000796;PRD000164;PXD000047;PRD000711;PXD000593;PRD000172;PRD000407;PRD000059;PXD001323;PRD000607;PRD000594;PXD000948;PXD000997;PRD000212;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000234;PRD000444;PRD000345;PRD000113;PRD000443;PRD000600;PXD001572;PXD001447;PRD000364;PXD000226;PRD000146	169	EBI-19794470;EBI-19794483			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];intermediate filament cytoskeleton organization [GO:0045104];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	0.54	53	PRD000073;PRD000733;PXD000746;PRD000069;PXD000743;PRD000123;PRD000443;PRD000597;PRD000345;PXD000529;PRD000373;PXD000387;PXD001328;PRD000092;PRD000154;PXD001422;PXD000593;PRD000796;PRD000164;PXD000047;PRD000711;PRD000172;PRD000416;PRD000407;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001402;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PRD000551;PRD000565;PRD000234;PRD000146;PRD000444;PRD000113;PXD000383;PRD000053;PRD000362;PXD000218;PXD001572;PXD001447;PRD000364;PXD000226	179	EBI-19793925;EBI-19793938	1264011		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	Q5XKE5	Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)	KRT79	0.4	49	PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000226;PRD000345;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PXD000593;PRD000172;PRD000407;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD001324;PRD000600;PRD000551;PRD000234;PRD000444;PRD000113;PRD000053;PRD000073;PXD001572;PXD001447;PRD000364;PXD000964;PRD000146	192	EBI-19793873;EBI-19793886			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	0.48	51	PRD000164;PRD000345;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000226;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PXD000593;PRD000172;PRD000407;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD001324;PRD000600;PRD000551;PRD000234;PRD000444;PRD000113;PXD000383;PRD000053;PRD000073;PXD001572;PXD001447;PRD000364;PXD000964	203				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	P02538	Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)	KRT6A	0.55	54	PRD000073;PRD000733;PRD000345;PRD000069;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PXD000593;PRD000796;PXD000047;PRD000711;PRD000172;PRD000416;PRD000407;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PRD000551;PRD000234;PRD000444;PRD000113;PXD000383;PRD000053;PRD000362;PXD000218;PXD001572;PXD001447;PRD000364;PXD000226;PXD000964;PRD000146	203	EBI-19793128;EBI-19793141			R-HSA-6809371;R-HSA-6805567	morphogenesis of an epithelium [GO:0002009];cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P08779	Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)	KRT16	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.45	33	PXD000593;PRD000234;PRD000416;PRD000092;PRD000113;PRD000164;PRD000407;PRD000069;PRD000733;PXD000743;PXD001323;PXD000746;PRD000059;PRD000607;PRD000345;PRD000594;PRD000146;PXD001572;PXD001324;PRD000212;PXD001422;PXD000387;PXD001447;PXD001328;PXD000997;PXD000164;PRD000154;PRD000597;PRD000151;PRD000019;PXD001402;PXD000226;PRD000711	82				R-HSA-6809371;R-HSA-6805567	keratinization [GO:0031424];aging [GO:0007568];cornification [GO:0070268];epidermis development [GO:0008544];hair cycle [GO:0042633]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	0.48	2	PRD000345;PXD000529	33						cytosol [GO:0005829]	identical protein binding [GO:0042802]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	P42229	Signal transducer and activator of transcription 5A	STAT5A	0.44	2	PRD000345;PXD000529	33						cytosol [GO:0005829]	
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	0.4	1	PRD000345	31						nucleus [GO:0005634]	identical protein binding [GO:0042802]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	0.49	2	PRD000345;PXD000529	35						nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829]	identical protein binding [GO:0042802]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	0.48	3	PRD000345;PXD000529;PXD000533	35						cytosol [GO:0005829]	
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q9NVH6	Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)	TMLHE	0.44	2	PRD000345;PXD000529	25							
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.44	1	PRD000345	31						cytoplasm [GO:0005737]	
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.53	2	PRD000345;PXD000533	34						nucleus [GO:0005634]	
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	0.43	2	PRD000345;PXD000533	33						nucleus [GO:0005634];cytosol [GO:0005829]	metal ion binding [GO:0046872]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	P46109	Crk-like protein	CRKL	0.4	4	PRD000345;PRD000032;PXD000529;PXD000533	37						cytosol [GO:0005829]	identical protein binding [GO:0042802]
P35520	Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase)	CBS	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.48	2	PRD000345;PXD000529	33						cytosol [GO:0005829]	
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.45	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q8IUE6	Histone H2A type 2-B	HIST2H2AB	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.45	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];enzyme binding [GO:0019899];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q7L7L0	Histone H2A type 3	HIST3H2A	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93079	Histone H2B type 1-H (Histone H2B.j) (H2B/j)	HIST1H2BH	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.43	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9Y6C2	EMILIN-1 (Elastin microfibril interface-located protein 1) (Elastin microfibril interfacer 1)	EMILIN1	Q92743	Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)	HTRA1	0.44	4	PXD001328;PRD000600;PRD000269;PXD000746	17					negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];collagen-containing extracellular matrix [GO:0062023]	identical protein binding [GO:0042802]
Q13200	26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2)	PSMD2	Q99460	26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112)	PSMD1	0.41	19	PRD000154;PXD000426;PXD000948;PRD000594;PRD000671;PRD000092;PRD000597;PXD000533;PXD000593;PXD000529;PXD001572;PXD001324;PXD000314;PXD001328;PXD001422;PRD000053;PRD000345;PRD000565;PRD000711	61		1268167;924256;741160	193;32	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-6798695;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];regulation of protein catabolic process [GO:0042176];proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161];protein deubiquitination [GO:0016579];neutrophil degranulation [GO:0043312]	cytosol [GO:0005829];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome regulatory particle [GO:0005838];proteasome accessory complex [GO:0022624];proteasome regulatory particle, base subcomplex [GO:0008540];membrane [GO:0016020];nucleus [GO:0005634];extracellular region [GO:0005576];proteasome storage granule [GO:0034515]	enzyme regulator activity [GO:0030234]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.49	20	PRD000417;PRD000345;PRD000631;PRD000551;PRD000671;PXD000383;PRD000019;PXD000743;PXD001324;PRD000416;PRD000212;PRD000053;PXD001403;PRD000185;PXD001422;PRD000059;PXD000164;PXD000047;PRD000269;PXD001174	56				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.46	17	PRD000417;PRD000345;PRD000631;PRD000671;PRD000551;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD001403;PXD001422;PXD000164;PRD000269;PXD001174	47				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.43	18	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PXD000047;PRD000019;PXD001324;PRD000212;PXD000743;PRD000185;PXD001403;PXD001422;PRD000345;PXD000164;PRD000269;PXD001174	47				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.49	20	PRD000417;PRD000631;PRD000059;PRD000551;PRD000416;PRD000671;PXD000383;PRD000019;PXD000743;PXD001324;PRD000212;PRD000053;PXD001403;PRD000185;PXD001422;PRD000345;PXD000164;PXD000047;PRD000269;PXD001174	54				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.47	16	PRD000417;PRD000345;PRD000631;PRD000551;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD001403;PXD001422;PXD000164;PXD001174	47				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.45	13	PXD001324;PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PRD000185;PXD001422;PXD000743;PXD000164	38				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.48	13	PRD000417;PRD000416;PRD000551;PXD000383;PRD000671;PRD000631;PRD000019;PXD000743;PXD001403;PXD001422;PRD000059;PRD000345;PXD000164	37				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.53	18	PRD000417;PRD000345;PRD000631;PRD000551;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD001403;PXD001422;PRD000059;PXD000164;PRD000269;PXD001174	54				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.53	17	PRD000417;PRD000631;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PXD000743;PRD000053;PXD001572;PRD000345;PXD001403;PXD000164;PXD001447;PXD001174;PRD000019	44				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.46	15	PRD000417;PRD000631;PRD000551;PRD000671;PXD000383;PXD000743;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD001403;PXD001422;PXD000164;PXD001174	45					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01593	Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT)	IGKV1D-33	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.4	14	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PRD000185;PXD001422;PXD001403;PXD001174;PRD000019	38					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134		747128		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.48	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.4	11	PRD000444;PRD000020;PRD000680;PRD000565;PXD001572;PRD000594;PRD000733;PXD001422;PRD000234;PXD000387;PRD000345	16				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689901;R-HSA-5689880;R-HSA-5689603;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214858;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	chromatin silencing [GO:0006342]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062];nuclear chromatin [GO:0000790]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20671	Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g)	HIST1H2AD	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9GZR7	ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)	DDX24	Q8TDD1	ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54)	DDX54	0.41	6	PXD000426;PXD001572;PRD000597;PXD000680;PXD000593;PXD000314	11					RNA secondary structure unwinding [GO:0010501];RNA metabolic process [GO:0016070]	nucleolus [GO:0005730];cytoplasm [GO:0005737];membrane [GO:0016020]	ATP binding [GO:0005524];RNA binding [GO:0003723];ATP-dependent RNA helicase activity [GO:0004004]
P62280	40S ribosomal protein S11 (Small ribosomal subunit protein uS17)	RPS11	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.43	23	PXD000948;PXD000218;PRD000565;PRD000053;PRD000020;PRD000444;PXD001323;PRD000046;PRD000443;PXD000529;PRD000733;PRD000146;PXD000997;PRD000345;PXD001572;PRD000594;PXD001422;PRD000465;PXD001310;PRD000269;PRD000711;PXD000964;PRD000668	61		1269379;743612	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62280	40S ribosomal protein S11 (Small ribosomal subunit protein uS17)	RPS11	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.42	18	PRD000053;PRD000020;PRD000444;PRD000594;PXD001323;PRD000565;PRD000733;PRD000146;PXD000997;PXD000948;PXD001572;PRD000796;PXD001422;PXD001310;PRD000269;PRD000711;PRD000668;PXD000218	58		1270553;742133	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62280	40S ribosomal protein S11 (Small ribosomal subunit protein uS17)	RPS11	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.43	24	PRD000053;PXD000218;PRD000731;PRD000345;PXD000529;PRD000020;PRD000444;PRD000594;PXD001323;PRD000668;PRD000046;PRD000600;PRD000671;PRD000565;PXD001310;PRD000146;PXD000997;PXD001572;PXD000533;PRD000796;PXD001422;PXD000948;PRD000711;PXD000964	72	EBI-8449956	1270569;742251	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P16050	Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase)	ALOX15	P22897	Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206)	MRC1	0.47	1	PRD000053	12						plasma membrane [GO:0005886]	
Q16401	26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B)	PSMD5	P35998	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1)	PSMC2	0.4	12	PRD000154;PXD001323;PXD000426;PXD000529;PXD001328;PRD000594;PXD001422;PRD000092;PRD000146;PRD000345;PRD000711;PXD000218	22	EBI-18987520;EBI-18968336;EBI-18987533;EBI-18968349;EBI-11782278;EBI-11776148;EBI-11776164;EBI-11775114;EBI-11773693;EBI-11773765;EBI-10521664;EBI-10393636;EBI-10364043;EBI-10237724;EBI-10207120;EBI-8638153;EBI-2365310;EBI-2364618;EBI-2364535;EBI-760210	2386720;2238829;1439025;1267932;1041296;740747;695405;695404;695403;666019;666010;335429;282094;122089	193;32	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	proteasome accessory complex [GO:0022624];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q16401	26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B)	PSMD5	Q13098	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1	0.42	6	PXD000050;PXD001328;PXD001323;PRD000154;PXD001422;PRD000711	12				R-HSA-8951664	post-translational protein modification [GO:0043687]	nucleoplasm [GO:0005654];cytosol [GO:0005829]	
P25786	Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	PSMA1	P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	0.4	25	PRD000053;PRD000668;PRD000417;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000073;PRD000146;PRD000416;PRD000269;PRD000711;PRD000597;PXD001323;PXD000426;PRD000565;PXD000218;PRD000731;PXD000593;PXD001324;PXD000997;PXD000948;PRD000594;PRD000345	102	EBI-16797733;EBI-16797676;EBI-16797631;EBI-16797556;EBI-16139988;EBI-19227105;EBI-19227118;EBI-10518386;EBI-10359265;EBI-10202016;EBI-3933284;EBI-1388466;EBI-1385684	2238662;1267595;1179050;1041167;923998;894076;740729;668255;594722;303148	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25786	Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	PSMA1	P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	0.4	20	PRD000053;PRD000668;PXD000948;PXD001572;PRD000154;PXD001422;PRD000416;PRD000711;PRD000269;PRD000597;PRD000417;PXD001323;PRD000059;PRD000565;PXD000426;PXD001324;PRD000146;PXD000218;PRD000594;PRD000410	87	EBI-16797676;EBI-16797631;EBI-16797556;EBI-16139988;EBI-1388466;EBI-1388446;EBI-1385684	2253668;1267632;1179061;924006;740896;668261;668223;668193	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25786	Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	PSMA1	Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	0.4	26	PRD000053;PRD000668;PRD000417;PXD000529;PXD001572;PRD000154;PXD001422;PRD000059;PRD000416;PRD000269;PRD000711;PRD000597;PXD001323;PXD000426;PRD000565;PRD000032;PRD000731;PXD000593;PXD000948;PXD001324;PRD000146;PXD000218;PXD000997;PRD000073;PRD000594;PRD000118	107		1267550;744313		R-HSA-983168;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634];proteasome core complex, alpha-subunit complex [GO:0019773];cytosol [GO:0005829];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
P25786	Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain)	PSMA1	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.44	26	PRD000032;PRD000053;PRD000668;PRD000417;PXD000529;PXD001572;PRD000154;PXD001422;PRD000059;PRD000416;PRD000269;PRD000711;PRD000597;PXD001323;PXD000426;PRD000565;PXD000218;PRD000731;PXD000593;PXD000948;PXD001324;PRD000146;PXD000997;PRD000073;PRD000594;PRD000118	114	EBI-16797733;EBI-16797676;EBI-16797631;EBI-16797556;EBI-16139988;EBI-7660417;EBI-7659266;EBI-1388466;EBI-1388404;EBI-1388238;EBI-1388227;EBI-1385684;EBI-696846;EBI-696762	2242090;1267549;1179054;924041;740900;696621;668469;668211;668200;668190;668182	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25787	Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)	PSMA2	P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	0.42	19	PRD000053;PRD000154;PRD000092;PXD000426;PXD001323;PRD000594;PRD000668;PRD000073;PXD000948;PXD000529;PRD000733;PXD000218;PXD001572;PXD000997;PXD000164;PRD000738;PXD001422;PRD000711;PRD000345	71	EBI-603379;EBI-603360	2251973;1267735;924070;825379;825365;741131;684049;603650	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25787	Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)	PSMA2	P49721	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	0.4	21	PRD000053;PRD000092;PRD000154;PXD001323;PRD000594;PRD000668;PRD000731;PRD000073;PXD000948;PXD000529;PRD000733;PXD001324;PXD001572;PXD000997;PXD000164;PRD000738;PXD001422;PXD000426;PRD000711;PRD000345;PRD000597	70	EBI-603379;EBI-603360	2232711;1267708;923992;825380;825366;741129;696622;684050;603653	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25787	Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3)	PSMA2	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.4	25	PRD000053;PRD000154;PRD000092;PXD000948;PRD000594;PRD000668;PRD000731;PXD001323;PXD000426;PXD000529;PRD000733;PXD001324;PRD000146;PXD000218;PXD000387;PXD000997;PXD001572;PXD000164;PRD000738;PXD001422;PRD000073;PRD000269;PRD000711;PRD000345;PRD000597	83	EBI-603379;EBI-603360	2229528;1267578;923991;825382;825368;741128;684052;603655	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-6798695;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];neutrophil degranulation [GO:0043312]	ficolin-1-rich granule lumen [GO:1904813];secretory granule lumen [GO:0034774];cytosol [GO:0005829];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];extracellular region [GO:0005576];proteasome core complex [GO:0005839];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	0.44	18	PRD000417;PRD000053;PRD000154;PRD000597;PRD000594;PRD000668;PXD001323;PRD000269;PXD001324;PRD000565;PRD000416;PXD000948;PRD000146;PXD000218;PXD001572;PXD000529;PXD001422;PRD000711	84	EBI-1388356;EBI-1388329;EBI-696826;EBI-696817	1267597;924007;740898;668263;668257;668218;668216;668195;668192	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	0.43	23	PRD000154;PRD000053;PRD000668;PRD000417;PXD000529;PXD000426;PXD001572;PXD001422;PRD000416;PRD000269;PRD000597;PRD000594;PRD000711;PXD001323;PXD001403;PRD000565;PXD000948;PRD000731;PXD000593;PXD001324;PRD000146;PXD000218;PXD000997	102		1267601;744315		R-HSA-983168;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634];proteasome core complex, alpha-subunit complex [GO:0019773];cytosol [GO:0005829];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.42	16	PRD000053;PXD000529;PRD000154;PRD000668;PXD001323;PXD000426;PRD000146;PXD001324;PXD001328;PXD001572;PXD001422;PXD000948;PRD000345;PRD000711;PRD000597;PRD000594	74					post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	P60900	Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6	0.45	24	PRD000154;PRD000053;PRD000668;PRD000416;PXD001328;PXD000997;PXD001572;PXD001422;PRD000146;PRD000711;PRD000597;PRD000417;PRD000594;PXD001323;PRD000020;PXD000948;PXD000426;PRD000565;PRD000731;PXD001324;PXD000218;PXD000529;PRD000113;PRD000345	106	EBI-19227131;EBI-19227144;EBI-10518424;EBI-10374438;EBI-10217887;EBI-7659176;EBI-7659127;EBI-710424;EBI-729150	1439022;1267599;1041215;927916;923999;885761;740721;668259;303149;271626	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.45	19	PRD000053;PRD000154;PRD000731;PRD000594;PRD000668;PXD001403;PXD000529;PRD000146;PRD000597;PXD000218;PXD001323;PXD001324;PXD001572;PXD000997;PRD000073;PXD001422;PRD000711;PRD000345;PXD000948	83	EBI-20314167	2234306;1267602;924050;741407	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25788	Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8)	PSMA3	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.45	23	PRD000154;PRD000053;PRD000668;PRD000417;PXD000529;PXD000426;PXD000997;PXD001572;PXD001422;PRD000416;PRD000269;PRD000711;PRD000597;PRD000594;PXD001323;PXD001403;PRD000565;PXD000218;PXD000948;PRD000731;PXD000593;PXD001324;PRD000146	107	EBI-7322929;EBI-3933324;EBI-7659266;EBI-1388368;EBI-1388247;EBI-1388222	1267600;924043;892782;740771;696627;668260;668202;668191;668185;600961	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	0.43	20	PRD000154;PRD000053;PRD000668;PXD001572;PXD001422;PRD000416;PRD000711;PRD000269;PRD000597;PRD000417;PRD000092;PRD000594;PXD001323;PRD000565;PXD000948;PXD001324;PRD000146;PXD000218;PXD000164;PRD000407	88		1267637;744316		R-HSA-983168;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	nucleus [GO:0005634];proteasome core complex, alpha-subunit complex [GO:0019773];cytosol [GO:0005829];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	0.41	13	PRD000053;PRD000154;PXD001310;PRD000594;PXD001323;PRD000668;PRD000597;PXD000218;PXD001572;PXD000164;PXD001422;PRD000711;PXD000948	71	EBI-10765902	2262524;1267736;924072;741419	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.41	14	PRD000154;PRD000053;PXD000529;PRD000092;PRD000594;PXD001323;PRD000668;PXD000948;PXD000218;PXD001572;PXD000164;PXD000533;PXD001422;PRD000711	70						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.41	17	PRD000053;PRD000154;PXD001323;PRD000594;PRD000668;PRD000059;PRD000597;PXD000948;PXD000218;PXD001324;PXD001572;PXD000164;PXD000533;PXD001422;PRD000073;PRD000407;PRD000711	83		2230581;1267638;924010;741408;668267	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	P28066	Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)	PSMA5	0.41	20	PRD000154;PRD000053;PRD000668;PXD000426;PXD001310;PXD001572;PXD001422;PRD000407;PRD000711;PXD000948;PRD000594;PXD001323;PXD000786;PRD000565;PXD001324;PRD000146;PXD000218;PRD000032;PRD000671;PXD000533	89	EBI-1388310	1267634;924025;740899;668264;668206;668196	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P25789	Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L)	PSMA4	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.43	23	PRD000154;PRD000053;PRD000668;PXD001572;PXD001422;PRD000416;PRD000407;PRD000711;PRD000269;PRD000597;PRD000417;PRD000092;PRD000594;PXD001323;PXD000218;PRD000565;PXD000948;PXD001324;PRD000146;PRD000032;PXD000164;PXD000533;PXD000426	96	EBI-19768986;EBI-19768999;EBI-7660508;EBI-7659266;EBI-1388482;EBI-1388347;EBI-1388256;EBI-1388217;EBI-696850;EBI-696834	1267636;924009;740902;696628;668266;668219;668208;668203;668198;668186	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P02649	Apolipoprotein E (Apo-E)	APOE	P04004	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	0.4	22	PRD000073;PXD000383;PXD000743;PXD000746;PRD000417;PRD000059;PRD000416;PRD000185;PRD000053;PXD001422;PXD000164;PRD000711;PRD000172;PXD001403;PRD000631;PXD000412;PXD001324;PRD000551;PRD000158;PRD000362;PRD000019;PRD000364	126					negative regulation of blood coagulation [GO:0030195]	extracellular exosome [GO:0070062];blood microparticle [GO:0072562];endoplasmic reticulum [GO:0005783];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576]	identical protein binding [GO:0042802];heparin binding [GO:0008201]
P02649	Apolipoprotein E (Apo-E)	APOE	P10909	Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]	CLU	0.4	26	PRD000032;PRD000073;PXD000743;PXD000746;PRD000417;PRD000059;PRD000416;PXD000383;PRD000185;PRD000053;PXD001422;PXD000164;PRD000269;PRD000711;PRD000172;PXD001403;PRD000631;PXD000412;PXD001324;PRD000600;PRD000551;PRD000113;PRD000158;PRD000019;PRD000364;PXD000533	135					regulation of neuron death [GO:1901214];negative regulation of amyloid-beta formation [GO:1902430];positive regulation of amyloid-beta formation [GO:1902004];reverse cholesterol transport [GO:0043691];regulation of amyloid-beta clearance [GO:1900221];protein import [GO:0017038];positive regulation of neuron death [GO:1901216];positive regulation of amyloid fibril formation [GO:1905908];positive regulation of neurofibrillary tangle assembly [GO:1902998]	extracellular matrix [GO:0031012];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];endoplasmic reticulum [GO:0005783];cytoplasm [GO:0005737];collagen-containing extracellular matrix [GO:0062023];Golgi apparatus [GO:0005794];extracellular space [GO:0005615];nucleus [GO:0005634];extracellular region [GO:0005576]	amyloid-beta binding [GO:0001540];tau protein binding [GO:0048156];low-density lipoprotein particle receptor binding [GO:0050750];protein-containing complex binding [GO:0044877]
Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	0.4	17	PRD000597;PRD000053;PRD000154;PXD000218;PXD000948;PRD000594;PXD001323;PRD000668;PRD000073;PXD000426;PXD000529;PXD001572;PXD000164;PXD000997;PXD001422;PXD001403;PRD000711	82		2218315;1267740;744326		R-HSA-983168;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
Q8TAA3	Proteasome subunit alpha-type 8 (EC 3.4.25.1) (Proteasome subunit alpha-type 7-like)	PSMA8	P28066	Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain)	PSMA5	0.41	24	PRD000154;PXD000948;PRD000059;PRD000053;PRD000668;PXD000529;PXD001572;PXD001422;PRD000465;PRD000711;PRD000597;PRD000594;PXD001323;PXD000426;PRD000565;PRD000731;PRD000671;PXD000593;PXD001324;PRD000146;PXD000218;PXD000997;PRD000073;PRD000407	97		1267669;744317		R-HSA-983168;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	nucleus [GO:0005634];proteasome core complex, alpha-subunit complex [GO:0019773];cytosol [GO:0005829];extracellular exosome [GO:0070062]	threonine-type endopeptidase activity [GO:0004298]
Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	P26373	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13	0.41	28	PRD000053;PXD000218;PXD001323;PXD001328;PXD001310;PRD000020;PRD000733;PRD000444;PXD000593;PRD000594;PRD000123;PRD000443;PRD000565;PRD000680;PXD000948;PRD000146;PXD000997;PXD000529;PXD000217;PRD000597;PRD000668;PXD000047;PXD001572;PRD000711;PXD000426;PXD000964;PRD000345;PXD001422	80	EBI-7809483	813891;813890;1270165;742051	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	0.4	25	PXD000948;PXD000218;PRD000565;PXD001328;PXD001310;PRD000053;PRD000733;PRD000444;PRD000594;PRD000123;PXD001323;PXD000593;PRD000680;PXD000426;PXD000529;PRD000146;PXD000997;PRD000671;PXD001572;PXD001422;PRD000668;PXD000047;PRD000711;PRD000597;PRD000118	78		1270253;741467	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];focal adhesion [GO:0005925];membrane [GO:0016020];polysomal ribosome [GO:0042788];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	cadherin binding [GO:0045296];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	P62753	40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)	RPS6	0.4	28	PRD000053;PRD000565;PXD001323;PXD001310;PRD000733;PRD000796;PXD000529;PRD000444;PRD000671;PRD000594;PRD000123;PRD000443;PXD000593;PXD000217;PRD000118;PXD000948;PRD000146;PXD000997;PXD000218;PXD001328;PRD000597;PXD001572;PXD001422;PXD000047;PRD000345;PRD000711;PXD000964;PRD000668	76	EBI-16798663	1271280;742503	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytoplasmic ribonucleoprotein granule [GO:0036464];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q02878	60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107)	RPL6	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.41	27	PRD000020;PRD000443;PXD000529;PXD001310;PRD000053;PXD001328;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000680;PXD000426;PXD000948;PXD000997;PXD000217;PRD000565;PXD000218;PRD000671;PRD000733;PRD000444;PXD001572;PXD000964	88		1270102;741464	5266;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	cytosol [GO:0005829];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];rough endoplasmic reticulum [GO:0005791];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
O94776	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex)	MTA2	Q96ST3	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	0.44	5	PXD000050;PRD000345;PXD000529;PXD000533;PRD000146	11		505060;255651	1257;888;632		negative regulation of transcription by RNA polymerase II [GO:0000122];positive regulation of transcription by RNA polymerase II [GO:0045944]	transcription factor complex [GO:0005667];nucleoplasm [GO:0005654]	chromatin binding [GO:0003682];RNA polymerase II repressing transcription factor binding [GO:0001103]
Q9HCE1	Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein)	MOV10	Q03701	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)	CEBPZ	0.5	5	PXD000529;PXD001572;PXD000426;PXD000533;PXD000593	11							RNA binding [GO:0003723]
Q9HCE1	Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein)	MOV10	Q96GQ7	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27	0.52	5	PXD000529;PXD000047;PXD001572;PXD000533;PXD000593	10							ATP binding [GO:0005524];RNA binding [GO:0003723]
Q9HCE1	Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein)	MOV10	Q7L2E3	Putative ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)	DHX30	0.46	4	PXD000529;PXD001572;PXD000533;PXD000593	10	EBI-20566937	1052129				cytosol [GO:0005829]	ATP binding [GO:0005524];RNA binding [GO:0003723]
Q9HCE1	Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein)	MOV10	Q15269	Periodic tryptophan protein 2 homolog	PWP2	0.49	5	PXD000529;PXD001572;PXD000426;PXD000533;PXD000593	10							RNA binding [GO:0003723]
P62191	26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1)	PSMC1	P35998	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1)	PSMC2	0.43	16	PXD000948;PRD000154;PXD000426;PRD000594;PXD001323;PRD000443;PXD000593;PRD000053;PXD000529;PXD001572;PXD000218;PRD000146;PXD001328;PXD001422;PXD000533;PRD000711	45	EBI-11123102;EBI-6305306;EBI-6305315;EBI-2365347;EBI-2365328	2245034;1446486;1267899;1191647;924131;740718;695400;669057;669042;666021;666020;316448;282093	193;181;32	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899];protein deubiquitination [GO:0016579];ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nuclear proteasome complex [GO:0031595];proteasome accessory complex [GO:0022624];proteasome regulatory particle, base subcomplex [GO:0008540];membrane [GO:0016020];nucleus [GO:0005634];cytosolic proteasome complex [GO:0031597]	ATP binding [GO:0005524];proteasome-activating ATPase activity [GO:0036402];TBP-class protein binding [GO:0017025];ATPase activity [GO:0016887]
P62195	26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG)	PSMC5	P35998	26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1)	PSMC2	0.41	17	PXD000593;PRD000154;PXD001323;PXD000529;PXD000426;PRD000594;PRD000443;PXD000948;PXD001572;PXD000218;PRD000053;PXD001328;PXD001422;PXD000533;PXD000997;PRD000345;PRD000711	43	EBI-6305315;EBI-2366738;EBI-2366718;EBI-2366703;EBI-2366649;EBI-2366475;EBI-2366407;EBI-2366358;EBI-2366341;EBI-8544630	2238618;1267995;740894;669236;669229;669045;668471	193;181;32	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899];protein deubiquitination [GO:0016579];ubiquitin-dependent ERAD pathway [GO:0030433]	cytosol [GO:0005829];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];nuclear proteasome complex [GO:0031595];proteasome accessory complex [GO:0022624];proteasome regulatory particle, base subcomplex [GO:0008540];membrane [GO:0016020];nucleus [GO:0005634];cytosolic proteasome complex [GO:0031597]	ATP binding [GO:0005524];proteasome-activating ATPase activity [GO:0036402];TBP-class protein binding [GO:0017025];ATPase activity [GO:0016887]
O15511	Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC)	ARPC5	P58546	Myotrophin (Protein V-1)	MTPN	0.41	14	PRD000733;PRD000172;PRD000053;PRD000711;PRD000477;PRD000668;PRD000738;PRD000269;PXD000948;PXD001323;PXD001422;PXD001572;PXD000164;PRD000417	54						cytosol [GO:0005829]	
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	0.41	64	PRD000733;PXD000948;PRD000814;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000443;PRD000059;PRD000032;PRD000417;PRD000345;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PRD000416;PXD000533;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000796;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000444;PRD000407;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PXD000964	397		949952;949335		R-HSA-3371497		myelin sheath [GO:0043209];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.42	65	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000032;PRD000345;PRD000068;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PXD000426;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000172;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PRD000444;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000164;PXD000472;PXD000786;PRD000731;PXD001324;PRD000407	362				R-HSA-3371497		myelin sheath [GO:0043209];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.43	65	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000594;PRD000032;PRD000345;PRD000068;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PXD000786;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000226;PXD001328;PRD000146;PRD000172;PRD000046;PXD000217;PRD000565;PXD000314;PRD000444;PRD000059;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000164;PXD000472;PRD000731;PXD001324;PRD000092;PRD000407;PXD000964	359				R-HSA-3371497		nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	P11021	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	HSPA5	0.42	58	PRD000733;PXD000948;PRD000345;PRD000032;PRD000269;PRD000020;PRD000053;PXD000743;PRD000738;PXD000529;PRD000123;PRD000668;PRD000443;PRD000059;PXD000426;PXD000387;PXD001328;PXD001422;PRD000796;PRD000073;PRD000146;PXD000164;PRD000417;PRD000416;PRD000407;PRD000711;PRD000597;PRD000477;PRD000671;PRD000594;PXD000593;PXD001323;PRD000046;PRD000607;PXD000997;PXD000786;PRD000168;PRD000151;PRD000001;PXD000217;PRD000565;PXD000218;PRD000731;PRD000444;PXD001324;PRD000684;PRD000234;PRD000113;PXD000314;PXD000050;PRD000118;PXD001572;PXD001447;PRD000364;PXD000533;PRD000410;PRD000092;PXD000964	335	EBI-11151540	1444951;1263375;743097	2721;929	R-HSA-3371453		extracellular exosome [GO:0070062];focal adhesion [GO:0005925];myelin sheath [GO:0043209];membrane [GO:0016020];melanosome [GO:0042470];nucleus [GO:0005634];plasma membrane [GO:0005886]	enzyme binding [GO:0019899];ATPase activity [GO:0016887];ATP binding [GO:0005524];cadherin binding [GO:0045296];unfolded protein binding [GO:0051082];ubiquitin protein ligase binding [GO:0031625];chaperone binding [GO:0051087]
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	0.43	66	PRD000733;PXD000948;PXD000426;PXD000743;PRD000123;PRD000053;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000269;PRD000059;PRD000032;PRD000417;PRD000345;PRD000168;PRD000416;PRD000234;PXD000997;PRD000113;PXD001323;PXD000834;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PXD001572;PRD000092;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000477;PRD000523;PRD000594;PRD000118;PXD001328;PRD000796;PRD000146;PRD000172;PRD000046;PXD000217;PRD000565;PRD000444;PXD001447;PRD000671;PXD000786;PXD000680;PXD000387;PRD000711;PRD000597;PRD000410;PXD000472;PRD000151;PRD000731;PXD001324;PRD000407;PRD000738;PXD000964	413		2459162;1263374	725	R-HSA-6798695;R-HSA-3371571;R-HSA-3371568;R-HSA-3371497	protein folding [GO:0006457];response to unfolded protein [GO:0006986];regulation of cellular response to heat [GO:1900034];neutrophil degranulation [GO:0043312]	ficolin-1-rich granule lumen [GO:1904813];secretory granule lumen [GO:0034774];cytosol [GO:0005829];nucleoplasm [GO:0005654];lysosomal membrane [GO:0005765];membrane [GO:0016020];melanosome [GO:0042470];nucleus [GO:0005634];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	ATPase activity, coupled [GO:0042623];heat shock protein binding [GO:0031072];ATP binding [GO:0005524];cadherin binding [GO:0045296];unfolded protein binding [GO:0051082];MHC class II protein complex binding [GO:0023026];ubiquitin protein ligase binding [GO:0031625];RNA binding [GO:0003723]
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	P07900	Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	HSP90AA1	0.4	67	PRD000733;PXD000948;PXD000426;PXD000743;PRD000123;PRD000053;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000269;PRD000032;PRD000059;PRD000417;PRD000416;PRD000168;PRD000234;PXD000997;PRD000113;PXD001323;PXD000834;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PXD001572;PRD000092;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000477;PRD000523;PRD000594;PRD000118;PXD001328;PRD000796;PRD000345;PRD000146;PRD000172;PRD000046;PXD000217;PRD000565;PRD000444;PXD001447;PRD000671;PXD000786;PXD000680;PXD000387;PXD000050;PRD000711;PRD000597;PRD000410;PXD000472;PRD000151;PRD000731;PXD001324;PRD000738;PRD000407;PXD000964	398	EBI-4310841;EBI-3388070	2197265;1263373;832640;818856;556524;279717	2721	R-HSA-6798695;R-HSA-6785807;R-HSA-3371571;R-HSA-3371568;R-HSA-3371497	response to unfolded protein [GO:0006986];regulation of cellular response to heat [GO:1900034];regulation of protein complex assembly [GO:0043254];cytokine-mediated signaling pathway [GO:0019221];chaperone-mediated autophagy [GO:0061684];protein refolding [GO:0042026];neutrophil degranulation [GO:0043312]	lysosomal lumen [GO:0043202];secretory granule lumen [GO:0034774];cytosol [GO:0005829];ficolin-1-rich granule lumen [GO:1904813];nucleoplasm [GO:0005654];myelin sheath [GO:0043209];membrane [GO:0016020];melanosome [GO:0042470];nucleus [GO:0005634];extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	ATPase activity, coupled [GO:0042623];ATPase activity [GO:0016887];ATP binding [GO:0005524];unfolded protein binding [GO:0051082];MHC class II protein complex binding [GO:0023026];ubiquitin protein ligase binding [GO:0031625];RNA binding [GO:0003723]
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.43	65	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000594;PRD000032;PRD000345;PRD000068;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PXD000786;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000226;PXD001328;PRD000146;PRD000172;PRD000046;PXD000217;PRD000565;PXD000314;PRD000444;PRD000059;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000164;PXD000472;PRD000731;PXD001324;PRD000092;PRD000407;PXD000964	359			2837	R-HSA-3371497		nucleus [GO:0005634]	
P11142	Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1)	HSPA8	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.44	66	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000594;PRD000059;PRD000032;PRD000345;PRD000068;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000529;PRD000523;PRD000535;PRD000118;PXD000226;PXD001328;PRD000146;PRD000172;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PXD000050;PRD000711;PRD000597;PRD000407;PRD000164;PXD000472;PRD000731;PXD001324;PXD000964	388		1273747		R-HSA-6798695	neutrophil degranulation [GO:0043312]	nucleus [GO:0005634];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	ubiquitin protein ligase binding [GO:0031625]
O15379	Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45)	HDAC3	A6NED2	RCC1 domain-containing protein 1	RCCD1	0.44	1	PRD000345	11					chromatin organization [GO:0006325]	plasma membrane [GO:0005886];cytosol [GO:0005829]	
P62266	40S ribosomal protein S23 (Small ribosomal subunit protein uS12)	RPS23	P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	0.43	25	PRD000053;PXD000529;PRD000594;PRD000123;PXD001323;PRD000443;PRD000269;PRD000680;PRD000565;PXD000948;PXD001310;PRD000146;PXD000218;PXD000997;PXD001572;PXD000533;PXD001422;PRD000796;PXD000593;PRD000668;PXD000217;PXD000047;PRD000711;PRD000597;PRD000733	69		1269667	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	endoplasmic reticulum [GO:0005783];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	0.42	28	PRD000053;PRD000731;PRD000345;PXD001310;PXD000218;PRD000444;PXD000217;PXD001323;PRD000668;PRD000443;PRD000146;PRD000680;PRD000733;PXD000529;PXD000948;PXD000997;PRD000600;PRD000597;PXD001572;PRD000234;PRD000796;PXD000593;PXD001422;PRD000565;PRD000020;PRD000711;PRD000594;PXD000964	82		1270785;924912	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	0.44	30	PRD000020;PRD000053;PRD000123;PRD000443;PXD000529;PXD001310;PXD000997;PXD001572;PXD001422;PRD000668;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000680;PXD000948;PXD000426;PXD000217;PRD000565;PXD000218;PRD000731;PRD000671;PRD000444;PXD000593;PRD000345;PRD000269;PXD000964	107		1270800;925326	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	0.47	30	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PXD001323;PRD000680;PXD000217;PXD000948;PRD000020;PXD000218;PRD000731;PRD000671;PRD000565;PRD000733;PRD000146;PXD000997;PRD000444;PXD000593;PRD000345;PRD000600;PRD000269;PXD000533	92		1270789;924981	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	small ribosomal subunit [GO:0015935];extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P30050	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	0.41	26	PRD000020;PRD000053;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PRD000565;PXD000218;PRD000731;PRD000733;PRD000444;PXD000593;PRD000345;PRD000234;PXD000533	90		1270750	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.42	28	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PXD000948;PRD000594;PXD001323;PRD000680;PXD000997;PXD000426;PRD000565;PRD000020;PXD000218;PRD000444;PXD000593;PRD000345;PRD000600;PXD000533;PXD000964	96		1270799;925303	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	protein kinase binding [GO:0019901];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.4	30	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PRD000020;PXD000948;PXD000997;PXD000217;PRD000565;PXD000218;PRD000731;PRD000671;PRD000146;PRD000444;PXD000593;PRD000345;PRD000269;PRD000600;PXD000533	108		1270749	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.4	32	PRD000020;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD000997;PXD001572;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000680;PXD000533;PXD000217;PRD000565;PXD000218;PRD000731;PRD000600;PRD000671;PRD000234;PRD000444;PXD000593;PRD000345;PXD000948;PXD000426;PXD000964	112		1270795;925210	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	protein kinase binding [GO:0019901];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62269	40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13)	RPS18	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.42	28	PRD000565;PRD000053;PRD000020;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PXD000948;PXD000997;PXD000217;PXD000218;PRD000731;PRD000600;PRD000671;PRD000733;PRD000146;PRD000444;PXD000593;PRD000345;PRD000269;PXD000964	97		925010	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	protein kinase binding [GO:0019901];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P01909	HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)	HLA-DQA1	P01911	HLA class II histocompatibility antigen, DRB1-15 beta chain (DW2.2/DR2.2) (MHC class II antigen DRB1*15)	HLA-DRB1	0.44	3	PRD000053;PXD001324;PXD001422	11				R-HSA-202424;R-HSA-202427;R-HSA-202430;R-HSA-202433;R-HSA-2132295;R-HSA-389948;R-HSA-877300	T cell receptor signaling pathway [GO:0050852];antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];interferon-gamma-mediated signaling pathway [GO:0060333]	trans-Golgi network membrane [GO:0032588];Golgi membrane [GO:0000139];transport vesicle membrane [GO:0030658];membrane [GO:0016020];endocytic vesicle membrane [GO:0030666];lysosomal membrane [GO:0005765];MHC class II protein complex [GO:0042613];ER to Golgi transport vesicle membrane [GO:0012507];integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556];plasma membrane [GO:0005886];clathrin-coated endocytic vesicle membrane [GO:0030669]	peptide antigen binding [GO:0042605]
P01909	HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)	HLA-DQA1	P79483	HLA class II histocompatibility antigen, DR beta 3 chain (MHC class II antigen DRB3)	HLA-DRB3	0.43	3	PRD000053;PXD001324;PXD001422	11				R-HSA-202424;R-HSA-202427;R-HSA-202430;R-HSA-202433;R-HSA-2132295;R-HSA-389948;R-HSA-877300	T cell receptor signaling pathway [GO:0050852];antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];interferon-gamma-mediated signaling pathway [GO:0060333]	trans-Golgi network membrane [GO:0032588];Golgi membrane [GO:0000139];transport vesicle membrane [GO:0030658];membrane [GO:0016020];endocytic vesicle membrane [GO:0030666];lysosomal membrane [GO:0005765];integral component of plasma membrane [GO:0005887];MHC class II protein complex [GO:0042613];ER to Golgi transport vesicle membrane [GO:0012507];integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556];plasma membrane [GO:0005886];clathrin-coated endocytic vesicle membrane [GO:0030669]	MHC class II receptor activity [GO:0032395];peptide antigen binding [GO:0042605]
P01909	HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)	HLA-DQA1	P04440	HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)	HLA-DPB1	0.5	2	PRD000053;PXD001422	10				R-HSA-202424;R-HSA-202427;R-HSA-202430;R-HSA-202433;R-HSA-2132295;R-HSA-389948;R-HSA-877300	T cell receptor signaling pathway [GO:0050852];antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];interferon-gamma-mediated signaling pathway [GO:0060333]	trans-Golgi network membrane [GO:0032588];Golgi membrane [GO:0000139];transport vesicle membrane [GO:0030658];membrane [GO:0016020];endocytic vesicle membrane [GO:0030666];lysosomal membrane [GO:0005765];MHC class II protein complex [GO:0042613];ER to Golgi transport vesicle membrane [GO:0012507];endosome membrane [GO:0010008];integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556];plasma membrane [GO:0005886];clathrin-coated endocytic vesicle membrane [GO:0030669]	peptide antigen binding [GO:0042605]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	0.4	23	PRD000053;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PXD000217;PRD000146;PXD000529;PXD000997;PRD000600;PXD001572;PXD001422;PRD000796;PXD000593;PRD000565;PRD000407;PRD000711;PRD000597;PRD000020;PRD000345;PRD000234	67		1271239;924926;742478	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];mRNA binding [GO:0003729];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	0.42	25	PRD000053;PRD000269;PXD001323;PXD001310;PXD000218;PRD000444;PRD000594;PRD000668;PXD000217;PRD000443;PRD000565;PXD000948;PRD000146;PXD000997;PRD000600;PXD001572;PXD000529;PXD001422;PXD000593;PRD000796;PRD000345;PRD000407;PRD000711;PRD000597;PRD000020	77		1270944;925099	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleoplasm [GO:0005654];extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	0.44	24	PRD000053;PRD000565;PXD001323;PXD001310;PXD000529;PRD000444;PRD000594;PRD000668;PRD000443;PRD000269;PXD000948;PXD000218;PRD000146;PRD000020;PXD000997;PXD001572;PXD000533;PXD001422;PXD000593;PRD000796;PXD000217;PRD000407;PRD000711;PRD000597	77		1269672	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.42	26	PRD000053;PXD000948;PXD001310;PRD000444;PRD000594;PXD001323;PRD000668;PXD000217;PRD000443;PRD000565;PRD000607;PRD000146;PRD000269;PXD000997;PRD000671;PXD001572;PRD000154;PXD000593;PXD001422;PRD000796;PRD000407;PRD000711;PRD000597;PRD000020;PRD000345;PXD000218	77		1271223;742467	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	0.41	21	PRD000053;PRD000269;PXD001323;PXD001310;PXD000218;PRD000444;PRD000594;PRD000668;PRD000443;PXD000948;PXD000529;PRD000146;PXD000997;PRD000565;PXD001572;PXD000533;PXD001422;PXD000593;PRD000796;PRD000020;PRD000711	58	EBI-494408	1271224;742466	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.44	23	PXD000948;PRD000053;PRD000565;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PXD000529;PRD000146;PXD000997;PRD000671;PXD001572;PXD000533;PXD001422;PXD000593;PRD000796;PRD000020;PRD000711;PRD000597;PRD000269;PRD000345	77		1269526;742812	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.41	21	PRD000053;PRD000565;PXD001310;PXD000218;PRD000444;PXD001323;PRD000443;PRD000269;PXD000948;PXD000529;PRD000146;PXD000997;PXD001572;PRD000594;PXD001422;PXD000593;PRD000345;PRD000020;PRD000711;PRD000597;PRD000668	62		1271222;743666	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.45	28	PRD000565;PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PRD000269;PXD001572;PRD000154;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD000948;PXD000217;PRD000020;PXD000218;PRD000146;PXD000997;PRD000444;PXD000593;PRD000345;PRD000600;PRD000671;PXD000533;PXD001422	92	EBI-8375919	1269120;742706	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.4	23	PRD000053;PRD000565;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PXD000948;PXD000217;PRD000443;PRD000146;PRD000607;PXD000997;PXD001572;PXD000533;PXD001422;PXD000593;PRD000796;PRD000407;PRD000711;PRD000597;PRD000345	71		1271220;742821	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.41	19	PRD000053;PRD000269;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000565;PXD000948;PRD000146;PXD000997;PXD001572;PXD001422;PXD000593;PRD000407;PRD000796;PRD000711;PRD000597;PRD000668	67		1269546;742470	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46782	40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]	RPS5	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.41	24	PXD000948;PRD000053;PRD000565;PXD001323;PXD001310;PXD000529;PXD000218;PRD000444;PRD000594;PRD000668;PXD000217;PRD000146;PXD000997;PRD000345;PRD000600;PRD000671;PXD001572;PXD001422;PXD000593;PRD000154;PRD000796;PRD000407;PRD000711;PRD000597	79		1270831;925027;742481	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal small subunit assembly [GO:0000028];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	P60900	Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6	0.41	20	PRD000154;PRD000032;PRD000053;PRD000668;PXD000426;PXD001572;PXD001422;PXD000948;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD001310;PRD000733;PXD000218;PXD000997;PRD000345;PXD000164;PRD000738	94	EBI-7659176	2248190;1267738;924073;741421	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	P49721	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	0.51	20	PRD000053;PRD000092;PRD000154;PRD000594;PXD001323;PRD000668;PRD000073;PRD000607;PXD000948;PXD000529;PRD000597;PRD000345;PXD000426;PXD001572;PXD000997;PXD000164;PRD000738;PXD001422;PRD000711;PRD000733	84	EBI-7659521;EBI-7659502;EBI-696925;EBI-696858	2221885;1267743;924076;740907;696564;696558;668662;668230;668229	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];proteasome core complex, beta-subunit complex [GO:0019774];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P49720	Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain)	PSMB3	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.47	22	PRD000154;PRD000032;PRD000053;PRD000668;PXD000529;PXD000426;PXD001572;PRD000711;PRD000597;PRD000092;PRD000594;PXD001323;PRD000607;PXD001403;PXD000948;PRD000733;PXD000218;PXD000997;PRD000345;PXD000164;PRD000738;PXD001422	87	EBI-7659356;EBI-696862	2224753;1267741;924075;740906;696552;668671;668225	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];proteasome core complex, beta-subunit complex [GO:0019774];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
Q9H0A0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	NAT10	Q96GQ7	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)	DDX27	0.49	7	PXD000047;PXD001572;PXD000529;PXD000426;PXD000533;PRD000597;PXD000593	12						nucleolus [GO:0005730]	ATP binding [GO:0005524];RNA binding [GO:0003723]
Q9H0A0	RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10)	NAT10	Q9BZE4	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4	0.5	7	PRD000146;PXD000047;PXD000426;PRD000565;PXD001572;PRD000597;PXD000593	13						nucleus [GO:0005634];nucleolus [GO:0005730];membrane [GO:0016020]	RNA binding [GO:0003723]
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P63104	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	0.46	51	PRD000032;PRD000053;PRD000059;PRD000738;PRD000123;PRD000668;PRD000417;PXD000948;PXD000529;PRD000269;PRD000416;PXD000387;PXD001328;PXD000426;PRD000154;PXD001422;PRD000796;PRD000345;PRD000146;PRD000407;PRD000597;PRD000477;PRD000594;PXD001323;PRD000046;PRD000073;PXD000786;PXD001403;PRD000068;PRD000001;PRD000020;PXD000164;PXD000218;PXD000314;PRD000092;PRD000731;PRD000551;PXD000217;PRD000565;PXD001324;PRD000234;PRD000444;PRD000113;PRD000711;PXD001572;PXD001447;PRD000364;PRD000523;PXD000533;PRD000118;PRD000108	242	EBI-7194294	926870				cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	0.4	57	PRD000269;PXD000426;PRD000059;PXD000948;PRD000053;PRD000032;PRD000417;PRD000738;PRD000123;PRD000668;PRD000416;PRD000146;PXD000529;PXD000387;PXD001328;PXD001422;PRD000154;PRD000796;PRD000477;PRD000465;PXD000164;PRD000046;PRD000597;PRD000407;PRD000594;PXD001323;PRD000073;PRD000607;PXD000786;PXD001403;PRD000001;PXD000217;PXD001402;PRD000020;PXD000218;PRD000092;PRD000731;PRD000103;PRD000671;PXD000746;PXD001324;PRD000234;PRD000108;PRD000565;PRD000444;PRD000345;PRD000733;PXD001572;PRD000019;PXD001447;PRD000364;PRD000523;PXD000533;PRD000118;PRD000711;PXD000314;PRD000113	329						membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];NAD binding [GO:0051287]
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P62258	14-3-3 protein epsilon (14-3-3E)	YWHAE	0.41	49	PRD000032;PXD000426;PRD000059;PRD000053;PRD000738;PRD000123;PRD000668;PRD000417;PXD000948;PXD000529;PRD000416;PXD000387;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000465;PRD000146;PRD000269;PRD000407;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000046;PRD000073;PXD000786;PRD000345;PRD000001;PRD000020;PXD000218;PXD000314;PRD000092;PRD000731;PXD000217;PXD001324;PRD000234;PRD000108;PRD000444;PRD000113;PRD000565;PXD000164;PXD001447;PRD000364;PRD000523;PXD000533;PRD000118	218						membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	0.46	36	PRD000053;PRD000032;PRD000668;PRD000738;PXD000948;PRD000416;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000345;PRD000465;PRD000146;PRD000269;PRD000417;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PXD000786;PRD000020;PRD000565;PXD000218;PRD000731;PXD000217;PXD001324;PRD000234;PXD000529;PRD000444;PRD000523;PXD001572;PRD000364;PXD000533	167						myelin sheath [GO:0043209];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.49	43	PXD000426;PXD000948;PRD000053;PRD000738;PRD000123;PRD000668;PRD000059;PXD000314;PXD000529;PRD000416;PXD001328;PXD000164;PXD001422;PRD000154;PRD000032;PRD000796;PRD000146;PRD000269;PRD000597;PRD000417;PRD000477;PRD000594;PXD001323;PRD000046;PRD000607;PXD000786;PRD000001;PRD000020;PXD001402;PXD000218;PRD000731;PRD000671;PXD001324;PRD000234;PXD000217;PRD000444;PRD000092;PRD000345;PRD000073;PRD000362;PXD001572;PRD000364;PRD000108	191	EBI-6272793;EBI-12719157;EBI-12704897;EBI-12696494;EBI-19232031;EBI-19232046;EBI-10510378;EBI-10352727;EBI-10195198;EBI-3931719	2231772;1438872;1039786;922557;892481;745082		R-HSA-70268	lactate metabolic process [GO:0006089];NAD metabolic process [GO:0019674];pyruvate metabolic process [GO:0006090]	membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	NAD binding [GO:0051287];kinase binding [GO:0019900];identical protein binding [GO:0042802];L-lactate dehydrogenase activity [GO:0004459]
P07195	L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46)	LDHB	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.43	45	PXD000426;PRD000059;PRD000053;PRD000417;PRD000738;PRD000123;PRD000668;PRD000416;PXD000948;PXD000529;PRD000269;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000465;PRD000146;PXD001323;PRD000597;PRD000407;PRD000594;PRD000046;PRD000073;PRD000607;PXD000786;PRD000032;PRD000001;PXD000217;PRD000020;PXD000218;PRD000731;PXD000746;PXD001324;PRD000234;PXD000314;PRD000113;PRD000444;PRD000345;PRD000477;PXD001572;PRD000523;PXD000533;PRD000118;PRD000711	239		1266558				membrane raft [GO:0045121];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		0.43	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD000217;PXD000680;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	359						nucleus [GO:0005634];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.62	66	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000383;PXD000314;PXD001447;PRD000671;PXD000387;PRD000711;PRD000597;PXD000472;PXD000786;PRD000731;PXD001324;PRD000407	386				R-HSA-983189;R-HSA-8955332;R-HSA-8854518;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5620912;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-3371497;R-HSA-2565942;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	regulation of G2/M transition of mitotic cell cycle [GO:0010389];ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];microtubule-based process [GO:0007017]	myelin sheath [GO:0043209];microtubule [GO:0005874];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.64	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	379	EBI-16799786	743469		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.43	61	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000269;PRD000444;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000594;PRD000059;PRD000680;PRD000417;PRD000345;PXD001310;PRD000168;PXD000746;PRD000234;PXD000997;PRD000032;PXD001323;PRD000167;PRD000600;PXD000218;PRD000416;PXD000593;PXD000533;PRD000443;PRD000796;PXD001572;PXD001422;PRD000073;PRD000607;PRD000565;PXD000314;PXD000529;PXD000164;PXD000226;PXD001328;PRD000154;PRD000146;PRD000046;PXD000217;PXD000680;PRD000180;PXD001447;PRD000671;PRD000108;PXD000387;PRD000711;PRD000597;PXD000472;PRD000151;PXD000786;PRD000731;PXD001324;PRD000407;PRD000738	359			3055			myelin sheath [GO:0043209];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	0.42	63	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PRD000020;PRD000668;PRD000465;PXD000047;PXD000426;PRD000059;PRD000594;PRD000032;PRD000417;PRD000345;PRD000068;PRD000168;PRD000234;PXD000997;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000533;PRD000443;PXD001572;PRD000738;PRD000684;PXD001422;PRD000073;PRD000607;PXD000314;PXD000529;PRD000108;PRD000523;PRD000269;PRD000118;PXD000164;PXD001328;PRD000796;PRD000146;PRD000046;PXD000217;PRD000565;PXD000680;PRD000444;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PRD000416;PXD000472;PRD000151;PRD000731;PXD001324;PRD000407;PRD000167;PXD000964	365	EBI-9394399	950010;949316		R-HSA-8852276;R-HSA-3371497		nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.6	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000668;PRD000465;PXD000047;PRD000594;PRD000032;PRD000680;PRD000167;PRD000345;PRD000068;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PXD000226;PRD000407;PRD000684	376	EBI-16800060;EBI-11898446;EBI-11898421;EBI-11898141;EBI-11897464;EBI-11897791;EBI-11897134;EBI-11706366;EBI-11706355	2272239;744934		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.64	64	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PXD000593;PRD000154;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PRD000796;PXD001572;PXD000426;PRD000738;PXD001422;PRD000073;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	379	EBI-16799786			R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule cytoskeleton [GO:0015630];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	0.59	67	PRD000733;PXD000948;PXD000743;PRD000123;PRD000053;PXD000383;PRD000269;PRD000020;PRD000032;PRD000668;PRD000465;PXD000047;PRD000594;PRD000059;PRD000680;PRD000167;PRD000345;PRD000417;PXD001310;PRD000168;PRD000234;PXD000997;PRD000151;PXD001323;PRD000600;PRD000154;PXD000218;PRD000001;PRD000364;PXD000593;PXD000426;PXD000533;PRD000443;PRD000073;PRD000796;PXD001572;PRD000738;PRD000684;PXD001422;PRD000607;PXD000529;PRD000108;PRD000444;PRD000523;PRD000535;PRD000118;PXD000164;PXD000226;PXD001328;PRD000146;PRD000046;PRD000092;PXD000217;PRD000565;PRD000068;PXD000314;PXD001447;PRD000671;PXD000786;PXD000387;PRD000711;PRD000597;PXD000472;PRD000731;PXD001324;PRD000407;PXD000964	414		939267;926310;744348	6703	R-HSA-8854518;R-HSA-5620912;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-2565942	ciliary basal body-plasma membrane docking [GO:0097711];G2/M transition of mitotic cell cycle [GO:0000086];cell division [GO:0051301];regulation of G2/M transition of mitotic cell cycle [GO:0010389];microtubule-based process [GO:0007017];cytoskeleton-dependent intracellular transport [GO:0030705]	nucleus [GO:0005634];microtubule [GO:0005874];extracellular exosome [GO:0070062];cytoplasmic ribonucleoprotein granule [GO:0036464];membrane raft [GO:0045121]	structural constituent of cytoskeleton [GO:0005200];GTPase activity [GO:0003924];protein domain specific binding [GO:0019904];structural molecule activity [GO:0005198];GTP binding [GO:0005525]
Q71U36	Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain]	TUBA1A	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.42	50	PRD000733;PXD000948;PRD000345;PXD000426;PRD000032;PRD000053;PXD000743;PRD000668;PRD000443;PXD000529;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PXD000680;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PRD000444;PXD000472;PXD000164;PRD000001;PXD000217;PRD000565;PXD000218;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PRD000118;PRD000523;PRD000535;PRD000269;PXD001447;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	289	EBI-11897791					cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P30038	Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)	ALDH4A1	P45954	Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)	ACADSB	0.41	7	PXD000529;PRD000443;PXD001422;PRD000020;PXD000533;PXD001324;PRD000053	16						mitochondrial matrix [GO:0005759]	
P54760	Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)	EPHB4	P07947	Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes)	YES1	0.4	4	PRD000032;PRD000167;PRD000814;PRD000168	78				R-HSA-3928665;R-HSA-3928662;R-HSA-2682334	ephrin receptor signaling pathway [GO:0048013]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein tyrosine kinase activity [GO:0004713]
P54760	Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11)	EPHB4	P07948	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	LYN	0.4	4	PRD000032;PRD000814;PRD000167;PRD000168	87				R-HSA-3928665;R-HSA-3928662;R-HSA-2682334	protein autophosphorylation [GO:0046777];ephrin receptor signaling pathway [GO:0048013]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];protein tyrosine kinase activity [GO:0004713]
P13639	Elongation factor 2 (EF-2)	EEF2	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.41	46	PRD000053;PXD000948;PXD000426;PRD000032;PRD000417;PXD000743;PRD000123;PRD000668;PRD000059;PRD000269;PXD000529;PXD000387;PXD000050;PXD001572;PXD001422;PRD000796;PRD000345;PRD000146;PXD001323;PRD000416;PRD000711;PRD000597;PRD000407;PRD000046;PRD000607;PRD000410;PXD000164;PRD000565;PRD000733;PRD000073;PRD000151;PXD000217;PXD000786;PRD000020;PXD000218;PRD000731;PRD000103;PXD001324;PRD000234;PRD000444;PRD000594;PXD001447;PXD001328;PXD000533;PRD000443;PXD000226	228					response to hydrogen peroxide [GO:0042542]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P13639	Elongation factor 2 (EF-2)	EEF2	P22314	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1)	UBA1	0.41	34	PXD000426;PRD000059;PXD000948;PRD000053;PRD000123;PRD000668;PRD000269;PXD000529;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000345;PRD000465;PRD000146;PXD001323;PRD000711;PRD000417;PRD000597;PRD000416;PRD000594;PXD000164;PXD000533;PRD000020;PXD000218;PRD000731;PRD000733;PXD001324;PRD000444;PRD000073;PRD000118;PXD000226;PRD000407	159						nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P13639	Elongation factor 2 (EF-2)	EEF2	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.4	40	PXD000948;PXD000426;PRD000059;PRD000053;PRD000417;PXD000743;PRD000123;PRD000668;PRD000269;PXD000529;PXD000387;PXD001422;PRD000796;PRD000465;PRD000146;PXD001323;PXD000047;PRD000416;PRD000711;PRD000597;PRD000407;PRD000046;PRD000607;PRD000020;PXD000164;PXD000533;PRD000073;PRD000151;PXD000217;PXD000786;PXD000218;PRD000731;PXD001324;PRD000234;PRD000444;PRD000345;PRD000594;PXD001328;PXD001572;PRD000118	194		1261418				membrane raft [GO:0045121];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	0.47	2	PRD000345;PXD000529	35						cytosol [GO:0005829]	zinc ion binding [GO:0008270];identical protein binding [GO:0042802]
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	0.42	2	PRD000345;PXD000529	36						cytosol [GO:0005829]	zinc ion binding [GO:0008270]
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	0.42	3	PRD000345;PRD000053;PXD000529	37						cytosol [GO:0005829]	zinc ion binding [GO:0008270]
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.52	2	PRD000345;PXD000529	33							
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.48	1	PRD000345	32							
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	0.4	1	PRD000345	32	EBI-7400147	602085				cytosol [GO:0005829]	
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	P46109	Crk-like protein	CRKL	0.46	4	PRD000345;PRD000146;PXD000529;PXD000948	38						cytosol [GO:0005829]	identical protein binding [GO:0042802]
P04183	Thymidine kinase, cytosolic (EC 2.7.1.21)	TK1	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.51	3	PRD000345;PRD000032;PXD000529	37						cytosol [GO:0005829]	
P02652	Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]	APOA2	P02656	Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)	APOC3	0.51	14	PRD000172;PRD000631;PRD000073;PRD000551;PXD001174;PXD000383;PRD000059;PRD000158;PXD001324;PRD000053;PXD001403;PRD000364;PXD000743;PXD000164	64				R-HSA-975634;R-HSA-8963901;R-HSA-8963888	cholesterol efflux [GO:0033344];high-density lipoprotein particle remodeling [GO:0034375];reverse cholesterol transport [GO:0043691];negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903];triglyceride metabolic process [GO:0006641];chylomicron assembly [GO:0034378];lipoprotein metabolic process [GO:0042157];retinoid metabolic process [GO:0001523];negative regulation of cholesterol import [GO:0060621];phospholipid efflux [GO:0033700];cholesterol homeostasis [GO:0042632];negative regulation of lipid catabolic process [GO:0050995];chylomicron remodeling [GO:0034371]	extracellular exosome [GO:0070062];chylomicron [GO:0042627];very-low-density lipoprotein particle [GO:0034361];early endosome [GO:0005769];extracellular region [GO:0005576];spherical high-density lipoprotein particle [GO:0034366]	phospholipid binding [GO:0005543];cholesterol binding [GO:0015485];lipase inhibitor activity [GO:0055102];high-density lipoprotein particle receptor binding [GO:0070653]
P02652	Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))]	APOA2	B9A064	Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1)	IGLL5	0.41	15	PRD000073;PRD000631;PXD000746;PXD000383;PRD000059;PXD000743;PRD000551;PRD000212;PRD000053;PXD001403;PRD000364;PXD001324;PXD001174;PXD000164;PRD000185	59						extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02655	Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)]	APOC2	P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	0.53	7	PXD000383;PRD000172;PRD000551;PRD000073;PRD000364;PRD000631;PXD000743	21					cholesterol efflux [GO:0033344];chylomicron remnant clearance [GO:0034382];phospholipid efflux [GO:0033700];high-density lipoprotein particle remodeling [GO:0034375];negative regulation of cholesterol transport [GO:0032375];negative regulation of very-low-density lipoprotein particle clearance [GO:0010916];negative regulation of receptor-mediated endocytosis [GO:0048261];negative regulation of lipid metabolic process [GO:0045833]	very-low-density lipoprotein particle [GO:0034361];chylomicron [GO:0042627];extracellular region [GO:0005576]	lipase inhibitor activity [GO:0055102]
P02655	Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)]	APOC2	P02656	Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)	APOC3	0.43	11	PRD000172;PRD000073;PRD000551;PRD000631;PXD000383;PRD000059;PRD000185;PRD000158;PRD000364;PXD000743;PXD001174	36				R-HSA-975634;R-HSA-8964058;R-HSA-8963901;R-HSA-8963888	cholesterol efflux [GO:0033344];high-density lipoprotein particle remodeling [GO:0034375];reverse cholesterol transport [GO:0043691];phospholipid efflux [GO:0033700];chylomicron assembly [GO:0034378];negative regulation of very-low-density lipoprotein particle clearance [GO:0010916];triglyceride homeostasis [GO:0070328];retinoid metabolic process [GO:0001523];negative regulation of receptor-mediated endocytosis [GO:0048261];cholesterol homeostasis [GO:0042632];negative regulation of lipid metabolic process [GO:0045833];chylomicron remodeling [GO:0034371];chylomicron remnant clearance [GO:0034382]	intermediate-density lipoprotein particle [GO:0034363];chylomicron [GO:0042627];very-low-density lipoprotein particle [GO:0034361];early endosome [GO:0005769];extracellular space [GO:0005615];extracellular region [GO:0005576];spherical high-density lipoprotein particle [GO:0034366]	lipase inhibitor activity [GO:0055102]
P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.48	5	PRD000073;PRD000631;PXD000383;PXD000743;PRD000364	27						extracellular region [GO:0005576]	
P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.41	5	PRD000631;PXD000383;PXD000743;PRD000551;PRD000073	26						extracellular region [GO:0005576]	
P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.45	2	PXD000383;PXD000743	14							
P02654	Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I]	APOC1	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.48	3	PXD000383;PRD000631;PXD000743	15							
P02656	Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3)	APOC3	P0CG04	Immunoglobulin lambda constant 1 (Ig lambda chain C region MGC) (Ig lambda-1 chain C region)		0.4	14	PRD000631;PRD000073;PXD000383;PRD000551;PRD000059;PXD001324;PRD000053;PXD001403;PRD000364;PXD000164;PXD001422;PXD000743;PXD001174;PRD000019	56						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	0.4	28	PRD000020;PRD000053;PRD000123;PRD000443;PXD000529;PXD001310;PXD001572;PRD000154;PXD000047;PRD000711;PRD000597;PRD000668;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PRD000565;PXD000218;PXD000593;PRD000671;PRD000146;PXD000997;PRD000444;PRD000345;PRD000269;PXD000786;PXD001422	87		1271410;925328;742573	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.4	29	PRD000053;PXD001323;PXD001310;PXD000529;PXD000948;PRD000444;PRD000465;PRD000594;PRD000123;PRD000668;PXD000746;PRD000680;PRD000565;PXD000218;PRD000146;PXD000997;PXD000387;PXD001572;PXD000533;PXD001422;PRD000443;PRD000597;PRD000345;PRD000796;PXD000047;PRD000020;PXD000593;PRD000711;PXD000426	80		1271357;1180960;925304;742531	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-6790901;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	0.45	23	PXD000948;PRD000565;PXD001328;PXD001310;PRD000053;PXD000529;PXD000593;PRD000594;PRD000123;PXD001323;PRD000680;PRD000146;PXD000218;PXD000997;PRD000671;PXD001572;PXD000533;PRD000444;PXD001422;PRD000668;PXD000047;PRD000711;PRD000597	82		1270265;742371	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytosol [GO:0005829];membrane [GO:0016020]	cadherin binding [GO:0045296];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.46	28	PXD000948;PRD000565;PXD001328;PXD001310;PRD000053;PXD000529;PRD000444;PRD000594;PRD000123;PRD000668;PXD001323;PXD000593;PRD000597;PRD000443;PRD000671;PRD000607;PRD000680;PXD000218;PRD000146;PXD000997;PXD000387;PXD001572;PXD000533;PXD000050;PRD000345;PRD000269;PRD000711;PXD001422	84		2266927;1271141;1180963;925189;742627	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P15880	40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5)	RPS2	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.4	23	PXD000948;PXD000218;PRD000565;PXD001310;PRD000053;PRD000020;PRD000444;PRD000465;PXD001323;PRD000443;PXD000529;PRD000146;PXD000997;PXD000387;PRD000345;PXD001572;PRD000594;PXD001422;PXD000593;PRD000597;PXD000047;PRD000711;PRD000668	72		1269383;743657	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P09228	Cystatin-SA (Cystatin-2) (Cystatin-S5)	CST2	P22079	Lactoperoxidase (LPO) (EC 1.11.1.7) (Salivary peroxidase) (SPO)	LPO	0.51	3	PRD000164;PRD000212;PRD000059	10					detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	extracellular space [GO:0005615]	
P09228	Cystatin-SA (Cystatin-2) (Cystatin-S5)	CST2	P23280	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)	CA6	0.58	2	PRD000164;PRD000212	10					detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	extracellular space [GO:0005615]	
P09228	Cystatin-SA (Cystatin-2) (Cystatin-S5)	CST2	Q96DA0	Zymogen granule protein 16 homolog B	ZG16B	0.44	2	PRD000164;PRD000212	11						extracellular space [GO:0005615]	
P01699	Immunoglobulin lambda variable 1-44 (Ig lambda chain V-I region MEM) (Ig lambda chain V-I region VOR)	IGLV1-44	A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	0.41	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01699	Immunoglobulin lambda variable 1-44 (Ig lambda chain V-I region MEM) (Ig lambda chain V-I region VOR)	IGLV1-44	P01624	Immunoglobulin kappa variable 3-15 (Ig kappa chain V-III region CLL) (Ig kappa chain V-III region POM)	IGKV3-15	0.44	8	PRD000417;PRD000416;PXD000383;PXD001422;PXD000743;PRD000269;PXD001174;PRD000212	25				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P0DMM9	Sulfotransferase 1A3 (ST1A3) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Catecholamine-sulfating phenol sulfotransferase) (HAST3) (M-PST) (Monoamine-sulfating phenol sulfotransferase) (Placental estrogen sulfotransferase) (Sulfotransferase 1A3/1A4) (Sulfotransferase, monoamine-preferring) (Thermolabile phenol sulfotransferase) (TL-PST)	SULT1A3	P50225	Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST)	SULT1A1	0.48	5	PRD000443;PRD000053;PXD001324;PXD001422;PXD000533	15		2217825;1181159		R-HSA-156584	ethanol catabolic process [GO:0006068];3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427];xenobiotic metabolic process [GO:0006805];flavonoid metabolic process [GO:0009812];sulfation [GO:0051923]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062];sulfotransferase activity [GO:0008146]
Q9UKV8	Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer)	AGO2	Q13616	Cullin-1 (CUL-1)	CUL1	0.46	5	PXD001572;PRD000154;PXD000529;PXD000533;PRD000092	16		689145				nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q9GZM7	Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP)	TINAGL1	Q08431	Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]	MFGE8	0.46	1	PRD000269	18					cell adhesion [GO:0007155]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];collagen-containing extracellular matrix [GO:0062023]	
P06310	Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410)	IGKV2-30	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.41	19	PRD000417;PRD000631;PRD000345;PXD001174;PRD000671;PRD000364;PRD000416;PXD000383;PXD000743;PRD000059;PXD001324;PRD000073;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000269;PRD000185	56				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P06310	Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410)	IGKV2-30	P01624	Immunoglobulin kappa variable 3-15 (Ig kappa chain V-III region CLL) (Ig kappa chain V-III region POM)	IGKV3-15	0.4	16	PRD000417;PRD000345;PRD000416;PRD000631;PXD001174;PRD000671;PXD000383;PXD000743;PRD000019;PXD001324;PRD000073;PXD001403;PXD001422;PRD000113;PRD000269;PXD000164	45				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
Q92743	Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11)	HTRA1	P27658	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin]	COL8A1	0.4	2	PXD000746;PRD000269	13						extracellular region [GO:0005576];collagen-containing extracellular matrix [GO:0062023]	
A0A0A0MT36	Immunoglobulin kappa variable 6D-21	IGKV6D-21	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.41	2	PXD001403;PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MT36	Immunoglobulin kappa variable 6D-21	IGKV6D-21	P01611	Immunoglobulin kappa variable 1D-12 (Ig kappa chain V-I region Wes)	IGKV1D-12	0.43	4	PRD000417;PRD000416;PXD000383;PXD001403	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0A0MT36	Immunoglobulin kappa variable 6D-21	IGKV6D-21	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.5	2	PXD001403;PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	0.45	1	PXD000383	10					adaptive immune response [GO:0002250]	plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	0.63	1	PXD000383	10						plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	0.61	1	PXD000383	10						plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.41	1	PXD000383	10					adaptive immune response [GO:0002250]	plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	0.43	1	PXD000383	10					adaptive immune response [GO:0002250]	plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.52	1	PXD000383	10					adaptive immune response [GO:0002250]	plasma membrane [GO:0005886]	
Q02223	Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269)	TNFRSF17	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.41	1	PXD000383	10					adaptive immune response [GO:0002250]	plasma membrane [GO:0005886]	
Q05707	Collagen alpha-1(XIV) chain (Undulin)	COL14A1	P22105	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB	0.4	5	PRD000416;PRD000417;PRD000269;PXD000743;PXD000164	54					collagen fibril organization [GO:0030199]	extracellular region [GO:0005576];extracellular matrix [GO:0031012];extracellular space [GO:0005615]	
P52565	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA	O95336	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	PGLS	0.42	19	PXD000426;PRD000059;PRD000053;PRD000668;PXD000948;PXD000529;PXD001422;PRD000146;PRD000416;PRD000269;PXD000164;PRD000711;PXD001323;PRD000417;PRD000731;PXD001324;PRD000444;PRD000113;PXD001572	88						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P52565	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA	P78417	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GSTO1	0.42	25	PRD000053;PRD000668;PRD000738;PRD000417;PXD000529;PXD001328;PXD001572;PXD001422;PRD000059;PRD000269;PRD000597;PXD000948;PRD000416;PRD000172;PRD000594;PXD001323;PXD000426;PRD000020;PRD000001;PXD000218;PXD001324;PXD001403;PRD000113;PRD000118;PXD000164	103						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P52565	Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha)	ARHGDIA	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.41	25	PRD000053;PRD000668;PXD000529;PXD000426;PXD001572;PXD001422;PRD000059;PRD000465;PRD000416;PRD000269;PRD000711;PRD000597;PRD000417;PRD000092;PRD000594;PXD001323;PXD000948;PXD001403;PXD000218;PRD000731;PXD001324;PXD000164;PXD000533;PRD000118;PXD000786	112						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q14254	Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1)	FLOT2	O75955	Flotillin-1	FLOT1	0.49	14	PRD000168;PRD000607;PRD000680;PRD000053;PXD001422;PXD000529;PXD000164;PRD000597;PRD000118;PRD000092;PRD000167;PXD000964;PRD000068;PXD001447	19	EBI-9840998;EBI-9840960;EBI-9514256;EBI-7105871;EBI-7105841	823762;745029		R-HSA-8849932	protein localization to plasma membrane [GO:0072659];membrane raft assembly [GO:0001765];protein stabilization [GO:0050821]	cell-cell adherens junction [GO:0005913];caveola [GO:0005901];extracellular exosome [GO:0070062];flotillin complex [GO:0016600];cell-cell contact zone [GO:0044291];endosome [GO:0005768];cytoplasmic vesicle [GO:0031410];membrane [GO:0016020];lamellipodium [GO:0030027];basolateral plasma membrane [GO:0016323];plasma membrane [GO:0005886];uropod [GO:0001931];focal adhesion [GO:0005925]	protein heterodimerization activity [GO:0046982];ionotropic glutamate receptor binding [GO:0035255];protease binding [GO:0002020]
P27658	Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin]	COL8A1	P02462	Collagen alpha-1(IV) chain [Cleaved into: Arresten]	COL4A1	0.4	3	PXD000746;PXD001572;PRD000269	12				R-HSA-1442490;R-HSA-1650814;R-HSA-2022090;R-HSA-216083;R-HSA-8948216	extracellular matrix organization [GO:0030198]	endoplasmic reticulum lumen [GO:0005788];extracellular region [GO:0005576];collagen-containing extracellular matrix [GO:0062023]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]
P12814	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	O43707	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	ACTN4	0.42	34	PXD000948;PRD000053;PRD000417;PRD000668;PRD000269;PXD000387;PXD001328;PXD001422;PRD000796;PXD001323;PXD000164;PXD000047;PRD000416;PRD000711;PRD000597;PXD000426;PRD000594;PRD000073;PRD000118;PXD000218;PXD000529;PRD000731;PXD001324;PRD000234;PRD000444;PRD000477;PRD000059;PXD001572;PXD001447;PRD000364;PXD000533;PRD000738;PXD000786;PXD000964	173		919896;747538		R-HSA-373753;R-HSA-114608	regulation of apoptotic process [GO:0042981];negative regulation of cellular component movement [GO:0051271];actin filament bundle assembly [GO:0051017];platelet degranulation [GO:0002576]	Z disc [GO:0030018];platelet alpha granule lumen [GO:0031093];brush border [GO:0005903];cytosol [GO:0005829];stress fiber [GO:0001725];cytoplasm [GO:0005737];focal adhesion [GO:0005925];extracellular space [GO:0005615];pseudopodium [GO:0031143];cell-cell junction [GO:0005911];intracellular [GO:0005622];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	protein homodimerization activity [GO:0042803];ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374];calcium ion binding [GO:0005509];actin filament binding [GO:0051015];integrin binding [GO:0005178];ion channel binding [GO:0044325]
P12814	Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1)	ACTN1	P18206	Vinculin (Metavinculin) (MV)	VCL	0.46	42	PXD000948;PRD000073;PRD000020;PRD000053;PRD000269;PRD000417;PRD000738;PRD000123;PRD000668;PRD000059;PRD000416;PRD000410;PXD000387;PXD001328;PXD001422;PXD000529;PRD000796;PXD000164;PRD000594;PRD000597;PXD001323;PXD000426;PXD000533;PRD000068;PRD000001;PRD000565;PXD000218;PRD000731;PRD000711;PRD000733;PXD001324;PRD000118;PXD000226;PRD000345;PRD000535;PXD001572;PXD001447;PRD000364;PRD000444;PRD000407;PXD000786;PRD000113	281			5177	R-HSA-114608	platelet degranulation [GO:0002576]	brush border [GO:0005903];cytosol [GO:0005829];fascia adherens [GO:0005916];focal adhesion [GO:0005925];cell-cell junction [GO:0005911];plasma membrane [GO:0005886];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	0.41	10	PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000053;PXD000743;PXD000164;PXD001403;PXD001174	28				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576]	antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	0.41	7	PXD000383;PRD000551;PXD001403;PRD000362;PXD000164;PXD000743;PRD000019	21					immune response [GO:0006955]		antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.42	10	PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000053;PXD000743;PXD000164;PXD001403;PXD001174	28				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	0.46	7	PRD000671;PXD000383;PXD000743;PRD000551;PRD000053;PXD001403;PXD000164	24				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576]	antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.41	2	PXD000383;PXD001403	13					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.46	3	PXD000383;PXD001403;PXD000743	14					immune response [GO:0006955]		antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.4	8	PXD000383;PXD000743;PRD000019;PRD000053;PXD001403;PRD000551;PXD000164;PRD000059	23				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576]	antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.41	8	PXD000383;PRD000671;PRD000059;PRD000551;PXD000743;PXD001403;PXD000164;PRD000019	24				R-HSA-202733	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];leukocyte migration [GO:0050900]	extracellular region [GO:0005576]	antigen binding [GO:0003823]
P15814	Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b)	IGLL1	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.4	4	PXD000383;PXD001403;PRD000671;PXD001174	16					immune response [GO:0006955]		antigen binding [GO:0003823]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	0.4	35	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000373;PXD001572;PXD001422;PRD000154;PXD000164;PXD000593;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PRD000212;PRD000151;PXD001402;PRD000565;PRD000020;PXD001324;PRD000234;PXD000997;PRD000345;PRD000113;PRD000443;PXD001323;PRD000671;PRD000600;PXD000218;PXD001447;PRD000364;PRD000019;PRD000146	139	EBI-19890290;EBI-19890303			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	Q86Y46	Keratin, type II cytoskeletal 73 (Cytokeratin-73) (CK-73) (Keratin-73) (K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)	KRT73	0.44	37	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PXD000387;PRD000373;PXD001572;PRD000154;PXD001422;PRD000345;PXD000164;PRD000671;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD001324;PRD000234;PXD000997;PRD000113;PRD000443;PXD001323;PRD000600;PRD000362;PXD001447;PRD000364;PRD000019;PRD000146;PRD000269	134				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	Q7Z794	Keratin, type II cytoskeletal 1b (Cytokeratin-1B) (CK-1B) (Keratin-77) (K77) (Type-II keratin Kb39)	KRT77	0.43	43	PRD000733;PRD000069;PRD000417;PXD000743;PRD000092;PXD000746;PRD000443;PRD000059;PRD000345;PXD000383;PXD000387;PRD000373;PXD001572;PRD000154;PXD001422;PXD000593;PRD000172;PRD000416;PRD000407;PXD001174;PRD000607;PRD000680;PRD000151;PXD001402;PXD000164;PRD000269;PRD000020;PRD000212;PRD000600;PRD000565;PXD001324;PRD000234;PXD000997;PRD000113;PXD001323;PRD000671;PRD000362;PXD000218;PXD001447;PRD000364;PRD000019;PXD000964;PRD000146	184	EBI-19889771;EBI-19889784			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	Q5XKE5	Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)	KRT79	0.42	39	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000443;PRD000345;PXD000387;PRD000373;PXD001572;PRD000154;PXD001422;PXD000164;PXD000593;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PRD000680;PRD000212;PRD000151;PXD001402;PRD000565;PRD000020;PRD000600;PXD001324;PRD000234;PXD000997;PRD000113;PXD001323;PRD000671;PXD000218;PXD001447;PRD000364;PRD000019;PXD000964;PRD000146;PRD000269	161	EBI-20114820;EBI-20114833			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	Q7RTS7	Keratin, type II cytoskeletal 74 (Cytokeratin-74) (CK-74) (Keratin-5c) (K5C) (Keratin-74) (K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)	KRT74	0.44	37	PRD000069;PRD000733;PXD000743;PRD000092;PRD000373;PXD001572;PRD000154;PXD001422;PRD000345;PXD000164;PRD000671;PRD000172;PXD000746;PRD000407;PRD000059;PXD001174;PRD000607;PRD000680;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD001324;PRD000234;PXD000997;PRD000113;PRD000443;PXD001323;PRD000600;PRD000362;PXD000218;PXD001447;PRD000364;PRD000019;PRD000146;PRD000269	133	EBI-19890316;EBI-19890329			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	0.41	40	PRD000345;PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000443;PXD000387;PRD000373;PXD001572;PRD000154;PXD001422;PXD000164;PXD000593;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PRD000680;PRD000212;PRD000151;PXD001402;PRD000565;PRD000020;PRD000600;PXD001324;PRD000234;PXD000997;PRD000113;PXD000383;PXD001323;PRD000671;PXD000218;PXD001447;PRD000364;PRD000019;PXD000964;PRD000146;PRD000269	169	EBI-19890368;EBI-19890381			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	Q3SY84	Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34)	KRT71	0.42	36	PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000373;PXD001572;PRD000154;PXD001422;PXD000164;PRD000671;PRD000172;PRD000407;PRD000059;PXD001174;PRD000607;PXD000593;PXD001323;PRD000151;PXD001402;PRD000565;PRD000020;PXD001324;PRD000234;PXD000997;PRD000345;PRD000113;PRD000443;PRD000600;PRD000362;PXD000218;PXD001447;PRD000364;PRD000019;PRD000146;PRD000269	129	EBI-20115040;EBI-20115053			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];hair follicle morphogenesis [GO:0031069];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
Q7Z3Y8	Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)	KRT27	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.4	39	PRD000345;PRD000069;PRD000733;PXD000743;PRD000092;PXD000746;PRD000443;PXD000387;PXD001572;PRD000154;PXD001422;PRD000417;PXD000164;PRD000172;PRD000416;PXD000593;PXD001323;PRD000059;PRD000607;PRD000680;PRD000212;PRD000151;PXD001402;PRD000565;PRD000020;PXD001174;PXD001324;PRD000234;PXD000997;PRD000113;PXD000383;PRD000269;PRD000600;PRD000362;PRD000407;PXD000218;PXD001447;PRD000019;PRD000146	134				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q13330	Metastasis-associated protein MTA1	MTA1	Q8WXI9	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)	GATAD2B	0.48	7	PXD001572;PRD000345;PXD000529;PXD000533;PRD000711;PXD000680;PXD000314	10	EBI-10891522	2224677;1264977;1192039;744771		R-HSA-3214815;R-HSA-427389;R-HSA-73762;R-HSA-8943724	transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]	zinc ion binding [GO:0008270];RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]
Q13330	Metastasis-associated protein MTA1	MTA1	Q96ST3	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)	SIN3A	0.4	6	PRD000345;PXD000529;PXD000533;PXD000680;PRD000146;PXD000314	12		255657	632		transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634];nucleoplasm [GO:0005654]	transcription corepressor activity [GO:0003714];chromatin binding [GO:0003682];RNA polymerase II repressing transcription factor binding [GO:0001103]
P63104	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	0.4	48	PXD000948;PRD000814;PRD000059;PRD000053;PRD000565;PXD000743;PRD000738;PRD000123;PRD000668;PRD000684;PXD000529;PRD000269;PXD000387;PXD001328;PXD000426;PXD000047;PRD000154;PXD001422;PRD000796;PRD000345;PRD000146;PXD000680;PRD000711;PRD000597;PRD000594;PRD000073;PXD001323;PRD000046;PRD000032;PXD000786;PXD000472;PRD000416;PXD000533;PRD000020;PXD000164;PXD000218;PRD000731;PXD000217;PXD001324;PXD000314;PRD000417;PRD000444;PRD000523;PXD001572;PXD001447;PRD000364;PRD000108;PRD000407	207	EBI-7194084;EBI-445553;EBI-445573				negative regulation of apoptotic process [GO:0043066]	cytosol [GO:0005829];cytoplasm [GO:0005737];focal adhesion [GO:0005925];extracellular space [GO:0005615];nucleus [GO:0005634];vesicle [GO:0031982];extracellular exosome [GO:0070062]	
P63104	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	P62258	14-3-3 protein epsilon (14-3-3E)	YWHAE	0.46	54	PXD000948;PRD000032;PRD000059;PRD000053;PRD000668;PRD000417;PRD000167;PXD000529;PRD000416;PXD000387;PXD001328;PRD000020;PXD000997;PXD000047;PXD001422;PRD000154;PXD000426;PRD000118;PRD000796;PRD000146;PRD000269;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000092;PRD000073;PXD000786;PXD000472;PRD000345;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000218;PRD000731;PXD000680;PXD000593;PRD000046;PRD000565;PXD001324;PXD000217;PRD000444;PRD000113;PRD000535;PXD000164;PXD001572;PRD000738;PRD000523;PXD000533;PRD000108;PRD000407	244	EBI-11011991;EBI-3951004;EBI-3934442;EBI-8063976;EBI-8063698;EBI-7980863	2386574;1448180;1274679;926813;894203;830717;741783;603569;603565;464639	5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]	cytosol [GO:0005829];cytoplasm [GO:0005737];mitochondrion [GO:0005739];focal adhesion [GO:0005925];melanosome [GO:0042470];nucleus [GO:0005634];extracellular exosome [GO:0070062]	ubiquitin protein ligase binding [GO:0031625];cadherin binding [GO:0045296];ion channel binding [GO:0044325];identical protein binding [GO:0042802];protein domain specific binding [GO:0019904];RNA binding [GO:0003723]
P63104	14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1)	YWHAZ	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.44	53	PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000417;PRD000059;PXD000948;PXD000529;PRD000269;PRD000416;PXD000387;PRD000684;PXD001328;PXD000426;PXD000164;PXD001422;PRD000154;PRD000032;PRD000796;PRD000345;PRD000146;PRD000597;PRD000172;PRD000477;PRD000594;PXD001323;PRD000092;PXD000786;PXD000533;PRD000068;PRD000073;PRD000151;PRD000001;PRD000020;PRD000565;PXD000218;PXD000314;PRD000731;PXD000217;PRD000671;PRD000046;PXD001324;PRD000234;PXD000680;PRD000118;PRD000444;PRD000711;PXD001572;PXD001447;PRD000364;PRD000108;PRD000407	255	EBI-7194326					nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];cadherin binding [GO:0045296]
Q14289	Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK)	PTK2B	Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)	CAMK2G	0.4	3	PRD000032;PRD000711;PRD000167	96					MAPK cascade [GO:0000165];protein autophosphorylation [GO:0046777]	postsynaptic density [GO:0014069];cytoplasm [GO:0005737];cytosol [GO:0005829]	ATP binding [GO:0005524];calmodulin-dependent protein kinase activity [GO:0004683]
P07203	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	P61019	Ras-related protein Rab-2A	RAB2A	0.41	11	PRD000733;PRD000053;PXD001323;PRD000668;PRD000092;PXD001324;PRD000001;PRD000154;PRD000738;PXD001422;PXD001572	37						cytosol [GO:0005829]	
P07203	Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase)	GPX1	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.41	10	PRD000733;PRD000053;PRD000154;PXD001323;PRD000668;PRD000092;PXD001324;PRD000001;PXD001422;PXD001572	35							
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.41	17	PRD000417;PRD000551;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	0.48	10	PRD000417;PXD001324;PRD000671;PXD000383;PRD000551;PRD000212;PRD000053;PXD001403;PXD000164;PRD000416	30				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.4	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.45	12	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.43	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.44	14	PRD000417;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PXD000743;PRD000053;PXD000164;PRD000631;PXD001403;PXD001174;PRD000019	40				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04432	Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi)	IGKV1D-39	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.41	14	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	42					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P42229	Signal transducer and activator of transcription 5A	STAT5A	Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	0.43	4	PRD000345;PXD000529;PRD000154;PXD001422	36						cytosol [GO:0005829]	
P42229	Signal transducer and activator of transcription 5A	STAT5A	O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	0.42	3	PRD000345;PXD000529;PXD001422	34						cytosol [GO:0005829]	
P42229	Signal transducer and activator of transcription 5A	STAT5A	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.44	2	PRD000345;PXD001422	33							
P42229	Signal transducer and activator of transcription 5A	STAT5A	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.46	2	PRD000345;PXD000529	33							
P42229	Signal transducer and activator of transcription 5A	STAT5A	Q96BW5	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) (hPHRP)	PTER	0.41	3	PRD000345;PXD001324;PXD001422	30							
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q8IUE6	Histone H2A type 2-B	HIST2H2AB	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	132				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.47	22	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000387;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	57				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.48	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	54				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.45	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	134			1227	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q7L7L0	Histone H2A type 3	HIST3H2A	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815			protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51			1227	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P33778	Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f)	HIST1H2BB	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P36897	TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I)	TGFBR1	Q08345	Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)	DDR1	0.4	1	PRD000032	30						receptor complex [GO:0043235];plasma membrane [GO:0005886]	metal ion binding [GO:0046872];ATP binding [GO:0005524]
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.45	59	PXD000948;PXD000743;PRD000123;PXD000746;PRD000053;PRD000668;PRD000269;PXD000164;PXD000426;PRD000059;PRD000417;PRD000416;PRD000032;PRD000020;PRD000234;PXD001323;PXD000218;PRD000001;PRD000364;PXD000533;PRD000443;PXD001572;PRD000738;PRD000146;PRD000684;PXD001422;PRD000607;PXD000314;PRD000103;PXD000529;PRD000477;PRD000594;PXD000226;PRD000209;PXD001328;PRD000154;PRD000796;PRD000046;PXD000786;PXD000217;PXD001402;PRD000565;PRD000733;PRD000444;PRD000345;PXD001447;PRD000671;PRD000118;PRD000108;PXD000387;PXD000050;PRD000597;PRD000711;PRD000410;PRD000073;PRD000151;PRD000731;PXD001324;PRD000407	360						nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];NAD binding [GO:0051287]
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P63267	Actin, gamma-enteric smooth muscle (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form]	ACTG2	0.4	78	PXD000948;PRD000814;PRD000733;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PRD000059;PRD000680;PRD000417;PRD000032;PRD000416;PRD000212;PXD001310;PRD000234;PXD000997;PXD000218;PRD000113;PXD001323;PRD000600;PXD000680;PRD000001;PRD000364;PXD000533;PRD000443;PXD001572;PXD000426;PRD000738;PRD000146;PXD001422;PRD000073;PRD000164;PRD000607;PXD000314;PRD000092;PRD000103;PXD000529;PRD000108;PRD000477;PRD000523;PRD000535;PRD000594;PRD000118;PXD000226;PRD000209;PXD001328;PRD000154;PRD000796;PRD000046;PXD000786;PXD000217;PXD001402;PRD000565;PRD000068;PXD001403;PRD000444;PRD000345;PRD000631;PXD001447;PRD000671;PXD000387;PXD000050;PRD000597;PRD000410;PXD000472;PRD000151;PRD000532;PRD000731;PXD001324;PRD000711;PRD000407	485						cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P06733	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)	ENO1	0.46	66	PXD000948;PRD000814;PXD000426;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PRD000269;PRD000668;PRD000465;PRD000733;PXD000164;PXD000047;PRD000059;PRD000417;PRD000416;PRD000068;PRD000020;PRD000212;PRD000234;PXD000218;PRD000113;PXD001323;PRD000001;PRD000364;PXD000533;PRD000443;PXD001572;PRD000032;PRD000738;PXD001422;PRD000607;PXD001403;PXD000314;PXD000529;PRD000523;PRD000594;PRD000118;PXD000226;PXD001328;PRD000154;PRD000796;PRD000146;PRD000164;PRD000046;PRD000073;PXD000786;PXD000217;PXD001402;PRD000565;PRD000444;PRD000345;PXD001447;PRD000671;PRD000108;PXD000387;PXD000050;PRD000597;PRD000711;PRD000410;PRD000151;PRD000532;PRD000731;PXD001324;PRD000407	401		1261746;746219		R-HSA-70263;R-HSA-70171	canonical glycolysis [GO:0061621];gluconeogenesis [GO:0006094]	cytosol [GO:0005829];cytoplasm [GO:0005737];membrane [GO:0016020];nucleus [GO:0005634];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	Q6S8J3	POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2)	POTEE	0.44	78	PXD000948;PRD000814;PRD000733;PXD000743;PRD000123;PXD000746;PRD000684;PRD000053;PRD000269;PRD000020;PRD000668;PRD000465;PXD000164;PXD000047;PXD000426;PRD000059;PRD000680;PRD000417;PRD000416;PRD000212;PXD001310;PRD000234;PRD000032;PXD000997;PXD000218;PRD000113;PXD001323;PRD000600;PXD000680;PRD000001;PRD000019;PRD000364;PXD000533;PRD000443;PXD001572;PRD000738;PRD000146;PXD001422;PRD000164;PRD000607;PXD000314;PRD000092;PRD000103;PXD000529;PRD000108;PRD000477;PRD000523;PRD000535;PRD000594;PRD000073;PRD000118;PXD000226;PRD000209;PXD001328;PRD000154;PRD000796;PXD000786;PXD000217;PXD001402;PRD000565;PRD000068;PXD001403;PRD000444;PRD000345;PRD000631;PXD001447;PRD000671;PXD000387;PXD000050;PRD000711;PRD000597;PRD000410;PXD000472;PRD000151;PRD000532;PRD000731;PXD001324;PRD000407	477						extracellular exosome [GO:0070062]	
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P04075	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)	ALDOA;AC093512.2	0.42	60	PXD000948;PRD000053;PXD000426;PRD000059;PRD000269;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000416;PRD000417;PRD000146;PXD000529;PXD000387;PXD001328;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PRD000364;PRD000594;PXD001323;PRD000607;PRD000020;PXD000218;PRD000212;PXD000786;PRD000151;PRD000001;PXD000217;PXD001402;PRD000532;PRD000731;PRD000046;PRD000565;PXD001324;PRD000234;PXD000314;PXD001403;PRD000118;PRD000444;PRD000345;PRD000032;PRD000477;PXD001572;PRD000600;PXD001447;PRD000671;PRD000523;PXD000533;PRD000407;PRD000113	291	EBI-16426431	1262361		R-HSA-70263;R-HSA-70171	canonical glycolysis [GO:0061621];gluconeogenesis [GO:0006094]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P07355	Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)	ANXA2	0.4	53	PXD000948;PRD000814;PXD000743;PRD000123;PRD000053;PRD000269;PRD000668;PRD000465;PRD000733;PXD000164;PXD000047;PRD000059;PRD000680;PRD000417;PRD000416;PRD000020;PRD000212;PXD000529;PXD000746;PXD000218;PRD000113;PXD001323;PRD000600;PXD000533;PXD001572;PXD000426;PRD000032;PRD000146;PXD001422;PXD001403;PRD000477;PRD000594;PRD000118;PXD000226;PXD001328;PRD000796;PRD000164;PRD000046;PXD000786;PRD000565;PRD000345;PRD000444;PXD001447;PRD000671;PRD000108;PXD000387;PRD000597;PRD000711;PRD000410;PRD000073;PRD000151;PXD001324;PRD000407	366						cytosol [GO:0005829];vesicle [GO:0031982];plasma membrane [GO:0005886];lipid droplet [GO:0005811];cytoplasm [GO:0005737];membrane [GO:0016020];nucleus [GO:0005634];perinuclear region of cytoplasm [GO:0048471];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P04406	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-)	GAPDH	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.42	50	PXD000426;PXD000948;PRD000416;PRD000053;PRD000059;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PXD000529;PRD000269;PXD000387;PRD000684;PXD001328;PXD000047;PXD001422;PRD000796;PRD000465;PRD000146;PXD000164;PRD000597;PRD000073;PXD001323;PRD000046;PRD000607;PRD000068;PRD000020;PRD000594;PRD000444;PRD000212;PXD000786;PRD000151;PRD000001;PXD000217;PXD000218;PRD000731;PXD000746;PXD001324;PRD000234;PXD000314;PRD000345;PRD000113;PRD000477;PXD001572;PRD000711;PRD000118;PRD000523;PXD000533;PRD000407	306	EBI-7907424;EBI-7907378	1415160;1262368;743482		R-HSA-70263;R-HSA-70171	canonical glycolysis [GO:0061621];gluconeogenesis [GO:0006094]	membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P48668	Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)	KRT6C	0.47	48	PRD000073;PRD000154;PRD000733;PXD000746;PRD000069;PXD000743;PRD000092;PRD000443;PRD000059;PRD000373;PXD000226;PRD000345;PXD000383;PXD001328;PXD001572;PXD001422;PXD000529;PXD000047;PRD000123;PRD000364;PRD000172;PXD000593;PXD001323;PRD000607;PRD000680;PXD000997;PRD000417;PXD000412;PRD000151;PXD001403;PXD001402;PXD000164;PRD000212;PXD001174;PXD001324;PRD000551;PRD000565;PRD000146;PRD000234;PRD000362;PRD000113;PXD000387;PRD000671;PRD000600;PXD001447;PRD000407;PXD000964;PRD000269	209				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	0.58	50	PRD000733;PRD000345;PRD000154;PRD000073;PRD000269;PRD000069;PRD000417;PXD000743;PRD000092;PXD000746;PRD000059;PRD000443;PRD000373;PXD000226;PXD000383;PXD001328;PXD001572;PXD001422;PXD000047;PRD000416;PRD000364;PRD000172;PXD000593;PXD001323;PRD000607;PRD000680;PXD000997;PXD000164;PXD000412;PRD000151;PXD001403;PXD001402;PRD000565;PRD000212;PXD001174;PXD000529;PXD001324;PRD000671;PRD000551;PRD000146;PRD000234;PRD000362;PRD000113;PXD000387;PRD000600;PRD000053;PXD001447;PRD000407;PRD000019;PXD000964	274				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular space [GO:0005615];membrane [GO:0016020];intermediate filament [GO:0005882];nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	0.49	47	PRD000073;PRD000154;PRD000733;PXD000746;PRD000069;PXD000743;PRD000092;PRD000443;PRD000373;PXD000226;PRD000345;PXD001328;PXD001572;PXD001422;PXD000529;PXD000047;PRD000123;PRD000364;PRD000172;PRD000407;PXD000593;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000417;PXD000412;PRD000151;PXD001403;PXD001402;PXD000164;PRD000212;PXD001174;PXD001324;PRD000551;PRD000565;PRD000234;PRD000146;PRD000362;PXD000383;PRD000113;PXD000387;PRD000671;PRD000600;PXD001447;PRD000269	190				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P02538	Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)	KRT6A	0.5	49	PRD000073;PRD000154;PRD000092;PRD000345;PRD000069;PXD000746;PRD000733;PXD000743;PRD000443;PRD000059;PRD000373;PXD000226;PXD000383;PXD001328;PXD001572;PXD001422;PXD000529;PXD000047;PRD000123;PRD000364;PRD000172;PRD000407;PXD001323;PRD000607;PRD000680;PXD000997;PRD000417;PXD000412;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000212;PXD001174;PXD001324;PXD000593;PRD000671;PRD000551;PRD000146;PRD000234;PRD000362;PRD000113;PXD000387;PRD000600;PXD001447;PRD000019;PXD000964;PRD000269	225				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P04264	Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)	KRT1	0.51	53	PRD000733;PRD000345;PRD000154;PRD000073;PRD000814;PRD000069;PRD000417;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000059;PRD000373;PXD000226;PXD000383;PXD001328;PXD001572;PXD001422;PXD000529;PXD000047;PRD000269;PRD000416;PRD000364;PRD000172;PRD000600;PXD000593;PXD001323;PRD000607;PRD000680;PRD000209;PXD000997;PRD000565;PXD000164;PXD000412;PRD000151;PXD001403;PXD001402;PRD000212;PXD001174;PXD001324;PRD000671;PRD000551;PRD000146;PRD000234;PRD000362;PRD000113;PXD000387;PRD000158;PXD001447;PRD000407;PRD000019;PXD000964	291		744892		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	membrane [GO:0016020];extracellular space [GO:0005615];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.42	50	PRD000345;PRD000073;PRD000069;PXD000743;PRD000123;PRD000092;PXD000746;PRD000059;PRD000443;PRD000373;PRD000733;PXD000383;PRD000185;PXD001328;PXD001572;PRD000154;PXD001422;PXD000529;PRD000417;PRD000146;PXD000047;PRD000364;PRD000172;PRD000416;PXD000593;PXD001323;PRD000607;PRD000680;PXD000997;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000212;PXD001174;PXD001324;PRD000551;PRD000234;PRD000113;PXD000387;PRD000269;PRD000671;PRD000600;PRD000053;PRD000362;PXD001447;PXD000226;PRD000407;PXD000964	202				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P35527	Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)	KRT9	P35908	Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)	KRT2	0.58	52	PRD000733;PRD000345;PRD000154;PRD000073;PRD000069;PRD000417;PRD000092;PXD000746;PRD000059;PRD000443;PRD000373;PXD000743;PXD000226;PXD000383;PXD001328;PXD001572;PXD001422;PXD000047;PRD000269;PRD000416;PRD000123;PRD000364;PRD000172;PRD000407;PRD000600;PXD000593;PXD001323;PRD000607;PRD000680;PXD000997;PXD000164;PXD000412;PRD000151;PXD001403;PXD001402;PRD000565;PRD000212;PXD001174;PXD000529;PXD001324;PRD000671;PRD000551;PRD000146;PRD000234;PRD000362;PRD000113;PRD000185;PRD000053;PXD001447;PXD000387;PRD000019;PXD000964	278				R-HSA-6809371;R-HSA-6805567	intermediate filament organization [GO:0045109];cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular space [GO:0005615];membrane [GO:0016020];intermediate filament [GO:0005882];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P01876	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	P01871	Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region BOT) (Ig mu chain C region GAL) (Ig mu chain C region OU)	IGHM	0.4	23	PRD000073;PRD000417;PRD000416;PXD000383;PRD000185;PRD000053;PXD001422;PRD000796;PRD000164;PXD000164;PXD001403;PXD000743;PRD000059;PRD000212;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000362;PRD000364;PRD000269;PRD000019	143				R-HSA-202733	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];antibacterial humoral response [GO:0019731];positive regulation of B cell activation [GO:0050871];leukocyte migration [GO:0050900]	extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01876	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	P01861	Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)	IGHG4	0.52	28	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000185;PRD000053;PXD001422;PRD000796;PRD000164;PXD000050;PXD000164;PXD000743;PXD000765;PRD000059;PRD000212;PXD001403;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000345;PRD000362;PRD000364;PXD001447	205					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	extracellular region [GO:0005576];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01876	Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO)	IGHA1	P01860	Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)		0.48	29	PRD000073;PRD000417;PXD000746;PRD000416;PRD000019;PRD000269;PXD000383;PRD000185;PRD000053;PXD001422;PRD000796;PRD000164;PXD000050;PXD000164;PXD001403;PXD000743;PXD000765;PRD000059;PRD000212;PRD000631;PXD001324;PRD000671;PRD000551;PRD000146;PRD000113;PRD000345;PRD000362;PRD000364;PXD001447	214					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];retina homeostasis [GO:0001895];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	extracellular region [GO:0005576];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P12724	Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)	RNASE3	P10153	Non-secretory ribonuclease (EC 3.1.27.5) (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2) (RNase 2) (Ribonuclease US)	RNASE2	0.41	5	PRD000684;PXD000164;PRD000118;PXD001422;PRD000059	16				R-HSA-6798695	RNA catabolic process [GO:0006401];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578]	ribonuclease activity [GO:0004540];endonuclease activity [GO:0004519];nucleic acid binding [GO:0003676]
P12724	Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)	RNASE3	P49913	Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37]		0.43	5	PRD000684;PRD000668;PRD000118;PXD000164;PRD000053	23				R-HSA-6798695;R-HSA-6803157	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];antimicrobial humoral response [GO:0019730];defense response to Gram-positive bacterium [GO:0050830];innate immune response in mucosa [GO:0002227];defense response to Gram-negative bacterium [GO:0050829];antibacterial humoral response [GO:0019731];innate immune response [GO:0045087];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];extracellular space [GO:0005615]	
P12724	Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)	RNASE3	P06731	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	CEACAM5	0.43	2	PRD000684;PXD000164	20						extracellular region [GO:0005576]	
P12724	Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3)	RNASE3	P31997	Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)	CEACAM8	0.44	3	PRD000684;PRD000118;PXD000164	22				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular space [GO:0005615]	
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	0.47	25	PRD000053;PXD000218;PRD000345;PXD001310;PXD000948;PRD000444;PRD000594;PXD001323;PRD000668;PXD000217;PXD000529;PRD000680;PRD000565;PRD000733;PRD000146;PXD000593;PXD000997;PRD000600;PXD001572;PRD000796;PXD001422;PRD000020;PRD000407;PRD000711;PRD000597	69		1270934;924919;743063	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];nucleoplasm [GO:0005654];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	0.43	26	PXD000948;PRD000053;PRD000731;PRD000345;PXD001310;PXD000218;PRD000444;PXD000217;PXD001323;PRD000668;PXD000529;PRD000146;PRD000680;PRD000565;PRD000733;PXD000997;PRD000600;PXD001572;PRD000594;PXD000533;PRD000796;PXD000593;PXD001422;PRD000597;PRD000020;PRD000711	76		1270599;924911;742228	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P30050	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	0.43	26	PRD000053;PRD000731;PRD000345;PXD000218;PRD000146;PRD000444;PRD000594;PXD001323;PRD000668;PXD000529;PRD000680;PRD000565;PXD000426;PXD001310;PXD000997;PXD001572;PXD000948;PXD000593;PRD000796;PXD001422;PRD000020;PRD000407;PRD000711;PRD000597;PRD000733;PRD000234	79		1269167;742146	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.44	26	PRD000053;PXD000218;PRD000345;PXD001310;PXD000948;PRD000444;PRD000465;PRD000594;PXD001323;PRD000668;PRD000443;PXD000529;PRD000146;PRD000680;PRD000565;PXD000997;PRD000600;PRD000597;PXD001572;PXD000533;PRD000796;PXD000593;PXD001422;PRD000020;PRD000711;PXD000964	79		1271351;924927;742526	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	mRNA 5'-UTR binding [GO:0048027];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.4	26	PRD000053;PRD000731;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PRD000680;PRD000565;PXD000426;PXD000529;PRD000146;PXD000997;PRD000597;PXD001572;PXD000948;PXD001422;PXD000533;PRD000796;PXD000593;PRD000345;PRD000020;PRD000711;PXD000964;PRD000733	70		1269516;743060	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];nucleolus [GO:0005730];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.44	23	PXD000948;PXD000218;PXD001310;PRD000053;PRD000444;PRD000465;PXD001323;PRD000443;PRD000565;PXD000426;PXD000529;PRD000146;PXD000997;PRD000597;PXD001572;PRD000594;PXD001422;PXD000593;PRD000345;PRD000020;PRD000711;PXD000964;PRD000668	65		1269380;743614	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P35268	60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22)	RPL22	0.4	27	PRD000053;PRD000731;PRD000345;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000443;PXD000217;PXD000529;PRD000407;PRD000565;PRD000733;PRD000146;PRD000600;PRD000597;PXD001572;PXD000997;PRD000796;PXD000593;PXD001422;PRD000020;PXD000948;PRD000711;PXD000964;PRD000668	69	EBI-8338396;EBI-8333649;EBI-8328780;EBI-8312518	1269467;742974	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62277	40S ribosomal protein S13 (Small ribosomal subunit protein uS15)	RPS13	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.44	26	PRD000053;PRD000731;PRD000345;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PXD000529;PRD000146;PRD000565;PRD000733;PXD000997;PRD000600;PRD000597;PXD001572;PXD000533;PRD000796;PXD000593;PXD001422;PXD000217;PRD000407;PRD000711;PXD000964;PXD000948	76	EBI-8450054	1270600;924913;742252	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	0.42	8	PXD000383;PXD000743;PRD000551;PXD000164;PRD000631;PXD001403;PXD001447;PRD000019	24					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.43	2	PXD000383;PXD001403	12							antigen binding [GO:0003823]
A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.44	4	PXD000383;PXD001403;PXD000743;PRD000059	14					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J2D9	Immunoglobulin kappa variable 1D-13	IGKV1D-13	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.51	3	PXD000383;PXD001403;PXD000743	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q03701	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)	CEBPZ	Q8IY81	pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3	0.4	7	PXD000426;PXD001572;PXD000533;PRD000597;PXD000593;PRD000146;PXD000314	11						nucleus [GO:0005634]	RNA binding [GO:0003723]
P45984	Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2)	MAPK9	P49841	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	0.49	2	PRD000032;PXD000533	87					protein phosphorylation [GO:0006468];peptidyl-serine phosphorylation [GO:0018105];positive regulation of gene expression [GO:0010628]	nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829];mitochondrion [GO:0005739]	ATP binding [GO:0005524]
P48668	Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)	KRT6C	P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	0.43	56	PRD000020;PRD000073;PRD000154;PRD000733;PRD000345;PRD000069;PXD000743;PRD000092;PRD000443;PRD000059;PXD000226;PXD000383;PXD000680;PRD000373;PXD000387;PXD000593;PXD001328;PXD001422;PRD000796;PXD000746;PXD000047;PRD000364;PRD000172;PRD000416;PRD000407;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PRD000164;PRD000417;PXD000412;PRD000151;PXD001403;PXD001402;PXD000164;PXD001174;PXD001324;PRD000600;PRD000551;PRD000565;PRD000146;PRD000234;PRD000444;PRD000113;PRD000597;PRD000594;PRD000671;PRD000053;PRD000362;PXD000218;PXD001572;PXD001447;PXD000964;PRD000269	222				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P48668	Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)	KRT6C	P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	0.54	40	PRD000073;PRD000345;PRD000069;PRD000733;PXD000743;PXD000746;PXD001328;PXD001572;PXD001422;PRD000796;PRD000164;PXD000164;PRD000092;PRD000364;PRD000416;PXD000593;PXD001174;PXD001323;PRD000059;PRD000607;PRD000594;PRD000212;PRD000417;PRD000151;PXD001403;PXD001402;PRD000443;PRD000172;PRD000146;PXD001324;PRD000234;PXD000997;PRD000444;PRD000113;PXD000383;PRD000671;PRD000362;PXD000218;PXD001447;PRD000407	131				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P48668	Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)	KRT6C	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.63	56	PRD000073;PRD000345;PXD000746;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000059;PRD000597;PXD000226;PXD000383;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PRD000364;PRD000172;PRD000416;PRD000407;PRD000164;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PXD000593;PRD000551;PRD000053;PRD000234;PRD000146;PRD000362;PRD000444;PRD000113;PRD000671;PXD000218;PXD001572;PXD001447;PXD000964	207	EBI-19769751;EBI-19769764			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	0.47	38	PRD000733;PRD000668;PRD000443;PXD000948;PRD000053;PRD000345;PXD000529;PXD001310;PXD000387;PXD001328;PRD000154;PXD001422;PXD000050;PXD000426;PRD000711;PRD000597;PRD000092;PRD000594;PXD001323;PRD000046;PRD000607;PRD000032;PRD000565;PXD000164;PRD000001;PXD000217;PRD000020;PXD000218;PRD000731;PXD001572;PXD001324;PRD000146;PXD000593;PXD000997;PRD000444;PXD000533;PRD000738;PRD000407	167		1259809;741602	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	nucleoplasm [GO:0005654];centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.49	32	PRD000345;PRD000154;PXD000948;PRD000053;PRD000668;PRD000443;PXD000529;PXD000387;PXD001328;PXD001422;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PRD000607;PXD000218;PXD000533;PRD000092;PRD000001;PRD000565;PRD000020;PXD001310;PXD001324;PRD000146;PXD000593;PXD000997;PRD000444;PXD001572;PRD000671;PRD000407	142		1259759;741573	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P50991	T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding)	CCT4	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.44	35	PRD000733;PRD000345;PRD000154;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PXD000387;PXD001328;PXD001422;PRD000711;PRD000597;PXD000426;PRD000407;PRD000594;PXD001323;PRD000046;PRD000607;PXD000533;PRD000092;PRD000001;PRD000565;PRD000020;PXD000050;PXD000593;PRD000671;PXD001324;PRD000146;PXD000218;PXD000997;PRD000444;PXD001572;PRD000738	155		2239162;1259758;920587;741556	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082];RNA binding [GO:0003723]
P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	0.46	33	PXD000426;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD000387;PRD000345;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000092;PRD000001;PRD000565;PRD000020;PXD000218;PXD001310;PRD000600;PXD001324;PRD000146;PXD000593;PXD000997;PRD000444;PRD000407;PXD001328;PXD001572;PXD000533;PRD000118	157		1259810;920603;741524	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	centrosome [GO:0005813];extracellular exosome [GO:0070062];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];cytosol [GO:0005829]	ATP binding [GO:0005524];protein binding involved in protein folding [GO:0044183];unfolded protein binding [GO:0051082]
P50990	T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15)	CCT8	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.41	36	PRD000733;PRD000053;PRD000345;PRD000668;PRD000443;PXD000948;PXD001310;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PXD000529;PXD000050;PRD000711;PRD000597;PRD000407;PXD000593;PXD001323;PRD000046;PRD000607;PXD000997;PRD000068;PRD000001;PRD000565;PRD000020;PRD000600;PXD001324;PRD000146;PXD000218;PRD000444;PRD000594;PXD001328;PXD000533;PRD000738;PRD000092	157		2250096;1259808;741525	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];pore complex assembly [GO:0046931];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
Q7KZI7	Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b)	MARK2	P49841	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	GSK3B	0.44	6	PRD000032;PRD000123;PXD000529;PXD000680;PXD000533;PXD000948	95					protein phosphorylation [GO:0006468];peptidyl-threonine phosphorylation [GO:0018107];intracellular signal transduction [GO:0035556];regulation of microtubule cytoskeleton organization [GO:0070507];Wnt signaling pathway [GO:0016055];regulation of axonogenesis [GO:0050770];peptidyl-serine phosphorylation [GO:0018105];establishment of cell polarity [GO:0030010];protein autophosphorylation [GO:0046777]	plasma membrane [GO:0005886];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];mitochondrion [GO:0005739];dendrite [GO:0030425]	tau-protein kinase activity [GO:0050321];ATP binding [GO:0005524];protein serine/threonine kinase activity [GO:0004674]
Q9Y3B7	39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11) (Mitochondrial large ribosomal subunit protein uL11m)	MRPL11	Q9Y3D9	28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt) (Mitochondrial small ribosomal subunit protein mS23)	MRPS23	0.45	6	PRD000565;PXD001572;PXD001323;PRD000053;PXD000529;PXD001422	13			320	R-HSA-5368286;R-HSA-5389840;R-HSA-5419276	mitochondrial translational elongation [GO:0070125];mitochondrial translational termination [GO:0070126]	mitochondrial inner membrane [GO:0005743];mitochondrion [GO:0005739]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P21796	Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM)	VDAC1	P35232	Prohibitin	PHB	0.4	24	PRD000020;PRD000032;PRD000053;PRD000668;PRD000443;PXD000529;PXD000387;PXD001328;PXD001572;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD000218;PRD000565;PRD000671;PXD001324;PRD000444;PRD000345;PRD000073;PXD000164;PXD000533	108		1266635				nucleus [GO:0005634];mitochondrion [GO:0005739];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P21796	Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM)	VDAC1	P45880	Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2)	VDAC2	0.48	31	PRD000032;PRD000053;PRD000668;PRD000443;PXD000387;PXD001328;PXD001572;PXD001422;PXD000529;PRD000146;PRD000711;PRD000597;PRD000594;PRD000671;PXD001323;PRD000607;PRD000680;PXD000472;PRD000565;PXD000218;PXD001324;PRD000234;PXD000314;PRD000444;PXD000593;PRD000269;PRD000118;PXD001447;PXD000164;PXD000533;PXD000746	97	EBI-20313312;EBI-20312205;EBI-20309844;EBI-20307902;EBI-20303980	2362503;746321		R-HSA-8949215;R-HSA-5689880	anion transport [GO:0006820]	pore complex [GO:0046930];mitochondrial outer membrane [GO:0005741];membrane raft [GO:0045121];mitochondrion [GO:0005739];mitochondrial nucleoid [GO:0042645];nucleus [GO:0005634]	porin activity [GO:0015288];voltage-gated anion channel activity [GO:0008308]
Q9UL26	Ras-related protein Rab-22A (Rab-22)	RAB22A	P35754	Glutaredoxin-1 (Thioltransferase-1) (TTase-1)	GLRX	0.4	3	PRD000053;PXD001323;PXD001422	10						extracellular exosome [GO:0070062]	
Q13795	ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP)	ARFRP1	Q9UBI1	COMM domain-containing protein 3 (Protein Bup) (Protein PIL)	COMMD3	0.41	3	PRD000053;PXD001323;PXD001422	15							
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P62854	40S ribosomal protein S26 (Small ribosomal subunit protein eS26)	RPS26	0.41	22	PRD000053;PXD001310;PRD000444;PXD000743;PRD000594;PXD001323;PRD000269;PRD000565;PRD000680;PRD000733;PRD000443;PRD000146;PXD000997;PRD000345;PXD000529;PXD001572;PXD000593;PXD001422;PRD000407;PRD000711;PRD000597;PRD000668	69		1270939;925095;743395	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	small ribosomal subunit [GO:0015935];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic small ribosomal subunit [GO:0022627]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	0.41	24	PRD000053;PRD000600;PXD001323;PRD000444;PXD000743;PRD000594;PRD000668;PXD000217;PRD000443;PRD000269;PRD000565;PRD000680;PXD001310;PXD000948;PRD000146;PXD000997;PRD000020;PXD001572;PXD001422;PXD000593;PRD000796;PRD000407;PRD000711;PRD000597	76		1269668;742313	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P62888	60S ribosomal protein L30 (Large ribosomal subunit protein eL30)	RPL30	0.4	21	PRD000053;PRD000565;PRD000345;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PRD000269;PXD000948;PRD000733;PRD000146;PXD000997;PXD000529;PXD001572;PXD001422;PRD000796;PRD000407;PXD000217;PRD000711	70		1269755	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.42	24	PRD000053;PRD000269;PXD000529;PXD001310;PRD000444;PRD000594;PXD001323;PRD000668;PXD000217;PRD000443;PRD000565;PRD000680;PXD000948;PRD000146;PXD000997;PXD001572;PXD000593;PXD001422;PRD000796;PRD000407;PRD000711;PRD000597;PRD000020;PRD000345	75		1270914;742309	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];nucleolus [GO:0005730]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.41	23	PRD000053;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000668;PRD000565;PRD000680;PRD000733;PXD000948;PRD000146;PXD000997;PXD000529;PXD001572;PXD001422;PRD000796;PXD000593;PRD000020;PRD000711;PRD000597;PRD000269;PRD000345	75		1270919;742833	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];nucleolus [GO:0005730];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.43	24	PRD000053;PRD000600;PXD001323;PRD000345;PXD000218;PRD000444;PRD000594;PRD000668;PXD000948;PXD000217;PRD000443;PRD000565;PRD000680;PRD000269;PXD001310;PRD000146;PXD000997;PXD001572;PXD001422;PXD000593;PRD000796;PRD000020;PRD000711;PRD000597	84		1270912;742307	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleolus [GO:0005730];cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P35268	60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22)	RPL22	0.42	25	PRD000053;PRD000345;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PXD000217;PXD000529;PRD000565;PXD000948;PRD000733;PRD000146;PRD000600;PXD001572;PXD000997;PXD000593;PXD001422;PRD000796;PRD000407;PRD000711;PRD000597;PRD000020;PRD000668;PRD000269	78		1270917	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.43	21	PRD000053;PXD000218;PXD001310;PXD000948;PRD000444;PRD000594;PXD001323;PRD000668;PXD000593;PXD000217;PRD000443;PRD000565;PRD000146;PXD000997;PXD001572;PXD001422;PRD000796;PRD000407;PRD000711;PRD000597;PRD000345	72		1270913;742669	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.42	21	PRD000053;PRD000269;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000565;PRD000680;PRD000733;PXD000948;PRD000146;PXD000997;PXD001572;PXD001422;PRD000796;PXD000593;PRD000407;PRD000711;PRD000597;PRD000668	69		1270920;742312	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62851	40S ribosomal protein S25 (Small ribosomal subunit protein eS25)	RPS25	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.45	25	PRD000053;PRD000600;PXD001323;PRD000345;PXD000218;PRD000444;PXD000743;PRD000594;PRD000668;PRD000269;PRD000565;PXD000529;PRD000733;PXD001310;PRD000146;PXD000997;PXD001572;PXD000593;PXD001422;PRD000796;PXD000948;PRD000407;PXD000217;PRD000711;PRD000597	85		1270937;925092;743178	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];nucleoplasm [GO:0005654];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	RNA binding [GO:0003723]
P02462	Collagen alpha-1(IV) chain [Cleaved into: Arresten]	COL4A1	Q9UBX5	Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50)	FBLN5	0.42	3	PRD000269;PXD001324;PXD000746	11					extracellular matrix organization [GO:0030198]	extracellular region [GO:0005576];extracellular matrix [GO:0031012];collagen-containing extracellular matrix [GO:0062023]	
Q96CV9	Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP)	OPTN	Q13619	Cullin-4A (CUL-4A)	CUL4A	0.41	6	PXD000529;PXD001328;PRD000154;PXD001422;PXD000533;PRD000053	10						nucleoplasm [GO:0005654]	
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	0.45	17	PRD000417;PRD000551;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.4	15	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD000743;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	0.45	10	PRD000417;PXD001324;PRD000671;PXD000383;PRD000551;PRD000212;PRD000053;PXD001403;PXD000164;PRD000416	30				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.43	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.42	15	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	43				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.42	3	PXD000383;PXD001403;PXD000743	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.4	8	PRD000631;PXD000383;PXD000743;PRD000019;PRD000053;PXD001403;PRD000551;PXD000164	26				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.52	12	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.47	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.51	15	PRD000417;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PXD000743;PRD000053;PXD000164;PRD000631;PXD001403;PXD001447;PXD001174;PRD000019	41				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.41	8	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PXD001174	25					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.47	14	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	42					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01599	Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA)	IGKV1-17	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.41	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD001422;PXD001403;PXD001174;PRD000019	34					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	0.45	21	PRD000073;PRD000059;PRD000416;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PXD001403;PRD000711;PXD000743;PRD000631;PXD001174;PRD000172;PXD001324;PRD000269;PRD000551;PRD000417;PRD000158;PRD000362;PRD000364	163						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.47	17	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000711;PRD000416;PXD001403;PXD000412;PRD000631;PRD000172;PXD001324;PRD000417;PRD000551;PRD000158;PRD000362	141						extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	0.48	19	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD001422;PRD000416;PXD000164;PXD001403;PRD000711;PXD000743;PRD000631;PRD000172;PRD000417;PRD000551;PRD000158;PRD000362;PRD000019;PRD000364	127		302516		R-HSA-381426;R-HSA-114608	cellular protein metabolic process [GO:0044267];platelet degranulation [GO:0002576]	extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102]
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.48	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD001174;PXD001324;PRD000551;PRD000158;PRD000362	134				R-HSA-114608	platelet degranulation [GO:0002576]	extracellular exosome [GO:0070062];blood microparticle [GO:0072562];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093]	
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.54	20	PRD000073;PRD000059;PRD000416;PRD000185;PRD000019;PXD000383;PRD000053;PXD000164;PRD000711;PRD000477;PXD001403;PRD000631;PRD000172;PXD001324;PRD000417;PRD000269;PRD000551;PRD000158;PXD001174;PRD000362	152						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P01042	Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]	KNG1	P00734	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	0.52	19	PRD000073;PXD000383;PRD000069;PRD000059;PRD000185;PRD000053;PXD000164;PRD000711;PXD001403;PXD000412;PRD000631;PRD000172;PRD000551;PRD000416;PRD000158;PRD000362;PRD000417;PRD000364;PXD000743	131				R-HSA-416476;R-HSA-381426;R-HSA-375276;R-HSA-140837	cellular protein metabolic process [GO:0044267];G-protein coupled receptor signaling pathway [GO:0007186];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];blood coagulation, intrinsic pathway [GO:0007597];negative regulation of proteolysis [GO:0045861]	endoplasmic reticulum lumen [GO:0005788];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102];heparin binding [GO:0008201]
Q6PJ69	Tripartite motif-containing protein 65	TRIM65	Q8N4Q0	Prostaglandin reductase 3 (PRG-3) (EC 1.3.1.48) (Zinc-binding alcohol dehydrogenase domain-containing protein 2)	ZADH2	0.43	3	PRD000345;PXD001422;PXD000533	11							zinc ion binding [GO:0008270]
P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	0.53	19	PRD000073;PRD000059;PRD000185;PRD000269;PXD000383;PRD000053;PXD000164;PRD000711;PRD000417;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000416;PRD000551;PRD000158;PRD000362;PXD001422	148						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.42	16	PRD000073;PRD000059;PRD000185;PXD001174;PXD000383;PRD000053;PXD000164;PRD000269;PRD000172;PXD001403;PRD000631;PRD000212;PRD000551;PXD001324;PRD000158;PRD000362	142						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.58	20	PRD000073;PRD000059;PRD000416;PRD000185;PXD000383;PRD000269;PRD000053;PXD000164;PRD000711;PRD000417;PXD001174;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000146;PRD000158;PRD000362	159						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02790	Hemopexin (Beta-1B-glycoprotein)	HPX	P00734	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	0.45	17	PRD000073;PXD000383;PRD000059;PRD000416;PRD000185;PRD000053;PXD000164;PRD000417;PRD000711;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PRD000364;PXD000743	133						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P04083	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)	ANXA1	P08758	Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)	ANXA5	0.4	32	PXD000948;PRD000053;PXD000743;PRD000123;PRD000668;PRD000417;PXD000529;PXD000387;PXD001328;PRD000684;PXD000164;PXD001422;PRD000796;PRD000146;PRD000416;PRD000269;PXD000050;PRD000597;PRD000594;PXD001323;PRD000059;PXD000426;PRD000020;PXD000218;PXD001324;PXD000226;PRD000444;PRD000113;PRD000600;PRD000032;PRD000073;PRD000118	159		659100			signal transduction [GO:0007165];negative regulation of apoptotic process [GO:0043066]	focal adhesion [GO:0005925];extracellular region [GO:0005576];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509];calcium-dependent phospholipid binding [GO:0005544];phospholipid binding [GO:0005543]
P04083	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)	ANXA1	A6NMY6	Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene)		0.43	38	PXD000948;PRD000032;PXD000743;PRD000059;PRD000053;PRD000123;PRD000668;PRD000417;PRD000416;PRD000345;PRD000146;PXD000529;PRD000410;PXD000387;PXD001328;PXD001422;PRD000796;PRD000465;PRD000269;PRD000597;PRD000164;PXD001323;PRD000212;PRD000151;PRD000565;PRD000020;PXD000218;PXD000746;PXD001324;PXD000226;PRD000444;PRD000113;PRD000594;PRD000600;PRD000118;PRD000671;PXD000164;PRD000407	200						extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509];calcium-dependent phospholipid binding [GO:0005544]
P04083	Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35)	ANXA1	P07355	Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)	ANXA2	0.41	39	PXD000948;PRD000032;PXD000743;PRD000059;PRD000053;PRD000123;PRD000668;PRD000417;PRD000416;PRD000345;PRD000146;PXD000529;PRD000410;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000465;PRD000269;PRD000597;PRD000477;PRD000164;PXD001323;PRD000212;PRD000151;PRD000565;PRD000020;PXD000218;PXD000746;PXD001324;PXD000226;PRD000444;PRD000113;PRD000594;PRD000600;PRD000118;PRD000671;PRD000407	213				R-HSA-445355	positive regulation of vesicle fusion [GO:0031340]	cell-cell adherens junction [GO:0005913];cytosol [GO:0005829];vesicle [GO:0031982];cytoplasm [GO:0005737];cell surface [GO:0009986];endosome [GO:0005768];extracellular space [GO:0005615];sarcolemma [GO:0042383];nucleus [GO:0005634];basolateral plasma membrane [GO:0016323];plasma membrane [GO:0005886];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509];cadherin binding involved in cell-cell adhesion [GO:0098641];phospholipase A2 inhibitor activity [GO:0019834];calcium-dependent protein binding [GO:0048306];calcium-dependent phospholipid binding [GO:0005544]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	0.46	2	PXD000383;PRD000671	12					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	0.44	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.48	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	0.45	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.55	1	PXD000383	11							antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	0.54	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.48	1	PXD000383	11							
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	0.45	1	PXD000383	10							antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.46	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.6	2	PXD000383;PRD000671	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.55	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.61	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.45	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.42	2	PXD000383;PRD000671	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	P08493	Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)	MGP	0.41	1	PXD000383	11							
A0A075B6H9	Immunoglobulin lambda variable 4-69	IGLV4-69	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.59	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
O95395	Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.148) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (hC2GnT-M) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase) (C2/4GnT)	GCNT3	Q8TEM1	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	NUP210	0.46	2	PXD000529;PRD000069	10						integral component of membrane [GO:0016021];membrane [GO:0016020]	
P32969	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.4	25	PRD000053;PRD000565;PXD001310;PRD000444;PRD000594;PXD001323;PRD000597;PRD000020;PXD000948;PXD000529;PRD000733;PXD000426;PRD000146;PXD000997;PXD000387;PRD000417;PRD000671;PXD001422;PXD000533;PXD000593;PRD000345;PXD001572;PRD000711;PRD000269;PXD000218	63		1269512;742727	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];rRNA binding [GO:0019843];RNA binding [GO:0003723]
P32969	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.43	22	PXD000948;PRD000565;PXD001310;PRD000053;PRD000444;PXD001323;PRD000597;PXD000529;PRD000733;PXD000426;PRD000146;PXD000218;PXD000997;PXD000387;PXD001572;PRD000594;PXD001422;PXD000593;PRD000345;PRD000269;PRD000020;PRD000711	55		1269378;743609	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P32969	60S ribosomal protein L9 (Large ribosomal subunit protein uL6)	RPL9	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.4	17	PRD000053;PRD000565;PXD001310;PRD000444;PRD000594;PXD001323;PRD000597;PRD000733;PXD000948;PRD000146;PXD000997;PXD001572;PXD001422;PXD000593;PRD000269;PRD000711;PXD000218	53		1270321;742113	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	0.45	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137						nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	132				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.47	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	132				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	132				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	132				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q8IUE6	Histone H2A type 2-B	HIST2H2AB	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.46	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000047;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000164;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	137				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	0.49	14	PRD000073;PRD000631;PRD000551;PRD000671;PRD000164;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422	56					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	0.49	20	PRD000417;PRD000631;PRD000345;PRD000671;PRD000416;PXD000383;PXD000743;PXD001324;PRD000551;PRD000073;PRD000269;PRD000212;PRD000053;PXD001403;PRD000364;PXD000164;PXD001422;PRD000059;PRD000019;PXD001174	55				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	0.5	14	PRD000073;PRD000631;PRD000551;PRD000671;PRD000164;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422	56					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.53	19	PRD000417;PRD000631;PRD000073;PRD000671;PXD000383;PXD000743;PXD000047;PRD000019;PXD001324;PRD000416;PRD000269;PRD000212;PRD000059;PRD000185;PRD000364;PXD000164;PXD001422;PXD001403;PXD001174	53				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.54	18	PRD000417;PRD000345;PRD000551;PRD000671;PRD000631;PRD000416;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PRD000053;PRD000059;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	51				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	0.43	19	PRD000417;PRD000631;PRD000345;PRD000671;PRD000416;PXD000383;PXD000743;PRD000551;PRD000073;PRD000269;PRD000212;PRD000053;PXD001403;PRD000364;PXD000164;PXD001422;PRD000059;PRD000019;PXD001174	51					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.59	21	PRD000417;PRD000631;PRD000073;PRD000551;PRD000212;PRD000671;PRD000416;PXD000383;PXD000743;PXD000047;PRD000019;PXD001324;PRD000269;PRD000053;PRD000059;PRD000185;PXD001403;PXD000164;PXD001422;PXD000746;PXD001174	65				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.5	20	PRD000417;PRD000631;PRD000345;PRD000073;PRD000671;PXD000383;PXD000743;PRD000551;PRD000019;PRD000416;PRD000212;PRD000053;PXD001403;PRD000364;PXD001324;PXD000164;PXD001422;PRD000059;PRD000185;PXD001174	57				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0B4J1X5	Immunoglobulin heavy variable 3-74	IGHV3-74	0.44	17	PXD000383;PRD000671;PRD000631;PRD000073;PRD000551;PRD000164;PXD000743;PXD001324;PRD000212;PRD000053;PRD000059;PRD000185;PRD000364;PXD000164;PXD001422;PXD001403;PRD000019	60					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0B4J1V1	Immunoglobulin heavy variable 3-21	IGHV3-21	0.43	16	PXD000383;PRD000631;PRD000073;PRD000551;PRD000671;PRD000164;PXD000743;PRD000019;PXD001324;PRD000212;PRD000053;PRD000059;PRD000185;PXD000164;PXD001422;PXD001403	61					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.41	13	PRD000671;PRD000551;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PRD000185;PRD000364;PXD000164;PXD001422;PXD000743	40				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P01766	Immunoglobulin heavy variable 3-13 (Ig heavy chain V-III region BRO)	IGHV3-13	0.41	16	PXD000383;PRD000631;PRD000073;PRD000551;PRD000671;PRD000164;PXD000743;PXD001324;PRD000212;PRD000053;PRD000059;PRD000185;PXD000164;PXD001422;PXD001403;PRD000019	59				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.42	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422;PRD000345	25					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.47	12	PRD000417;PRD000551;PXD000383;PRD000671;PXD000743;PRD000416;PRD000019;PXD001403;PXD000164;PXD001422;PRD000059;PRD000631	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.54	19	PXD000383;PRD000417;PRD000631;PRD000073;PRD000164;PRD000671;PRD000416;PXD000743;PRD000551;PRD000019;PRD000212;PRD000053;PRD000059;PXD001324;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	60				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.49	13	PRD000417;PRD000631;PRD000671;PRD000416;PXD000383;PXD000743;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PRD000059;PXD001174	40				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.52	17	PRD000417;PRD000551;PRD000671;PRD000631;PRD000416;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PRD000053;PRD000059;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.48	17	PRD000417;PRD000631;PRD000551;PRD000671;PXD000383;PXD000743;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD001403;PRD000364;PXD000164;PXD001422;PRD000059;PXD001174	46					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01619	Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)	IGKV3-20	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.52	16	PRD000417;PRD000631;PRD000671;PXD000383;PRD000059;PRD000212;PRD000551;PRD000416;PXD001403;PRD000053;PRD000185;PXD000164;PXD001422;PXD000743;PRD000269;PXD001174	42					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P27348	14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)	YWHAQ	P62258	14-3-3 protein epsilon (14-3-3E)	YWHAE	0.4	43	PRD000032;PXD000426;PRD000053;PRD000668;PRD000059;PRD000417;PXD000529;PXD000387;PXD001328;PRD000020;PXD001572;PRD000154;PXD001422;PRD000146;PRD000416;PRD000269;PXD000948;PRD000407;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000046;PXD000218;PRD000068;PRD000168;PRD000364;PRD000443;PRD000092;PRD000731;PXD000217;PXD000593;PXD001324;PXD000997;PRD000444;PRD000113;PXD000680;PRD000118;PXD000786;PRD000535;PRD000671;PXD000533	181	EBI-8440340;EBI-8429350;EBI-8412660;EBI-8408168;EBI-8401905;EBI-8383997;EBI-8372752;EBI-8357768;EBI-8350757;EBI-8345298;EBI-8328780;EBI-15609664;EBI-3951158;EBI-3936387;EBI-3452968	894442;830720;568527;464767	5615;5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	substantia nigra development [GO:0021762];membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]	cytosol [GO:0005829];cytoplasm [GO:0005737];mitochondrion [GO:0005739];focal adhesion [GO:0005925];membrane [GO:0016020];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];protein domain specific binding [GO:0019904]
P27348	14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)	YWHAQ	P31946	14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]	YWHAB	0.46	36	PRD000053;PRD000668;PRD000059;PRD000417;PXD000529;PXD000948;PXD000387;PXD001328;PRD000020;PXD001572;PRD000154;PXD001422;PRD000032;PRD000146;PRD000407;PRD000711;PRD000269;PRD000597;PXD000426;PRD000594;PRD000416;PXD001323;PRD000046;PRD000168;PXD000218;PRD000731;PXD000593;PXD001324;PXD000997;PRD000113;PRD000092;PRD000444;PXD000680;PRD000118;PXD000786;PXD000533	140	EBI-15609460;EBI-8796749	926791;914154;568572	5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];negative regulation of transcription, DNA-templated [GO:0045892]	cytosol [GO:0005829];cytoplasm [GO:0005737];mitochondrion [GO:0005739];focal adhesion [GO:0005925];membrane [GO:0016020];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];protein domain specific binding [GO:0019904]
P27348	14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1)	YWHAQ	P61981	14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]	YWHAG	0.46	39	PRD000032;PRD000053;PRD000668;PRD000059;PRD000417;PXD000529;PRD000185;PXD000387;PXD001328;PXD001572;PRD000154;PXD001422;PRD000146;PRD000416;PRD000269;PRD000407;PRD000711;PRD000597;PXD000426;PRD000092;PRD000594;PXD001323;PRD000046;PRD000073;PXD000948;PXD000218;PXD001403;PRD000168;PRD000020;PRD000731;PXD000217;PXD000593;PXD001324;PXD000997;PRD000444;PRD000113;PXD000680;PXD000533;PRD000118	153	EBI-15609631	926826;568528	5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];mitochondrion [GO:0005739];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];protein domain specific binding [GO:0019904]
Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	0.41	58	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000053;PXD001310;PRD000269;PRD000444;PXD000387;PXD001328;PRD000565;PXD000997;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PXD000593;PXD000426;PRD000164;PXD001323;PRD000046;PRD000059;PRD000607;PRD000680;PRD000594;PXD000218;PXD000472;PXD000533;PRD000417;PXD000217;PXD000050;PXD000529;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PXD000226;PRD000407;PRD000731;PXD001447;PXD000164;PXD000786;PRD000738;PRD000108	325						nucleus [GO:0005634];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.41	55	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000053;PXD001310;PRD000269;PRD000444;PXD000387;PXD001328;PRD000565;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000465;PRD000146;PXD000164;PRD000711;PRD000597;PXD000593;PXD000426;PXD001323;PRD000046;PRD000607;PRD000680;PRD000594;PXD000472;PXD000217;PXD000050;PXD000529;PRD000731;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PXD000218;PXD000226;PRD000407;PXD000314;PXD000533;PXD001447;PXD000786;PRD000738;PRD000108	317						nucleus [GO:0005634];cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q5VTE0	Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5)		Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.4	58	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PRD000053;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PRD000444;PXD000387;PXD001328;PRD000565;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000164;PRD000711;PRD000597;PXD000593;PXD000426;PRD000164;PXD001323;PRD000046;PRD000607;PRD000680;PRD000594;PXD000472;PRD000417;PXD000217;PXD000050;PXD000529;PRD000731;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PXD000218;PXD000226;PRD000407;PXD000314;PXD000533;PXD001447;PXD000786;PRD000738;PRD000108	322						nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
O14976	Cyclin-G-associated kinase (EC 2.7.11.1)	GAK	P00519	Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150)	ABL1	0.42	3	PRD000032;PRD000167;PRD000168	110						perinuclear region of cytoplasm [GO:0048471];cytosol [GO:0005829]	ATP binding [GO:0005524]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	0.48	22	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000387;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	58				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.49	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.49	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.46	22	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000387;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	56				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];antibacterial humoral response [GO:0019731];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular space [GO:0005615];cytosol [GO:0005829];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q7L7L0	Histone H2A type 3	HIST3H2A	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138							protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.48	46	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000477;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	140				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.46	24	PRD000345;PRD000684;PXD000529;PRD000444;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000020;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000387;PXD000314;PXD001422;PRD000796;PXD000050;PXD000164;PXD000217;PXD000948;PRD000597	65				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P57053	Histone H2B type F-S (Histone H2B.s) (H2B/s)	H2BFS	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.44	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000387;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	53				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];antibacterial humoral response [GO:0019731];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular space [GO:0005615];cytosol [GO:0005829];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P07237	Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55)	P4HB	P30101	Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60)	PDIA3	0.42	43	PXD000948;PRD000020;PRD000053;PRD000123;PRD000668;PRD000443;PRD000059;PRD000417;PXD000529;PRD000269;PXD000387;PRD000185;PRD000684;PXD000426;PXD000164;PXD001422;PRD000796;PRD000416;PRD000733;PRD000146;PXD000050;PRD000711;PRD000597;PXD001323;PRD000046;PRD000594;PRD000092;PRD000151;PRD000001;PRD000738;PXD000218;PRD000068;PXD000217;PRD000032;PXD001572;PXD001324;PRD000444;PRD000345;PRD000118;PXD001328;PRD000073;PXD000533;PRD000410	179	EBI-7636060;EBI-7171935	1266021			protein folding [GO:0006457];response to endoplasmic reticulum stress [GO:0034976];cell redox homeostasis [GO:0045454]	endoplasmic reticulum lumen [GO:0005788];focal adhesion [GO:0005925];endoplasmic reticulum [GO:0005783];extracellular exosome [GO:0070062];melanosome [GO:0042470]	RNA binding [GO:0003723];peptide disulfide oxidoreductase activity [GO:0015037];protein disulfide isomerase activity [GO:0003756]
P07948	Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)	LYN	P41240	Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL)	CSK	0.45	8	PRD000032;PRD000167;PXD001572;PXD001422;PRD000711;PRD000168;PRD000001;PRD000738	122					protein phosphorylation [GO:0006468];regulation of cytokine production [GO:0001817];adaptive immune response [GO:0002250];negative regulation of ERK1 and ERK2 cascade [GO:0070373];negative regulation of cell proliferation [GO:0008285];innate immune response [GO:0045087];peptidyl-tyrosine autophosphorylation [GO:0038083];T cell costimulation [GO:0031295];central nervous system development [GO:0007417];transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	extrinsic component of cytoplasmic side of plasma membrane [GO:0031234];cytosol [GO:0005829];cytoplasm [GO:0005737];membrane raft [GO:0045121];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	signaling receptor binding [GO:0005102];protein tyrosine kinase activity [GO:0004713];ATP binding [GO:0005524];non-membrane spanning protein tyrosine kinase activity [GO:0004715];kinase activity [GO:0016301]
P61019	Ras-related protein Rab-2A	RAB2A	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.44	21	PRD000733;PRD000053;PRD000711;PRD000092;PXD001323;PRD000668;PXD000948;PXD000426;PXD001324;PRD000001;PRD000146;PXD000529;PRD000154;PXD000164;PXD000533;PRD000738;PXD001422;PRD000410;PRD000020;PXD001572;PRD000597	58				R-HSA-8873719	post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P61019	Ras-related protein Rab-2A	RAB2A	P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	0.4	17	PRD000053;PRD000711;PRD000092;PXD001323;PRD000668;PRD000733;PXD001324;PXD000529;PRD000154;PXD000164;PXD000533;PRD000796;PRD000738;PXD001422;PRD000410;PXD001572;PRD000597	54		1268624				melanosome [GO:0042470];Golgi membrane [GO:0000139];cytosol [GO:0005829];endoplasmic reticulum membrane [GO:0005789];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61019	Ras-related protein Rab-2A	RAB2A	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.41	17	PRD000053;PRD000711;PXD001323;PRD000668;PRD000092;PXD000948;PRD000001;PXD000218;PXD000529;PRD000154;PXD000164;PXD000533;PRD000738;PXD001422;PRD000733;PRD000020;PXD001572	53						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61019	Ras-related protein Rab-2A	RAB2A	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.42	17	PRD000020;PRD000733;PRD000053;PRD000711;PRD000092;PXD001323;PRD000668;PXD000948;PXD001324;PRD000146;PXD000529;PRD000001;PXD000164;PRD000154;PRD000738;PXD001422;PXD001572	50		1268538		R-HSA-8873719	protein transport [GO:0015031]	melanosome [GO:0042470];extracellular exosome [GO:0070062];lysosomal membrane [GO:0005765]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P61019	Ras-related protein Rab-2A	RAB2A	P61106	Ras-related protein Rab-14	RAB14	0.44	20	PRD000020;PRD000733;PRD000711;PRD000053;PRD000092;PXD001323;PRD000668;PXD000948;PXD001324;PRD000001;PRD000146;PXD000529;PXD000164;PRD000154;PXD000533;PRD000796;PRD000738;PXD001422;PXD001572;PRD000597	55				R-HSA-8873719	protein transport [GO:0015031]	Golgi membrane [GO:0000139];cytosol [GO:0005829];lysosomal membrane [GO:0005765];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
Q14684	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)	RRP1B	P46087	Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	NOP2	0.44	9	PXD000529;PXD001572;PXD000426;PXD000533;PXD000680;PXD000964;PXD000593;PRD000118;PXD000314	14	EBI-16686997;EBI-16687362					nucleoplasm [GO:0005654];nucleolus [GO:0005730]	RNA binding [GO:0003723]
P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	P13646	Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)	KRT13	0.46	41	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PRD000373;PXD001328;PXD000047;PXD001422;PRD000154;PRD000796;PRD000164;PXD000164;PRD000711;PXD000593;PXD000746;PRD000594;PRD000059;PXD001174;PRD000607;PRD000212;PRD000151;PXD001403;PXD001402;PRD000020;PXD000218;PXD001324;PRD000551;PRD000234;PRD000146;PXD000997;PRD000444;PRD000345;PRD000113;PRD000443;PXD001323;PXD001572;PXD001447;PRD000671;PRD000407	132				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	0.4	33	PRD000164;PRD000069;PRD000733;PXD000743;PXD000746;PRD000154;PXD000593;PXD001422;PRD000796;PXD000164;PXD000047;PRD000597;PRD000092;PRD000594;PXD001323;PRD000059;PRD000607;PRD000151;PXD001402;PRD000212;PRD000234;PXD001324;PRD000146;PXD000529;PRD000444;PRD000345;PRD000113;PXD001174;PRD000600;PXD001572;PXD001447;PRD000671;PRD000407	90	EBI-19887297;EBI-19887310			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.52	43	PXD000746;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000373;PXD001328;PXD000047;PXD001422;PRD000154;PRD000796;PRD000164;PXD000164;PRD000711;PRD000597;PRD000172;PRD000594;PRD000059;PXD001323;PRD000607;PXD000948;PXD000997;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000345;PRD000113;PRD000443;PRD000600;PXD001572;PXD001447;PRD000407	140				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P12035	Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)	KRT3	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.4	47	PXD000746;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PXD000226;PRD000373;PXD001328;PRD000154;PXD001422;PRD000796;PRD000164;PXD000164;PXD000047;PRD000711;PRD000671;PRD000172;PRD000407;PRD000059;PXD001323;PRD000607;PRD000594;PXD000948;PXD000997;PRD000212;PXD000593;PRD000151;PRD000364;PXD001403;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000345;PRD000113;PRD000443;PRD000600;PXD001572;PXD001447	172	EBI-8440340;EBI-8429350;EBI-8401905;EBI-8338396;EBI-8333649;EBI-8328780;EBI-19769881;EBI-19769894	748246		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P05787	Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)	KRT8	P05783	Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)	KRT18	0.42	34	PRD000020;PRD000123;PXD000746;PRD000443;PXD000948;PXD000529;PXD001328;PXD001572;PRD000796;PRD000146;PRD000345;PXD000050;PXD000047;PRD000711;PRD000597;PRD000600;PRD000073;PRD000059;PXD001323;PRD000594;PXD000786;PXD000472;PRD000565;PXD000218;PRD000671;PRD000444;PRD000113;PXD000593;PXD000743;PXD001447;PXD000164;PXD000533;PRD000407;PXD000964	94	EBI-19979608;EBI-19979621;EBI-9087691;EBI-9074521;EBI-3950556;EBI-3931519;EBI-1382281;EBI-1371676;EBI-1371670;EBI-1255881;EBI-1255730;EBI-445615	892472;317420		R-HSA-6809371;R-HSA-6805567	keratinization [GO:0031424];hepatocyte apoptotic process [GO:0097284];tumor necrosis factor-mediated signaling pathway [GO:0033209];cornification [GO:0070268];extrinsic apoptotic signaling pathway [GO:0097191];viral process [GO:0016032]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198];scaffold protein binding [GO:0097110]
P36404	ADP-ribosylation factor-like protein 2	ARL2	O43617	Trafficking protein particle complex subunit 3 (BET3 homolog)	TRAPPC3	0.4	7	PRD000053;PXD001323;PRD000154;PXD000533;PRD000565;PXD001422;PRD000733	18						cytosol [GO:0005829];Golgi apparatus [GO:0005794]	
P01861	Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region)	IGHG4	P01860	Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region)		0.53	28	PRD000164;PRD000073;PXD000383;PRD000417;PRD000738;PXD000746;PRD000416;PRD000019;PRD000269;PRD000053;PXD001422;PRD000796;PXD000164;PXD000743;PRD000364;PXD000765;PRD000059;PRD000212;PXD001403;PRD000551;PRD000151;PRD000565;PRD000631;PXD001324;PRD000671;PRD000146;PRD000185;PRD000345	190				R-HSA-977606;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-173623;R-HSA-166663	phagocytosis, recognition [GO:0006910];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, engulfment [GO:0006911];B cell receptor signaling pathway [GO:0050853];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];regulation of complement activation [GO:0030449];complement activation [GO:0006956];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P62937	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA	P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	0.45	50	PXD000948;PRD000154;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000417;PRD000443;PRD000416;PXD000387;PRD000684;PRD000565;PXD000426;PXD000164;PXD001422;PXD000529;PRD000073;PRD000345;PRD000465;PRD000733;PRD000146;PXD000047;PRD000711;PRD000597;PRD000269;PRD000407;PRD000594;PRD000059;PXD001323;PRD000046;PRD000607;PXD000786;PXD000472;PXD000533;PRD000020;PXD000218;PRD000731;PXD000217;PRD000032;PXD001324;PXD000314;PRD000444;PRD000523;PXD001572;PXD001447;PRD000364;PXD000226;PRD000796;PRD000108	229		1267109		R-HSA-8950505;R-HSA-114608	interleukin-12-mediated signaling pathway [GO:0035722]	cytosol [GO:0005829];focal adhesion [GO:0005925];extracellular space [GO:0005615];membrane [GO:0016020];nucleus [GO:0005634];vesicle [GO:0031982];extracellular exosome [GO:0070062]	
P62937	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.42	54	PXD000426;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000417;PRD000059;PRD000001;PXD000529;PXD000948;PRD000416;PXD000387;PRD000684;PXD000164;PXD001422;PRD000345;PRD000146;PRD000407;PRD000711;PRD000597;PRD000154;PRD000477;PRD000594;PXD001323;PRD000046;PRD000607;PXD000786;PRD000068;PRD000073;PRD000151;PRD000020;PRD000565;PXD000218;PXD000314;PRD000269;PRD000731;PRD000103;PRD000444;PXD000217;PXD000746;PRD000733;PXD001324;PRD000234;PRD000118;PXD000226;PRD000032;PXD001572;PXD001447;PRD000364;PXD000533;PRD000796;PRD000108	230		1267115				nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62937	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA	Q06830	Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2)	PRDX1	0.47	53	PXD000948;PRD000154;PXD000426;PRD000053;PRD000796;PRD000565;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000417;PRD000059;PRD000001;PRD000345;PXD000529;PRD000416;PRD000373;PRD000269;PXD000164;PXD001422;PRD000032;PRD000465;PRD000733;PRD000146;PXD000047;PRD000711;PRD000597;PRD000407;PRD000594;PXD001323;PRD000046;PRD000073;PRD000607;PXD000786;PRD000544;PXD000533;PRD000068;PRD000151;PRD000020;PXD000218;PRD000731;PXD000217;PXD000746;PXD001324;PRD000234;PRD000444;PXD000387;PXD001572;PRD000600;PXD001447;PRD000118;PRD000108	245						nucleus [GO:0005634];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
P62937	Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]	PPIA	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.48	47	PRD000032;PXD000426;PRD000053;PRD000738;PXD000529;PRD000123;PRD000668;PRD000059;PRD000001;PXD000948;PXD000387;PRD000684;PXD000164;PXD001422;PRD000796;PRD000073;PRD000465;PRD000733;PRD000146;PXD000047;PXD000226;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000020;PXD000786;PXD000218;PRD000731;PRD000103;PXD000217;PRD000417;PRD000565;PXD001324;PRD000108;PRD000118;PRD000444;PRD000345;PRD000416;PRD000269;PXD001572;PRD000535;PRD000364;PXD000533;PXD000314	210				R-HSA-114608		focal adhesion [GO:0005925];nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	RNA binding [GO:0003723]
Q9UBQ0	Vacuolar protein sorting-associated protein 29 (hVPS29) (PEP11 homolog) (Vesicle protein sorting 29)	VPS29	Q15126	Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2)	PMVK	0.41	8	PRD000020;PRD000733;PRD000053;PXD001323;PXD000529;PXD001324;PRD000711;PXD001422	18						cytosol [GO:0005829]	
Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	0.4	4	PRD000345;PRD000711;PRD000443;PXD000529	47						nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829]	
Q13547	Histone deacetylase 1 (HD1) (EC 3.5.1.98)	HDAC1	Q14687	Genetic suppressor element 1	GSE1	0.43	2	PRD000345;PRD000407	34	EBI-11132348;EBI-6597549;EBI-3505028	2220324;1451967;871862;832397	632;633				
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.4	25	PRD000053;PRD000123;PRD000443;PXD000529;PXD001310;PXD000426;PXD001572;PXD001422;PRD000668;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PRD000565;PRD000020;PXD000218;PRD000444;PXD000593;PRD000345;PXD000964	88		1271366;925340;742699	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	P26373	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13	0.45	29	PRD000565;PRD000020;PRD000733;PRD000123;PRD000443;PRD000053;PXD001310;PXD001572;PXD001422;PRD000668;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000594;PRD000607;PRD000680;PXD000948;PXD000997;PXD000218;PXD000217;PXD000593;PXD000529;PRD000444;PRD000345;PRD000269;PXD000426;PXD000964	93		1269214;742538	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];endoplasmic reticulum [GO:0005783];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.4	29	PRD000020;PRD000053;PRD000123;PRD000443;PXD001310;PXD001572;PXD001422;PRD000154;PRD000733;PRD000668;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PXD000997;PXD000217;PRD000565;PXD000218;PRD000671;PRD000146;PXD000529;PRD000444;PXD000593;PRD000269;PXD000426	91		1271384;742542	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];endoplasmic reticulum [GO:0005783];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.42	26	PRD000053;PRD000565;PXD001323;PXD001310;PXD000529;PRD000444;PRD000594;PRD000123;PRD000443;PXD000593;PRD000597;PRD000671;PRD000607;PRD000680;PXD000948;PRD000146;PXD000997;PXD000218;PXD000217;PXD000426;PXD001572;PXD001422;PRD000668;PRD000345;PRD000269;PRD000711	81		2271283;1271144;1183186;925337;742574	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];endoplasmic reticulum [GO:0005783];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	P62753	40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)	RPS6	0.45	28	PRD000733;PRD000123;PRD000443;PRD000053;PXD000529;PXD001310;PXD001572;PXD001422;PRD000668;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PXD000997;PXD000217;PRD000565;PXD000218;PXD000593;PRD000671;PXD000948;PRD000444;PRD000345;PRD000269;PXD000964	86	EBI-16798663	1271303;925291;742578	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];endoplasmic reticulum [GO:0005783];nucleoplasm [GO:0005654];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62241	40S ribosomal protein S8 (Small ribosomal subunit protein eS8)	RPS8	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.41	32	PRD000020;PRD000053;PRD000443;PXD000529;PXD001310;PXD000997;PXD000047;PXD001422;PRD000154;PRD000733;PRD000668;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PXD000948;PXD000217;PRD000565;PXD000218;PRD000731;PXD000593;PRD000671;PRD000345;PRD000444;PRD000113;PRD000269;PXD001572;PXD000964	110		1271107;925221;742575	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];endoplasmic reticulum [GO:0005783];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	0.56	55	PRD000020;PRD000345;PRD000053;PRD000565;PRD000738;PRD000668;PRD000443;PRD000167;PXD000948;PXD000529;PXD001310;PRD000269;PRD000032;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PRD000796;PRD000465;PRD000733;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000671;PRD000172;PXD000593;PRD000594;PRD000607;PRD000680;PXD000426;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000786;PXD000217;PXD001324;PRD000234;PXD000218;PRD000444;PRD000523;PXD001572;PRD000600;PXD001447;PXD000164;PXD000533;PRD000073;PXD000314;PRD000092;PRD000108;PRD000407	251				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	0.41	58	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000053;PXD001310;PRD000269;PXD000387;PXD001328;PRD000565;PXD000997;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PXD000593;PXD000426;PRD000164;PXD001323;PRD000046;PRD000059;PRD000607;PRD000680;PRD000594;PXD000218;PXD000472;PXD000533;PRD000417;PXD000217;PXD000050;PXD000529;PRD000731;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PRD000444;PXD000226;PRD000407;PXD001447;PXD000164;PXD000786;PRD000738;PRD000108	325						myelin sheath [GO:0043209];nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.47	53	PRD000020;PXD000948;PRD000345;PRD000073;PRD000053;PRD000565;PRD000738;PRD000668;PRD000443;PRD000167;PXD000529;PXD001310;PRD000269;PXD000387;PRD000733;PXD001328;PXD000997;PXD001572;PXD001422;PRD000154;PRD000796;PRD000465;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000032;PRD000671;PRD000172;PXD000593;PRD000594;PRD000607;PRD000680;PXD000426;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PXD000786;PXD000050;PXD001324;PRD000234;PXD000218;PRD000444;PXD000226;PRD000523;PRD000600;PXD000164;PXD000533;PRD000407	252				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];neuronal cell body [GO:0043025];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.56	55	PRD000020;PRD000345;PRD000053;PRD000565;PRD000738;PRD000668;PRD000443;PRD000167;PXD000948;PXD000529;PXD001310;PRD000269;PRD000032;PXD000387;PXD001328;PXD000593;PRD000154;PXD001422;PRD000796;PRD000465;PRD000733;PRD000146;PXD000047;PXD001323;PRD000711;PRD000597;PRD000671;PRD000172;PRD000594;PRD000607;PRD000680;PXD000426;PXD000997;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000786;PXD000217;PXD001324;PRD000234;PXD000218;PRD000444;PRD000523;PXD001572;PRD000600;PXD001447;PXD000164;PXD000533;PRD000073;PXD000314;PRD000092;PRD000108;PRD000407	249				R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
P04350	Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain)	TUBB4A	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.4	50	PRD000733;PXD000948;PXD000426;PRD000032;PRD000345;PRD000053;PXD000743;PRD000668;PRD000443;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000118;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PRD000565;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000444;PRD000523;PRD000535;PRD000269;PXD001447;PXD000164;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	274						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	P30050	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	0.46	26	PRD000053;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PXD001323;PRD000607;PRD000680;PXD000948;PRD000565;PRD000020;PXD000997;PXD000218;PRD000731;PRD000733;PRD000146;PRD000444;PXD000593;PRD000345;PRD000594;PXD000533	94		1269170;741478	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.4	27	PRD000053;PRD000123;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PXD001323;PRD000680;PXD000426;PRD000565;PRD000020;PXD000218;PXD000948;PRD000733;PRD000146;PXD000997;PRD000444;PXD000593;PRD000345;PRD000600;PRD000594;PXD000533	86		1271355;925302;743217	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];ribosomal small subunit biogenesis [GO:0042274];rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];nucleoplasm [GO:0005654];cytosolic small ribosomal subunit [GO:0022627]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.41	34	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PXD001323;PRD000607;PRD000680;PRD000565;PXD000217;PXD000948;PRD000020;PXD000218;PRD000731;PRD000671;PRD000733;PRD000146;PXD000997;PRD000444;PXD000593;PRD000345;PRD000600;PXD001447;PRD000594;PXD000426;PXD000533;PRD000269	96	EBI-20313969	1270708;742204	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62249	40S ribosomal protein S16 (Small ribosomal subunit protein uS9)	RPS16	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.47	29	PRD000032;PRD000053;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PXD001323;PXD000217;PRD000565;PXD000948;PXD000218;PRD000731;PRD000671;PRD000733;PRD000146;PRD000234;PXD000997;PRD000444;PXD000593;PRD000345;PRD000600;PRD000269;PXD001447;PRD000594;PXD000533	91		1270823;924982;742254	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];ribosomal small subunit biogenesis [GO:0042274];maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462];rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q96L21	60S ribosomal protein L10-like (Large ribosomal subunit protein uL16-like)	RPL10L	P61313	60S ribosomal protein L15 (Large ribosomal subunit protein eL15)	RPL15	0.42	20	PRD000053;PXD001310;PXD001323;PXD000426;PXD000948;PXD000529;PRD000146;PXD000997;PRD000671;PXD000964;PXD001572;PRD000594;PXD001422;PXD000533;PXD000593;PRD000565;PXD000047;PRD000711;PRD000597;PXD000218	39		1269300;746538		R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P12236	ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]	SLC25A6	Q00325	Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)	SLC25A3	0.41	25	PRD000020;PRD000668;PRD000053;PRD000345;PXD000529;PXD000593;PXD001572;PXD001422;PRD000032;PXD001323;PRD000711;PRD000671;PRD000594;PRD000607;PRD000680;PRD000168;PRD000565;PRD000146;PRD000234;PRD000444;PRD000597;PRD000523;PRD000118;PXD001447;PXD000533	87						mitochondrial inner membrane [GO:0005743];mitochondrion [GO:0005739]	
P12235	ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)	SLC25A4	Q00325	Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)	SLC25A3	0.4	23	PRD000020;PXD000593;PRD000345;PXD000529;PRD000032;PRD000053;PRD000168;PRD000671;PRD000594;PRD000668;PRD000607;PRD000146;PRD000234;PRD000118;PRD000523;PXD001572;PXD001422;PXD000533;PRD000444;PRD000597;PXD001323;PRD000711;PXD001447	75						mitochondrial inner membrane [GO:0005743];integral component of plasma membrane [GO:0005887];mitochondrion [GO:0005739];myelin sheath [GO:0043209]	
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	0.65	3	PXD000383;PXD001403;PRD000416	14					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.41	12	PRD000019;PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059	40					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.41	15	PXD000383;PRD000073;PXD001324;PRD000671;PRD000631;PRD000551;PRD000019;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000059;PRD000113;PXD000743	46					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	P01768	Immunoglobulin heavy variable 3-30 (Ig heavy chain V-III region BUR) (Ig heavy chain V-III region CAM) (Ig heavy chain V-III region GA) (Ig heavy chain V-III region NIE)	IGHV3-30	0.41	18	PRD000416;PRD000551;PRD000631;PXD000383;PRD000671;PRD000417;PRD000269;PXD001324;PRD000185;PRD000146;PXD001403;PRD000053;PRD000164;PXD000164;PXD001422;PRD000059;PRD000019;PXD000743	43					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.49	17	PRD000416;PRD000019;PXD001324;PRD000551;PRD000671;PXD000383;PRD000417;PRD000269;PRD000185;PRD000146;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059;PRD000113	51					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.41	14	PRD000073;PXD000383;PXD001324;PRD000671;PRD000631;PRD000551;PRD000019;PRD000212;PXD001403;PRD000053;PRD000164;PXD000164;PXD001422;PRD000059	46					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.41	12	PRD000019;PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059	40					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1Y9	Immunoglobulin heavy variable 3-72	IGHV3-72	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.42	12	PRD000073;PXD000383;PRD000671;PRD000631;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000059;PRD000113;PRD000019	35							antigen binding [GO:0003823]
P61204	ADP-ribosylation factor 3	ARF3	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.42	21	PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PRD000118;PRD000711;PRD000597;PXD001323;PXD000948;PRD000001;PRD000020;PRD000733;PRD000345;PXD000426;PRD000594;PXD000164;PRD000407;PXD001422	86						extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61204	ADP-ribosylation factor 3	ARF3	O14950	Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)	MYL12B	0.4	26	PXD000948;PRD000053;PRD000668;PRD000738;PXD000529;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000594;PXD001323;PXD000218;PRD000068;PRD000001;PRD000731;PRD000671;PRD000733;PRD000180;PRD000345;PXD001447;PXD000164;PRD000118;PRD000407	105						extracellular exosome [GO:0070062]	
P61204	ADP-ribosylation factor 3	ARF3	P19105	Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)	MYL12A	0.4	26	PXD000948;PRD000053;PRD000668;PRD000738;PXD000529;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000594;PXD001323;PXD000218;PRD000068;PRD000001;PRD000731;PRD000671;PRD000733;PRD000180;PRD000345;PXD001447;PXD000164;PRD000118;PRD000407	105						extracellular exosome [GO:0070062]	
P61204	ADP-ribosylation factor 3	ARF3	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.45	28	PRD000733;PRD000668;PRD000443;PRD000738;PRD000053;PXD000529;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000020;PXD001403;PRD000565;PRD000068;PXD000218;PRD000671;PRD000032;PRD000345;PRD000118;PRD000600;PXD000164;PRD000407	103					protein transport [GO:0015031]	Golgi membrane [GO:0000139]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61204	ADP-ribosylation factor 3	ARF3	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.43	22	PRD000053;PXD000529;PXD000948;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000565;PXD000426;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000068;PRD000020;PXD001447;PRD000711;PRD000733;PRD000118	83						extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61204	ADP-ribosylation factor 3	ARF3	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.43	24	PRD000053;PRD000668;PRD000738;PXD000948;PXD000529;PXD000387;PXD001328;PXD001572;PRD000154;PRD000118;PRD000796;PRD000711;PRD000594;PXD001323;PRD000020;PRD000068;PRD000001;PRD000565;PRD000733;PXD000218;PXD000426;PXD001447;PXD000164;PXD001422	86						extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	P01782	Immunoglobulin heavy variable 3-9 (Ig heavy chain V-III region DOB)		0.53	1	PXD000383	10				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	0.69	1	PXD000383	11				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	P60985	Keratinocyte differentiation-associated protein	KRTDAP	0.83	1	PXD000383	10							
P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	0.63	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01715	Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X)	IGLV3-1	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.4	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P05109	Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A)	S100A8	P06702	Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)	S100A9	0.46	25	PRD000668;PRD000059;PRD000684;PRD000417;PRD000731;PRD000053;PXD001572;PXD001422;PRD000073;PRD000164;PRD000416;PXD000164;PRD000477;PRD000212;PRD000631;PXD000412;PRD000151;PRD000103;PXD000383;PRD000032;PXD001324;PRD000345;PRD000733;PRD000118;PXD001447	103	EBI-10097905;EBI-10097914;EBI-10091925;EBI-10091918;EBI-3450747;EBI-2105572;EBI-2105568	2211993;464571	6827;6826	R-HSA-6799990;R-HSA-6798695;R-HSA-5686938	positive regulation of inflammatory response [GO:0050729];leukocyte migration involved in inflammatory response [GO:0002523];defense response to fungus [GO:0050832];positive regulation of peptide secretion [GO:0002793];cytokine production [GO:0001816];neutrophil degranulation [GO:0043312];sequestering of zinc ion [GO:0032119];antimicrobial humoral response [GO:0019730];positive regulation of NF-kappaB transcription factor activity [GO:0051092];chemokine production [GO:0032602];inflammatory response [GO:0006954];activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919];neutrophil aggregation [GO:0070488];positive regulation of intrinsic apoptotic signaling pathway [GO:2001244];positive regulation of cell growth [GO:0030307];autophagy [GO:0006914];neutrophil chemotaxis [GO:0030593];astrocyte development [GO:0014002];regulation of cytoskeleton organization [GO:0051493];apoptotic process [GO:0006915];defense response to bacterium [GO:0042742];toll-like receptor signaling pathway [GO:0002224];innate immune response [GO:0045087]	secretory granule lumen [GO:0034774];extracellular exosome [GO:0070062];cytosol [GO:0005829];extracellular space [GO:0005615];nucleus [GO:0005634];extracellular region [GO:0005576];plasma membrane [GO:0005886];cytoskeleton [GO:0005856]	RAGE receptor binding [GO:0050786];Toll-like receptor 4 binding [GO:0035662];calcium ion binding [GO:0005509];microtubule binding [GO:0008017];zinc ion binding [GO:0008270];arachidonic acid binding [GO:0050544]
P13727	Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]	PRG2	P40199	Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c)	CEACAM6	0.4	2	PRD000684;PXD000164	15				R-HSA-6798695	neutrophil degranulation [GO:0043312]		
P13727	Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]	PRG2	P31997	Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)	CEACAM8	0.46	2	PRD000684;PXD000164	19				R-HSA-6798695	neutrophil degranulation [GO:0043312]	extracellular exosome [GO:0070062]	
P13727	Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)]	PRG2	P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	0.42	2	PRD000684;PXD000164	16							
Q8IY81	pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3	P46087	Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	NOP2	0.41	10	PRD000118;PXD000426;PXD000047;PXD001572;PXD000533;PRD000597;PXD000593;PRD000146;PXD000964;PXD000314	19		1265752;746577				nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q8IY81	pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)	FTSJ3	Q9BZE4	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4	0.42	7	PRD000597;PXD000047;PXD000426;PXD001572;PRD000146;PXD000593;PXD000964	13					maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	nucleus [GO:0005634];nucleolus [GO:0005730]	RNA binding [GO:0003723]
P34931	Heat shock 70 kDa protein 1-like (Heat shock 70 kDa protein 1L) (Heat shock 70 kDa protein 1-Hom) (HSP70-Hom)	HSPA1L	P54652	Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2)	HSPA2	0.44	44	PRD000733;PRD000345;PRD000053;PRD000032;PRD000532;PRD000123;PRD000443;PRD000059;PRD000269;PXD000529;PXD000387;PXD001328;PXD000164;PXD001422;PRD000154;PRD000465;PRD000146;PXD000047;PRD000416;PRD000711;PRD000597;PRD000417;PXD000948;PRD000172;PRD000407;PXD001323;PRD000607;PXD000593;PXD000997;PXD000426;PRD000668;PRD000565;PRD000671;PXD001324;PRD000234;PXD000218;PRD000444;PRD000594;PRD000118;PXD001572;PXD001447;PRD000092;PXD000786;PXD000964	225				R-HSA-3371568;R-HSA-3371497;R-HSA-3371453	response to unfolded protein [GO:0006986];protein refolding [GO:0042026]	cytosol [GO:0005829];blood microparticle [GO:0072562]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
P51149	Ras-related protein Rab-7a	RAB7A	Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	0.45	25	PRD000020;PRD000053;PRD000668;PRD000738;PRD000001;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PXD000948;PRD000711;PRD000597;PXD001323;PRD000092;PRD000733;PXD001324;PRD000146;PRD000345;PXD000426;PRD000118;PRD000594;PXD000164;PXD000533;PRD000407	90		1268588;746497		R-HSA-8873719;R-HSA-8854214		phagocytic vesicle [GO:0045335];phagocytic vesicle membrane [GO:0030670];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P51149	Ras-related protein Rab-7a	RAB7A	P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	0.43	30	PRD000053;PXD000948;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000416;PRD000146;PRD000711;PRD000597;PRD000417;PRD000407;PRD000594;PXD001323;PRD000269;PRD000607;PRD000565;PRD000020;PXD000164;PXD000314;PRD000733;PXD001324;PRD000444;PRD000345;PXD000426;PXD001447;PXD000533	125	EBI-11050319	1443702				cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	A6NIZ1	Ras-related protein Rap-1b-like protein		0.4	23	PRD000020;PRD000053;PRD000711;PRD000154;PXD000948;PRD000594;PRD000668;PRD000738;PRD000092;PRD000118;PRD000001;PRD000607;PXD000529;PRD000733;PRD000146;PRD000345;PXD001324;PXD001572;PXD001422;PXD000533;PXD001323;PXD000164;PRD000597	84						plasma membrane [GO:0005886];cytosol [GO:0005829]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P51149	Ras-related protein Rab-7a	RAB7A	P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	0.42	21	PRD000020;PRD000053;PXD000948;PRD000668;PRD000738;PXD001328;PXD001572;PXD001422;PRD000146;PXD000164;PRD000711;PRD000597;PRD000594;PXD001323;PXD000426;PRD000565;PXD001324;PRD000444;PRD000345;PRD000118;PXD000533	107						extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	P61224	Ras-related protein Rap-1b (GTP-binding protein smg p21B)	RAP1B	0.44	26	PRD000020;PRD000053;PXD000948;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000417;PRD000594;PXD001323;PRD000092;PRD000607;PRD000001;PXD000164;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000118;PXD000533	91		1268592		R-HSA-6798695	neutrophil degranulation [GO:0043312]	lipid droplet [GO:0005811];plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P51149	Ras-related protein Rab-7a	RAB7A	P37802	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2	0.43	28	PRD000053;PRD000668;PRD000738;PRD000001;PXD000529;PXD001328;PXD001572;PXD001422;PRD000416;PRD000146;PXD000164;PXD000050;PRD000711;PRD000597;PRD000417;PRD000594;PXD001323;PRD000269;PRD000607;PXD000948;PRD000020;PRD000733;PXD001324;PRD000345;PXD000426;PRD000118;PXD000533;PRD000407	107						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.43	25	PRD000020;PRD000053;PRD000668;PRD000738;PXD000529;PXD001572;PRD000154;PXD001422;PRD000146;PXD000948;PXD000164;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PRD000565;PRD000417;PRD000733;PXD001324;PRD000444;PRD000345;PRD000118;PRD000407	106					protein transport [GO:0015031]		GTPase activity [GO:0003924];GTP binding [GO:0005525]
P51149	Ras-related protein Rab-7a	RAB7A	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.45	18	PRD000053;PXD000426;PRD000154;PRD000594;PRD000668;PRD000738;PRD000711;PRD000733;PXD001324;PXD001323;PXD000948;PRD000345;PXD001422;PXD000164;PXD000533;PRD000146;PRD000020;PXD001572	81		1268579		R-HSA-6798695	neutrophil degranulation [GO:0043312]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	P23284	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	PPIB	0.43	31	PRD000020;PRD000053;PXD000948;PRD000668;PRD000738;PRD000001;PXD000529;PXD001328;PXD000164;PXD001422;PRD000416;PRD000146;PXD000050;PRD000711;PRD000597;PRD000417;PRD000594;PXD001323;PRD000269;PRD000607;PXD001572;PRD000565;PXD000426;PRD000733;PXD001324;PRD000444;PRD000345;PRD000092;PXD001447;PXD000533;PRD000407	120						extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	P30086	Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)]	PEBP1	0.4	18	PRD000020;PRD000053;PRD000668;PXD000529;PXD001572;PXD001422;PRD000711;PRD000417;PRD000594;PXD001323;PXD000948;PXD000164;PRD000733;PXD001324;PXD000314;PRD000345;PXD000533;PRD000738	94						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P51149	Ras-related protein Rab-7a	RAB7A	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.41	28	PRD000053;PRD000668;PRD000738;PRD000001;PXD000529;PXD001572;PXD001422;PRD000146;PXD000948;PRD000711;PRD000597;PRD000594;PXD001323;PRD000269;PRD000607;PXD000426;PRD000565;PRD000020;PXD000164;PXD000314;PRD000417;PRD000733;PXD001324;PRD000444;PRD000345;PRD000032;PRD000118;PXD000533	117						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q03591	Complement factor H-related protein 1 (FHR-1) (H factor-like protein 1) (H-factor-like 1) (H36)	CFHR1	P03952	Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain]	KLKB1	0.45	14	PRD000073;PRD000172;PRD000631;PRD000416;PRD000059;PRD000185;PXD000383;PRD000417;PXD000743;PRD000551;PRD000053;PXD001403;PXD000164;PRD000158	70						extracellular region [GO:0005576];extracellular space [GO:0005615]	
P30050	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	0.44	26	PRD000053;PRD000668;PXD000529;PXD001310;PXD000387;PXD001572;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PXD000948;PRD000594;PXD001323;PRD000680;PXD000426;PXD000997;PRD000565;PRD000020;PXD000218;PRD000733;PRD000444;PXD000593;PRD000345;PXD000533	97		1269182	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P30050	60S ribosomal protein L12 (Large ribosomal subunit protein uL11)	RPL12	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.41	28	PRD000053;PRD000565;PXD001323;PXD001310;PRD000814;PRD000020;PRD000444;PRD000594;PRD000668;PRD000416;PRD000597;PRD000607;PXD000948;PRD000733;PRD000146;PXD000997;PXD001572;PXD000529;PRD000154;PXD000593;PRD000680;PRD000796;PXD001422;PRD000345;PRD000407;PRD000711;PXD000047;PXD000426	85		1269136;741922	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	Q9P2K3	REST corepressor 3	RCOR3	0.45	1	PRD000345	22	EBI-11087905	2222776;1454673	626		negative regulation of transcription by RNA polymerase II [GO:0000122];transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding transcription factor activity [GO:0003700];RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	Q14687	Genetic suppressor element 1	GSE1	0.5	1	PRD000345	30	EBI-11087905	2218191;1451969					
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	0.4	1	PRD000345	33							
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	Q9NVH6	Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)	TMLHE	0.47	1	PRD000345	26							
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.43	1	PRD000345	33							
Q9NP66	High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1)	HMG20A	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.44	1	PRD000345	31						nucleus [GO:0005634]	
P13611	Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M)	VCAN	P16112	Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2]	ACAN	0.46	3	PRD000417;PRD000269;PRD000416	33				R-HSA-3000178	extracellular matrix organization [GO:0030198];skeletal system development [GO:0001501];central nervous system development [GO:0007417];cell adhesion [GO:0007155]	Golgi lumen [GO:0005796];lysosomal lumen [GO:0043202];extracellular region [GO:0005576];collagen-containing extracellular matrix [GO:0062023]	extracellular matrix structural constituent conferring compression resistance [GO:0030021];hyaluronic acid binding [GO:0005540];carbohydrate binding [GO:0030246];extracellular matrix structural constituent [GO:0005201]
P01782	Immunoglobulin heavy variable 3-9 (Ig heavy chain V-III region DOB)		P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	0.45	1	PXD000383	10				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01782	Immunoglobulin heavy variable 3-9 (Ig heavy chain V-III region DOB)		P01611	Immunoglobulin kappa variable 1D-12 (Ig kappa chain V-I region Wes)	IGKV1D-12	0.4	2	PRD000551;PXD000383	15				R-HSA-166663;R-HSA-173623;R-HSA-198933;R-HSA-202733;R-HSA-2029481;R-HSA-2029482;R-HSA-2029485;R-HSA-2168880;R-HSA-2454202;R-HSA-2730905;R-HSA-2871796;R-HSA-2871809;R-HSA-2871837;R-HSA-5690714;R-HSA-977606;R-HSA-983695	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	0.42	3	PXD000383;PXD001403;PRD000212	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A075B6R2	Immunoglobulin heavy variable 4-4	IGHV4-4	0.42	5	PRD000416;PXD000383;PXD001403;PRD000417;PRD000146	19					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.5	3	PXD000383;PXD001403;PRD000212	16					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	P01772	Immunoglobulin heavy variable 3-33 (Ig heavy chain V-III region HIL) (Ig heavy chain V-III region KOL)	IGHV3-33	0.51	9	PRD000416;PXD000383;PRD000417;PRD000269;PRD000146;PRD000212;PXD001403;PRD000164;PRD000671	28				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A0B4J1X8	Immunoglobulin heavy variable 3-43	IGHV3-43	0.41	7	PRD000416;PXD000383;PXD001403;PRD000269;PRD000417;PRD000146;PRD000019	20					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.45	3	PXD000383;PXD001403;PRD000671	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.43	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.44	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01780	Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON)	IGHV3-7	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.41	3	PXD000383;PXD001403;PRD000212	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	0.47	3	PRD000345;PXD000529;PXD001422	39						cytosol [GO:0005829]	zinc ion binding [GO:0008270]
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.46	2	PRD000345;PXD001422	35						cytoplasm [GO:0005737]	
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.5	2	PRD000345;PXD001422	36						nucleus [GO:0005634]	
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	0.42	3	PRD000345;PXD001323;PXD001422	37						nucleus [GO:0005634];cytosol [GO:0005829]	
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	P46109	Crk-like protein	CRKL	0.42	5	PRD000345;PXD001323;PRD000711;PXD000529;PXD001422	41						cytosol [GO:0005829]	identical protein binding [GO:0042802]
Q9ULA0	Aspartyl aminopeptidase (EC 3.4.11.21)	DNPEP	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.45	2	PRD000345;PXD000529	35						cytosol [GO:0005829]	
P20160	Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP)	AZU1	P08246	Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)	ELANE	0.65	8	PRD000684;PRD000668;PRD000118;PXD000164;PXD000412;PRD000053;PXD001422;PRD000113	28				R-HSA-6798695	antimicrobial humoral response [GO:0019730];proteolysis [GO:0006508];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	heparin binding [GO:0008201];peptidase activity [GO:0008233]
P20160	Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP)	AZU1	P24158	Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)	PRTN3	0.47	8	PRD000167;PRD000684;PRD000668;PRD000118;PRD000053;PXD000164;PXD000412;PXD001422	31				R-HSA-6798695	antimicrobial humoral response [GO:0019730];proteolysis [GO:0006508];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
Q9P2K3	REST corepressor 3	RCOR3	Q14687	Genetic suppressor element 1	GSE1	0.45	1	PRD000345	21	EBI-19064663;EBI-19031079;EBI-19064678;EBI-19031094;EBI-10551362;EBI-10471491;EBI-10318687;EBI-2351001;EBI-2349983;EBI-756976	1046293;838736;120973					
O15144	Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC)	ARPC2	P47756	F-actin-capping protein subunit beta (CapZ beta)	CAPZB	0.41	21	PRD000053;PRD000738;PRD000668;PRD000417;PXD000529;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PRD000154;PRD000416;PXD000164;PRD000711;PRD000477;PXD001323;PRD000001;PRD000565;PRD000731;PXD001324;PRD000118	97		1258878				extracellular exosome [GO:0070062];actin cytoskeleton [GO:0015629];cytosol [GO:0005829]	actin binding [GO:0003779]
O15145	Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC)	ARPC3	Q13404	Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)	UBE2V1	0.41	12	PRD000053;PRD000731;PRD000668;PRD000711;PRD000146;PXD000529;PRD000597;PXD001323;PXD000164;PXD000533;PXD001422;PRD000738	58						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q9Y265	RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha)	RUVBL1	Q9Y230	RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta)	RUVBL2	0.46	19	PRD000053;PXD000426;PRD000345;PXD000948;PRD000154;PRD000594;PXD001323;PXD000593;PRD000565;PXD000529;PXD000218;PRD000146;PXD001328;PXD001572;PXD001422;PRD000444;PXD000997;PRD000407;PRD000711	44	EBI-449148;EBI-769253;EBI-769446;EBI-1059975;EBI-1073966;EBI-1772285;EBI-1772343;EBI-1772353;EBI-1772367;EBI-1772378;EBI-1772455;EBI-1772463;EBI-1772726;EBI-1772737;EBI-1772772;EBI-1772993;EBI-1773055;EBI-1773067;EBI-1773004;EBI-1773015;EBI-1773025;EBI-3903677;EBI-3903698;EBI-10325470;EBI-10478133;EBI-10630866;EBI-18916789;EBI-18916776;EBI-15676218;EBI-15676241;EBI-15676280	2360523;2360497;2217628;1504223;1271610;1043812;925385;862551;856443;856177;241505;242271;424685;424697;465147;478366;513953;513957;530433;544078;544082;563233;563246;606929;740802;824271;824272;856173;856174	1173;1170;1166;799;798;787;781;529;525;304;302	R-HSA-3214847;R-HSA-171319	regulation of growth [GO:0040008];DNA recombination [GO:0006310];DNA repair [GO:0006281];chromatin remodeling [GO:0006338];histone H4 acetylation [GO:0043967];histone H2A acetylation [GO:0043968];transcription, DNA-templated [GO:0006351];box C/D snoRNP assembly [GO:0000492];positive regulation of telomerase RNA localization to Cajal body [GO:1904874]	R2TP complex [GO:0097255];ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];MLL1 complex [GO:0071339];NuA4 histone acetyltransferase complex [GO:0035267];nucleoplasm [GO:0005654];nuclear matrix [GO:0016363];Ino80 complex [GO:0031011];Swr1 complex [GO:0000812];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	ATP-dependent 5'-3' DNA helicase activity [GO:0043141];TBP-class protein binding [GO:0017025];DNA helicase activity [GO:0003678];ATPase binding [GO:0051117];ATP binding [GO:0005524];TFIID-class transcription factor binding [GO:0001094];ATP-dependent DNA helicase activity [GO:0004003];ADP binding [GO:0043531]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.4	27	PRD000053;PRD000269;PXD001310;PRD000444;PRD000594;PRD000123;PRD000668;PRD000443;PXD000217;PRD000565;PRD000680;PXD000948;PRD000146;PXD000997;PRD000020;PXD001323;PRD000597;PXD001572;PRD000733;PXD001422;PXD000593;PRD000410;PRD000796;PXD000047;PRD000407;PRD000711;PXD000218	77	EBI-776423	1269627;741975	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	endoplasmic reticulum [GO:0005783];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	P46778	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	0.4	23	PRD000053;PRD000565;PXD001310;PRD000594;PXD001323;PRD000443;PXD000948;PXD000529;PRD000146;PXD000997;PXD000218;PXD001572;PRD000444;PXD000533;PXD001422;PXD000593;PXD000217;PXD000047;PRD000269;PRD000711;PRD000597;PRD000668;PRD000020	62		1269630	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	endoplasmic reticulum [GO:0005783];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.43	25	PRD000053;PRD000565;PXD001310;PRD000444;PRD000594;PRD000668;PXD001323;PRD000733;PRD000680;PXD000948;PXD000529;PRD000146;PXD000997;PRD000597;PRD000180;PXD001572;PXD000533;PXD001422;PRD000796;PXD000047;PXD000593;PRD000020;PRD000711;PRD000269;PXD000218	78		1269633;741977	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.42	28	PRD000053;PRD000123;PRD000668;PRD000443;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PXD000217;PRD000565;PRD000020;PXD000218;PXD000426;PRD000146;PRD000444;PXD000593;PRD000269;PRD000600;PXD000533	88		1269623;741972	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.44	23	PRD000053;PRD000565;PXD001310;PRD000407;PRD000444;PXD000217;PRD000668;PXD001323;PRD000443;PXD000948;PRD000146;PXD000997;PRD000597;PXD001572;PRD000594;PXD000533;PXD001422;PXD000593;PRD000796;PXD000047;PRD000711;PXD000218;PRD000733	74		1269626;743148	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46776	60S ribosomal protein L27a (Large ribosomal subunit protein uL15)	RPL27A	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.46	22	PRD000053;PRD000269;PXD001310;PRD000444;PRD000594;PRD000668;PRD000123;PRD000565;PRD000680;PXD000948;PRD000146;PXD000997;PRD000180;PXD001572;PXD001422;PRD000796;PXD000047;PXD001323;PXD000593;PRD000407;PRD000711;PRD000597	71	EBI-776423	1269634;742764	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	endoplasmic reticulum [GO:0005783];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P08246	Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)	ELANE	P24158	Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen)	PRTN3	0.44	10	PRD000684;PRD000362;PRD000668;PRD000118;PRD000164;PXD000164;PXD000412;PRD000053;PRD000212;PXD001422	32				R-HSA-6803157;R-HSA-6798695	antimicrobial humoral response [GO:0019730];proteolysis [GO:0006508];neutrophil degranulation [GO:0043312]	extracellular region [GO:0005576];azurophil granule lumen [GO:0035578];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	serine-type endopeptidase activity [GO:0004252]
P23083	Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)	IGHV1-2	A0A0B4J2H0	Immunoglobulin heavy variable 1-69D	IGHV1-69D	0.42	5	PXD000383;PXD001403;PRD000269;PRD000146;PRD000416	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P23083	Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)	IGHV1-2	A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	0.4	4	PXD000383;PXD001403;PXD000164;PRD000146	14					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P23083	Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)	IGHV1-2	A0A0C4DH29	Immunoglobulin heavy variable 1-3	IGHV1-3	0.41	5	PXD000383;PXD001403;PRD000269;PRD000146;PRD000416	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P23083	Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35)	IGHV1-2	P01743	Immunoglobulin heavy variable 1-46 (Ig heavy chain V-I region DOT) (Ig heavy chain V-I region HG3) (Ig heavy chain V-I region Mot)	IGHV1-46	0.45	6	PXD000383;PXD001403;PRD000269;PRD000551;PRD000146;PRD000416	16				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P02675	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	FGB	P02679	Fibrinogen gamma chain	FGG	0.61	27	PRD000073;PRD000417;PRD000738;PRD000416;PRD000185;PXD000383;PRD000053;PRD000118;PXD000164;PXD001403;PRD000269;PRD000477;PRD000158;PRD000059;PRD000032;PRD000020;PRD000212;PXD000743;PRD000631;PRD000068;PRD000532;PXD001324;PRD000551;PRD000001;PRD000362;PRD000364;PXD001422	225		281194	6417	R-HSA-6802955;R-HSA-6802952;R-HSA-6802949;R-HSA-6802948;R-HSA-6802946;R-HSA-5686938;R-HSA-5674135;R-HSA-372708;R-HSA-354194;R-HSA-354192;R-HSA-216083;R-HSA-140875;R-HSA-114608	extracellular matrix organization [GO:0030198];positive regulation of ERK1 and ERK2 cascade [GO:0070374];positive regulation of vasoconstriction [GO:0045907];cell-matrix adhesion [GO:0007160];fibrinolysis [GO:0042730];negative regulation of endothelial cell apoptotic process [GO:2000352];platelet aggregation [GO:0070527];cellular response to interleukin-1 [GO:0071347];negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042];response to calcium ion [GO:0051592];positive regulation of heterotypic cell-cell adhesion [GO:0034116];positive regulation of protein secretion [GO:0050714];positive regulation of peptide hormone secretion [GO:0090277];protein polymerization [GO:0051258];positive regulation of substrate adhesion-dependent cell spreading [GO:1900026];blood coagulation [GO:0007596];plasminogen activation [GO:0031639];platelet degranulation [GO:0002576];positive regulation of exocytosis [GO:0045921];toll-like receptor signaling pathway [GO:0002224];blood coagulation, fibrin clot formation [GO:0072378];cellular protein-containing complex assembly [GO:0034622]	fibrinogen complex [GO:0005577];platelet alpha granule [GO:0031091];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];cell surface [GO:0009986];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102];structural molecule activity [GO:0005198]
P02675	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	FGB	P02671	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	FGA	0.62	26	PRD000073;PRD000417;PRD000738;PRD000416;PRD000185;PXD000383;PRD000053;PRD000118;PXD000164;PXD001403;PRD000269;PRD000477;PRD000158;PRD000059;PRD000020;PRD000212;PXD000743;PRD000631;PXD001324;PRD000068;PRD000551;PRD000001;PRD000535;PRD000362;PRD000364;PXD001422	200	EBI-16223035;EBI-16223006;EBI-15688007;EBI-1034460;EBI-1038131	281195	6417	R-HSA-6802955;R-HSA-6802952;R-HSA-6802949;R-HSA-6802948;R-HSA-6802946;R-HSA-5686938;R-HSA-5674135;R-HSA-372708;R-HSA-354194;R-HSA-354192;R-HSA-216083;R-HSA-140875;R-HSA-114608	extracellular matrix organization [GO:0030198];positive regulation of ERK1 and ERK2 cascade [GO:0070374];positive regulation of vasoconstriction [GO:0045907];cell-matrix adhesion [GO:0007160];innate immune response [GO:0045087];fibrinolysis [GO:0042730];negative regulation of endothelial cell apoptotic process [GO:2000352];adaptive immune response [GO:0002250];platelet aggregation [GO:0070527];negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042];response to calcium ion [GO:0051592];positive regulation of heterotypic cell-cell adhesion [GO:0034116];induction of bacterial agglutination [GO:0043152];positive regulation of protein secretion [GO:0050714];positive regulation of peptide hormone secretion [GO:0090277];protein polymerization [GO:0051258];positive regulation of substrate adhesion-dependent cell spreading [GO:1900026];blood coagulation [GO:0007596];plasminogen activation [GO:0031639];platelet degranulation [GO:0002576];positive regulation of exocytosis [GO:0045921];toll-like receptor signaling pathway [GO:0002224];blood coagulation, fibrin clot formation [GO:0072378];cellular protein-containing complex assembly [GO:0034622]	fibrinogen complex [GO:0005577];platelet alpha granule [GO:0031091];extracellular vesicle [GO:1903561];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];cell surface [GO:0009986];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];cell cortex [GO:0005938];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];plasma membrane [GO:0005886]	signaling receptor binding [GO:0005102];structural molecule activity [GO:0005198]
P02675	Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain]	FGB	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.41	17	PRD000073;PRD000417;PRD000416;PRD000185;PXD000383;PRD000269;PRD000053;PXD000164;PRD000477;PRD000059;PRD000212;PXD001403;PRD000631;PRD000551;PXD001324;PRD000158;PRD000362	144						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	0.45	16	PRD000417;PRD000631;PXD001174;PRD000671;PXD000383;PXD000743;PXD001324;PRD000416;PRD000269;PRD000212;PXD001403;PRD000364;PXD000164;PXD001422;PRD000345;PRD000185	50				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.45	17	PRD000417;PRD000345;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000551;PRD000269;PXD001174	44				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	0.43	2	PXD000383;PRD000671	12					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.48	18	PRD000417;PRD000631;PXD001174;PRD000671;PXD000383;PXD000743;PXD001324;PRD000416;PRD000269;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000551;PRD000059;PRD000113;PRD000345	54				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.51	19	PRD000417;PRD000631;PRD000345;PXD001174;PRD000671;PRD000364;PRD000416;PXD000383;PXD000743;PRD000059;PXD001324;PRD000073;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000269;PRD000185	56				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.53	18	PRD000417;PRD000631;PRD000345;PRD000416;PRD000671;PXD000383;PXD000743;PXD001324;PRD000073;PXD000997;PRD000212;PRD000053;PXD001403;PXD000164;PRD000551;PXD001422;PRD000269;PXD001174	59				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.41	12	PRD000417;PRD000631;PRD000671;PRD000416;PXD000383;PXD000743;PRD000551;PRD000212;PXD001403;PXD000164;PRD000345;PXD001174	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.45	17	PRD000417;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000416;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000551;PRD000345;PRD000269;PXD001174	43				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.49	17	PRD000417;PRD000631;PXD001174;PRD000671;PRD000416;PXD000383;PXD000743;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000364;PRD000269;PRD000185	50					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6P5	Immunoglobulin kappa variable 2-28	IGKV2-28	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.41	13	PRD000417;PRD000631;PRD000671;PXD000383;PRD000416;PRD000212;PXD001403;PXD000164;PXD001422;PRD000113;PXD000743;PRD000269;PXD001174	39					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P02679	Fibrinogen gamma chain	FGG	P02671	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	FGA	0.57	27	PRD000073;PRD000417;PRD000738;PRD000443;PRD000416;PRD000185;PXD000383;PRD000053;PRD000269;PXD001422;PXD000164;PRD000477;PRD000158;PRD000059;PRD000020;PRD000212;PXD001403;PRD000631;PRD000068;PXD000743;PXD001324;PRD000551;PRD000001;PRD000535;PRD000362;PRD000118;PRD000364	217	EBI-16223035;EBI-16223006;EBI-15688007;EBI-1034460;EBI-1038131	281193	6417	R-HSA-8957275;R-HSA-6802955;R-HSA-6802952;R-HSA-6802949;R-HSA-6802948;R-HSA-6802946;R-HSA-5686938;R-HSA-5674135;R-HSA-381426;R-HSA-372708;R-HSA-354194;R-HSA-354192;R-HSA-216083;R-HSA-140875;R-HSA-114608	extracellular matrix organization [GO:0030198];positive regulation of ERK1 and ERK2 cascade [GO:0070374];positive regulation of vasoconstriction [GO:0045907];cell-matrix adhesion [GO:0007160];post-translational protein modification [GO:0043687];fibrinolysis [GO:0042730];negative regulation of endothelial cell apoptotic process [GO:2000352];platelet aggregation [GO:0070527];negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042];response to calcium ion [GO:0051592];positive regulation of heterotypic cell-cell adhesion [GO:0034116];cellular protein metabolic process [GO:0044267];positive regulation of protein secretion [GO:0050714];positive regulation of peptide hormone secretion [GO:0090277];protein polymerization [GO:0051258];positive regulation of substrate adhesion-dependent cell spreading [GO:1900026];blood coagulation [GO:0007596];plasminogen activation [GO:0031639];platelet degranulation [GO:0002576];positive regulation of exocytosis [GO:0045921];toll-like receptor signaling pathway [GO:0002224];blood coagulation, fibrin clot formation [GO:0072378];cellular protein-containing complex assembly [GO:0034622]	endoplasmic reticulum lumen [GO:0005788];fibrinogen complex [GO:0005577];platelet alpha granule [GO:0031091];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];cell surface [GO:0009986];extracellular space [GO:0005615];external side of plasma membrane [GO:0009897];extracellular region [GO:0005576];platelet alpha granule lumen [GO:0031093];plasma membrane [GO:0005886]	metal ion binding [GO:0046872];signaling receptor binding [GO:0005102];structural molecule activity [GO:0005198]
P02679	Fibrinogen gamma chain	FGG	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.4	18	PRD000073;PRD000417;PRD000416;PRD000185;PXD000383;PRD000269;PRD000053;PXD000164;PRD000477;PRD000059;PRD000158;PRD000212;PXD001403;PRD000631;PXD001324;PRD000551;PRD000032;PRD000362	146						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
Q96AK3	DNA dC->dU-editing enzyme APOBEC-3D (A3D) (EC 3.5.4.-)	APOBEC3D	Q96P47	Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP-3) (CRAM-associated GTPase) (CRAG) (Centaurin-gamma-3) (Cnt-g3) (MR1-interacting protein) (MRIP-1)	AGAP3	0.41	1	PRD000345	13						cytoplasm [GO:0005737]	
P46087	Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120)	NOP2	O00567	Nucleolar protein 56 (Nucleolar protein 5A)	NOP56	0.4	11	PXD000047;PXD001572;PXD000218;PXD000533;PXD000680;PRD000146;PXD000964;PXD000593;PRD000597;PRD000118;PXD000314	18	EBI-11069711	1445836;1265759;746086		R-HSA-6790901		nucleoplasm [GO:0005654];nucleolus [GO:0005730]	RNA binding [GO:0003723]
Q00839	Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120)	HNRNPU	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.44	27	PXD000948;PRD000443;PXD000529;PRD000053;PXD000426;PXD000997;PXD000047;PXD001422;PRD000796;PRD000146;PXD000050;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000565;PXD000217;PXD000218;PRD000671;PRD000444;PXD001328;PXD001572;PXD000533;PRD000407	112	EBI-11088773	1446845	3055			nucleus [GO:0005634];ribonucleoprotein complex [GO:1990904];membrane [GO:0016020]	RNA binding [GO:0003723]
P62888	60S ribosomal protein L30 (Large ribosomal subunit protein eL30)	RPL30	P25398	40S ribosomal protein S12 (Small ribosomal subunit protein eS12)	RPS12	0.4	23	PRD000053;PRD000565;PXD001323;PRD000345;PXD001310;PRD000444;PRD000594;PRD000668;PRD000269;PRD000417;PXD000948;PRD000733;PXD000529;PXD000218;PRD000146;PXD000997;PXD001572;PXD000533;PXD001422;PRD000796;PXD000217;PRD000407;PRD000711	76		1269746	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62888	60S ribosomal protein L30 (Large ribosomal subunit protein eL30)	RPL30	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.44	25	PRD000053;PXD000218;PRD000565;PXD001323;PRD000345;PXD001310;PRD000711;PRD000444;PRD000594;PRD000416;PRD000668;PRD000269;PRD000417;PRD000733;PXD000529;PXD000997;PRD000032;PXD001572;PXD000217;PXD001422;PXD000533;PRD000146;PRD000796;PXD000948;PRD000407	84		1269751	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];translation [GO:0006412];translational initiation [GO:0006413];killing of cells of other organism [GO:0031640];defense response to Gram-negative bacterium [GO:0050829];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	0.46	22	PRD000053;PXD001328;PXD000529;PRD000711;PRD000154;PRD000092;PRD000668;PXD001323;PRD000738;PRD000118;PRD000565;PXD000948;PRD000733;PXD001324;PXD001572;PXD000164;PXD000533;PRD000410;PRD000345;PRD000597;PRD000269;PXD001422	79						recycling endosome membrane [GO:0055038];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P84085	ADP-ribosylation factor 5	ARF5	0.41	20	PRD000053;PXD001328;PXD000529;PRD000154;PRD000668;PXD001323;PXD000948;PRD000738;PRD000733;PRD000001;PXD001572;PRD000594;PXD000164;PXD000426;PXD001422;PRD000345;PRD000020;PRD000407;PRD000711;PRD000597	81						extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P30048	Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)	PRDX3	0.4	19	PRD000053;PRD000600;PRD000668;PXD001323;PXD000948;PRD000738;PRD000711;PRD000118;PXD000529;PRD000733;PXD001324;PRD000146;PXD001572;PRD000594;PXD000164;PXD001422;PRD000345;PRD000020;PRD000269	75						cytosol [GO:0005829]	
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P61224	Ras-related protein Rap-1b (GTP-binding protein smg p21B)	RAP1B	0.4	25	PRD000053;PRD000600;PXD001328;PXD000529;PRD000711;PRD000154;PRD000738;PRD000668;PRD000092;PRD000118;PRD000146;PRD000565;PRD000733;PXD001324;PRD000001;PRD000684;PRD000345;PXD001572;PRD000594;PXD000533;PXD001422;PXD001323;PRD000020;PRD000597;PRD000269	82						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.49	25	PRD000053;PRD000020;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PRD000118;PXD000948;PRD000711;PRD000597;PXD000426;PRD000092;PXD001323;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000600;PRD000594;PXD000164;PRD000407;PRD000269;PXD001422	90							GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.44	19	PRD000053;PXD000529;PRD000711;PRD000154;PXD001323;PRD000668;PRD000738;PRD000092;PXD000948;PRD000001;PXD001328;PXD001572;PRD000594;PXD000164;PRD000118;PXD000533;PXD001422;PRD000020;PRD000269	70						cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.5	22	PRD000053;PRD000600;PXD001328;PRD000711;PRD000154;PRD000092;PRD000668;PXD001323;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001572;PRD000594;PXD000164;PRD000738;PXD001422;PRD000001;PRD000345;PRD000407;PRD000269	74		1268562		R-HSA-8873719;R-HSA-8854214		extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.4	17	PRD000053;PXD000529;PRD000154;PRD000668;PRD000738;PRD000711;PXD000426;PRD000733;PXD001324;PXD000948;PXD001323;PRD000594;PXD000164;PXD001422;PRD000345;PRD000020;PXD001572	66						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.42	19	PRD000053;PRD000154;PRD000668;PRD000711;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PXD001323;PXD001572;PXD000164;PXD001422;PXD000533;PRD000738;PRD000345;PRD000407;PRD000594;PRD000597	73					post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.4	20	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PRD000668;PXD001323;PRD000738;PRD000118;PXD000948;PRD000733;PXD001324;PXD001328;PXD001572;PXD000164;PXD000533;PXD001422;PRD000410;PRD000345;PRD000269	78						phagocytic vesicle membrane [GO:0030670];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P61006	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A	0.4	23	PRD000053;PRD000600;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PRD000118;PRD000565;PXD000948;PRD000733;PXD001324;PRD000146;PXD001323;PXD000529;PRD000345;PXD001572;PXD000164;PXD001422;PRD000407;PRD000597;PRD000269	80		746417		R-HSA-8873719;R-HSA-8854214	post-translational protein modification [GO:0043687]	phagocytic vesicle [GO:0045335];extracellular exosome [GO:0070062];synaptic vesicle [GO:0008021];phagocytic vesicle membrane [GO:0030670];recycling endosome membrane [GO:0055038];cytosol [GO:0005829]	GTP binding [GO:0005525];GTPase activity [GO:0003924];myosin V binding [GO:0031489];GDP binding [GO:0019003]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P61026	Ras-related protein Rab-10	RAB10	0.41	26	PRD000600;PXD001328;PRD000053;PRD000020;PRD000711;PRD000154;PRD000738;PRD000092;PRD000668;PXD001323;PRD000118;PRD000565;PXD000948;PXD000529;PRD000733;PXD001324;PRD000146;PRD000345;PXD001572;PRD000594;PXD000164;PXD000533;PXD001422;PRD000407;PRD000597;PRD000269	84				R-HSA-8873719	establishment of protein localization to membrane [GO:0090150]	recycling endosome [GO:0055037];phagocytic vesicle membrane [GO:0030670];recycling endosome membrane [GO:0055038];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];myosin V binding [GO:0031489];GDP binding [GO:0019003]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.4	18	PRD000053;PXD000948;PRD000154;PRD000668;PXD001323;PRD000711;PXD000426;PXD000529;PXD001324;PRD000146;PXD001572;PXD000164;PRD000118;PRD000345;PXD001422;PRD000407;PRD000597;PRD000594	78					post-translational protein modification [GO:0043687]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P61106	Ras-related protein Rab-14	RAB14	0.44	24	PRD000600;PRD000711;PRD000053;PRD000020;PRD000154;PRD000738;PRD000092;PRD000668;PXD000948;PRD000001;PXD000529;PRD000733;PXD001324;PRD000146;PXD001572;PXD000164;PXD000533;PXD001422;PRD000345;PXD001323;PRD000407;PRD000597;PRD000269;PRD000118	69				R-HSA-8873719		phagocytic vesicle [GO:0045335];recycling endosome [GO:0055037];recycling endosome membrane [GO:0055038];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];myosin V binding [GO:0031489];GDP binding [GO:0019003]
Q15907	Ras-related protein Rab-11B (GTP-binding protein YPT3)	RAB11B	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.41	20	PRD000053;PXD000529;PRD000711;PRD000154;PXD001323;PRD000668;PRD000738;PRD000092;PRD000733;PXD000948;PRD000001;PXD001328;PXD001572;PRD000594;PXD000164;PRD000118;PXD000533;PXD001422;PRD000020;PXD000426	72						cell junction [GO:0030054];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	Q92930	Ras-related protein Rab-8B	RAB8B	0.4	23	PRD000053;PRD000668;PRD000738;PXD001572;PXD001422;PRD000118;PRD000796;PRD000711;PRD000597;PRD000154;PRD000092;PXD001323;PRD000607;PXD000948;PRD000068;PXD000164;PXD000529;PRD000565;PRD000733;PXD001324;PRD000345;PRD000600;PRD000269	86						secretory granule membrane [GO:0030667];recycling endosome membrane [GO:0055038];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.41	24	PRD000053;PRD000668;PRD000738;PXD000529;PXD001572;PRD000154;PRD000118;PRD000796;PXD000164;PRD000711;PRD000597;PRD000594;PRD000092;PXD001323;PRD000607;PXD000948;PRD000068;PRD000565;PRD000733;PXD001324;PRD000345;PRD000600;PXD001422;PRD000269	92						Golgi membrane [GO:0000139];endoplasmic reticulum membrane [GO:0005789]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.47	22	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PRD000594;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PRD000733;PXD000948;PXD001328;PXD001572;PXD001422;PXD000164;PXD000533;PRD000118;PRD000068;PXD001447;PRD000269	82		1268863		R-HSA-5663220;R-HSA-5625900;R-HSA-5625740;R-HSA-416482;R-HSA-194840	positive regulation of stress fiber assembly [GO:0051496];regulation of small GTPase mediated signal transduction [GO:0051056];G-protein coupled receptor signaling pathway [GO:0007186]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	P59998	Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC)	ARPC4	0.4	20	PRD000053;PRD000154;PRD000594;PRD000668;PRD000738;PRD000711;PRD000118;PRD000607;PRD000733;PXD000529;PXD001323;PRD000600;PXD000164;PRD000796;PXD001422;PRD000345;PXD001572;PXD001447;PRD000269;PXD000948	78				R-HSA-5663213;R-HSA-3928662;R-HSA-2029482	Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];ephrin receptor signaling pathway [GO:0048013];actin filament polymerization [GO:0030041]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	enzyme binding [GO:0019899]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.43	22	PRD000053;PRD000711;PRD000154;PRD000594;PRD000092;PRD000668;PXD001323;PXD000948;PRD000607;PRD000565;PXD000529;PRD000733;PXD001324;PXD001328;PRD000600;PXD001572;PXD000164;PXD000533;PRD000738;PXD001422;PXD001447;PRD000269	79				R-HSA-6798695	neutrophil degranulation [GO:0043312]	melanosome [GO:0042470];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	P61026	Ras-related protein Rab-10	RAB10	0.4	25	PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PXD001422;PRD000154;PRD000796;PRD000711;PRD000597;PRD000092;PXD001323;PRD000607;PXD000948;PRD000068;PRD000565;PRD000733;PXD001324;PRD000345;PXD000164;PRD000118;PRD000600;PXD000533;PRD000269	88				R-HSA-6798695;R-HSA-1445148	neutrophil degranulation [GO:0043312]	trans-Golgi network [GO:0005802];cytosol [GO:0005829];recycling endosome membrane [GO:0055038];focal adhesion [GO:0005925];endoplasmic reticulum membrane [GO:0005789];secretory granule membrane [GO:0030667];Golgi membrane [GO:0000139];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P63000	Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1)	RAC1	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.47	22	PRD000053;PRD000668;PRD000738;PXD000529;PXD001328;PXD001572;PRD000154;PXD001422;PRD000118;PRD000796;PXD000164;PRD000711;PRD000092;PRD000594;PXD001323;PRD000607;PRD000068;PRD000565;PRD000733;PXD000948;PXD001447;PXD000533	87				R-HSA-8849471;R-HSA-6798695;R-HSA-5663220;R-HSA-5625970;R-HSA-5625900;R-HSA-5625740;R-HSA-4420097;R-HSA-416550;R-HSA-416482;R-HSA-4086400;R-HSA-3928662;R-HSA-194840;R-HSA-114604	actin cytoskeleton organization [GO:0030036];positive regulation of stress fiber assembly [GO:0051496];G-protein coupled receptor signaling pathway [GO:0007186];Wnt signaling pathway, planar cell polarity pathway [GO:0060071];regulation of small GTPase mediated signal transduction [GO:0051056];vascular endothelial growth factor receptor signaling pathway [GO:0048010];cell-matrix adhesion [GO:0007160];ephrin receptor signaling pathway [GO:0048013];regulation of cell migration [GO:0030334];neutrophil degranulation [GO:0043312]	lamellipodium [GO:0030027];extracellular exosome [GO:0070062];ruffle membrane [GO:0032587];focal adhesion [GO:0005925];endoplasmic reticulum membrane [GO:0005789];secretory granule membrane [GO:0030667];ficolin-1-rich granule membrane [GO:0101003];dendritic spine [GO:0043197];plasma membrane [GO:0005886];cytosol [GO:0005829]	GTPase activity [GO:0003924];Rho GDP-dissociation inhibitor binding [GO:0051022];GTP binding [GO:0005525]
Q13098	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1	P61201	COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15)	COPS2	0.52	9	PXD001328;PXD001572;PXD001422;PXD000529;PRD000154;PXD000426;PRD000711;PXD001323;PXD000533	15	EBI-16203313;EBI-16203258;EBI-16203206;EBI-16203229;EBI-16113910;EBI-16113633;EBI-15848484;EBI-15848417;EBI-15848393;EBI-19273334;EBI-19273347;EBI-10766278	2224241;1262733;1191664;956802;921673;741368;696949;693306;684218;668753;658182	726;727;728;2174;6482	R-HSA-5696394;R-HSA-6781823;R-HSA-8856825;R-HSA-8951664	post-translational protein modification [GO:0043687];protein deneddylation [GO:0000338];transcription-coupled nucleotide-excision repair [GO:0006283];nucleotide-excision repair, DNA damage recognition [GO:0000715]	COP9 signalosome [GO:0008180];nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q13098	COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH)	GPS1	P54725	UV excision repair protein RAD23 homolog A (HR23A) (hHR23A)	RAD23A	0.41	8	PXD001328;PXD000426;PRD000154;PXD001422;PRD000711;PXD001323;PXD000533;PXD000314	15				R-HSA-5696394		nucleoplasm [GO:0005654];cytosol [GO:0005829]	
Q8N9T8	Protein KRI1 homolog	KRI1	Q9Y3T9	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)	NOC2L	0.46	5	PXD001572;PXD000680;PXD000533;PXD000948;PXD000314	11						nucleolus [GO:0005730]	RNA binding [GO:0003723]
O14965	Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)	AURKA	Q13555	Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17)	CAMK2G	0.4	1	PRD000032	78					protein autophosphorylation [GO:0046777]	nucleoplasm [GO:0005654];cytosol [GO:0005829]	ATP binding [GO:0005524];protein serine/threonine kinase activity [GO:0004674]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	55				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	134		2216849		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q7L7L0	Histone H2A type 3	HIST3H2A	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815			protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.47	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23527	Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n)	HIST1H2BO	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.47	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	52				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	P30041	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	PRDX6	0.41	39	PXD000948;PRD000059;PRD000053;PXD000743;PRD000738;PRD000668;PRD000443;PXD000529;PXD000387;PXD000426;PXD001572;PRD000154;PXD001422;PRD000796;PRD000345;PRD000465;PRD000146;PRD000269;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PXD000218;PXD000786;PRD000416;PXD000533;PRD000565;PRD000020;PXD000164;PRD000417;PRD000032;PRD000733;PXD001324;PRD000444;PRD000523;PRD000073;PRD000364	171						cytosol [GO:0005829];cytoplasm [GO:0005737];extracellular space [GO:0005615];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	0.4	33	PXD000948;PRD000565;PRD000053;PRD000668;PRD000738;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000345;PRD000073;PRD000465;PRD000146;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PXD000786;PXD000217;PRD000020;PXD000218;PRD000731;PXD001324;PXD000529;PRD000444;PRD000523;PRD000032;PXD001572;PRD000364;PXD000533	149		1264443				nucleus [GO:0005634];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.43	48	PXD000948;PRD000032;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000417;PRD000443;PXD000529;PRD000416;PXD000387;PRD000684;PXD001328;PXD000426;PXD000164;PXD001422;PRD000796;PRD000345;PRD000146;PRD000269;PRD000407;PRD000711;PRD000597;PRD000364;PRD000154;PRD000594;PXD001323;PRD000046;PRD000059;PRD000607;PXD000218;PXD000786;PXD000217;PRD000565;PRD000020;PXD000314;PRD000731;PRD000671;PRD000733;PXD001324;PXD000226;PRD000444;PXD001572;PXD001447;PXD000533;PRD000108;PRD000073	213		1264073				nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	P37802	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2	0.46	40	PXD000948;PRD000053;PRD000738;PRD000123;PRD000668;PRD000417;PXD000529;PRD000416;PXD000387;PRD000733;PXD001328;PXD000164;PXD001422;PRD000796;PRD000345;PRD000146;PRD000269;PRD000711;PRD000597;PXD000426;PRD000407;PRD000594;PXD001323;PRD000046;PRD000059;PRD000073;PRD000607;PXD000218;PXD000786;PRD000631;PXD000217;PRD000565;PRD000731;PRD000032;PXD001324;PRD000020;PXD001572;PRD000364;PXD000533;PXD000743	174		1273018		R-HSA-114608		vesicle [GO:0031982];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	O00299	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)	CLIC1	0.4	39	PXD000948;PRD000565;PRD000053;PRD000738;PRD000123;PRD000668;PRD000443;PXD000529;PXD000387;PXD001328;PXD000164;PXD001422;PRD000796;PRD000345;PRD000059;PRD000465;PRD000146;PRD000711;PRD000597;PXD000426;PRD000154;PRD000594;PXD001323;PRD000046;PRD000607;PXD000218;PXD000472;PXD001403;PXD000217;PXD000314;PRD000731;PXD001324;PRD000032;PRD000020;PRD000073;PXD001572;PRD000364;PXD000533;PRD000108	157						extracellular exosome [GO:0070062];cytoplasm [GO:0005737];extracellular space [GO:0005615];membrane [GO:0016020];nucleus [GO:0005634];vesicle [GO:0031982]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	Q06830	Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2)	PRDX1	0.4	44	PXD000948;PRD000154;PRD000733;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000417;PRD000443;PXD000529;PRD000416;PXD000387;PRD000269;PXD000426;PXD000164;PXD001422;PRD000796;PRD000345;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000059;PRD000607;PXD000786;PRD000032;PRD000565;PXD001403;PXD000217;PRD000020;PXD000218;PRD000731;PXD000533;PXD001324;PRD000444;PXD001572;PXD001447;PRD000108;PRD000407	202		1267296				nucleus [GO:0005634];extracellular space [GO:0005615];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P23528	Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)	CFL1	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.48	45	PRD000814;PRD000053;PRD000738;PRD000123;PRD000668;PXD000948;PXD000529;PXD000387;PRD000684;PXD000426;PXD000164;PXD001422;PRD000733;PRD000796;PRD000059;PRD000465;PRD000146;PXD000047;PRD000711;PRD000597;PRD000594;PRD000073;PXD001323;PRD000046;PRD000269;PRD000607;PXD000533;PRD000631;PXD001403;PXD000217;PRD000565;PXD000218;PRD000731;PRD000417;PXD001324;PRD000032;PRD000020;PXD000226;PRD000444;PRD000345;PXD000786;PXD001572;PRD000364;PRD000108;PXD000314	191		1259928		R-HSA-114608	actin cytoskeleton organization [GO:0030036]	cytosol [GO:0005829];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P09871	Complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain]	C1S	P06681	Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]	C2	0.4	10	PRD000073;PRD000059;PRD000185;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000551;PRD000158	94				R-HSA-977606;R-HSA-166663	regulation of complement activation [GO:0030449];complement activation [GO:0006956];complement activation, classical pathway [GO:0006958]	extracellular region [GO:0005576]	serine-type endopeptidase activity [GO:0004252]
Q9NRW3	DNA dC->dU-editing enzyme APOBEC-3C (A3C) (EC 3.5.4.-) (APOBEC1-like) (Phorbolin I)	APOBEC3C	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.46	2	PRD000345;PXD001422	29						nucleus [GO:0005634]	RNA binding [GO:0003723]
A6NIZ1	Ras-related protein Rap-1b-like protein		Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.4	25	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PXD000948;PXD001403;PRD000068;PXD000164;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PRD000118;PRD000364	93							GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q86Y46	Keratin, type II cytoskeletal 73 (Cytokeratin-73) (CK-73) (Keratin-73) (K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)	KRT73	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.43	42	PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000597;PRD000373;PXD000387;PXD001328;PXD001572;PRD000154;PXD001422;PRD000345;PXD000047;PRD000711;PRD000172;PRD000059;PRD000607;PXD000997;PRD000212;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD000593;PXD001324;PRD000146;PRD000234;PRD000444;PRD000113;PRD000443;PXD001323;PRD000594;PRD000600;PRD000362;PXD001447;PRD000407	127	EBI-18738773;EBI-18738786;EBI-10581012;EBI-10415258;EBI-10260638	1039581		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P60900	Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.51	25	PRD000154;PRD000032;PRD000053;PRD000668;PRD000059;PXD000426;PXD001572;PXD001422;PRD000146;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PXD000948;PRD000731;PRD000733;PXD001324;PXD000218;PXD000997;PRD000345;PXD000164;PRD000738;PRD000407	104	EBI-8440340;EBI-8429350;EBI-8419242;EBI-8412660;EBI-8408168;EBI-8401905;EBI-8392519;EBI-8383997;EBI-8372752;EBI-8362519;EBI-8357768;EBI-8354201;EBI-8350757;EBI-8345298;EBI-8333649;EBI-8328780;EBI-8312518;EBI-7659176	2229591;1267687;924051;741410	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];proteolysis involved in cellular protein catabolic process [GO:0051603];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P60900	Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain)	PSMA6	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.49	26	PRD000154;PRD000032;PRD000053;PRD000668;PXD000426;PXD000997;PXD001572;PXD001422;PRD000059;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000565;PRD000731;PXD001324;PRD000146;PXD000218;PXD000529;PRD000345;PRD000073;PXD001447;PXD000164;PRD000407	116	EBI-7660342;EBI-7660323;EBI-7659266;EBI-7659176;EBI-7659127;EBI-1388301;EBI-1388265;EBI-1388212;EBI-1388202;EBI-696854;EBI-696842	2207074;1267694;924044;740904;696633;696631;668221;668205;668199;668189;668188	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];protein deubiquitination [GO:0016579];ubiquitin-dependent protein catabolic process [GO:0006511]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];proteasome core complex, alpha-subunit complex [GO:0019773];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P62258	14-3-3 protein epsilon (14-3-3E)	YWHAE	P31946	14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]	YWHAB	0.41	42	PRD000032;PRD000053;PRD000668;PRD000059;PRD000417;PXD000948;PXD000529;PXD000426;PRD000416;PXD000387;PXD001328;PRD000020;PXD000997;PXD001572;PXD000593;PRD000154;PRD000118;PRD000796;PRD000146;PRD000407;PRD000711;PRD000269;PRD000597;PRD000594;PXD001323;PRD000092;PRD000738;PRD000068;PRD000168;PRD000001;PXD000164;PRD000731;PXD000680;PRD000046;PXD001324;PXD000218;PRD000113;PRD000444;PRD000523;PXD000533;PXD000786;PXD001422	176	EBI-15609716;EBI-8798209;EBI-8796749;EBI-3452947	1274656;914151;830722;464638	5613;5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-2028269;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];viral process [GO:0016032];hippo signaling [GO:0035329];MAPK cascade [GO:0000165];protein targeting [GO:0006605]	cytosol [GO:0005829];cytoplasm [GO:0005737];mitochondrion [GO:0005739];focal adhesion [GO:0005925];membrane [GO:0016020];melanosome [GO:0042470];nucleus [GO:0005634];extracellular exosome [GO:0070062]	histone deacetylase binding [GO:0042826];enzyme binding [GO:0019899];cadherin binding [GO:0045296];identical protein binding [GO:0042802];phosphoserine residue binding [GO:0050815];phosphoprotein binding [GO:0051219];protein domain specific binding [GO:0019904]
P62258	14-3-3 protein epsilon (14-3-3E)	YWHAE	P61981	14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]	YWHAG	0.41	42	PRD000032;PRD000053;PRD000668;PRD000059;PRD000417;PXD000948;PRD000407;PXD000529;PRD000416;PXD000387;PXD001328;PXD001572;PXD000593;PRD000154;PRD000118;PRD000146;PRD000269;PXD000680;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000092;PRD000738;PXD000997;PXD000472;PRD000345;PRD000168;PRD000001;PRD000020;PXD000218;PRD000731;PXD000217;PXD001324;PRD000444;PRD000113;PXD000164;PRD000046;PRD000523;PXD000533;PXD001422	186	EBI-15609564;EBI-3934432;EBI-3913827;EBI-3453496;EBI-3452954	1274668;894202;830721;464640	5199	R-HSA-8854518;R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-5620912;R-HSA-380320;R-HSA-380284;R-HSA-380270;R-HSA-380259;R-HSA-2565942;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];G2/M transition of mitotic cell cycle [GO:0000086];regulation of G2/M transition of mitotic cell cycle [GO:0010389];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];ciliary basal body-plasma membrane docking [GO:0097711];protein targeting [GO:0006605]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];mitochondrion [GO:0005739];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];RNA binding [GO:0003723];protein domain specific binding [GO:0019904]
Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	P11021	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	HSPA5	0.4	59	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PXD001310;PXD000426;PXD000387;PXD001328;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000073;PRD000146;PXD000050;PXD000164;PRD000711;PRD000597;PXD000593;PRD000535;PRD000407;PRD000671;PRD000594;PXD001323;PRD000046;PRD000607;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000565;PRD000001;PXD000217;PXD000786;PXD000218;PXD000529;PRD000731;PRD000444;PXD001572;PXD001324;PRD000234;PXD000314;PRD000118;PRD000269;PRD000600;PXD001447;PRD000059;PXD000226;PRD000108;PXD000964	330						nucleus [GO:0005634];extracellular exosome [GO:0070062]	
Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.41	51	PRD000020;PXD000948;PRD000053;PRD000032;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PRD000345;PXD000529;PRD000269;PXD000387;PXD001328;PXD000997;PRD000154;PXD001422;PRD000796;PRD000733;PRD000146;PXD000050;PXD000047;PRD000711;PRD000597;PRD000168;PRD000671;PRD000172;PXD000593;PRD000594;PXD001323;PRD000607;PRD000680;PXD000426;PRD000364;PRD000151;PRD000001;PRD000565;PRD000068;PXD000217;PXD001324;PRD000234;PXD000218;PRD000444;PRD000523;PXD001572;PXD001447;PRD000600;PXD000164;PXD000533;PRD000092;PRD000407	209		2259054		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];extracellular exosome [GO:0070062];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q13885	Tubulin beta-2A chain (Tubulin beta class IIa)	TUBB2A	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.41	50	PRD000733;PXD000948;PRD000032;PRD000345;PXD000743;PRD000668;PRD000443;PRD000053;PXD001310;PXD000426;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PRD000565;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000118;PRD000444;PRD000523;PRD000535;PRD000269;PXD001447;PXD000164;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	276						cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	
A0A0B4J2H0	Immunoglobulin heavy variable 1-69D	IGHV1-69D	A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	0.52	5	PXD000383;PXD001403;PRD000416;PRD000269;PRD000146	16					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0B4J2H0	Immunoglobulin heavy variable 1-69D	IGHV1-69D	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.4	9	PRD000417;PRD000269;PRD000416;PXD000383;PXD000743;PRD000146;PRD000053;PXD001403;PRD000019	33					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P84085	ADP-ribosylation factor 5	ARF5	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.42	26	PRD000053;PRD000668;PRD000443;PRD000738;PXD000426;PXD001572;PRD000154;PXD001422;PRD000733;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PRD000020;PRD000068;PRD000671;PRD000032;PRD000565;PXD000218;PXD000529;PRD000345;PRD000600;PXD000164;PRD000407	94					protein transport [GO:0015031]		GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84085	ADP-ribosylation factor 5	ARF5	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.43	21	PRD000053;PXD000529;PXD000948;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000565;PXD000426;PRD000020;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000068;PXD001447;PRD000711;PRD000733	77						plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84085	ADP-ribosylation factor 5	ARF5	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.4	22	PXD000948;PRD000053;PXD001323;PRD000154;PRD000594;PRD000668;PRD000443;PXD000529;PRD000733;PXD001328;PRD000600;PXD001572;PXD000426;PXD000164;PRD000738;PRD000565;PXD001422;PXD001447;PRD000001;PRD000345;PRD000407;PRD000711	81					protein transport [GO:0015031]	plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P84085	ADP-ribosylation factor 5	ARF5	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.41	22	PXD000948;PRD000053;PXD000529;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000565;PRD000733;PRD000020;PRD000001;PXD000218;PXD001328;PXD001572;PXD000164;PXD001422;PRD000796;PRD000068;PXD001447;PXD000426;PRD000711	79						plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P48643	T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon)	CCT5	P49368	T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5)	CCT3	0.47	35	PRD000345;PRD000154;PRD000053;PRD000668;PRD000443;PXD000948;PXD000529;PXD001310;PXD000387;PXD000426;PXD001572;PXD000593;PRD000465;PRD000407;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PXD000533;PRD000565;PRD000032;PRD000092;PRD000001;PRD000020;PRD000600;PXD001324;PRD000146;PXD000218;PXD000997;PRD000444;PXD001328;PXD001422;PRD000671	144		2253219;1259740;741521	6247	R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-390450;R-HSA-389960;R-HSA-389957	'de novo' protein folding [GO:0006458];positive regulation of protein localization to Cajal body [GO:1904871];protein folding [GO:0006457];toxin transport [GO:1901998];positive regulation of telomere maintenance via telomerase [GO:0032212];positive regulation of establishment of protein localization to telomere [GO:1904851];binding of sperm to zona pellucida [GO:0007339];chaperone-mediated protein folding [GO:0061077];positive regulation of telomerase RNA localization to Cajal body [GO:1904874];protein stabilization [GO:0050821]	cytosol [GO:0005829];zona pellucida receptor complex [GO:0002199];microtubule [GO:0005874];chaperonin-containing T-complex [GO:0005832];cell body [GO:0044297];myelin sheath [GO:0043209];extracellular exosome [GO:0070062]	ATP binding [GO:0005524];unfolded protein binding [GO:0051082]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q6FI13	Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o)	HIST2H2AA3;HIST2H2AA4	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q13404	Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)	UBE2V1	O75608	Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1	0.4	11	PRD000053;PXD000529;PXD001323;PRD000668;PRD000711;PXD001324;PXD000218;PXD000164;PXD001422;PRD000796;PRD000738	52						cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q13404	Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A)	UBE2V1	Q04760	Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase)	GLO1	0.4	13	PRD000053;PXD000948;PRD000594;PXD001323;PRD000668;PRD000597;PXD000529;PXD001324;PXD000426;PXD001572;PXD001422;PRD000738;PRD000711	54						nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P30048	Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)	PRDX3	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.4	21	PRD000053;PRD000600;PXD001323;PRD000711;PRD000594;PRD000668;PRD000443;PRD000607;PRD000565;PXD000948;PXD000529;PRD000733;PXD001324;PXD001572;PXD000164;PXD001422;PRD000738;PRD000345;PXD001447;PRD000269;PXD000426	78						early endosome [GO:0005769]	
P30041	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	PRDX6	P37802	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2	0.4	35	PXD000948;PRD000345;PRD000053;PRD000738;PRD000668;PRD000059;PXD000529;PRD000416;PXD000387;PXD001572;PXD001422;PRD000796;PRD000146;PRD000269;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PRD000073;PRD000607;PXD000218;PXD000786;PRD000417;PRD000032;PRD000001;PRD000020;PRD000565;PXD000164;PRD000733;PXD001324;PRD000364;PXD000533;PRD000118	159						extracellular region [GO:0005576];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P30041	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	PRDX6	O00299	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)	CLIC1	0.4	35	PRD000059;PRD000053;PRD000738;PRD000668;PRD000443;PRD000345;PXD000387;PXD001572;PXD001422;PXD000529;PRD000796;PRD000465;PRD000146;PRD000269;PRD000711;PRD000597;PXD000948;PRD000416;PXD000426;PRD000154;PRD000594;PXD001323;PRD000046;PRD000073;PRD000607;PXD000218;PRD000417;PRD000565;PRD000020;PXD000164;PXD001324;PRD000113;PRD000364;PXD000533;PRD000118	159						extracellular exosome [GO:0070062];membrane [GO:0016020];cytoplasm [GO:0005737];extracellular space [GO:0005615];perinuclear region of cytoplasm [GO:0048471];nucleus [GO:0005634]	cadherin binding [GO:0045296]
P30041	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	PRDX6	Q06830	Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2)	PRDX1	0.41	40	PXD000426;PRD000345;PRD000796;PRD000053;PXD000743;PRD000738;PRD000668;PRD000443;PRD000417;PRD000059;PXD000948;PRD000416;PXD000387;PXD001572;PRD000154;PXD000529;PXD001422;PRD000465;PRD000146;PRD000269;PRD000711;PRD000597;PRD000092;PRD000594;PXD001323;PRD000046;PRD000607;PXD000786;PXD000164;PXD000533;PRD000565;PRD000001;PRD000020;PXD000218;PRD000032;PRD000733;PXD001324;PRD000444;PRD000118;PXD000997	206		752017		R-HSA-3299685	hydrogen peroxide catabolic process [GO:0042744];cell redox homeostasis [GO:0045454]	nucleus [GO:0005634];extracellular space [GO:0005615];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P30041	Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12)	PRDX6	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.4	37	PXD000426;PRD000059;PRD000053;PRD000738;PRD000668;PXD000948;PXD000529;PXD000387;PXD001572;PXD001422;PRD000796;PRD000465;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000073;PRD000607;PRD000020;PXD000164;PXD000533;PRD000565;PRD000001;PXD000218;PRD000417;PRD000733;PXD001324;PRD000444;PRD000345;PXD000786;PRD000416;PRD000684;PRD000269;PRD000364;PRD000118	161						nucleus [GO:0005634];membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	P30044	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)	PRDX5	0.43	20	PRD000053;PXD001323;PRD000711;PRD000444;PRD000594;PRD000668;PRD000059;PXD000948;PXD000426;PXD001324;PRD000001;PRD000597;PXD000218;PXD000387;PXD000164;PXD001422;PRD000146;PRD000345;PRD000020;PXD001572	83							
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	O95336	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	PGLS	0.43	16	PRD000053;PRD000711;PRD000668;PRD000059;PXD000948;PXD001323;PXD000529;PXD001324;PXD000164;PXD001422;PRD000444;PRD000417;PRD000146;PRD000020;PXD001572;PRD000269	74							
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.4	15	PXD001323;PRD000053;PRD000092;PRD000668;PRD000711;PXD000948;PXD000426;PXD000529;PRD000001;PXD000218;PXD001572;PRD000594;PXD000164;PXD001422;PRD000020	70							
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	P54819	Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]	AK2	0.44	18	PRD000053;PXD001323;PRD000345;PRD000711;PRD000444;PRD000594;PRD000668;PRD000059;PXD000948;PXD000529;PXD001324;PRD000001;PXD000218;PXD000164;PXD001422;PXD000387;PRD000146;PXD001572	83							
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.42	15	PRD000053;PRD000594;PRD000668;PRD000059;PRD000711;PXD000948;PXD001323;PXD000426;PXD001324;PXD000164;PXD001422;PRD000146;PRD000345;PRD000020;PXD001572	68							
P30040	Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31)	ERP29	P78417	Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R)	GSTO1	0.4	20	PRD000053;PRD000668;PRD000059;PXD000529;PXD000426;PXD001572;PXD001422;PRD000269;PRD000597;PRD000092;PRD000594;PRD000416;PXD001323;PXD000948;PRD000001;PRD000020;PXD000164;PXD001324;PRD000146;PRD000417	86							
P30044	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)	PRDX5	P54819	Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]	AK2	0.4	21	PRD000053;PRD000711;PRD000444;PRD000594;PRD000668;PRD000059;PRD000118;PXD000948;PXD001323;PXD000218;PRD000001;PXD000387;PXD001324;PRD000154;PXD000529;PXD000164;PXD001422;PRD000738;PRD000146;PXD001572;PRD000345	85						extracellular exosome [GO:0070062]	
P30044	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)	PRDX5	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.41	20	PRD000053;PXD000426;PXD000529;PRD000594;PRD000668;PRD000032;PRD000059;PRD000711;PXD000948;PXD001323;PRD000733;PXD001324;PXD000218;PXD000164;PXD001422;PRD000738;PRD000146;PRD000020;PXD001572;PRD000345	74						cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P30044	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20)	PRDX5	Q99714	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)	HSD17B10	0.4	22	PRD000053;PXD000529;PRD000444;PRD000594;PRD000668;PRD000711;PXD000948;PXD001323;PXD000426;PXD001324;PRD000146;PRD000234;PXD000387;PXD000218;PXD000164;PXD001422;PXD000533;PRD000738;PRD000118;PXD001572;PRD000020;PRD000345	75						cytoplasm [GO:0005737];mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P13674	Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)	P4HA1	Q96AY3	Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase)	FKBP10	0.46	8	PXD001328;PXD001323;PRD000345;PXD000529;PRD000053;PXD001324;PXD000533;PXD000387	14						endoplasmic reticulum lumen [GO:0005788]	
P13674	Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)	P4HA1	O15460	Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)	P4HA2	0.43	6	PXD001328;PXD001323;PRD000345;PXD000529;PXD000387;PXD000593	11				R-HSA-1650814		endoplasmic reticulum lumen [GO:0005788];endoplasmic reticulum [GO:0005783];intracellular membrane-bounded organelle [GO:0043231]	procollagen-proline 4-dioxygenase activity [GO:0004656];oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702];iron ion binding [GO:0005506];L-ascorbic acid binding [GO:0031418]
P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	0.45	34	PRD000053;PRD000020;PRD000668;PRD000417;PXD000948;PRD000416;PXD000387;PRD000269;PXD000164;PXD001422;PRD000796;PRD000345;PRD000146;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PRD000738;PRD000444;PXD000786;PXD000217;PRD000565;PXD000218;PRD000731;PXD001324;PRD000234;PXD000529;PXD001328;PXD001572;PRD000364;PXD000533;PRD000118	172						nucleus [GO:0005634];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	O00299	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)	CLIC1	0.4	32	PXD000948;PRD000053;PRD000668;PRD000417;PRD000416;PXD000387;PRD000269;PXD000164;PXD001422;PRD000796;PRD000345;PRD000465;PRD000146;PXD000426;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000738;PRD000565;PXD000217;PRD000731;PXD001324;PXD000218;PXD000529;PRD000020;PXD001328;PRD000118;PXD001572;PRD000364;PXD000533	142						nucleus [GO:0005634];mitochondrion [GO:0005739];extracellular exosome [GO:0070062];membrane [GO:0016020]	
P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	P25705	ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)	ATP5F1A	0.4	31	PRD000020;PRD000053;PRD000668;PXD000948;PRD000345;PXD000387;PXD000426;PXD001572;PXD001422;PRD000796;PXD001323;PRD000711;PRD000597;PRD000594;PRD000151;PXD000217;PXD000218;PRD000738;PXD001324;PRD000146;PRD000234;PXD000529;PRD000444;PRD000523;PRD000535;PRD000073;PXD001328;PRD000364;PXD000164;PRD000118;PXD000997	129	EBI-6272793	749949				myelin sheath [GO:0043209];mitochondrial matrix [GO:0005759];extracellular exosome [GO:0070062];mitochondrion [GO:0005739];membrane [GO:0016020]	RNA binding [GO:0003723]
P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.41	31	PRD000053;PRD000668;PRD000738;PXD000948;PXD000387;PXD000426;PXD000164;PXD001422;PRD000796;PRD000465;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000020;PRD000565;PXD000217;PXD000218;PRD000731;PXD001324;PXD000529;PRD000444;PRD000345;PRD000118;PXD001572;PRD000364;PRD000032;PXD000533;PXD000786	148						nucleus [GO:0005634];extracellular exosome [GO:0070062];membrane [GO:0016020]	RNA binding [GO:0003723]
P40926	Malate dehydrogenase, mitochondrial (EC 1.1.1.37)	MDH2	P06576	ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) (ATP synthase F1 subunit beta)	ATP5F1B	0.41	33	PXD000948;PRD000020;PRD000053;PRD000668;PRD000345;PRD000269;PXD000387;PXD001328;PXD001572;PXD001422;PRD000796;PRD000146;PXD001323;PRD000711;PRD000597;PRD000416;PRD000594;PXD000426;PRD000565;PXD000217;PXD000218;PRD000738;PXD001324;PRD000234;PXD000529;PRD000444;PRD000523;PRD000535;PRD000073;PRD000118;PXD000164;PXD000533;PXD000997	142		752678				extracellular exosome [GO:0070062];mitochondrial matrix [GO:0005759];mitochondrion [GO:0005739];myelin sheath [GO:0043209];membrane [GO:0016020];nucleus [GO:0005634]	
P62879	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2)	GNB2	P62873	Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1)	GNB1	0.44	16	PXD001323;PXD001324;PRD000092;PRD000269;PRD000607;PRD000053;PXD000948;PXD000218;PXD000387;PXD001328;PRD000594;PXD001422;PXD000529;PXD000050;PXD001572;PXD000164	37				R-HSA-997272;R-HSA-6814122;R-HSA-500657;R-HSA-456926;R-HSA-432040;R-HSA-428930;R-HSA-420092;R-HSA-418597;R-HSA-418594;R-HSA-418592;R-HSA-418555;R-HSA-418217;R-HSA-416482;R-HSA-416476;R-HSA-4086398;R-HSA-400042;R-HSA-392851;R-HSA-392451;R-HSA-392170;R-HSA-381676;R-HSA-202040;R-HSA-163359;R-HSA-1296041	protein folding [GO:0006457];G-protein coupled receptor signaling pathway [GO:0007186]	cytosol [GO:0005829];cell body [GO:0044297];lysosomal membrane [GO:0005765];myelin sheath [GO:0043209];membrane [GO:0016020];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase binding [GO:0051020];GTPase activity [GO:0003924];protein-containing complex binding [GO:0044877]
Q9UIG0	Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2)	BAZ1B	Q8IZL8	Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)	PELP1	0.46	5	PXD000529;PXD001572;PXD000680;PXD000218;PXD000314	11					transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]	
P02042	Hemoglobin subunit delta (Delta-globin) (Hemoglobin delta chain)	HBD	P69905	Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain)	HBA1;HBA2	0.6	53	PRD000020;PRD000053;PRD000154;PXD001174;PRD000032;PRD000417;PXD000743;PRD000738;PRD000668;PXD000746;PRD000416;PRD000631;PXD000948;PRD000269;PXD000383;PRD000373;PRD000684;PXD001328;PXD001422;PRD000796;PRD000073;PXD000164;PRD000477;PRD000092;PRD000059;PRD000680;PRD000551;PRD000212;PXD001403;PRD000544;PRD000364;PRD000565;PRD000532;PRD000600;PXD001324;PRD000234;PRD000108;PRD000180;PRD000362;PRD000118;PXD000226;PRD000597;PRD000523;PRD000535;PXD001323;PRD000733;PRD000345;PRD000731;PRD000019;PXD000387;PRD000711;PRD000407;PRD000146	299	EBI-20013119;EBI-20013132					hemoglobin complex [GO:0005833];cytosol [GO:0005829];blood microparticle [GO:0072562]	heme binding [GO:0020037];oxygen binding [GO:0019825];oxygen carrier activity [GO:0005344]
P09651	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]	HNRNPA1	P22626	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)	HNRNPA2B1	0.44	37	PRD000814;PXD000948;PRD000123;PRD000668;PRD000443;PRD000053;PXD000529;PXD000387;PXD000426;PXD000047;PXD001422;PRD000345;PRD000465;PRD000146;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000020;PXD000997;PXD000786;PXD000472;PXD000533;PXD000217;PRD000565;PXD000218;PXD000680;PXD000593;PXD001572;PXD000314;PRD000444;PRD000059;PRD000118;PXD000164	127	EBI-11077958	1444860;1263050;1241477;921877;741376;424643	1181	R-HSA-72203;R-HSA-72163	mRNA splicing, via spliceosome [GO:0000398];RNA metabolic process [GO:0016070]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];spliceosomal complex [GO:0005681];catalytic step 2 spliceosome [GO:0071013];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];membrane [GO:0016020];nucleus [GO:0005634]	identical protein binding [GO:0042802];miRNA binding [GO:0035198];RNA binding [GO:0003723];G-rich strand telomeric DNA binding [GO:0098505]
P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.41	55	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PRD000053;PXD001310;PRD000269;PRD000444;PXD000387;PXD001328;PRD000565;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000465;PRD000146;PXD000164;PRD000711;PRD000597;PXD000593;PXD000426;PXD001323;PRD000046;PRD000607;PRD000680;PRD000594;PXD000472;PXD000217;PXD000050;PXD000529;PRD000731;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PXD000218;PXD000226;PRD000407;PXD000314;PXD000533;PXD001447;PXD000786;PRD000738;PRD000108	317						nucleus [GO:0005634];cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P68104	Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7)	EEF1A1	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.4	58	PRD000733;PRD000032;PXD000948;PRD000345;PRD000020;PRD000053;PXD000743;PRD000123;PRD000668;PRD000443;PRD000167;PXD001310;PRD000269;PRD000444;PXD000387;PXD001328;PRD000565;PXD000997;PXD000047;PXD001422;PRD000154;PRD000796;PRD000073;PRD000465;PRD000146;PXD000164;PRD000711;PRD000597;PXD000593;PXD000426;PRD000164;PXD001323;PRD000046;PRD000607;PRD000680;PRD000594;PXD000472;PRD000417;PXD000217;PXD000050;PXD000529;PRD000731;PRD000168;PRD000600;PRD000671;PXD001572;PXD001324;PRD000234;PRD000151;PXD000218;PXD000226;PRD000407;PXD000314;PXD000533;PXD001447;PXD000786;PRD000738;PRD000108	322						nucleus [GO:0005634];cytoplasm [GO:0005737]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
O95336	6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)	PGLS	P54819	Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]	AK2	0.4	15	PRD000053;PRD000731;PRD000711;PRD000059;PRD000668;PXD000948;PXD000529;PXD001324;PXD001323;PXD000164;PXD001422;PRD000345;PRD000444;PRD000146;PXD001572	79						extracellular exosome [GO:0070062]	
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.48	21	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	54				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];antibacterial humoral response [GO:0019731];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular space [GO:0005615];cytosol [GO:0005829];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q7L7L0	Histone H2A type 3	HIST3H2A	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815			protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.41	22	PRD000345;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000020;PRD000565;PRD000680;PRD000733;PXD001572;PRD000269;PXD000314;PXD000529;PXD001422;PRD000796;PXD000164;PXD000050;PXD000217;PXD000948;PRD000597	58				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.5	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
O60814	Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1)	HIST1H2BK	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	innate immune response in mucosa [GO:0002227];protein ubiquitination [GO:0016567];defense response to Gram-positive bacterium [GO:0050830];antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];nucleosome assembly [GO:0006334];killing of cells of other organism [GO:0031640];defense response to Gram-negative bacterium [GO:0050829];antibacterial humoral response [GO:0019731]	nucleus [GO:0005634];nucleosome [GO:0000786];extracellular space [GO:0005615];cytosol [GO:0005829];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	P60985	Keratinocyte differentiation-associated protein	KRTDAP	0.67	1	PXD000383	10							
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	0.45	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	0.47	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	0.53	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	0.44	1	PXD000383	10					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.41	1	PXD000383	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01709	Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC)	IGLV2-8	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.4	1	PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.42	12	PRD000019;PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059	40					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.42	15	PXD000383;PRD000073;PXD001324;PRD000671;PRD000631;PRD000551;PRD000019;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000059;PRD000113;PXD000743	46					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	P01768	Immunoglobulin heavy variable 3-30 (Ig heavy chain V-III region BUR) (Ig heavy chain V-III region CAM) (Ig heavy chain V-III region GA) (Ig heavy chain V-III region NIE)	IGHV3-30	0.42	18	PRD000416;PRD000551;PRD000631;PXD000383;PRD000671;PRD000417;PRD000269;PXD001324;PRD000185;PRD000146;PXD001403;PRD000053;PRD000164;PXD000164;PXD001422;PRD000059;PRD000019;PXD000743	43					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.51	17	PRD000416;PRD000019;PXD001324;PRD000551;PRD000671;PXD000383;PRD000417;PRD000269;PRD000185;PRD000146;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059;PRD000113	51					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.4	10	PXD000383;PRD000671;PRD000631;PRD000551;PXD001403;PXD001422;PRD000059;PXD000164;PXD000743;PRD000019	29					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.42	14	PRD000073;PXD000383;PXD001324;PRD000671;PRD000631;PRD000551;PRD000019;PRD000212;PXD001403;PRD000053;PRD000164;PXD000164;PXD001422;PRD000059	46					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.42	12	PRD000019;PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PRD000059	40					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0B4J1V0	Immunoglobulin heavy variable 3-15	IGHV3-15	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.41	11	PXD000383;PRD000671;PRD000631;PRD000059;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000113;PRD000019	34							antigen binding [GO:0003823]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	P06733	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)	ENO1	0.42	56	PRD000053;PXD000948;PXD000426;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PXD000746;PRD000443;PRD000059;PRD000416;PXD000314;PXD000529;PRD000269;PXD000387;PRD000684;PXD001328;PXD001422;PRD000154;PRD000796;PRD000146;PXD001323;PXD000164;PRD000597;PRD000594;PRD000607;PXD000786;PXD000533;PRD000073;PRD000151;PRD000001;PXD001402;PRD000565;PRD000020;PXD000218;PXD000050;PRD000731;PRD000046;PRD000671;PXD001324;PRD000234;PXD000217;PRD000118;PXD000226;PRD000345;PRD000444;PXD000593;PRD000362;PRD000711;PXD001572;PXD001447;PRD000364;PRD000410;PRD000108;PRD000407	319		1261750				nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	A6NMY6	Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene)		0.43	43	PRD000269;PXD000948;PRD000053;PRD000345;PRD000417;PXD000743;PRD000123;PRD000668;PRD000059;PRD000416;PRD000410;PXD000387;PXD001328;PXD001572;PXD001422;PXD000529;PRD000796;PRD000073;PRD000146;PRD000046;PRD000597;PRD000594;PXD001323;PRD000565;PRD000020;PXD000218;PXD000746;PXD001324;PRD000151;PXD000680;PXD000226;PRD000444;PXD000314;PXD000593;PRD000711;PXD001447;PRD000671;PXD000164;PXD000533;PRD000118;PRD000108;PRD000407;PXD000426	267						extracellular exosome [GO:0070062]	
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	P04075	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)	ALDOA;AC093512.2	0.4	53	PXD000948;PXD000426;PRD000053;PRD000269;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000059;PRD000416;PXD000314;PXD000387;PXD001328;PXD000164;PXD001422;PXD000529;PRD000154;PRD000796;PRD000073;PRD000146;PXD000050;PRD000711;PRD000417;PRD000597;PRD000364;PRD000594;PXD001323;PRD000607;PXD000786;PXD000533;PRD000068;PRD000151;PRD000001;PXD000217;PXD001402;PRD000020;PXD000218;PRD000731;PRD000046;PXD001324;PRD000234;PRD000565;PRD000118;PRD000444;PRD000345;PRD000092;PRD000477;PRD000362;PXD001572;PRD000019;PXD001447;PRD000671	247		1264069			glycolytic process [GO:0006096]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];cadherin binding [GO:0045296]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	P07355	Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)	ANXA2	0.41	46	PRD000269;PXD000948;PXD000426;PRD000345;PRD000053;PRD000417;PXD000743;PRD000123;PRD000668;PRD000059;PRD000416;PRD000410;PXD000387;PXD001328;PXD001422;PXD000529;PRD000796;PRD000073;PRD000146;PXD000164;PRD000046;PRD000597;PRD000594;PXD001323;PRD000477;PXD000786;PRD000032;PRD000565;PXD000533;PRD000020;PXD000218;PXD000746;PXD001324;PRD000151;PXD000680;PXD000226;PRD000444;PXD000314;PXD000593;PRD000711;PXD001572;PXD001447;PRD000671;PRD000118;PRD000108;PRD000407	291						nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	Q06830	Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2)	PRDX1	0.4	50	PXD000426;PRD000345;PRD000053;PXD000948;PRD000565;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PRD000417;PRD000059;PRD000416;PRD000001;PXD000529;PRD000410;PXD000387;PXD000164;PRD000020;PRD000154;PXD001422;PRD000032;PRD000796;PRD000146;PXD000050;PRD000269;PRD000597;PRD000172;PRD000594;PXD001323;PRD000046;PRD000607;PXD000786;PRD000151;PXD001402;PXD000218;PRD000731;PXD000217;PXD000746;PRD000733;PXD001324;PRD000234;PRD000444;PRD000092;PRD000711;PXD001572;PXD001447;PXD000533;PRD000108;PRD000407	240						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];cadherin binding [GO:0045296]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.41	42	PXD000426;PRD000053;PRD000738;PRD000123;PRD000668;PRD000059;PXD000948;PXD000529;PXD000387;PRD000684;PXD000164;PXD001422;PRD000032;PRD000796;PRD000073;PRD000146;PRD000711;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000001;PRD000020;PXD000218;PXD000314;PRD000731;PRD000103;PXD000217;PRD000565;PRD000733;PXD001324;PRD000118;PRD000444;PRD000345;PXD000786;PXD001572;PRD000364;PXD000533;PXD000226;PRD000410;PRD000108	172						nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P00338	L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)	LDHA	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.45	43	PRD000053;PXD000948;PXD000426;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PRD000059;PRD000416;PXD000529;PRD000269;PXD000387;PRD000684;PXD001328;PXD000164;PXD001422;PRD000796;PRD000146;PXD001323;PRD000597;PRD000594;PRD000046;PRD000607;PXD000786;PXD000533;PRD000073;PRD000001;PXD000217;PRD000020;PXD000218;PRD000731;PXD000746;PXD001324;PRD000234;PXD000314;PRD000151;PRD000345;PRD000444;PRD000477;PRD000711;PXD001572;PRD000407	245		1266557			glycolytic process [GO:0006096]	membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q92841	Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72)	DDX17	Q08211	ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A)	DHX9	0.42	18	PXD000948;PXD000426;PXD000529;PXD000593;PRD000444;PRD000594;PRD000711;PXD000533;PRD000565;PRD000607;PXD000218;PRD000146;PXD000997;PXD001572;PXD001422;PRD000345;PXD000047;PRD000597	60		744548	3082;351		RNA processing [GO:0006396];RNA secondary structure unwinding [GO:0010501];alternative mRNA splicing, via spliceosome [GO:0000380];regulation of transcription by RNA polymerase II [GO:0006357];positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];membrane [GO:0016020];nucleus [GO:0005634]	ATP binding [GO:0005524];RNA binding [GO:0003723];RNA helicase activity [GO:0003724];transcription coactivator activity [GO:0003713];ATP-dependent RNA helicase activity [GO:0004004]
P27169	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	PON1	P08697	Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)	SERPINF2	0.42	13	PRD000172;PRD000073;PRD000362;PRD000158;PRD000631;PRD000185;PXD000383;PRD000551;PRD000059;PXD001403;PRD000053;PXD000164;PXD000743	73						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	protein homodimerization activity [GO:0042803]
P27169	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	PON1	P20742	Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6)	PZP	0.4	13	PRD000172;PRD000073;PRD000362;PRD000158;PRD000631;PRD000185;PXD000383;PRD000551;PRD000053;PRD000059;PXD001403;PRD000364;PXD000164	73						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P27169	Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1)	PON1	P05546	Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1)	SERPIND1	0.41	13	PRD000172;PRD000073;PXD000383;PRD000362;PRD000158;PRD000631;PRD000185;PRD000551;PRD000059;PXD001403;PRD000053;PXD000164;PXD000743	67						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	0.44	15	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PXD000164;PRD000416;PRD000711;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000158;PRD000019	125						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	0.42	16	PRD000073;PRD000059;PRD000185;PXD000383;PXD000164;PRD000416;PRD000711;PRD000172;PXD001403;PRD000417;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362;PRD000269	119						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	0.41	17	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PRD000711;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PRD000019;PRD000269	128						extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase activity [GO:0004252]
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.43	18	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000416;PRD000711;PRD000269;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000158;PRD000362	136				R-HSA-977606	regulation of complement activation [GO:0030449]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.51	15	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PRD000172;PXD001403;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362;PRD000417	135						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P06727	Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)	APOA4	0.4	14	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD000412;PXD001324;PRD000551;PRD000158;PRD000362	122						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.57	16	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000711;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000417;PRD000551;PRD000158;PRD000362	144						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	P00734	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	0.45	17	PRD000073;PRD000631;PRD000059;PXD000383;PRD000185;PRD000053;PXD000164;PRD000416;PRD000711;PXD001403;PRD000417;PXD000412;PRD000172;PRD000551;PRD000158;PRD000362;PRD000019	135				R-HSA-977606	regulation of complement activation [GO:0030449]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase activity [GO:0004252]
P00751	Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment]	CFB	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.43	15	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PXD000164;PRD000416;PRD000711;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362	139						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
O14950	Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)	MYL12B	P60660	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)	MYL6	0.43	38	PXD000948;PRD000032;PRD000020;PRD000053;PRD000668;PRD000738;PXD000529;PXD001310;PXD000387;PRD000684;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000407;PRD000711;PRD000535;PRD000477;PRD000594;PXD001323;PRD000680;PRD000001;PRD000565;PXD000164;PRD000731;PRD000671;PRD000733;PRD000444;PRD000269;PRD000600;PRD000416;PXD000218;PXD001447;PRD000364;PRD000118;PRD000108;PXD000964	138				R-HSA-5627123;R-HSA-5627117;R-HSA-5625900;R-HSA-5625740;R-HSA-445355;R-HSA-416572;R-HSA-3928663	muscle contraction [GO:0006936]	brush border [GO:0005903];cytosol [GO:0005829];extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]
O75608	Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1	Q9NR31	GTP-binding protein SAR1a (COPII-associated small GTPase)	SAR1A	0.41	12	PRD000053;PRD000154;PXD001323;PRD000668;PRD000565;PRD000733;PXD001324;PXD000164;PRD000796;PRD000738;PXD001422;PRD000020	48							
O75608	Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I)	LYPLA1	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.42	10	PRD000053;PXD000529;PRD000154;PXD001323;PRD000668;PRD000711;PRD000733;PXD001324;PRD000796;PXD001422	42						extracellular exosome [GO:0070062]	
P60660	Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6)	MYL6	P19105	Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)	MYL12A	0.43	38	PXD000948;PRD000032;PRD000020;PRD000053;PRD000565;PRD000668;PRD000738;PXD000529;PXD001310;PXD000387;PRD000684;PXD000426;PXD001572;PXD001422;PRD000796;PRD000146;PRD000407;PRD000711;PRD000535;PRD000477;PRD000594;PXD001323;PRD000680;PRD000001;PXD000164;PRD000731;PRD000671;PRD000733;PRD000444;PRD000269;PRD000600;PRD000416;PXD000218;PXD001447;PRD000364;PRD000118;PRD000108;PXD000964	138		922893	486	R-HSA-445355	muscle contraction [GO:0006936]	myosin complex [GO:0016459];cytosol [GO:0005829];extracellular exosome [GO:0070062]	calcium ion binding [GO:0005509]
P22079	Lactoperoxidase (LPO) (EC 1.11.1.7) (Salivary peroxidase) (SPO)	LPO	P01037	Cystatin-SN (Cystain-SA-I) (Cystatin-1) (Salivary cystatin-SA-1)	CST1	0.4	3	PRD000164;PRD000212;PRD000059	10					detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	extracellular space [GO:0005615]	
P61353	60S ribosomal protein L27 (Large ribosomal subunit protein eL27)	RPL27	P62910	60S ribosomal protein L32 (Large ribosomal subunit protein eL32)	RPL32	0.4	18	PRD000053;PXD001310;PXD000529;PRD000020;PXD000948;PRD000444;PRD000594;PXD001323;PRD000146;PXD000997;PXD000387;PXD001572;PXD001422;PRD000733;PXD000533;PRD000269;PRD000711;PXD000218	43		1269796	5380;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P61353	60S ribosomal protein L27 (Large ribosomal subunit protein eL27)	RPL27	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.41	21	PRD000053;PXD000948;PRD000020;PRD000444;PRD000594;PXD001323;PRD000269;PRD000680;PRD000565;PRD000733;PRD000146;PXD000997;PXD001572;PXD001422;PXD001310;PRD000796;PXD000593;PRD000407;PRD000711;PRD000597;PXD000218	64		1269595	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P26010	Integrin beta-7 (Gut homing receptor beta subunit)	ITGB7	P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	0.41	2	PRD000684;PXD000164	15						membrane [GO:0016020]	
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	0.55	16	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PXD001403;PXD001422;PRD000059;PRD000345;PXD000164;PRD000269;PXD001174	43				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0M8Q6	Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region)		0.4	19	PRD000417;PXD000743;PRD000073;PXD001403;PRD000631;PRD000671;PXD000383;PRD000416;PXD001324;PRD000269;PRD000212;PRD000059;PRD000185;PRD000364;PRD000019;PXD000164;PXD001422;PXD000047;PXD001174	58				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];regulation of complement activation [GO:0030449];complement activation, classical pathway [GO:0006958];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];receptor-mediated endocytosis [GO:0006898];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.58	16	PRD000417;PXD000743;PXD001174;PRD000416;PXD000746;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PXD001403;PXD000164;PXD001422;PXD000047;PRD000269;PRD000212	48				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.47	16	PRD000417;PXD000743;PRD000073;PXD001174;PRD000362;PRD000631;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PXD001403;PRD000364;PXD000164;PXD001422	51				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.52	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422;PRD000345	26					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.45	10	PRD000417;PRD000416;PXD000383;PRD000671;PRD000059;PRD000019;PXD001403;PXD001422;PXD000164;PXD000743	29				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.46	16	PRD000417;PXD000743;PRD000073;PRD000631;PRD000671;PXD000383;PRD000059;PRD000416;PRD000019;PXD001324;PRD000212;PXD001403;PXD000164;PXD001422;PRD000269;PXD001174	46				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.46	12	PRD000417;PXD000743;PRD000362;PRD000416;PRD000671;PXD000383;PRD000212;PXD001403;PXD000164;PRD000059;PRD000631;PXD001174	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.57	15	PRD000417;PRD000416;PRD000671;PRD000631;PXD000383;PXD000743;PRD000019;PXD001324;PRD000212;PXD001403;PXD001422;PRD000059;PXD000164;PRD000269;PXD001174	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.48	14	PRD000417;PXD000743;PXD001174;PRD000631;PRD000671;PXD000383;PRD000019;PXD001324;PRD000416;PRD000212;PXD001403;PRD000364;PXD000164;PXD001422	43					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04433	Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG)	IGKV3-11	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.55	14	PRD000417;PXD000743;PRD000631;PRD000671;PXD000383;PRD000059;PRD000416;PRD000212;PXD001403;PRD000185;PXD000164;PXD001422;PRD000269;PXD001174	36					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	0.42	3	PXD000164;PXD000383;PXD000743	15					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.4	3	PXD000383;PXD001403;PRD000212	15					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.4	3	PXD000383;PXD001403;PXD000743	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.42	2	PXD000383;PXD001403	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04430	Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN)	IGKV1-16	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.4	2	PXD000383;PXD000164	13					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P06681	Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]	C2	P05156	Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain]	CFI	0.4	10	PRD000073;PRD000059;PRD000185;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000551;PRD000158	90				R-HSA-977606	innate immune response [GO:0045087];regulation of complement activation [GO:0030449];complement activation, classical pathway [GO:0006958]	extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	metal ion binding [GO:0046872];serine-type endopeptidase activity [GO:0004252]
P06681	Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment]	C2	P05546	Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1)	SERPIND1	0.41	11	PRD000172;PRD000073;PRD000631;PRD000551;PRD000059;PRD000185;PRD000158;PRD000053;PXD001403;PXD000164;PXD000743	69						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
O95487	Protein transport protein Sec24B (SEC24-related protein B)	SEC24B	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.4	2	PRD000345;PXD000529	33							
O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Q9H857	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	NT5DC2	0.4	1	PRD000345	29							
O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.44	3	PRD000345;PXD000529;PXD001422	36							
O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.52	2	PRD000345;PXD000533	35							
O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Q96BW5	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) (hPHRP)	PTER	0.41	4	PRD000345;PXD000529;PXD001328;PXD001422	33							zinc ion binding [GO:0008270]
O95486	Protein transport protein Sec24A (SEC24-related protein A)	SEC24A	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.44	3	PRD000345;PXD000529;PRD000053	37						cytosol [GO:0005829]	
Q7Z794	Keratin, type II cytoskeletal 1b (Cytokeratin-1B) (CK-1B) (Keratin-77) (K77) (Type-II keratin Kb39)	KRT77	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.44	50	PRD000733;PRD000069;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PRD000345;PRD000373;PXD000387;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000417;PRD000146;PXD000164;PRD000711;PRD000172;PRD000416;PRD000407;PXD000593;PRD000594;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PXD000786;PRD000151;PXD000746;PXD001402;PRD000565;PRD000020;PRD000212;PXD001174;PXD000529;PXD001324;PRD000234;PRD000362;PRD000444;PRD000113;PXD000383;PRD000269;PRD000600;PRD000053;PXD000218;PXD001572;PXD001447	158	EBI-18739055;EBI-18739068	1039583		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.4	24	PRD000053;PXD000948;PRD000345;PXD001310;PXD000529;PRD000444;PRD000594;PXD001323;PRD000668;PRD000123;PRD000680;PRD000565;PXD000218;PRD000146;PXD000997;PXD000387;PRD000600;PXD000426;PXD001572;PXD000533;PXD001422;PXD000593;PRD000711;PRD000597	75		1271362;925310	3055;338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627]	mRNA 5'-UTR binding [GO:0048027];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.4	27	PRD000053;PRD000668;PXD000529;PXD001310;PXD000387;PXD001572;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000597;PXD000948;PRD000594;PXD001323;PRD000680;PXD000997;PRD000565;PRD000020;PXD000218;PRD000733;PRD000444;PXD000593;PRD000345;PXD000426;PXD000533;PXD000964	86		1269527;742843	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];nucleolus [GO:0005730]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.41	26	PRD000053;PXD000218;PXD000948;PXD001310;PRD000444;PRD000465;PXD001323;PRD000597;PRD000565;PXD000426;PXD000529;PRD000733;PRD000146;PXD000997;PXD000387;PXD001572;PRD000594;PXD001422;PRD000443;PRD000345;PXD000047;PRD000020;PXD000593;PRD000711;PXD000964;PRD000668	74			3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62081	40S ribosomal protein S7 (Small ribosomal subunit protein eS7)	RPS7	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.41	22	PRD000053;PXD001323;PRD000345;PXD001310;PXD000529;PRD000444;PRD000594;PRD000668;PRD000146;PRD000565;PXD000948;PXD000997;PXD000218;PRD000600;PRD000597;PXD001572;PRD000796;PXD000533;PXD000593;PXD001422;PRD000711;PXD000964	84		1271356;925028;743311	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];ribosomal small subunit biogenesis [GO:0042274];rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];focal adhesion [GO:0005925];membrane [GO:0016020];ribosome [GO:0005840];cytosolic small ribosomal subunit [GO:0022627]	protein kinase binding [GO:0019901];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134		932310	6737;551	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16777	Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q)	HIST2H2AC	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q5QNW6	Histone H2B type 2-F	HIST2H2BF	0.45	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	134		546886;479422;479421		R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q7L7L0	Histone H2A type 3	HIST3H2A	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q16778	Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q)	HIST2H2BE	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.46	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9NR46	Endophilin-B2 (SH3 domain-containing GRB2-like protein B2)	SH3GLB2	P61201	COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15)	COPS2	0.44	6	PXD000529;PXD001328;PRD000154;PXD001422;PXD001572;PRD000711	10						nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829]	
P84098	60S ribosomal protein L19 (Large ribosomal subunit protein eL19)	RPL19	P46779	60S ribosomal protein L28 (Large ribosomal subunit protein eL28)	RPL28	0.44	17	PXD001323;PXD001310;PRD000444;PRD000594;PRD000443;PRD000410;PRD000146;PXD000997;PRD000671;PXD001572;PXD000529;PXD000593;PXD000047;PRD000269;PRD000711;PRD000597;PXD001422	35		2268349;1269678	5380;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P61224	Ras-related protein Rap-1b (GTP-binding protein smg p21B)	RAP1B	Q92928	Putative Ras-related protein Rab-1C (hRab1c)		0.42	28	PRD000020;PRD000053;PRD000738;PRD000668;PXD000529;PXD001572;PRD000154;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000092;PRD000607;PXD000948;PRD000417;PXD001403;PRD000068;PRD000565;PRD000733;PXD001324;PRD000146;PRD000345;PRD000269;PXD000164;PRD000600;PRD000118;PRD000364	103							GTPase activity [GO:0003924];GTP binding [GO:0005525]
P08697	Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2)	SERPINF2	P05546	Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1)	SERPIND1	0.47	15	PRD000172;PRD000073;PXD000383;PRD000362;PRD000551;PRD000185;PRD000631;PRD000059;PRD000158;PRD000146;PRD000053;PXD001403;PXD000164;PXD000743;PRD000711	82						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	serine-type endopeptidase inhibitor activity [GO:0004867];endopeptidase inhibitor activity [GO:0004866]
P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	0.66	18	PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PRD000073;PXD000164;PXD001403;PRD000416;PRD000711;PRD000172;PRD000053;PXD000743;PRD000631;PXD001324;PRD000551;PRD000158;PRD000364	120					hyaluronan metabolic process [GO:0030212]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.43	17	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PXD000164;PXD001403;PRD000416;PRD000711;PXD000743;PRD000631;PRD000172;PXD001324;PRD000551;PRD000477;PRD000158	122						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.4	13	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PXD000164;PRD000416;PRD000172;PXD001403;PRD000631;PRD000551;PXD001324;PRD000158	113						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P19827	Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH1	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.62	16	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PXD000164;PXD001403;PRD000416;PRD000477;PRD000711;PXD000743;PRD000631;PRD000172;PRD000551;PRD000158	137					hyaluronan metabolic process [GO:0030212]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.42	17	PRD000059;PRD000417;PRD000185;PXD000383;PRD000269;PRD000073;PXD000164;PXD001403;PRD000416;PRD000711;PRD000172;PXD000743;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362	115						extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867]
P19823	Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP)	ITIH2	Q14624	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4	0.57	16	PRD000073;PRD000417;PRD000059;PXD000743;PRD000185;PXD000383;PRD000269;PXD000164;PRD000416;PRD000711;PRD000172;PXD001403;PRD000631;PRD000551;PRD000158;PRD000362	128					hyaluronan metabolic process [GO:0030212]	extracellular region [GO:0005576];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	serine-type endopeptidase inhibitor activity [GO:0004867];endopeptidase inhibitor activity [GO:0004866]
Q5QNW6	Histone H2B type 2-F	HIST2H2BF	P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PRD000053;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139					nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q5QNW6	Histone H2B type 2-F	HIST2H2BF	Q7L7L0	Histone H2A type 3	HIST3H2A	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q5QNW6	Histone H2B type 2-F	HIST2H2BF	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139						nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q5QNW6	Histone H2B type 2-F	HIST2H2BF	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q5QNW6	Histone H2B type 2-F	HIST2H2BF	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.43	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P11021	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	HSPA5	Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	0.4	57	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PXD001310;PXD000426;PXD000387;PXD001328;PXD000997;PXD000164;PXD001422;PRD000154;PRD000796;PRD000073;PRD000146;PXD000050;PXD000047;PRD000407;PRD000711;PRD000597;PRD000269;PRD000671;PRD000535;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000565;PRD000001;PXD000217;PXD000786;PXD000218;PXD000529;PRD000731;PXD001572;PXD001324;PRD000234;PXD000314;PRD000444;PRD000118;PRD000600;PXD001447;PRD000059;PRD000108	321						nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P11021	Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein)	HSPA5	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.4	59	PRD000733;PXD000948;PRD000032;PRD000345;PRD000020;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000443;PXD001310;PXD000426;PXD000387;PXD001328;PXD000997;PXD000164;PXD001422;PRD000154;PRD000796;PRD000073;PRD000146;PXD000050;PXD000047;PRD000711;PRD000597;PXD000593;PRD000535;PRD000407;PRD000671;PRD000594;PXD001323;PRD000046;PRD000607;PXD000533;PRD000068;PRD000168;PRD000364;PRD000151;PRD000565;PRD000001;PXD000217;PXD000786;PXD000218;PXD000529;PRD000731;PRD000444;PXD001572;PXD001324;PRD000234;PXD000314;PRD000118;PRD000269;PRD000600;PXD001447;PRD000059;PXD000226;PRD000108;PXD000964	330						nucleus [GO:0005634]	
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.42	7	PXD000383;PRD000671;PRD000019;PRD000345;PXD001403;PXD001422;PRD000212	18					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	0.41	16	PRD000417;PRD000345;PRD000671;PRD000631;PRD000551;PXD000383;PRD000019;PRD000416;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	41					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.57	18	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PRD000345;PXD001403;PRD000269;PXD001174	50				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.5	16	PRD000417;PRD000345;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	44				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0B4J1X5	Immunoglobulin heavy variable 3-74	IGHV3-74	0.4	13	PRD000019;PXD001324;PRD000671;PRD000631;PXD000383;PRD000551;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403	42					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0B4J1V1	Immunoglobulin heavy variable 3-21	IGHV3-21	0.4	13	PRD000019;PRD000551;PRD000671;PRD000631;PXD000383;PXD000743;PXD001324;PRD000212;PRD000053;PXD000164;PXD001422;PRD000059;PXD001403	44					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.48	12	PXD001324;PRD000671;PXD000383;PRD000059;PRD000551;PRD000019;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PXD000743	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.48	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000416;PXD001403;PXD000164;PXD001422;PRD000345;PRD000019	24					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.56	13	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PXD000743;PXD000164;PXD001422;PRD000059;PRD000345;PXD001403	37				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.57	18	PRD000417;PRD000345;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PRD000059;PXD001403;PRD000269;PXD001174	51				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.6	16	PRD000417;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PXD000743;PRD000053;PXD000164;PRD000631;PRD000345;PXD001403;PXD001447;PXD001174;PRD000019	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.56	6	PXD000383;PXD000164;PXD001422;PRD000416;PXD001403;PRD000345	18				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.4	8	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PXD001174	25					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.54	15	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000743;PRD000073;PXD000164;PXD001422;PXD001403;PXD001174	43					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01594	Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka)	IGKV1-33	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.51	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD001422;PXD001403;PXD001174;PRD000019	34					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P12109	Collagen alpha-1(VI) chain	COL6A1	P12110	Collagen alpha-2(VI) chain	COL6A2	0.5	15	PRD000597;PRD000600;PRD000416;PXD000746;PRD000269;PRD000417;PXD000743;PXD001323;PRD000680;PXD000529;PXD001324;PXD001447;PXD001328;PRD000796;PRD000053	67				R-HSA-8948216;R-HSA-419037;R-HSA-3000178;R-HSA-216083;R-HSA-2022090;R-HSA-186797;R-HSA-1650814;R-HSA-1442490	protein heterotrimerization [GO:0070208];extracellular matrix organization [GO:0030198];cell adhesion [GO:0007155]	endoplasmic reticulum lumen [GO:0005788];extracellular matrix [GO:0031012];extracellular exosome [GO:0070062];protein-containing complex [GO:0032991];sarcolemma [GO:0042383];extracellular region [GO:0005576];collagen-containing extracellular matrix [GO:0062023]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6R2	Immunoglobulin heavy variable 4-4	IGHV4-4	0.42	3	PXD000383;PXD001403;PXD001422	14							antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	0.4	2	PXD000383;PXD000743	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.44	3	PXD000383;PXD001403;PRD000212	14							antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	0.47	2	PXD000383;PXD001422	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	0.41	2	PXD000383;PXD001403	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.42	2	PXD000383;PRD000345	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6I0	Immunoglobulin lambda variable 8-61	IGLV8-61	0.47	2	PXD001403;PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.46	3	PXD000383;PXD001403;PXD000743	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	P01611	Immunoglobulin kappa variable 1D-12 (Ig kappa chain V-I region Wes)	IGKV1D-12	0.42	3	PXD000383;PXD001403;PRD000345	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.41	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.65	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A087WSZ0	Immunoglobulin kappa variable 1D-8	IGKV1D-8	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.51	3	PXD000383;PXD000743;PRD000345	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
O00483	Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit)	NDUFA4	Q9UHA4	Ragulator complex protein LAMTOR3 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3) (MEK-binding partner 1) (Mp1) (Mitogen-activated protein kinase kinase 1-interacting protein 1) (Mitogen-activated protein kinase scaffold protein 1)	LAMTOR3	0.43	5	PRD000053;PXD001323;PXD001422;PRD000597;PRD000711	21				R-HSA-5628897			
P52895	Aldo-keto reductase family 1 member C2 (EC 1.-.-.-) (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2) (DD-2) (DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein) (DD/BABP) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20) (Type III 3-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.357)	AKR1C2	P42330	Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)	AKR1C3	0.45	7	PXD001328;PRD000059;PRD000443;PRD000020;PXD001324;PXD000529;PRD000053	24		2219489;1184357		R-HSA-193807;R-HSA-193775;R-HSA-193368	positive regulation of protein kinase B signaling [GO:0051897];prostaglandin metabolic process [GO:0006693];daunorubicin metabolic process [GO:0044597];doxorubicin metabolic process [GO:0044598];steroid metabolic process [GO:0008202];oxidation-reduction process [GO:0055114];G-protein coupled receptor signaling pathway [GO:0007186];cellular response to prostaglandin D stimulus [GO:0071799];positive regulation of cell proliferation [GO:0008284];progesterone metabolic process [GO:0042448];cellular response to jasmonic acid stimulus [GO:0071395]	cytoplasm [GO:0005737]	alditol:NADP+ 1-oxidoreductase activity [GO:0004032];oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655];trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115];ketosteroid monooxygenase activity [GO:0047086];phenanthrene 9,10-monooxygenase activity [GO:0018636]
P37802	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2	P23284	Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP)	PPIB	0.43	38	PRD000053;PRD000738;PRD000668;PRD000417;PXD000948;PXD000529;PRD000416;PXD000387;PRD000269;PRD000733;PXD001328;PXD000164;PXD001422;PRD000032;PRD000796;PRD000146;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000607;PXD000786;PXD000426;PRD000068;PRD000001;PRD000020;PRD000407;PXD000218;PRD000731;PXD001324;PRD000345;PRD000535;PXD000533;PRD000410;PXD000743;PXD001572	161						extracellular exosome [GO:0070062]	
P37802	Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog)	TAGLN2	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.44	43	PRD000032;PRD000053;PRD000738;PRD000123;PRD000668;PRD000059;PXD000948;PXD000529;PXD000383;PXD000387;PXD000164;PXD001422;PRD000796;PRD000146;PXD001323;PRD000711;PRD000597;PRD000594;PRD000046;PRD000269;PRD000073;PRD000607;PXD000426;PRD000631;PRD000001;PXD000217;PXD000218;PRD000731;PRD000417;PRD000565;PRD000733;PXD001324;PRD000020;PRD000345;PRD000185;PRD000416;PRD000118;PXD001572;PRD000535;PRD000364;PXD000533;PRD000410;PXD000786	172				R-HSA-114608		cytosol [GO:0005829];extracellular exosome [GO:0070062]	cadherin binding [GO:0045296]
P02452	Collagen alpha-1(I) chain (Alpha-1 type I collagen)	COL1A1	P08123	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	0.57	18	PRD000172;PXD001323;PRD000345;PXD000746;PRD000269;PXD000743;PRD000600;PRD000059;PRD000417;PRD000680;PRD000073;PXD000387;PXD001447;PXD001328;PXD000047;PRD000416;PXD000412;PRD000053	58		589776;860063		R-HSA-8948216;R-HSA-8874081;R-HSA-76009;R-HSA-75892;R-HSA-430116;R-HSA-3000480;R-HSA-3000178;R-HSA-3000171;R-HSA-3000170;R-HSA-2243919;R-HSA-2214320;R-HSA-216083;R-HSA-202733;R-HSA-2022090;R-HSA-198933;R-HSA-1650814;R-HSA-1474244;R-HSA-1442490;R-HSA-114604	regulation of immune response [GO:0050776];extracellular matrix organization [GO:0030198];blood vessel development [GO:0001568];skeletal system development [GO:0001501];cellular response to amino acid stimulus [GO:0071230];skin morphogenesis [GO:0043589];platelet activation [GO:0030168];protein heterotrimerization [GO:0070208];blood coagulation [GO:0007596];collagen fibril organization [GO:0030199];leukocyte migration [GO:0050900]	endoplasmic reticulum lumen [GO:0005788];extracellular matrix [GO:0031012];collagen-containing extracellular matrix [GO:0062023];extracellular space [GO:0005615];extracellular region [GO:0005576];collagen type I trimer [GO:0005584]	metal ion binding [GO:0046872];identical protein binding [GO:0042802];platelet-derived growth factor binding [GO:0048407];extracellular matrix structural constituent conferring tensile strength [GO:0030020];protease binding [GO:0002020]
A0M8Q6	Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region)		A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.45	23	PRD000417;PRD000631;PRD000113;PRD000073;PRD000551;PRD000212;PXD000743;PRD000416;PRD000671;PXD000383;PRD000059;PXD000047;PXD001324;PRD000269;PRD000053;PXD000746;PRD000185;PRD000019;PXD001403;PXD000164;PXD001422;PXD000412;PXD001174	70				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];regulation of complement activation [GO:0030449];complement activation, classical pathway [GO:0006958];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];receptor-mediated endocytosis [GO:0006898];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P61201	COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15)	COPS2	P54725	UV excision repair protein RAD23 homolog A (HR23A) (hHR23A)	RAD23A	0.41	7	PXD001328;PXD000426;PXD001422;PRD000154;PRD000711;PXD001323;PXD000533	13				R-HSA-5696394		nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829]	
Q12851	Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein)	MAP4K2	Q7Z3U7	Protein MON2 homolog (Protein SF21)	MON2	0.42	2	PRD000032;PRD000168	11							
Q08495	Dematin (Dematin actin-binding protein) (Erythrocyte membrane protein band 4.9)	DMTN	P28289	Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod)	TMOD1	0.41	3	PRD000020;PRD000092;PRD000154	10						cytosol [GO:0005829];actin filament [GO:0005884];cortical cytoskeleton [GO:0030863]	actin binding [GO:0003779]
P42766	60S ribosomal protein L35 (Large ribosomal subunit protein uL29)	RPL35	Q9Y3U8	60S ribosomal protein L36 (Large ribosomal subunit protein eL36)	RPL36	0.43	19	PRD000053;PXD001310;PXD000217;PXD001323;PRD000443;PRD000269;PRD000565;PXD000948;PRD000733;PRD000146;PXD000997;PXD000387;PXD001572;PRD000796;PXD000593;PXD001422;PRD000711;PRD000597;PXD000218	36		1269843;743156	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];nucleolus [GO:0005730];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P42766	60S ribosomal protein L35 (Large ribosomal subunit protein uL29)	RPL35	P62847	40S ribosomal protein S24 (Small ribosomal subunit protein eS24)	RPS24	0.4	20	PRD000053;PXD001310;PXD000217;PXD001323;PRD000443;PRD000565;PXD000948;PXD000426;PRD000146;PXD000997;PXD000387;PXD001572;PXD000593;PXD001422;PXD000047;PRD000020;PRD000711;PRD000597;PRD000733;PXD000218	44		743250	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P06733	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein)	ENO1	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.42	49	PXD000426;PXD000948;PRD000053;PRD000059;PRD000417;PXD000743;PRD000738;PRD000123;PRD000668;PRD000416;PRD000001;PXD000529;PRD000269;PXD000387;PRD000684;PXD001328;PXD000047;PXD001422;PRD000796;PRD000465;PRD000146;PXD000164;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000068;PRD000212;PXD000786;PXD000533;PRD000073;PRD000151;PXD000217;PRD000020;PXD000218;PRD000731;PXD000746;PXD001324;PRD000234;PXD000314;PRD000444;PRD000345;PRD000113;PXD001572;PRD000118;PRD000523;PRD000711;PRD000407	290		1261758;746127		R-HSA-70263;R-HSA-70171	canonical glycolysis [GO:0061621];gluconeogenesis [GO:0006094]	membrane [GO:0016020];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P04233	HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74)	CD74	P04440	HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)	HLA-DPB1	0.42	4	PRD000053;PRD000607;PXD001422;PXD000314	11		1176543		R-HSA-2132295	antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]	trans-Golgi network membrane [GO:0032588];Golgi membrane [GO:0000139];MHC class II protein complex [GO:0042613];transport vesicle membrane [GO:0030658];membrane [GO:0016020];endocytic vesicle membrane [GO:0030666];cell surface [GO:0009986];lysosomal membrane [GO:0005765];ER to Golgi transport vesicle membrane [GO:0012507];integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556];plasma membrane [GO:0005886];clathrin-coated endocytic vesicle membrane [GO:0030669]	
Q92928	Putative Ras-related protein Rab-1C (hRab1c)		P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	0.42	22	PRD000269;PRD000053;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PXD000426;PXD000529;PXD000948;PXD000218;PXD001572;PRD000594;PXD000164;PRD000118;PXD001422;PRD000068;PRD000733;PRD000020	84							GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q92928	Putative Ras-related protein Rab-1C (hRab1c)		P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.49	23	PRD000020;PRD000053;PRD000668;PRD000443;PXD000529;PXD001572;PRD000154;PRD000711;PRD000092;PXD001323;PRD000607;PXD000948;PRD000565;PRD000733;PXD001324;PRD000146;PXD000164;PRD000594;PRD000600;PRD000738;PXD001422;PRD000407;PRD000269	92					protein transport [GO:0015031]		GTPase activity [GO:0003924];GTP binding [GO:0005525]
Q92928	Putative Ras-related protein Rab-1C (hRab1c)		P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.42	24	PRD000053;PRD000668;PRD000738;PXD000529;PRD000154;PRD000118;PRD000796;PXD000164;PRD000711;PRD000092;PXD001323;PRD000607;PRD000020;PRD000068;PRD000565;PRD000733;PXD000948;PXD000218;PRD000597;PRD000269;PRD000594;PXD001572;PRD000364;PXD001422	89						endoplasmic reticulum membrane [GO:0005789]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
A0A075B6R2	Immunoglobulin heavy variable 4-4	IGHV4-4	P01772	Immunoglobulin heavy variable 3-33 (Ig heavy chain V-III region HIL) (Ig heavy chain V-III region KOL)	IGHV3-33	0.4	6	PXD000383;PRD000417;PRD000416;PXD001403;PRD000146;PXD001422	20					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A075B6R2	Immunoglobulin heavy variable 4-4	IGHV4-4	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.44	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
P43652	Afamin (Alpha-albumin) (Alpha-Alb)	AFM	P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	0.41	13	PRD000631;PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PXD001174;PRD000172;PRD000551;PRD000158;PRD000362	102						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P43652	Afamin (Alpha-albumin) (Alpha-Alb)	AFM	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.44	14	PRD000073;PRD000059;PRD000185;PXD001174;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD000765;PRD000551;PRD000158;PRD000362	117						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P43652	Afamin (Alpha-albumin) (Alpha-Alb)	AFM	Q96PD5	N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L)	PGLYRP2	0.4	13	PXD000383;PRD000073;PRD000059;PXD001174;PRD000185;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000551;PRD000158;PRD000019	91						extracellular region [GO:0005576];extracellular exosome [GO:0070062]	
P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	0.45	2	PXD000383;PRD000073	12							
P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.44	1	PXD000383	11							
P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.45	3	PXD000383;PRD000172;PRD000631	15						extracellular region [GO:0005576]	
P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.5	1	PXD000383	11						extracellular space [GO:0005615]	
P01344	Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin]	IGF2	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.41	2	PXD000383;PRD000019	12						extracellular space [GO:0005615]	
P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	0.45	20	PRD000053;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PXD000948;PRD000607;PRD000565;PXD000529;PXD001328;PXD001572;PRD000594;PXD000164;PXD000533;PRD000738;PXD001422;PRD000001;PXD001447;PRD000269	72						plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	0.41	15	PRD000053;PXD000529;PRD000154;PRD000594;PXD001323;PRD000668;PRD000738;PRD000711;PXD000948;PXD001422;PXD000164;PXD000533;PRD000733;PRD000020;PXD001572	71						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.41	16	PRD000154;PRD000269;PRD000053;PXD000948;PRD000594;PXD001323;PRD000668;PRD000711;PRD000607;PXD000529;PXD000218;PXD001572;PXD000164;PXD000533;PRD000738;PXD001422	74						nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.43	21	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PRD000733;PXD000948;PXD001328;PXD001572;PXD001422;PXD000164;PXD000533;PRD000118;PRD000068;PXD001447;PRD000269	80				R-HSA-416482;R-HSA-194840	regulation of small GTPase mediated signal transduction [GO:0051056];small GTPase mediated signal transduction [GO:0007264];G-protein coupled receptor signaling pathway [GO:0007186]	plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P08134	Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9)	RHOC	P61026	Ras-related protein Rab-10	RAB10	0.4	21	PRD000269;PRD000053;PRD000711;PRD000154;PXD000529;PRD000092;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PXD000948;PXD001328;PXD001572;PRD000594;PXD001422;PXD000164;PXD000533;PRD000068;PRD000733;PRD000020	80						plasma membrane [GO:0005886];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P54819	Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]	AK2	Q99714	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)	HSD17B10	0.41	20	PRD000053;PRD000738;PRD000345;PXD000426;PRD000444;PRD000594;PRD000668;PXD001323;PRD000711;PXD000948;PXD000529;PXD001324;PXD000218;PXD000164;PXD000533;PXD001422;PRD000565;PXD000387;PRD000146;PXD001572	75							
A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	A0A0C4DH29	Immunoglobulin heavy variable 1-3	IGHV1-3	0.52	5	PXD000383;PXD001403;PRD000416;PRD000269;PRD000146	16					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	P01743	Immunoglobulin heavy variable 1-46 (Ig heavy chain V-I region DOT) (Ig heavy chain V-I region HG3) (Ig heavy chain V-I region Mot)	IGHV1-46	0.42	5	PXD000383;PXD001403;PRD000416;PRD000269;PRD000146	16					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH31	Immunoglobulin heavy variable 1-18	IGHV1-18	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.41	13	PRD000671;PRD000416;PXD000746;PRD000417;PRD000059;PXD000383;PRD000269;PRD000146;PRD000212;PXD001403;PXD001422;PRD000019;PXD000743	35					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	0.52	3	PXD000383;PXD001403;PRD000212	14					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.4	4	PRD000671;PXD000383;PXD001403;PRD000073	14							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.54	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.54	5	PXD000383;PXD001403;PRD000019;PXD001422;PRD000185	16							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.48	5	PRD000671;PXD000383;PXD001403;PXD001422;PRD000185	16					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.44	5	PRD000671;PXD000383;PXD000164;PXD001403;PRD000212	16					complement activation, classical pathway [GO:0006958]	blood microparticle [GO:0072562]	antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.44	6	PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PRD000212	17					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.4	4	PXD000383;PXD001403;PXD001422;PRD000212	15							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.49	4	PRD000671;PXD000383;PXD001403;PXD001422	15							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.45	6	PRD000671;PXD000383;PXD000164;PXD001403;PXD001422;PRD000059	17							antigen binding [GO:0003823]
A0A0C4DH38	Immunoglobulin heavy variable 5-51	IGHV5-51	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.51	7	PRD000671;PXD000383;PXD000164;PXD001403;PXD001422;PRD000212;PRD000073	19							antigen binding [GO:0003823]
Q01082	Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)	SPTBN1	Q13813	Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)	SPTAN1	0.41	31	PXD000948;PXD000426;PRD000020;PRD000053;PXD000743;PRD000092;PXD000529;PRD000345;PRD000032;PXD001572;PXD001422;PRD000118;PRD000417;PRD000146;PXD000050;PRD000477;PRD000594;PRD000269;PXD000533;PRD000416;PXD000164;PXD000218;PXD001324;PXD000314;PRD000444;PRD000597;PRD000523;PXD000997;PRD000733;PXD001447;PXD000964	126	EBI-1200167;EBI-1180210;EBI-1180193;EBI-1180176;EBI-1180159;EBI-1180142;EBI-1179954;EBI-1179933	2298117;1272516;817560;741390		R-HSA-6807878;R-HSA-5673001;R-HSA-445095;R-HSA-375165;R-HSA-373753	actin filament capping [GO:0051693];MAPK cascade [GO:0000165];axon guidance [GO:0007411];ER to Golgi vesicle-mediated transport [GO:0006888]	spectrin [GO:0008091];cytosol [GO:0005829];extracellular exosome [GO:0070062]	calmodulin binding [GO:0005516];actin binding [GO:0003779];Ras guanyl-nucleotide exchange factor activity [GO:0005088];cadherin binding [GO:0045296];structural constituent of cytoskeleton [GO:0005200]
P26373	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13	Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	0.42	28	PRD000053;PXD001323;PRD000020;PRD000733;PRD000444;PRD000594;PRD000123;PRD000443;PXD000948;PRD000565;PRD000607;PRD000680;PXD001310;PRD000597;PRD000146;PXD000997;PRD000410;PXD000529;PXD000217;PXD001572;PXD000593;PXD000047;PRD000345;PRD000407;PRD000711;PXD000426;PRD000668;PXD001422	84		1269189;924712;741923	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];endoplasmic reticulum [GO:0005783];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P26373	60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13)	RPL13	P62753	40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)	RPS6	0.52	27	PRD000053;PRD000565;PRD000443;PXD001328;PRD000733;PRD000444;PXD000593;PRD000594;PRD000123;PXD001323;PXD000948;PXD000217;PRD000607;PXD001310;PRD000146;PXD000997;PXD000529;PRD000597;PXD001572;PXD000533;PRD000345;PRD000668;PXD000047;PRD000711;PXD000964;PXD000218;PXD001422	78	EBI-16798663	1271254;742491	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];endoplasmic reticulum [GO:0005783];nucleolus [GO:0005730];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	P04004	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	0.4	23	PRD000073;PRD000269;PRD000059;PXD000383;PRD000738;PRD000417;PRD000185;PRD000053;PXD001422;PXD000164;PXD001403;PRD000416;PRD000172;PRD000711;PRD000212;PXD000743;PRD000631;PRD000551;PRD000158;PRD000032;PRD000362;PRD000364;PRD000068	132						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.43	18	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PXD001403;PRD000416;PRD000711;PRD000212;PRD000417;PRD000631;PRD000172;PRD000551;PRD000158;PRD000032;PRD000362;PRD000019	124						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P00747	Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]	PLG	P00734	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	0.46	18	PRD000073;PXD000383;PRD000417;PRD000059;PRD000185;PRD000053;PXD000164;PRD000416;PRD000711;PXD001403;PRD000631;PRD000551;PRD000158;PRD000172;PRD000362;PRD000364;PXD000743;PRD000019	119				R-HSA-381426	cellular protein metabolic process [GO:0044267];blood coagulation [GO:0007596];proteolysis [GO:0006508];fibrinolysis [GO:0042730];negative regulation of fibrinolysis [GO:0051918]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	signaling receptor binding [GO:0005102];serine-type endopeptidase activity [GO:0004252]
P0CG38	POTE ankyrin domain family member I	POTEI	Q9BYX7	Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K)		0.45	65	PXD000743;PRD000053;PRD000738;PRD000123;PXD000746;PRD000443;PRD000059;PRD000092;PXD000529;PXD001310;PXD000383;PRD000684;PRD000269;PXD000387;PXD001328;PXD000997;PXD000164;PXD001422;PRD000154;PRD000796;PRD000668;PRD000465;PRD000146;PXD000948;PXD000047;PRD000711;PRD000597;PRD000417;PRD000172;PXD000593;PRD000600;PRD000594;PRD000416;PRD000607;PRD000680;PXD000426;PRD000068;PRD000168;PRD000364;PRD000151;PRD000001;PXD000217;PRD000565;PRD000020;PXD001572;PXD000314;PRD000532;PRD000731;PRD000103;PXD001324;PRD000234;PXD000226;PRD000444;PRD000345;PRD000113;PXD001323;PRD000032;PXD000786;PRD000535;PXD000218;PRD000362;PRD000118;PXD001447;PRD000671;PXD000964	244						extracellular exosome [GO:0070062]	
Q71UI9	Histone H2A.V (H2A.F/Z)	H2AFV	Q96A08	Histone H2B type 1-A (Histone H2B, testis) (TSH2B.1) (hTSH2B) (Testis-specific histone H2B)	HIST1H2BA	0.47	31	PRD000733;PXD000786;PRD000565;PRD000345;PXD000529;PRD000684;PXD000218;PRD000796;PRD000020;PRD000444;PXD000743;PRD000594;PRD000123;PXD000746;PRD000680;PXD001572;PXD001324;PRD000269;PRD000234;PXD000997;PXD000387;PXD000314;PRD000600;PXD000047;PXD001422;PRD000118;PXD001403;PXD000164;PRD000407;PRD000711;PRD000597	85				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	P61006	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A	0.42	22	PRD000020;PRD000053;PRD000600;PRD000711;PRD000154;PRD000092;PRD000668;PRD000443;PRD000607;PRD000565;PXD000948;PXD001324;PRD000146;PXD001323;PXD000529;PXD001572;PXD000164;PXD001422;PRD000738;PRD000407;PRD000269;PRD000733	83		1268599		R-HSA-8876198;R-HSA-8873719;R-HSA-8854214		plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	P61026	Ras-related protein Rab-10	RAB10	0.42	26	PRD000020;PRD000053;PRD000668;PRD000443;PXD000529;PXD001328;PXD001572;PRD000154;PRD000711;PRD000092;PXD001323;PRD000607;PXD000948;PRD000565;PRD000733;PXD001324;PRD000146;PXD000164;PRD000600;PRD000594;PXD000533;PRD000738;PXD001422;PRD000345;PRD000407;PRD000269	89		1268560		R-HSA-8876198;R-HSA-8873719;R-HSA-6798695	neutrophil degranulation [GO:0043312]	endosome [GO:0005768];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	P61106	Ras-related protein Rab-14	RAB14	0.43	23	PRD000020;PRD000053;PRD000711;PRD000154;PRD000092;PRD000668;PRD000443;PRD000607;PRD000407;PXD000529;PRD000600;PXD001324;PRD000146;PXD001323;PXD000426;PXD001572;PXD000164;PRD000738;PXD001422;PRD000001;PXD000948;PRD000269;PRD000733	70				R-HSA-8876198;R-HSA-8873719;R-HSA-6798695	regulation of endocytosis [GO:0030100];protein transport [GO:0015031];neutrophil degranulation [GO:0043312]	early endosome membrane [GO:0031901];early endosome [GO:0005769];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];lysosomal membrane [GO:0005765]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P51148	Ras-related protein Rab-5C (L1880) (RAB5L)	RAB5C	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.42	20	PRD000053;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PXD000948;PRD000607;PRD000565;PXD000529;PRD000733;PXD001328;PXD001572;PRD000594;PRD000001;PXD000164;PXD001422;PXD000533;PRD000738;PXD001447	74				R-HSA-6798695	neutrophil degranulation [GO:0043312]	endosome [GO:0005768];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P50225	Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST)	SULT1A1	P0DMN0	Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4)	SULT1A4	0.48	5	PRD000443;PRD000053;PXD001324;PXD001422;PXD000533	15				R-HSA-156584	3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427];catecholamine metabolic process [GO:0006584]	cytosol [GO:0005829]	aryl sulfotransferase activity [GO:0004062]
P61254	60S ribosomal protein L26 (Large ribosomal subunit protein uL24)	RPL26	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.4	19	PXD000948;PXD001310;PRD000053;PRD000020;PRD000444;PXD001323;PRD000123;PRD000565;PRD000733;PRD000146;PXD000997;PXD001572;PRD000796;PXD000593;PXD001422;PRD000269;PRD000711;PRD000597;PXD000218	45		1269559	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	extracellular exosome [GO:0070062];membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P05155	Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1)	SERPING1	P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	0.5	16	PRD000073;PRD000059;PRD000417;PRD000185;PXD000383;PRD000053;PXD000164;PRD000416;PRD000172;PXD001403;PRD000631;PXD001174;PXD001324;PRD000551;PRD000158;PRD000362	122				R-HSA-114608	platelet degranulation [GO:0002576]	platelet alpha granule lumen [GO:0031093];extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	P01615	Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)	IGKV2D-28	0.43	2	PXD000164;PXD000383	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.5	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1Z2	Immunoglobulin kappa variable 1D-43	IGKV1D-43	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.49	3	PXD000164;PXD000383;PRD000345	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	0.43	54	PRD000073;PRD000154;PRD000733;PRD000345;PRD000069;PXD000743;PRD000092;PXD000746;PRD000443;PRD000373;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PXD000593;PRD000796;PRD000362;PXD000047;PRD000671;PRD000172;PRD000407;PRD000594;PRD000059;PXD001174;PXD001323;PRD000607;PRD000212;PXD001403;PRD000164;PRD000417;PXD000412;PRD000151;PRD000364;PXD001402;PXD000164;PRD000020;PRD000234;PRD000551;PRD000600;PRD000416;PRD000565;PRD000680;PXD001324;PRD000146;PXD000226;PRD000444;PRD000113;PXD000383;PRD000597;PRD000053;PXD000218;PXD001447;PRD000269	201		1264008		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];cytoplasm [GO:0005737];membrane [GO:0016020];intermediate filament [GO:0005882];nucleus [GO:0005634];extracellular exosome [GO:0070062]	
P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	P02538	Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)	KRT6A	0.45	57	PRD000073;PRD000154;PRD000092;PRD000733;PXD000743;PRD000345;PRD000069;PXD000746;PRD000443;PRD000059;PRD000373;PXD000383;PXD000387;PXD001328;PXD000997;PXD001572;PXD001422;PXD000593;PRD000796;PXD000047;PRD000671;PRD000172;PRD000407;PRD000594;PXD001174;PRD000607;PRD000212;PXD001403;PRD000164;PRD000417;PXD000412;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000948;PRD000551;PRD000600;PRD000416;PXD001323;PXD001324;PRD000146;PRD000234;PXD000226;PRD000362;PRD000444;PRD000113;PRD000597;PRD000053;PXD000218;PXD001447;PRD000364;PRD000680;PRD000019;PXD000964;PRD000269	239				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];membrane [GO:0016020];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	P04264	Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)	KRT1	0.64	58	PRD000733;PRD000345;PRD000154;PRD000092;PRD000073;PXD000743;PRD000020;PRD000069;PRD000565;PXD000746;PRD000443;PRD000059;PRD000373;PRD000269;PRD000417;PXD000383;PRD000416;PXD000387;PXD000593;PXD001328;PXD000997;PXD001572;PXD001422;PRD000146;PXD000047;PXD001323;PRD000671;PRD000172;PRD000407;PRD000594;PRD000607;PRD000212;PXD000786;PXD001403;PRD000164;PXD000412;PRD000151;PRD000364;PXD001402;PXD000164;PXD000948;PXD001174;PRD000234;PXD000529;PRD000551;PRD000600;PXD001324;PXD000226;PRD000362;PRD000444;PRD000113;PRD000597;PRD000053;PXD000218;PXD001447;PRD000680;PRD000019;PXD000964	329		1264006;746303		R-HSA-6809371;R-HSA-6805567	protein heterotetramerization [GO:0051290];cornification [GO:0070268];peptide cross-linking [GO:0018149];keratinization [GO:0031424]	cytosol [GO:0005829];cornified envelope [GO:0001533];extracellular space [GO:0005615];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];structural constituent of epidermis [GO:0030280]
P13645	Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)	KRT10	P35908	Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)	KRT2	0.68	59	PRD000733;PRD000345;PRD000154;PRD000092;PRD000073;PXD000743;PRD000020;PRD000069;PXD000746;PRD000059;PRD000443;PRD000373;PRD000269;PRD000417;PXD000383;PXD000529;PRD000416;PXD000387;PXD000593;PXD001328;PXD000997;PXD001572;PXD001422;PRD000146;PXD000047;PXD001323;PRD000671;PRD000172;PRD000407;PRD000594;PRD000607;PRD000680;PRD000212;PXD001403;PRD000164;PXD000412;PRD000151;PRD000364;PXD001402;PXD000164;PXD000948;PXD001174;PRD000551;PRD000600;PRD000796;PRD000565;PXD001324;PRD000234;PXD000226;PRD000362;PRD000444;PRD000113;PRD000597;PRD000053;PXD000218;PRD000711;PXD001447;PRD000019;PXD000964	312		1264007;750413		R-HSA-6809371;R-HSA-6805567	positive regulation of epidermis development [GO:0045684];cornification [GO:0070268];peptide cross-linking [GO:0018149];keratinization [GO:0031424]	cytosol [GO:0005829];cornified envelope [GO:0001533];extracellular space [GO:0005615];membrane [GO:0016020];intermediate filament [GO:0005882];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of epidermis [GO:0030280]
P13646	Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)	KRT13	Q5XKE5	Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)	KRT79	0.44	46	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PRD000345;PRD000373;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000164;PXD000164;PRD000711;PXD000593;PRD000172;PXD000746;PRD000594;PRD000059;PRD000607;PRD000212;PXD001323;PRD000151;PXD001403;PXD001402;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PXD000997;PRD000444;PRD000113;PRD000443;PRD000053;PRD000073;PXD001572;PXD001447;PRD000671;PRD000407;PXD000964;PRD000269	148		1039512		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
P13646	Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)	KRT13	O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	0.46	48	PRD000345;PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000597;PXD000529;PRD000373;PXD001328;PXD000164;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PXD000593;PRD000172;PXD000746;PRD000594;PRD000059;PRD000607;PRD000212;PXD001323;PRD000151;PXD001403;PXD001402;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PXD000997;PRD000444;PRD000113;PRD000443;PXD000383;PRD000053;PRD000073;PXD001572;PXD001447;PRD000671;PRD000407;PXD000964;PRD000269	154	EBI-19439278;EBI-19439291			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural molecule activity [GO:0005198]
P13646	Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)	KRT13	P19013	Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)	KRT4	0.51	47	PRD000069;PXD000743;PRD000123;PRD000092;PRD000597;PRD000345;PXD000529;PRD000373;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000164;PXD000164;PRD000711;PXD000593;PRD000172;PXD000746;PRD000594;PRD000059;PRD000607;PRD000212;PXD001323;PRD000151;PXD001403;PXD001402;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000733;PRD000234;PRD000146;PXD000997;PRD000444;PRD000113;PRD000443;PXD000383;PRD000053;PRD000362;PXD001572;PXD001447;PRD000671;PRD000407;PXD000964	145	EBI-8839050;EBI-19439062;EBI-19439075	1039449		R-HSA-6809371;R-HSA-6805567	cytoskeleton organization [GO:0007010];cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];intermediate filament cytoskeleton [GO:0045111];keratin filament [GO:0045095];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	P02538	Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)	KRT6A	0.53	38	PRD000073;PRD000164;PRD000069;PRD000733;PXD000743;PXD000746;PXD001328;PXD001572;PXD001422;PRD000345;PXD000164;PXD001403;PRD000092;PRD000364;PRD000416;PRD000407;PXD000593;PXD001174;PXD001323;PRD000059;PRD000607;PRD000212;PRD000417;PRD000151;PXD001402;PRD000172;PRD000146;PXD001324;PRD000234;PXD000997;PRD000444;PRD000113;PXD000383;PRD000671;PRD000362;PXD001447;PRD000594;PRD000443	135				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];membrane [GO:0016020];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
P13647	Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)	KRT5	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.62	55	PRD000073;PRD000733;PXD000746;PRD000069;PXD000743;PRD000123;PRD000443;PRD000597;PXD000226;PRD000345;PXD000529;PXD000593;PRD000373;PXD000387;PXD001328;PRD000092;PRD000154;PXD001422;PRD000796;PXD000047;PRD000711;PRD000364;PRD000172;PRD000416;PRD000407;PRD000164;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001403;PXD001402;PRD000565;PXD000164;PRD000020;PXD001174;PXD001324;PRD000600;PRD000551;PRD000053;PRD000234;PRD000146;PRD000362;PRD000444;PRD000113;PXD000383;PRD000671;PXD000218;PXD001572;PXD001447	189	EBI-20567507;EBI-15988065;EBI-15988023;EBI-15988044;EBI-15988006;EBI-15987967;EBI-15987926;EBI-15987943;EBI-9074632	744358		R-HSA-6809371;R-HSA-6805567;R-HSA-446107	hemidesmosome assembly [GO:0031581];cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	cytosol [GO:0005829];cytoplasm [GO:0005737];keratin filament [GO:0045095];intermediate filament [GO:0005882];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
Q86TU7	Histone-lysine N-methyltransferase setd3 (EC 2.1.1.43) (SET domain-containing protein 3)	SETD3	Q8TEM1	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	NUP210	0.45	3	PXD001572;PRD000069;PXD000529	10							
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	0.41	21	PRD000053;PXD000948;PXD001310;PRD000796;PRD000444;PRD000594;PXD001323;PRD000668;PRD000443;PRD000733;PRD000146;PXD000997;PXD000529;PXD001572;PXD000593;PRD000565;PXD000047;PRD000269;PRD000020;PRD000711;PXD001422	64		2266308;1269421;741925	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	polysomal ribosome [GO:0042788];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	P62753	40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6)	RPS6	0.42	28	PRD000053;PRD000565;PXD001310;PRD000733;PRD000796;PRD000444;PRD000671;PRD000594;PRD000123;PRD000443;PXD000217;PRD000269;PXD000426;PRD000607;PXD000948;PRD000146;PXD000997;PXD000529;PXD001572;PXD001422;PXD000593;PRD000668;PXD000047;PXD001323;PRD000345;PRD000711;PRD000597;PXD000218	76	EBI-16798663	1271258;742495	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];endoplasmic reticulum [GO:0005783];nucleolus [GO:0005730];cytosol [GO:0005829];membrane [GO:0016020]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.43	25	PRD000053;PXD001323;PXD001310;PRD000020;PRD000796;PRD000444;PRD000594;PRD000668;PRD000597;PRD000565;PXD000948;PRD000733;PRD000146;PXD000997;PXD001572;PXD000529;PRD000671;PXD000426;PXD000593;PRD000680;PXD001422;PXD000047;PRD000711;PRD000269;PXD000218	82		1269396;924747;742629	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];nucleolus [GO:0005730];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.42	21	PRD000053;PRD000565;PXD001310;PRD000020;PRD000444;PXD001323;PRD000443;PRD000597;PRD000269;PRD000733;PRD000146;PXD000997;PXD000948;PXD001572;PRD000594;PXD000426;PRD000668;PXD001422;PXD000047;PXD000593;PRD000711	69	EBI-6914965	1269362;743586	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.45	29	PXD000426;PRD000053;PRD000123;PRD000668;PRD000443;PXD001310;PRD000269;PXD001572;PRD000154;PRD000796;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000607;PRD000680;PXD000948;PXD000997;PRD000565;PXD000217;PRD000020;PXD000218;PRD000671;PRD000733;PRD000146;PRD000444;PXD000593;PXD001422	97		1269393;741921	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	polysomal ribosome [GO:0042788];membrane [GO:0016020];cytosol [GO:0005829];nucleolus [GO:0005730];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q07020	60S ribosomal protein L18 (Large ribosomal subunit protein eL18)	RPL18	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.45	24	PRD000053;PXD000948;PXD001310;PRD000020;PRD000444;PRD000594;PXD001323;PRD000597;PRD000269;PRD000123;PRD000565;PRD000733;PRD000146;PXD000997;PXD001572;PRD000680;PXD001422;PRD000796;PXD000047;PXD000593;PRD000407;PRD000711;PRD000668;PXD000218	75		1269397;924770;741966	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	polysomal ribosome [GO:0042788];endoplasmic reticulum [GO:0005783];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q9Y233	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35)	PDE10A	Q08345	Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a)	DDR1	0.47	1	PRD000032	18							metal ion binding [GO:0046872]
P07741	Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7)	APRT	P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	0.43	16	PRD000053;PXD000529;PRD000154;PRD000668;PRD000738;PRD000711;PRD000565;PXD001323;PRD000733;PXD001324;PXD001422;PXD000164;PXD000533;PRD000345;PXD001572;PXD000948	74						cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P08238	Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84)	HSP90AB1	P07900	Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)	HSP90AA1	0.49	50	PXD000948;PXD000786;PXD000426;PRD000269;PRD000053;PRD000345;PRD000123;PRD000668;PRD000443;PRD000092;PXD000529;PRD000444;PXD000387;PRD000417;PXD001328;PXD001572;PXD001422;PRD000154;PRD000032;PRD000796;PRD000073;PRD000465;PRD000146;PXD000164;PXD000047;PXD000217;PRD000711;PRD000565;PRD000597;PRD000059;PRD000671;PXD000997;PRD000416;PXD000472;PXD001323;PRD000167;PRD000020;PXD000218;PXD000314;PXD000593;PXD001324;PXD000680;PRD000407;PRD000477;PRD000594;PRD000118;PRD000046;PXD000533;PRD000410;PXD000964	305	EBI-11143932;EBI-4310841;EBI-3388516;EBI-3388490;EBI-3388448;EBI-3388430;EBI-3388173;EBI-3388070;EBI-3387925	1444975;1263295;949670;949305;922022;832637;818817;543764	5286;5269;5268;5266;5234;5212;5199	R-HSA-9018519;R-HSA-8939211;R-HSA-8852276;R-HSA-6798695;R-HSA-5336415;R-HSA-399954;R-HSA-3371571;R-HSA-3371568;R-HSA-3371511;R-HSA-3371497;R-HSA-2029482	positive regulation of protein kinase B signaling [GO:0051897];central nervous system neuron axonogenesis [GO:0021955];positive regulation of peptidyl-serine phosphorylation [GO:0033138];regulation of cellular response to heat [GO:1900034];telomere maintenance via telomerase [GO:0007004];regulation of protein ubiquitination [GO:0031396];telomerase holoenzyme complex assembly [GO:1905323];axon extension [GO:0048675];chaperone-mediated protein complex assembly [GO:0051131];response to unfolded protein [GO:0006986];regulation of cellular protein localization [GO:1903827];positive regulation of telomerase activity [GO:0051973];positive regulation of nitric oxide biosynthetic process [GO:0045429];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];positive regulation of tau-protein kinase activity [GO:1902949];establishment of cell polarity [GO:0030010];protein stabilization [GO:0050821];neutrophil degranulation [GO:0043312]	ficolin-1-rich granule lumen [GO:1904813];nucleoplasm [GO:0005654];secretory granule lumen [GO:0034774];cytosol [GO:0005829];perinuclear region of cytoplasm [GO:0048471];neuronal cell body [GO:0043025];cytoplasm [GO:0005737];protein-containing complex [GO:0032991];dendritic growth cone [GO:0044294];membrane [GO:0016020];melanosome [GO:0042470];nucleus [GO:0005634];extracellular region [GO:0005576];axonal growth cone [GO:0044295];extracellular exosome [GO:0070062]	histone deacetylase binding [GO:0042826];disordered domain specific binding [GO:0097718];ATPase activity, coupled [GO:0042623];tau protein binding [GO:0048156];ubiquitin protein ligase binding [GO:0031625];TPR domain binding [GO:0030911];nitric-oxide synthase regulator activity [GO:0030235];ATP binding [GO:0005524];DNA polymerase binding [GO:0070182];unfolded protein binding [GO:0051082];MHC class II protein complex binding [GO:0023026];identical protein binding [GO:0042802];protein homodimerization activity [GO:0042803];RNA binding [GO:0003723]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	0.51	1	PXD000383	11							
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.58	2	PXD000383;PXD001403	12							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.71	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.43	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.45	2	PXD000383;PXD001403	13					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.47	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.56	3	PXD000383;PXD001403;PRD000212	14							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.57	2	PXD000383;PXD001403	13							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.42	1	PXD000383	11							antigen binding [GO:0003823]
A0A0A0MS15	Immunoglobulin heavy variable 3-49	IGHV3-49	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.4	3	PXD000383;PXD001403;PRD000212	16							antigen binding [GO:0003823]
P84095	Rho-related GTP-binding protein RhoG	RHOG	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.41	9	PRD000053;PRD000154;PXD001323;PRD000668;PRD000092;PXD000529;PXD000533;PRD000796;PXD001422	37						plasma membrane [GO:0005886];extracellular exosome [GO:0070062];endoplasmic reticulum membrane [GO:0005789]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P51991	Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3)	HNRNPA3	Q32P51	Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2)	HNRNPA1L2	0.42	25	PRD000565;PXD000426;PRD000814;PXD000948;PRD000444;PRD000594;PXD001323;PRD000607;PRD000053;PXD000529;PXD001572;PXD000218;PRD000146;PXD000387;PXD000314;PXD001422;PRD000020;PXD000533;PRD000465;PRD000345;PXD000047;PXD000050;PXD000217;PRD000711;PRD000597	74		752399			mRNA transport [GO:0051028]	cytoplasm [GO:0005737]	RNA binding [GO:0003723]
A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	0.41	17	PRD000417;PRD000631;PXD001174;PRD000671;PXD000383;PXD000743;PRD000416;PRD000269;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000551;PRD000059;PRD000113;PRD000345	50					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.45	18	PRD000417;PRD000631;PRD000345;PXD001174;PRD000671;PRD000364;PRD000416;PXD000383;PXD000743;PRD000059;PRD000073;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000269;PRD000185	54					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.47	17	PRD000417;PRD000631;PRD000345;PRD000416;PRD000671;PXD000383;PXD000743;PRD000073;PXD000997;PRD000212;PRD000053;PXD001403;PXD000164;PRD000551;PXD001422;PRD000269;PXD001174	55					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.46	15	PRD000417;PRD000631;PXD001174;PRD000671;PRD000416;PXD000383;PXD000743;PRD000059;PRD000053;PXD001403;PXD000164;PXD001422;PRD000364;PRD000269;PRD000185	48					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S2	Immunoglobulin kappa variable 2D-29	IGKV2D-29	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.4	13	PRD000417;PRD000631;PRD000671;PXD000383;PRD000416;PRD000212;PXD001403;PXD000164;PXD001422;PRD000113;PXD000743;PRD000269;PXD001174	36					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S6	Immunoglobulin kappa variable 2D-30	IGKV2D-30	P01624	Immunoglobulin kappa variable 3-15 (Ig kappa chain V-III region CLL) (Ig kappa chain V-III region POM)	IGKV3-15	0.42	15	PRD000417;PRD000345;PRD000416;PRD000631;PXD001174;PRD000671;PXD000383;PXD000743;PRD000019;PRD000073;PXD001403;PXD001422;PRD000113;PRD000269;PXD000164	44				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6S6	Immunoglobulin kappa variable 2D-30	IGKV2D-30	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.4	17	PRD000417;PRD000631;PRD000345;PRD000416;PRD000671;PXD000383;PXD000743;PRD000073;PXD000997;PRD000212;PRD000053;PXD001403;PXD000164;PRD000551;PXD001422;PRD000269;PXD001174	55				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A0B4J1X8	Immunoglobulin heavy variable 3-43	IGHV3-43	0.43	3	PXD000383;PXD000164;PRD000019	15							antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	0.41	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	P01615	Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)	IGKV2D-28	0.53	2	PXD000383;PXD000164	12					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.4	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.56	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.42	2	PXD000383;PXD001422	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6S4	Immunoglobulin kappa variable 1D-17	IGKV1D-17	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.54	2	PXD000383;PXD000164	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P04114	Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]	APOB	P0C0L5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B;C4B_2	0.46	18	PRD000032;PRD000073;PRD000059;PRD000185;PRD000053;PXD000164;PRD000711;PXD000383;PXD001403;PRD000416;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PRD000364;PXD000533;PXD000743	141						extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	
P04114	Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)]	APOB	P0C0L4	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A	0.46	18	PRD000032;PRD000073;PRD000059;PRD000185;PRD000053;PXD000164;PRD000711;PXD000383;PXD001403;PRD000416;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PRD000364;PXD000533;PXD000743	141				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular exosome [GO:0070062];extracellular space [GO:0005615];neuronal cell body [GO:0043025];extracellular region [GO:0005576];plasma membrane [GO:0005886]	
P35232	Prohibitin	PHB	Q99623	Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity)	PHB2	0.55	26	PRD000020;PRD000032;PRD000668;PRD000443;PRD000053;PXD000529;PXD000387;PXD001328;PXD001572;PXD001422;PRD000711;PRD000597;PRD000594;PXD001323;PRD000167;PRD000168;PRD000565;PXD001324;PXD000218;PRD000444;PRD000345;PRD000073;PRD000600;PRD000671;PXD000164;PXD000533	124		1266624;520775;520774	6289	R-HSA-8949664	positive regulation of ERK1 and ERK2 cascade [GO:0070374];mitochondrial calcium ion transmembrane transport [GO:0006851];protein stabilization [GO:0050821];mitochondrion organization [GO:0007005];negative regulation of transcription, DNA-templated [GO:0045892]	mitochondrial inner membrane [GO:0005743];nucleus [GO:0005634];cytoplasm [GO:0005737];mitochondrion [GO:0005739];cell surface [GO:0009986]	protein C-terminus binding [GO:0008022]
Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	P27635	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10	0.42	19	PRD000053;PXD000948;PXD001310;PRD000594;PXD001323;PRD000443;PXD000529;PRD000733;PRD000146;PXD000218;PXD000997;PXD001572;PXD000533;PXD001422;PXD000593;PXD000047;PRD000565;PRD000269;PRD000711	46	EBI-11035646	1446924;1268983	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.42	21	PRD000053;PXD000948;PXD001310;PXD000218;PRD000444;PXD001323;PRD000443;PXD000529;PRD000733;PRD000146;PXD001572;PRD000594;PXD000997;PXD000593;PXD001422;PXD000047;PRD000565;PRD000269;PRD000020;PRD000711;PRD000668	54		743585	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q02543	60S ribosomal protein L18a (Large ribosomal subunit protein eL20)	RPL18A	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.4	19	PRD000053;PXD000948;PXD001310;PXD000218;PRD000444;PRD000594;PXD001323;PRD000733;PRD000146;PXD000997;PXD001572;PXD000593;PXD001422;PRD000796;PXD000047;PRD000565;PRD000269;PRD000711;PRD000668	52		1269423;741965	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	polysomal ribosome [GO:0042788];membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	0.48	19	PRD000417;PXD000743;PRD000631;PRD000073;PRD000551;PRD000416;PRD000671;PXD000383;PXD000746;PRD000019;PXD001324;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000059;PRD000269;PXD001174	54				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A0B4J1X5	Immunoglobulin heavy variable 3-74	IGHV3-74	0.42	15	PXD000743;PRD000631;PRD000073;PXD001324;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PRD000053;PRD000185;PXD001403;PXD001422;PRD000113;PXD000164	52					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A0B4J1V1	Immunoglobulin heavy variable 3-21	IGHV3-21	0.41	16	PXD000743;PRD000631;PRD000073;PRD000551;PRD000671;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PRD000053;PRD000185;PXD001403;PXD001422;PRD000113;PXD000164	54					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.41	14	PXD001324;PXD000746;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PRD000053;PXD001403;PRD000185;PXD001422;PRD000113;PXD000743;PXD000164	39				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.49	11	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422;PRD000113;PRD000345	27					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.46	12	PRD000417;PRD000416;PRD000551;PXD000383;PRD000671;PRD000059;PRD000019;PRD000631;PXD001403;PXD001422;PXD000164;PXD000743	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.55	18	PRD000417;PXD000743;PRD000631;PRD000551;PRD000416;PRD000671;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000073;PRD000269;PXD001174	55				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.48	13	PRD000417;PXD000743;PRD000631;PRD000416;PRD000671;PRD000551;PXD000383;PRD000059;PRD000212;PRD000053;PXD001403;PXD000164;PXD001174	41				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.58	17	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PRD000053;PXD000743;PXD001403;PXD001422;PXD000164;PRD000269;PXD001174	49				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.5	17	PRD000417;PXD000743;PRD000631;PRD000551;PRD000416;PRD000671;PXD000383;PRD000019;PXD001324;PRD000053;PRD000212;PXD001403;PXD000164;PXD001422;PRD000059;PRD000269;PXD001174	49					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH25	Immunoglobulin kappa variable 3D-20	IGKV3D-20	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.53	17	PRD000417;PXD000743;PRD000631;PRD000671;PXD000383;PRD000269;PRD000551;PRD000416;PRD000212;PRD000059;PRD000053;PRD000185;PXD000164;PXD001422;PRD000113;PXD001403;PXD001174	40					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH29	Immunoglobulin heavy variable 1-3	IGHV1-3	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.4	9	PRD000417;PRD000269;PRD000416;PXD000383;PXD000743;PRD000146;PRD000053;PXD001403;PRD000019	33					complement activation, classical pathway [GO:0006958]		antigen binding [GO:0003823]
P02775	Platelet basic protein (PBP) (C-X-C motif chemokine 7) (Leukocyte-derived growth factor) (LDGF) (Macrophage-derived growth factor) (MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III (CTAP-III) (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81) (CTAP-III(1-81)); Beta-thromboglobulin (Beta-TG); Neutrophil-activating peptide 2(74) (NAP-2(74)); Neutrophil-activating peptide 2(73) (NAP-2(73)); Neutrophil-activating peptide 2 (NAP-2); TC-1; Neutrophil-activating peptide 2(1-66) (NAP-2(1-66)); Neutrophil-activating peptide 2(1-63) (NAP-2(1-63))]	PPBP	P02776	Platelet factor 4 (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form (Endothelial cell growth inhibitor)]	PF4	0.56	11	PRD000073;PRD000631;PRD000738;PXD000383;PRD000001;PRD000118;PRD000364;PXD001422;PRD000068;PRD000053;PRD000535	34				R-HSA-114608;R-HSA-380108;R-HSA-418594	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844];response to lipopolysaccharide [GO:0032496];inflammatory response [GO:0006954];G-protein coupled receptor signaling pathway [GO:0007186];platelet degranulation [GO:0002576];killing of cells of other organism [GO:0031640];immune response [GO:0006955];chemokine-mediated signaling pathway [GO:0070098];regulation of cell proliferation [GO:0042127];positive regulation of neutrophil chemotaxis [GO:0090023]	platelet alpha granule lumen [GO:0031093];extracellular region [GO:0005576];extracellular space [GO:0005615]	chemokine activity [GO:0008009]
O43707	Alpha-actinin-4 (Non-muscle alpha-actinin 4)	ACTN4	P18206	Vinculin (Metavinculin) (MV)	VCL	0.41	41	PXD000948;PRD000053;PRD000020;PRD000059;PRD000269;PRD000417;PRD000738;PRD000123;PRD000668;PRD000416;PRD000410;PXD000387;PXD001328;PXD000164;PXD001422;PXD000529;PRD000796;PRD000594;PRD000597;PXD001323;PXD000426;PXD000533;PRD000001;PRD000565;PRD000073;PXD000218;PRD000731;PRD000711;PRD000733;PXD001324;PRD000118;PXD000226;PRD000345;PRD000535;PXD001572;PXD001447;PRD000364;PRD000444;PRD000407;PXD000786;PRD000113	275				R-HSA-114608	platelet degranulation [GO:0002576]	brush border [GO:0005903];cytosol [GO:0005829];protein-containing complex [GO:0032991];focal adhesion [GO:0005925];cell-cell junction [GO:0005911];extracellular region [GO:0005576];extracellular exosome [GO:0070062]	actin binding [GO:0003779]
P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	0.45	21	PXD000948;PRD000565;PXD001328;PXD001310;PRD000053;PXD000529;PRD000444;PRD000594;PRD000123;PXD001323;PXD000593;PRD000680;PRD000146;PXD000997;PXD000218;PXD001572;PXD000533;PRD000668;PRD000711;PRD000597;PXD001422	76		1271132;741487	3055;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	focal adhesion [GO:0005925];nucleus [GO:0005634];cytoplasm [GO:0005737];cytosol [GO:0005829];nucleolus [GO:0005730]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62424	60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3)	RPL7A	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.42	23	PRD000565;PXD000948;PRD000733;PXD000529;PXD001310;PRD000053;PXD001328;PXD001572;PXD000593;PXD001422;PRD000146;PXD000047;PRD000711;PRD000597;PXD000426;PRD000594;PXD001323;PRD000046;PRD000680;PXD000997;PXD000218;PRD000444;PXD000533	93		1270251;741577	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q8N1N4	Keratin, type II cytoskeletal 78 (Cytokeratin-78) (CK-78) (Keratin-5b) (Keratin-78) (K78) (Type-II keratin Kb40)	KRT78	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.41	40	PRD000164;PRD000069;PXD000743;PRD000123;PRD000092;PRD000597;PRD000373;PXD001328;PXD001572;PXD001422;PRD000154;PRD000345;PXD000047;PRD000711;PRD000172;PRD000059;PRD000607;PXD000997;PXD001323;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PRD000212;PXD000218;PXD001174;PXD000593;PXD000746;PXD001324;PRD000146;PRD000234;PRD000444;PRD000113;PRD000443;PRD000594;PRD000600;PRD000733;PXD001447;PRD000407	120	EBI-18739163;EBI-18739176			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
O94887	FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain-including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2) (Pleckstrin homology domain-containing family C member 3) (PH domain-containing family C member 3)	FARP2	Q8TEM1	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	NUP210	0.53	3	PRD000069;PXD000529;PXD000533	10							
P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139	EBI-20565496	479436	1227	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.5	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	134			1227;1226;1223	R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.52	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	134				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P16104	Histone H2AX (H2a/x) (Histone H2A.X)	H2AFX	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.48	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PRD000053;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PXD001447;PRD000407	139				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P63244	Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]	RACK1	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.4	28	PRD000053;PRD000668;PRD000443;PXD000529;PXD001310;PXD001328;PXD001572;PXD001422;PRD000796;PXD000047;PXD000948;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000607;PXD000426;PRD000565;PXD000218;PXD000314;PRD000731;PRD000671;PRD000146;PXD000997;PRD000444;PRD000345;PRD000118	100	EBI-8660895	925201			negative regulation of translation [GO:0017148]	nucleus [GO:0005634];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	enzyme binding [GO:0019899];RNA binding [GO:0003723]
Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	Q9BVA1	Tubulin beta-2B chain	TUBB2B	0.41	51	PRD000020;PXD000948;PRD000032;PRD000053;PRD000738;PRD000123;PRD000668;PRD000443;PRD000167;PRD000345;PXD000529;PRD000269;PXD000387;PXD001328;PXD000593;PRD000154;PXD001422;PRD000796;PRD000733;PRD000146;PXD000050;PXD000047;PRD000711;PRD000597;PRD000168;PRD000671;PRD000172;PRD000594;PXD001323;PRD000607;PRD000680;PXD000426;PXD000997;PRD000151;PRD000001;PRD000565;PRD000068;PXD000217;PXD001324;PRD000234;PXD000218;PRD000444;PRD000523;PXD001572;PXD001447;PRD000364;PRD000600;PXD000164;PXD000533;PRD000092;PRD000407	207		2248736;1192432		R-HSA-983189;R-HSA-8955332;R-HSA-8852276;R-HSA-68877;R-HSA-6811436;R-HSA-6811434;R-HSA-6807878;R-HSA-5663220;R-HSA-5626467;R-HSA-5620924;R-HSA-5617833;R-HSA-5610787;R-HSA-437239;R-HSA-389977;R-HSA-389960;R-HSA-389957;R-HSA-380320;R-HSA-3371497;R-HSA-2500257;R-HSA-2467813;R-HSA-2132295;R-HSA-190861;R-HSA-190840;R-HSA-1445148	microtubule-based process [GO:0007017]	nucleus [GO:0005634];cytoplasm [GO:0005737];microtubule [GO:0005874]	GTPase activity [GO:0003924];structural constituent of cytoskeleton [GO:0005200];GTP binding [GO:0005525]
Q13509	Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III)	TUBB3	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.41	49	PRD000733;PXD000948;PXD000426;PRD000032;PRD000345;PRD000053;PRD000565;PXD000743;PRD000668;PRD000443;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PRD000407;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000444;PRD000523;PRD000535;PRD000269;PRD000118;PXD001447;PXD000164;PXD000533;PRD000738;PRD000073	271						cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	
P45974	Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5)	USP5	P13798	Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH)	APEH	0.47	11	PRD000154;PXD000426;PRD000053;PRD000594;PRD000668;PRD000059;PXD001324;PXD001328;PXD001422;PXD000533;PRD000118	34						cytosol [GO:0005829]	
P61247	40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1)	RPS3A	P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	0.4	30	PRD000345;PRD000668;PRD000443;PRD000053;PXD000529;PXD001310;PXD001328;PXD001572;PXD001422;PRD000146;PXD000050;PRD000711;PRD000597;PRD000269;PRD000594;PXD001323;PRD000607;PRD000680;PRD000410;PXD000948;PXD000997;PRD000565;PXD000218;PXD000217;PXD000593;PRD000671;PRD000444;PXD000426;PRD000600;PXD000533	91	EBI-8383997;EBI-8354201	1271143;925194;741493	338;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72702;R-HSA-72695;R-HSA-72689;R-HSA-72649;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];extracellular exosome [GO:0070062];nucleolus [GO:0005730];endoplasmic reticulum [GO:0005783];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];focal adhesion [GO:0005925];nucleus [GO:0005634];cytosolic small ribosomal subunit [GO:0022627];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P49721	Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I)	PSMB2	P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	0.43	23	PRD000053;PRD000668;PRD000059;PXD000529;PXD001572;PRD000154;PRD000711;PRD000597;PRD000092;PRD000594;PXD001323;PRD000032;PRD000607;PXD000948;PRD000731;PRD000733;PXD001324;PXD000997;PRD000345;PXD000164;PXD000533;PRD000738;PXD001422	88	EBI-7659466;EBI-7659337	2221454;1267713;924053;741417;696557;696551	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];proteolysis involved in cellular protein catabolic process [GO:0051603];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];proteasome core complex, beta-subunit complex [GO:0019774];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	O14818	Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7)	PSMA7	0.48	24	PRD000154;PRD000032;PRD000053;PRD000668;PXD000529;PXD000426;PXD001572;PXD001422;PRD000059;PXD000050;PRD000711;PRD000597;PRD000594;PXD001323;PXD000218;PXD000533;PXD001403;PRD000731;PXD000948;PXD001324;PXD000997;PRD000345;PXD000164;PRD000407	100		2228075;1267695;953966;924052;741411;668670	194;193;192;191;181	R-HSA-983168;R-HSA-9604323;R-HSA-9020702;R-HSA-9010553;R-HSA-8951664;R-HSA-8948751;R-HSA-8941858;R-HSA-8939902;R-HSA-8939236;R-HSA-8854050;R-HSA-8852276;R-HSA-69601;R-HSA-69481;R-HSA-69229;R-HSA-69017;R-HSA-68949;R-HSA-68827;R-HSA-5689880;R-HSA-5689603;R-HSA-5687128;R-HSA-5678895;R-HSA-5676590;R-HSA-5668541;R-HSA-5658442;R-HSA-5632684;R-HSA-5610785;R-HSA-5610783;R-HSA-5610780;R-HSA-5607764;R-HSA-5607761;R-HSA-5362768;R-HSA-5358346;R-HSA-4641258;R-HSA-4641257;R-HSA-4608870;R-HSA-450408;R-HSA-382556;R-HSA-350562;R-HSA-349425;R-HSA-2871837;R-HSA-2467813;R-HSA-211733;R-HSA-202424;R-HSA-195253;R-HSA-187577;R-HSA-180585;R-HSA-180534;R-HSA-174184;R-HSA-174178;R-HSA-174154;R-HSA-174113;R-HSA-174084;R-HSA-1236978;R-HSA-1236974;R-HSA-1234176;R-HSA-1169091	post-translational protein modification [GO:0043687];viral process [GO:0016032];protein deubiquitination [GO:0016579]	cytosol [GO:0005829];extracellular exosome [GO:0070062];proteasome complex [GO:0000502];nucleoplasm [GO:0005654];nucleus [GO:0005634];proteasome core complex [GO:0005839]	threonine-type endopeptidase activity [GO:0004298]
P20618	Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain)	PSMB1	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.44	18	PRD000154;PRD000053;PXD000948;PRD000594;PXD001323;PRD000668;PRD000711;PRD000607;PXD000529;PRD000733;PXD000218;PXD000387;PXD001572;PXD000164;PXD000533;PXD001422;PRD000738;PRD000269	77				R-HSA-6798695	viral process [GO:0016032];protein deubiquitination [GO:0016579];neutrophil degranulation [GO:0043312]	nucleus [GO:0005634];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	P01615	Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)	IGKV2D-28	0.42	2	PXD000383;PXD001403	10					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1Y8	Immunoglobulin lambda variable 9-49	IGLV9-49	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.52	2	PXD000383;PXD001403	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01037	Cystatin-SN (Cystain-SA-I) (Cystatin-1) (Salivary cystatin-SA-1)	CST1	P23280	Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase)	CA6	0.47	2	PRD000164;PRD000212	10					detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]	extracellular space [GO:0005615]	
P01037	Cystatin-SN (Cystain-SA-I) (Cystatin-1) (Salivary cystatin-SA-1)	CST1	Q6P5S2	Protein LEG1 homolog	C6orf58	0.41	3	PRD000164;PRD000212;PXD000412	12						extracellular space [GO:0005615]	
Q5XKE5	Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)	KRT79	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.52	47	PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PRD000345;PRD000373;PXD000387;PXD001328;PXD000047;PRD000154;PXD001422;PRD000796;PRD000164;PXD000164;PRD000711;PRD000172;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PRD000551;PXD001324;PRD000234;PRD000444;PRD000113;PRD000594;PRD000600;PRD000053;PRD000073;PXD001572;PXD001447;PRD000407;PXD000964;PRD000146	155	EBI-18738613;EBI-18738626;EBI-10565234;EBI-10403854;EBI-10248506	1039582		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
Q9NVH6	Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)	TMLHE	Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	0.44	1	PRD000345	27							
Q9UBX5	Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50)	FBLN5	P29400	Collagen alpha-5(IV) chain	COL4A5	0.41	3	PXD000746;PRD000269;PXD000743	10					extracellular matrix organization [GO:0030198]	extracellular region [GO:0005576]	
Q7L7L0	Histone H2A type 3	HIST3H2A	Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q7L7L0	Histone H2A type 3	HIST3H2A	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815			protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q7L7L0	Histone H2A type 3	HIST3H2A	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815			protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q7L7L0	Histone H2A type 3	HIST3H2A	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-5689880;R-HSA-3214847;R-HSA-3214815		extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P20339	Ras-related protein Rab-5A	RAB5A	Q8WUD1	Ras-related protein Rab-2B	RAB2B	0.41	13	PRD000733;PRD000711;PRD000053;PRD000154;PXD001323;PRD000668;PRD000092;PXD001324;PXD000529;PRD000001;PXD000533;PXD001422;PXD001572	40		2249491		R-HSA-8873719	protein transport [GO:0015031];positive regulation of exocytosis [GO:0045921]	plasma membrane [GO:0005886];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P80108	Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D)	GPLD1	Q9UK55	Protein Z-dependent protease inhibitor (PZ-dependent protease inhibitor) (PZI) (Serpin A10)	SERPINA10	0.42	7	PRD000172;PRD000073;PRD000551;PRD000631;PRD000185;PRD000158;PXD000164	37						extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P04217	Alpha-1B-glycoprotein (Alpha-1-B glycoprotein)	A1BG	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.49	16	PRD000073;PRD000059;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PRD000212;PXD001324;PXD000765;PRD000551;PRD000158;PXD001174;PRD000362	135						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
Q9H857	5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-)	NT5DC2	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.42	1	PRD000345	28							
P78386	Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85) (K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)	KRT85	Q14525	Keratin, type I cuticular Ha3-II (Hair keratin, type I Ha3-II) (Keratin-33B) (K33B)	KRT33B	0.41	15	PRD000053;PRD000733;PRD000444;PXD000743;PXD001324;PRD000154;PRD000796;PXD000746;PXD000218;PRD000151;PRD000345;PXD001572;PRD000407;PRD000020;PRD000711	28	EBI-18914031;EBI-18914044			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	extracellular space [GO:0005615];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P78386	Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85) (K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)	KRT85	O76009	Keratin, type I cuticular Ha3-I (Hair keratin, type I Ha3-I) (Keratin-33A) (K33A)	KRT33A	0.43	9	PXD001572;PRD000053;PRD000407;PXD001324;PRD000733;PRD000796;PRD000345;PRD000020;PXD000746	10				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	extracellular space [GO:0005615];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P78386	Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85) (K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)	KRT85	O76011	Keratin, type I cuticular Ha4 (Hair keratin, type I Ha4) (Keratin-34) (K34)	KRT34	0.42	9	PXD001572;PRD000345;PRD000053;PRD000407;PXD001324;PRD000733;PRD000796;PRD000020;PXD000746	11	EBI-19246910;EBI-19246923			R-HSA-6805567;R-HSA-6809371	cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	extracellular space [GO:0005615];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P78385	Keratin, type II cuticular Hb3 (Hair keratin K2.10) (Keratin-83) (K83) (Type II hair keratin Hb3) (Type-II keratin Kb23)	KRT83	O76009	Keratin, type I cuticular Ha3-I (Hair keratin, type I Ha3-I) (Keratin-33A) (K33A)	KRT33A	0.43	9	PXD001572;PRD000053;PRD000407;PXD001324;PRD000733;PRD000796;PRD000345;PRD000020;PXD000746	10				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	extracellular space [GO:0005615];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P78385	Keratin, type II cuticular Hb3 (Hair keratin K2.10) (Keratin-83) (K83) (Type II hair keratin Hb3) (Type-II keratin Kb23)	KRT83	O76011	Keratin, type I cuticular Ha4 (Hair keratin, type I Ha4) (Keratin-34) (K34)	KRT34	0.41	9	PXD001572;PRD000345;PRD000053;PRD000407;PXD001324;PRD000733;PRD000796;PRD000020;PXD000746	11	EBI-19245676;EBI-19245689			R-HSA-6805567;R-HSA-6809371	cornification [GO:0070268];epidermis development [GO:0008544];keratinization [GO:0031424]	extracellular space [GO:0005615];cytosol [GO:0005829]	structural molecule activity [GO:0005198]
P01743	Immunoglobulin heavy variable 1-46 (Ig heavy chain V-I region DOT) (Ig heavy chain V-I region HG3) (Ig heavy chain V-I region Mot)	IGHV1-46	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.41	9	PRD000417;PRD000416;PXD000383;PXD000743;PRD000269;PRD000146;PRD000053;PXD001403;PRD000019	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P46777	60S ribosomal protein L5 (Large ribosomal subunit protein uL18)	RPL5	P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	0.42	25	PRD000053;PRD000565;PXD000426;PRD000020;PRD000444;PRD000594;PXD001323;PRD000668;PRD000733;PXD000529;PXD001310;PXD000948;PRD000146;PXD000997;PRD000597;PXD001572;PXD000533;PXD000593;PXD001422;PRD000796;PXD000047;PRD000711;PRD000345;PXD000964;PXD000218	66		1270134;742040	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];cytoplasm [GO:0005737];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46777	60S ribosomal protein L5 (Large ribosomal subunit protein uL18)	RPL5	P27635	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10	0.41	21	PRD000053;PRD000565;PXD001310;PXD000948;PRD000594;PXD001323;PRD000046;PXD000426;PRD000597;PRD000607;PXD000529;PRD000146;PXD000997;PXD000218;PXD001572;PXD000533;PXD000593;PXD001422;PXD000047;PRD000711;PXD000964	57	EBI-11035646	1446852;1270125;743259	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];endoplasmic reticulum [GO:0005783];protein-containing complex [GO:0032991];membrane [GO:0016020];nucleus [GO:0005634];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P46778	60S ribosomal protein L21 (Large ribosomal subunit protein eL21)	RPL21	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.41	24	PXD000948;PXD000218;PRD000565;PXD001310;PRD000053;PXD001323;PRD000443;PRD000597;PXD000529;PRD000733;PRD000146;PXD000997;PXD000387;PXD001572;PRD000594;PRD000444;PXD000593;PXD001422;PXD000047;PRD000269;PRD000711;PXD000426;PRD000668;PRD000020	68	EBI-8586548	924719;741939	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P43897	Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)	TSFM	Q53H82	Endoribonuclease LACTB2 (EC 3.1.27.-) (Beta-lactamase-like protein 2)	LACTB2	0.46	7	PXD000529;PXD001323;PXD000948;PXD000426;PXD000533;PRD000711;PXD001422	12						mitochondrial matrix [GO:0005759]	
Q7RTS7	Keratin, type II cytoskeletal 74 (Cytokeratin-74) (CK-74) (Keratin-5c) (K5C) (Keratin-74) (K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)	KRT74	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.42	41	PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000597;PRD000373;PXD001328;PXD001572;PRD000154;PXD001422;PRD000345;PXD000047;PRD000711;PRD000172;PRD000059;PRD000607;PRD000680;PXD000997;PRD000151;PXD001402;PRD000565;PXD000164;PRD000020;PXD000218;PXD001174;PXD000593;PXD001324;PRD000146;PRD000234;PRD000444;PRD000113;PRD000443;PXD001323;PRD000594;PRD000600;PRD000362;PXD001447;PRD000407	126	EBI-18739215;EBI-18739228			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P05452	Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein)	CLEC3B	P02753	Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176)]	RBP4	0.43	15	PRD000073;PRD000417;PRD000172;PXD000383;PRD000631;PRD000416;PXD001323;PRD000059;PRD000551;PRD000373;PRD000053;PXD001403;PRD000185;PRD000019;PXD000164	77						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P27635	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10	0.4	22	PRD000053;PXD001310;PRD000594;PXD001323;PRD000597;PXD000948;PXD000529;PRD000733;PXD000426;PRD000146;PXD000997;PXD000387;PRD000671;PXD001572;PXD000533;PXD001422;PXD000593;PXD000047;PRD000565;PRD000711;PXD000964;PXD000218	57	EBI-11035646	1446943;1269488;743379	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.5	24	PRD000053;PXD000218;PXD000948;PXD001310;PXD001572;PRD000020;PRD000444;PXD001323;PRD000597;PRD000565;PXD000426;PXD000529;PRD000733;PRD000146;PXD000997;PXD000387;PRD000594;PXD001422;PRD000345;PXD000047;PXD000593;PRD000711;PXD000964;PRD000668	72		1269365;743798	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.45	28	PRD000053;PRD000345;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000680;PXD000948;PXD000997;PRD000565;PRD000020;PXD000218;PRD000731;PRD000733;PRD000146;PRD000444;PXD000593;PRD000671;PXD000426;PXD000533;PRD000269	91		1269489;741946	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];nucleolus [GO:0005730];cytoplasm [GO:0005737];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P62917	60S ribosomal protein L8 (Large ribosomal subunit protein uL2)	RPL8	0.4	27	PRD000053;PXD001310;PRD000020;PRD000444;PRD000594;PXD001323;PRD000680;PRD000565;PXD000529;PRD000146;PXD000997;PXD000387;PXD000948;PXD001572;PRD000671;PRD000597;PXD000426;PXD001422;PXD000593;PRD000733;PRD000345;PRD000668;PXD000047;PRD000711;PRD000269;PXD000964;PXD000218	68		1269511;742097	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.43	23	PRD000053;PXD001310;PRD000796;PRD000444;PRD000594;PRD000668;PXD001323;PRD000597;PRD000565;PRD000733;PXD000948;PRD000146;PXD000997;PXD001572;PXD000218;PXD000533;PXD001422;PXD000047;PXD000593;PRD000711;PRD000345;PXD000964;PXD000314	79		1269491;741947	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	cadherin binding [GO:0045296];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.52	23	PRD000053;PXD001310;PRD000020;PRD000444;PRD000594;PRD000668;PRD000597;PRD000565;PXD000948;PRD000733;PRD000146;PXD000997;PXD001323;PRD000180;PXD001572;PXD001422;PRD000796;PRD000680;PXD000047;PXD000593;PRD000711;PRD000269;PXD000218	80		1269498;924771;741970	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];cytoplasm [GO:0005737];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	cadherin binding [GO:0045296];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62750	60S ribosomal protein L23a (Large ribosomal subunit protein uL23)	RPL23A	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.41	25	PRD000053;PRD000565;PRD000731;PXD001310;PRD000020;PRD000444;PRD000594;PRD000668;PXD000948;PXD000529;PRD000146;PXD000997;PRD000733;PXD001323;PRD000671;PRD000597;PXD001572;PXD001422;PXD000533;PRD000796;PXD000593;PRD000345;PRD000711;PXD000964;PXD000218	81		1270810;742245	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleolus [GO:0005730];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P04075	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase)	ALDOA;AC093512.2	P00558	Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2)	PGK1	0.46	47	PXD000948;PXD000426;PRD000059;PRD000053;PXD000743;PRD000738;PRD000123;PRD000668;PRD000416;PRD000001;PRD000269;PXD000529;PXD000387;PXD001328;PXD000047;PXD001422;PRD000796;PRD000073;PRD000465;PRD000146;PRD000711;PRD000417;PRD000597;PRD000594;PXD001323;PRD000046;PRD000607;PRD000020;PRD000212;PXD000786;PXD000533;PRD000151;PXD000217;PXD000164;PXD000218;PRD000731;PXD001324;PRD000234;PXD000314;PRD000444;PRD000345;PRD000113;PRD000477;PRD000118;PXD001572;PRD000523;PRD000407	230		1258498;746365		R-HSA-70263;R-HSA-70171	glycolytic process [GO:0006096];canonical glycolysis [GO:0061621];gluconeogenesis [GO:0006094]	membrane [GO:0016020];extracellular space [GO:0005615];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P02671	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	FGA	P0C0L5	Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain]	C4B;C4B_2	0.4	22	PRD000073;PRD000417;PXD000743;PRD000416;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000477;PRD000158;PRD000059;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000146;PRD000032;PRD000362;PRD000364	169					innate immune response [GO:0045087]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
P02671	Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain]	FGA	P0C0L4	Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain]	C4A	0.4	22	PRD000073;PRD000417;PXD000743;PRD000416;PRD000185;PXD000383;PRD000053;PXD001422;PXD000164;PRD000477;PRD000158;PRD000059;PRD000212;PXD001403;PRD000631;PRD000172;PXD001324;PRD000551;PRD000146;PRD000032;PRD000362;PRD000364	169				R-HSA-8957275;R-HSA-381426	cellular protein metabolic process [GO:0044267];innate immune response [GO:0045087];post-translational protein modification [GO:0043687]	endoplasmic reticulum lumen [GO:0005788];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];extracellular space [GO:0005615];extracellular region [GO:0005576];plasma membrane [GO:0005886]	
P04440	HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)	HLA-DPB1	Q30154	HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)	HLA-DRB5	0.45	3	PRD000053;PXD001422;PXD000743	11				R-HSA-202424;R-HSA-202427;R-HSA-202430;R-HSA-202433;R-HSA-2132295;R-HSA-389948;R-HSA-877300	T cell receptor signaling pathway [GO:0050852];antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886];interferon-gamma-mediated signaling pathway [GO:0060333]	trans-Golgi network membrane [GO:0032588];Golgi membrane [GO:0000139];transport vesicle membrane [GO:0030658];endocytic vesicle membrane [GO:0030666];lysosomal membrane [GO:0005765];MHC class II protein complex [GO:0042613];ER to Golgi transport vesicle membrane [GO:0012507];integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556];plasma membrane [GO:0005886];clathrin-coated endocytic vesicle membrane [GO:0030669]	peptide antigen binding [GO:0042605]
Q96IJ6	Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha)	GMPPA	Q9Y5P6	Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta)	GMPPB	0.4	7	PXD001328;PXD001323;PXD000529;PXD001422;PRD000154;PXD000426;PXD000533	11	EBI-18762318;EBI-18762331;EBI-10603534;EBI-10481771;EBI-10329152;EBI-758749	2233948;1262576;1188833;1047139;921620;741824;121587		R-HSA-446205		cytoplasm [GO:0005737]	
P07357	Complement component C8 alpha chain (Complement component 8 subunit alpha)	C8A	P07358	Complement component C8 beta chain (Complement component 8 subunit beta)	C8B	0.41	15	PRD000073;PRD000417;PRD000416;PRD000172;PXD000383;PRD000362;PRD000551;PRD000185;PXD000746;PRD000059;PXD000743;PRD000158;PRD000053;PRD000631;PXD001403	74				R-HSA-977606;R-HSA-166665	immune response [GO:0006955];complement activation, classical pathway [GO:0006958];complement activation, alternative pathway [GO:0006957];regulation of complement activation [GO:0030449];cytolysis [GO:0019835];complement activation [GO:0006956]	extracellular region [GO:0005576];membrane attack complex [GO:0005579];extracellular exosome [GO:0070062];membrane [GO:0016020]	protein-containing complex binding [GO:0044877]
Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q99879	Histone H2B type 1-M (Histone H2B.e) (H2B/e)	HIST1H2BM	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.44	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PRD000269;PXD000314;PRD000020;PXD001572;PRD000796;PXD001422;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P31946	14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]	YWHAB	P61981	14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]	YWHAG	0.42	34	PRD000032;PRD000053;PRD000668;PRD000059;PRD000417;PXD000948;PXD000529;PXD000680;PXD000387;PXD001328;PXD001572;PRD000154;PRD000146;PRD000711;PRD000597;PXD000426;PRD000092;PRD000594;PRD000416;PRD000020;PXD000997;PXD000218;PXD000533;PRD000168;PXD001403;PXD001324;PRD000113;PXD001323;PRD000118;PXD000593;PRD000523;PXD000164;PRD000269;PXD001422	131	EBI-15609755;EBI-8796749	1274667;914152	5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];protein targeting [GO:0006605]	focal adhesion [GO:0005925];membrane [GO:0016020];cytosol [GO:0005829];mitochondrion [GO:0005739];extracellular exosome [GO:0070062]	identical protein binding [GO:0042802];protein domain specific binding [GO:0019904]
O00299	Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC)	CLIC1	P07737	Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I)	PFN1	0.41	36	PRD000053;PRD000738;PRD000123;PRD000668;PRD000059;PXD000948;PXD000529;PXD000387;PXD000164;PXD001422;PRD000796;PRD000465;PRD000146;PXD000426;PRD000711;PRD000597;PXD001323;PRD000046;PRD000073;PRD000607;PRD000565;PXD001403;PXD000217;PXD000314;PRD000731;PXD001324;PXD000218;PRD000032;PRD000020;PRD000345;PRD000594;PRD000118;PXD001572;PRD000364;PXD000533;PRD000108	153						nucleus [GO:0005634];cytoplasm [GO:0005737];extracellular exosome [GO:0070062];blood microparticle [GO:0072562];membrane [GO:0016020]	cadherin binding [GO:0045296]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	P01614	Immunoglobulin kappa variable 2D-40 (Ig kappa chain V-II region Cum)	IGKV2D-40	0.42	19	PRD000417;PRD000269;PXD000743;PRD000345;PRD000631;PRD000416;PRD000671;PXD000383;PRD000059;PXD001324;PRD000073;PRD000212;PRD000053;PRD000364;PXD000164;PXD001422;PXD001403;PRD000185;PXD001174	55				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.4	14	PRD000364;PRD000362;PRD000551;PRD000671;PXD000383;PXD001324;PRD000212;PRD000053;PXD001403;PRD000185;PXD000164;PXD001422;PRD000059;PXD000743	35				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.4	10	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PRD000185;PXD001403;PXD000164;PXD001422	26					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.43	12	PRD000417;PRD000416;PXD000383;PRD000671;PXD000743;PRD000551;PRD000185;PRD000019;PRD000631;PXD000164;PXD001422;PXD001403	33				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.5	18	PRD000417;PXD000743;PRD000345;PRD000073;PRD000631;PRD000416;PRD000671;PXD000383;PRD000019;PXD001324;PRD000212;PRD000053;PRD000551;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	54				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.43	13	PRD000417;PXD000743;PRD000631;PRD000362;PRD000416;PRD000671;PXD000383;PRD000551;PRD000212;PXD001403;PRD000053;PXD000164;PXD001174	37				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P80748	Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT)	IGLV3-21	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.48	15	PRD000417;PXD001324;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PRD000551;PRD000212;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	43				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
Q96DA0	Zymogen granule protein 16 homolog B	ZG16B	Q6P5S2	Protein LEG1 homolog	C6orf58	0.5	4	PRD000164;PXD000412;PRD000212;PRD000796	13						extracellular space [GO:0005615];extracellular exosome [GO:0070062]	
Q96QD9	UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3)	FYTTD1	Q8TEM1	Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa)	NUP210	0.41	4	PXD001572;PRD000069;PRD000146;PXD000533	11				R-HSA-159236	mRNA export from nucleus [GO:0006406]		
Q9BZE4	Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB)	GTPBP4	Q9BVP2	Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47) (NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin)	GNL3	0.4	7	PXD000529;PXD001572;PXD000426;PRD000146;PXD000593;PXD000964;PRD000597	11						nucleus [GO:0005634];nucleolus [GO:0005730];membrane [GO:0016020]	GTPase activity [GO:0003924];RNA binding [GO:0003723];GTP binding [GO:0005525]
Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	P46109	Crk-like protein	CRKL	0.44	9	PRD000345;PXD001323;PRD000711;PRD000565;PXD000426;PRD000032;PXD001422;PXD000533;PXD000529	49						cytosol [GO:0005829]	
Q15437	Protein transport protein Sec23B (hSec23B) (SEC23-related protein B)	SEC23B	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.41	3	PRD000345;PXD001323;PXD000529	37						cytosol [GO:0005829]	
O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.52	49	PRD000345;PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PXD000746;PRD000443;PRD000597;PXD000529;PRD000373;PXD000387;PXD001328;PXD000164;PRD000154;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000172;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000234;PRD000444;PRD000113;PXD000383;PRD000594;PRD000600;PRD000053;PRD000073;PXD001572;PXD001447;PRD000407;PXD000964	162	EBI-18739241;EBI-18739254			R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
O95678	Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)	KRT75	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.46	53	PRD000345;PRD000164;PRD000069;PRD000733;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PXD000226;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PXD000593;PRD000796;PRD000146;PXD000164;PXD000047;PRD000711;PRD000364;PRD000172;PRD000059;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PXD000746;PRD000151;PXD001403;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000600;PRD000551;PRD000053;PRD000234;PRD000444;PRD000113;PXD000383;PRD000671;PRD000073;PXD001572;PXD001447;PRD000407;PXD000964	208				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	
P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.49	1	PXD000383	11							
P55056	Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4)	APOC4	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.56	1	PXD000383	11							
A0A0B4J1X5	Immunoglobulin heavy variable 3-74	IGHV3-74	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.45	16	PRD000417;PRD000551;PRD000185;PRD000671;PXD000383;PRD000059;PRD000019;PXD001324;PRD000146;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000416;PRD000113	52					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
P30084	Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)	ECHS1	Q99714	3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH)	HSD17B10	0.4	19	PRD000053;PRD000345;PXD000529;PRD000444;PRD000594;PRD000668;PRD000443;PXD001323;PXD000426;PXD001324;PXD000218;PXD001572;PRD000234;PXD001422;PXD000387;PRD000146;PRD000020;PRD000711;PXD000948	71						mitochondrion [GO:0005739];mitochondrial matrix [GO:0005759]	
P13224	Platelet glycoprotein Ib beta chain (GP-Ib beta) (GPIb-beta) (GPIbB) (Antigen CD42b-beta) (CD antigen CD42c)	GP1BB	P14770	Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a)	GP9	0.4	5	PRD000364;PRD000068;PRD000053;PXD001422;PRD000738	15	EBI-10891490			R-HSA-140837;R-HSA-430116;R-HSA-75892;R-HSA-76009	blood coagulation [GO:0007596];platelet activation [GO:0030168];blood coagulation, intrinsic pathway [GO:0007597];cell adhesion [GO:0007155]	integral component of plasma membrane [GO:0005887];plasma membrane [GO:0005886]	
Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	0.56	1	PRD000345	32							
Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	0.42	2	PRD000345;PXD001422	31							
Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	P46109	Crk-like protein	CRKL	0.45	4	PRD000345;PXD001422;PRD000565;PXD000529	38					intracellular signal transduction [GO:0035556]		
Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	Q96BW5	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) (hPHRP)	PTER	0.45	3	PRD000345;PXD001422;PXD000529	32							
Q9BYB4	Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF)	GNB1L	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.5	2	PRD000345;PXD000529	35							
P27635	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10	P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	0.4	23	PRD000053;PXD000948;PXD001310;PXD001323;PRD000443;PRD000046;PRD000597;PXD000426;PXD000529;PRD000733;PRD000146;PXD000997;PXD000218;PXD000387;PRD000565;PXD000964;PXD001572;PRD000594;PXD001422;PXD000593;PXD000047;PRD000269;PRD000711	59		1446916	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	nucleus [GO:0005634];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P27635	60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM)	RPL10	P62917	60S ribosomal protein L8 (Large ribosomal subunit protein uL2)	RPL8	0.4	22	PRD000053;PXD001310;PXD000948;PRD000594;PXD001323;PRD000443;PXD000593;PXD000964;PXD000529;PRD000146;PXD000997;PXD000218;PXD000387;PRD000671;PXD000426;PXD001572;PRD000607;PXD001422;PXD000047;PRD000565;PRD000711;PRD000597	56	EBI-11035646	1446875;1270282;743276	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	0.48	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.51	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	134				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9BTM1	Histone H2A.J (H2a/j)	H2AFJ	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	139				R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleosome [GO:0000786];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q9BVA1	Tubulin beta-2B chain	TUBB2B	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.42	50	PRD000733;PXD000948;PRD000032;PRD000345;PXD000743;PRD000668;PRD000443;PRD000053;PXD001310;PXD000426;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PRD000597;PRD000594;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PRD000565;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000118;PRD000444;PRD000523;PRD000535;PRD000269;PXD001447;PXD000164;PXD000533;PRD000738;PRD000073;PXD000226;PRD000407	276						cytoplasm [GO:0005737]	
A0A0B4J1V1	Immunoglobulin heavy variable 3-21	IGHV3-21	P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	0.5	18	PRD000671;PRD000551;PRD000185;PRD000416;PXD000383;PRD000059;PRD000019;PXD001324;PRD000269;PRD000146;PRD000212;PRD000053;PXD001403;PRD000417;PXD000164;PXD001422;PRD000113;PXD000743	58					phagocytosis, engulfment [GO:0006911];complement activation, classical pathway [GO:0006958];innate immune response [GO:0045087];defense response to bacterium [GO:0042742];phagocytosis, recognition [GO:0006910];B cell receptor signaling pathway [GO:0050853];positive regulation of B cell activation [GO:0050871]	immunoglobulin complex, circulating [GO:0042571];external side of plasma membrane [GO:0009897];blood microparticle [GO:0072562]	immunoglobulin receptor binding [GO:0034987];antigen binding [GO:0003823]
A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	0.54	1	PXD000383	10							antigen binding [GO:0003823]
A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.41	1	PXD000383	10							antigen binding [GO:0003823]
A0A0B4J1V6	Immunoglobulin heavy variable 3-73	IGHV3-73	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.46	1	PXD000383	10							antigen binding [GO:0003823]
P07437	Tubulin beta chain (Tubulin beta-5 chain)	TUBB	P10809	60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)	HSPD1	0.41	50	PRD000733;PXD000948;PXD000426;PRD000032;PRD000345;PXD000743;PRD000668;PRD000443;PRD000053;PXD001310;PXD000387;PXD001328;PXD000593;PXD001572;PXD001422;PRD000020;PRD000796;PRD000465;PRD000146;PXD001323;PRD000711;PRD000597;PRD000073;PRD000046;PRD000607;PXD000997;PXD000472;PRD000001;PXD000217;PRD000565;PXD000050;PXD000529;PRD000600;PRD000671;PXD001324;PRD000234;PXD000314;PXD000218;PRD000118;PRD000444;PRD000523;PRD000535;PRD000594;PRD000269;PXD001447;PXD000164;PXD000533;PRD000738;PXD000226;PRD000407	288						cytoplasm [GO:0005737];extracellular exosome [GO:0070062]	ubiquitin protein ligase binding [GO:0031625]
P02538	Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)	KRT6A	P02533	Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)	KRT14	0.61	56	PRD000073;PRD000733;PXD000746;PRD000069;PXD000743;PRD000123;PRD000092;PRD000443;PRD000059;PRD000597;PXD000226;PRD000345;PXD000383;PXD000529;PRD000373;PXD000387;PXD001328;PRD000154;PXD001422;PRD000796;PXD000164;PXD000047;PRD000711;PRD000364;PRD000172;PRD000416;PRD000407;PRD000164;PXD001323;PRD000607;PRD000680;PRD000594;PXD000997;PRD000212;PRD000417;PRD000151;PXD001403;PXD001402;PRD000565;PRD000020;PXD001174;PXD001324;PRD000600;PXD000593;PRD000551;PRD000053;PRD000146;PRD000234;PRD000362;PRD000444;PRD000113;PRD000671;PXD000218;PXD001572;PXD001447;PXD000964	213				R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	nucleus [GO:0005634];keratin filament [GO:0045095];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of cytoskeleton [GO:0005200]
Q8N257	Histone H2B type 3-B (H2B type 12)	HIST3H2BB	Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	0.49	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000997;PXD001572;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PRD000594;PXD001323;PRD000073;PRD000680;PXD000948;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000164;PXD000218;PXD000314;PRD000733;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P25705	ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)	ATP5F1A	P06576	ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) (ATP synthase F1 subunit beta)	ATP5F1B	0.54	48	PRD000345;PRD000020;PRD000053;PXD000743;PRD000668;PRD000443;PXD000948;PXD000529;PXD000387;PXD001328;PXD001572;PXD001422;PRD000796;PRD000733;PXD000050;PXD001323;PRD000711;PRD000597;PXD000593;PRD000594;PRD000607;PRD000680;PXD000218;PRD000032;PXD000164;PXD000412;PRD000168;PRD000001;PXD000217;PRD000738;PRD000532;PRD000600;PRD000671;PXD000746;PXD001324;PRD000146;PRD000234;PXD000997;PRD000444;PRD000523;PRD000269;PRD000535;PRD000073;PXD001447;PRD000118;PXD000426;PXD000533;PXD000314	199		2236527;1259072;1037079;742996	563	R-HSA-8949613;R-HSA-163210;R-HSA-1268020	ATP biosynthetic process [GO:0006754];positive regulation of blood vessel endothelial cell migration [GO:0043536];mitochondrial ATP synthesis coupled proton transport [GO:0042776];lipid metabolic process [GO:0006629];cristae formation [GO:0042407]	extracellular exosome [GO:0070062];mitochondrial matrix [GO:0005759];mitochondrial proton-transporting ATP synthase complex [GO:0005753];mitochondrion [GO:0005739];proton-transporting ATP synthase complex [GO:0045259];myelin sheath [GO:0043209];membrane [GO:0016020];plasma membrane [GO:0005886]	proton-transporting ATP synthase activity, rotational mechanism [GO:0046933];transmembrane transporter activity [GO:0022857];ATP binding [GO:0005524];angiostatin binding [GO:0043532];MHC class I protein binding [GO:0042288]
P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	0.4	24	PRD000053;PRD000565;PXD000218;PRD000444;PXD001323;PRD000443;PXD000948;PXD000529;PRD000733;PRD000146;PXD000997;PRD000345;PXD001572;PRD000594;PXD000426;PXD001422;PXD001310;PXD000047;PXD000593;PRD000269;PRD000020;PRD000711;PRD000597;PRD000668	73		1269358;743580	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P18621	60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1)	RPL17	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.46	20	PRD000053;PXD000218;PRD000565;PRD000020;PRD000444;PXD001323;PXD000948;PRD000733;PRD000146;PXD000997;PXD001572;PRD000594;PXD001422;PXD001310;PXD000047;PXD000593;PRD000269;PRD000711;PRD000597;PRD000668	64		1269366;743588	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P04264	Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)	KRT1	P35908	Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)	KRT2	0.59	58	PRD000733;PRD000345;PRD000154;PRD000073;PXD000743;PRD000164;PRD000069;PRD000092;PRD000443;PRD000059;PRD000373;PXD000383;PXD000529;PXD001403;PRD000053;PXD000387;PXD000593;PRD000269;PXD001328;PRD000020;PXD001422;PRD000796;PRD000146;PXD000047;PRD000711;PRD000671;PRD000172;PXD000746;PXD000218;PRD000597;PRD000607;PRD000680;PXD000997;PRD000416;PRD000212;PXD001323;PRD000417;PXD000412;PRD000151;PRD000364;PXD001402;PRD000565;PXD000164;PXD001174;PRD000234;PRD000551;PRD000600;PXD001324;PXD000948;PRD000362;PRD000444;PXD000226;PRD000113;PRD000594;PRD000407;PXD001572;PXD001447;PXD000964	267		1264013;746414		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];peptide cross-linking [GO:0018149];keratinization [GO:0031424]	cytosol [GO:0005829];cornified envelope [GO:0001533];extracellular space [GO:0005615];keratin filament [GO:0045095];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of epidermis [GO:0030280]
A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.47	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6I1	Immunoglobulin lambda variable 4-60	IGLV4-60	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.42	1	PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6I0	Immunoglobulin lambda variable 8-61	IGLV8-61	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.58	2	PXD001403;PXD000383	10					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P09619	Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b)	PDGFRB	P35916	Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4)	FLT4	0.5	2	PRD000032;PRD000073	14					positive regulation of cell proliferation [GO:0008284];protein autophosphorylation [GO:0046777];negative regulation of apoptotic process [GO:0043066];positive regulation of ERK1 and ERK2 cascade [GO:0070374];peptidyl-tyrosine phosphorylation [GO:0018108]	plasma membrane [GO:0005886];cytoplasm [GO:0005737]	ATP binding [GO:0005524]
P15153	Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2)	RAC2	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.42	21	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PRD000738;PRD000607;PRD000565;PRD000733;PXD000948;PXD001328;PXD001572;PXD001422;PXD000164;PXD000533;PRD000118;PRD000796;PRD000068;PXD001447	85				R-HSA-416482;R-HSA-4086400;R-HSA-194840;R-HSA-114604	regulation of small GTPase mediated signal transduction [GO:0051056];G-protein coupled receptor signaling pathway [GO:0007186]	focal adhesion [GO:0005925];plasma membrane [GO:0005886];lamellipodium [GO:0030027];cytosol [GO:0005829];extracellular exosome [GO:0070062]	GTPase activity [GO:0003924];GTP binding [GO:0005525]
P61006	Ras-related protein Rab-8A (Oncogene c-mel)	RAB8A	P61586	Transforming protein RhoA (Rho cDNA clone 12) (h12)	RHOA	0.4	21	PRD000053;PXD000529;PRD000711;PRD000154;PRD000092;PXD001323;PRD000668;PRD000738;PRD000068;PRD000607;PRD000565;PXD000948;PRD000020;PRD000733;PRD000364;PXD001572;PXD001422;PXD000164;PRD000796;PRD000597;PRD000269	82						extracellular exosome [GO:0070062];midbody [GO:0030496];secretory granule membrane [GO:0030667];dendritic spine [GO:0043197];plasma membrane [GO:0005886];cytosol [GO:0005829]	GTP binding [GO:0005525];GTPase activity [GO:0003924];GDP binding [GO:0019003]
P40199	Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c)	CEACAM6	P31997	Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)	CEACAM8	0.5	3	PRD000684;PXD000164;PRD000118	17	EBI-4314580	858372		R-HSA-1566977;R-HSA-202733;R-HSA-6798695	neutrophil degranulation [GO:0043312];heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157];leukocyte migration [GO:0050900]	azurophil granule membrane [GO:0035577];extracellular space [GO:0005615];plasma membrane [GO:0005886];anchored component of membrane [GO:0031225];cell surface [GO:0009986]	protein heterodimerization activity [GO:0046982]
P40199	Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c)	CEACAM6	P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	0.46	2	PRD000684;PXD000164	13							
A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	0.62	2	PXD000383;PXD001403	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.5	2	PXD000383;PXD001403	12					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.52	3	PXD000383;PXD001403;PXD000743	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.43	3	PRD000671;PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6K0	Immunoglobulin lambda variable 3-16	IGLV3-16	P08493	Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)	MGP	0.4	2	PXD000383;PXD000743	12							
Q04917	14-3-3 protein eta (Protein AS1)	YWHAH	P61981	14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]	YWHAG	0.4	34	PRD000032;PRD000053;PRD000417;PXD000529;PRD000185;PXD001328;PXD001572;PRD000154;PXD001422;PRD000668;PRD000146;PRD000416;PRD000269;PRD000407;PRD000711;PRD000597;PRD000092;PRD000594;PRD000059;PXD000426;PXD000218;PXD001403;PRD000001;PRD000020;PXD000680;PXD000948;PXD001323;PXD001324;PRD000113;PRD000073;PXD000593;PXD000164;PRD000738;PRD000118	117	EBI-11003456;EBI-1644092	1448185;1274669;926847	5199	R-HSA-75035;R-HSA-5628897;R-HSA-5625740;R-HSA-1445148;R-HSA-111447	membrane organization [GO:0061024];regulation of synaptic plasticity [GO:0048167];positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740];regulation of neuron differentiation [GO:0045664]	mitochondrion [GO:0005739];cytosol [GO:0005829];extracellular exosome [GO:0070062]	insulin-like growth factor receptor binding [GO:0005159];identical protein binding [GO:0042802];protein domain specific binding [GO:0019904]
Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	Q8TEQ6	Gem-associated protein 5 (Gemin5)	GEMIN5	0.43	3	PRD000345;PXD000529;PXD000533	30							RNA binding [GO:0003723]
Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	0.45	4	PRD000345;PXD000529;PXD001422;PXD000533	35						nucleus [GO:0005634]	
Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	P46109	Crk-like protein	CRKL	0.41	3	PRD000345;PXD000533;PXD001422	36							RNA binding [GO:0003723]
Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	Q96BW5	Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) (hPHRP)	PTER	0.47	1	PRD000345	28							
Q9BRJ7	Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos)	NUDT16L1	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.48	1	PRD000345	31							hydrolase activity [GO:0016787]
P06731	Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e)	CEACAM5	P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	0.47	2	PRD000684;PXD000164	16							
P01614	Immunoglobulin kappa variable 2D-40 (Ig kappa chain V-II region Cum)	IGKV2D-40	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.43	18	PRD000417;PRD000631;PRD000345;PRD000416;PRD000671;PXD000383;PXD000743;PXD001324;PRD000073;PXD000997;PRD000212;PRD000053;PXD001403;PXD000164;PRD000551;PXD001422;PRD000269;PXD001174	56				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01615	Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)	IGKV2D-28	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.47	2	PXD000383;PXD001403	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01615	Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW)	IGKV2D-28	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.42	2	PXD000383;PXD000164	11					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01611	Immunoglobulin kappa variable 1D-12 (Ig kappa chain V-I region Wes)	IGKV1D-12	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.47	3	PXD000383;PXD001403;PRD000671	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	0.52	44	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PRD000168;PRD000151;PXD001403;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	133				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
Q93077	Histone H2A type 1-C (Histone H2A/l)	HIST1H2AC	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.49	45	PXD000743;PRD000123;PRD000668;PXD000746;PRD000684;PXD000529;PXD000680;PXD000387;PRD000269;PRD000020;PXD000164;PXD001422;PRD000796;PRD000164;PRD000465;PXD000050;PXD000047;PRD000711;PRD000597;PXD001323;PRD000073;PRD000680;PXD000948;PRD000594;PXD000997;PXD000786;PXD001403;PRD000168;PRD000151;PXD000217;PXD001402;PRD000565;PXD000218;PXD000314;PRD000733;PXD001572;PXD001324;PRD000146;PRD000234;PRD000444;PRD000345;PRD000600;PRD000053;PXD001447;PRD000407	138				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-73777;R-HSA-73728;R-HSA-606279;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632		nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];extracellular exosome [GO:0070062]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.41	25	PRD000053;PRD000565;PXD001310;PRD000796;PRD000443;PRD000444;PRD000594;PRD000668;PXD000948;PXD001572;PXD000217;PRD000146;PRD000607;PRD000020;PRD000733;PXD000997;PXD001323;PRD000597;PXD000533;PXD001422;PXD000593;PXD000047;PRD000711;PRD000345;PXD000218	85		1269096;741907	5380;3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];ribosomal large subunit biogenesis [GO:0042273]	membrane [GO:0016020];extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.42	22	PRD000053;PXD000948;PXD001310;PRD000444;PRD000594;PRD000668;PRD000123;PRD000565;PRD000733;PRD000146;PXD000997;PXD001572;PXD001323;PRD000597;PXD001422;PRD000680;PRD000796;PXD000047;PRD000269;PXD000593;PRD000711;PXD000218	78		1269103;741960	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];cytoplasmic translation [GO:0002181];ribosomal large subunit assembly [GO:0000027];translation [GO:0006412];translational initiation [GO:0006413];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	extracellular exosome [GO:0070062];cytoplasm [GO:0005737];membrane [GO:0016020];polysomal ribosome [GO:0042788];cytosolic large ribosomal subunit [GO:0022625];cytosol [GO:0005829]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62913	60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5)	RPL11	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.42	25	PRD000565;PRD000053;PRD000668;PXD000529;PXD001310;PXD001572;PXD001422;PRD000796;PRD000711;PRD000597;PRD000594;PXD001323;PXD000948;PXD000997;PXD000217;PXD000218;PRD000731;PRD000671;PRD000146;PRD000444;PXD000593;PRD000345;PRD000600;PXD001447;PXD000533	91		1270806;742743	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	rRNA processing [GO:0006364];translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	cytosol [GO:0005829];nucleolus [GO:0005730];nucleoplasm [GO:0005654];cytoplasm [GO:0005737];membrane [GO:0016020];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P62917	60S ribosomal protein L8 (Large ribosomal subunit protein uL2)	RPL8	P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	0.4	25	PRD000053;PXD000218;PXD000593;PXD001323;PXD000948;PRD000444;PRD000443;PRD000597;PXD000217;PRD000607;PRD000565;PXD001310;PRD000146;PXD000997;PXD001328;PXD000047;PRD000594;PRD000733;PXD001422;PRD000345;PXD001572;PRD000711;PRD000269;PXD000964;PRD000668	71	EBI-8429350;EBI-8412660;EBI-8408168;EBI-8401905;EBI-8392519;EBI-8387620;EBI-8383997;EBI-8372752;EBI-8357768;EBI-8354201;EBI-8350757;EBI-8338396;EBI-8328780;EBI-8312518	592130;1269275;742647	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	P01767	Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT)	IGHV3-53	0.44	3	PXD000383;PXD001403;PXD000743	14					immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.47	3	PXD000383;PXD001403;PXD000743	14					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.46	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	0.5	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.42	3	PXD000383;PXD001403;PXD000743	14					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.54	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.51	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0B4J1U3	Immunoglobulin lambda variable 1-36	IGLV1-36	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.44	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	P01766	Immunoglobulin heavy variable 3-13 (Ig heavy chain V-III region BRO)	IGHV3-13	0.48	18	PRD000417;PRD000019;PRD000551;PRD000185;PRD000416;PRD000671;PRD000059;PXD000383;PRD000269;PXD001324;PRD000146;PRD000212;PRD000053;PXD001403;PXD001422;PRD000113;PXD000743;PXD000164	58				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	0.4	8	PXD000383;PRD000671;PRD000019;PXD001403;PXD001422;PRD000113;PXD000743;PXD000164	22					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	0.41	8	PXD000383;PRD000671;PRD000059;PRD000551;PXD001403;PXD001422;PXD000164;PRD000019	27				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.4	10	PRD000551;PRD000671;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PXD001422;PXD000164	35				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.44	10	PRD000362;PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PXD000743;PXD000164;PRD000019	31				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.48	12	PRD000551;PRD000671;PXD000383;PRD000059;PRD000019;PXD001324;PRD000212;PRD000053;PXD001403;PXD001422;PXD000743;PXD000164	36				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.41	13	PRD000364;PRD000551;PRD000671;PXD000383;PRD000059;PXD001324;PRD000212;PRD000053;PXD001403;PRD000185;PXD001422;PXD000743;PXD000164	32					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01764	Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP)	IGHV3-23	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.41	10	PRD000671;PXD000383;PRD000059;PRD000551;PRD000212;PXD001403;PRD000185;PXD001422;PRD000113;PRD000019	29					immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P23396	40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3)	RPS3	P36578	60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4)	RPL4	0.4	31	PRD000020;PXD000948;PRD000443;PXD000529;PXD001310;PRD000053;PXD001328;PXD000997;PXD000047;PXD001422;PRD000796;PRD000146;PXD000426;PRD000711;PRD000597;PXD000593;PRD000594;PXD001323;PRD000046;PRD000607;PRD000680;PRD000565;PXD000217;PXD000218;PRD000671;PRD000733;PXD000314;PRD000444;PXD001572;PXD000533;PXD000964	113		1270110;741539	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];cytoplasmic translation [GO:0002181];SRP-dependent cotranslational protein targeting to membrane [GO:0006614];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]	ribonucleoprotein complex [GO:1990904];cytosol [GO:0005829];nucleolus [GO:0005730];cytoplasm [GO:0005737];focal adhesion [GO:0005925];membrane [GO:0016020];nucleus [GO:0005634];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.49	8	PXD000383;PRD000417;PXD001403;PXD000743;PRD000416;PXD000164;PRD000345;PRD000019	21					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.42	6	PXD000383;PRD000417;PXD001403;PXD001422;PRD000416;PRD000671	17					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.49	9	PRD000417;PXD000383;PRD000671;PXD000743;PRD000019;PRD000416;PXD001403;PXD000164;PXD001422	25					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH72	Immunoglobulin kappa variable 1-6	IGKV1-6	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.52	8	PXD000383;PRD000417;PRD000671;PRD000019;PXD001403;PXD001422;PRD000416;PRD000113	20					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	0.44	11	PRD000417;PRD000416;PRD000551;PXD000383;PRD000671;PRD000059;PRD000631;PXD000164;PXD001422;PRD000345;PXD001403	34				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.57	11	PRD000417;PRD000416;PRD000551;PXD000383;PXD000743;PRD000059;PRD000671;PRD000345;PXD001403;PXD000164;PRD000019	31				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.46	9	PRD000417;PRD000416;PRD000551;PXD000383;PRD000671;PRD000059;PRD000019;PRD000631;PXD001403	31				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.5	7	PRD000417;PRD000416;PXD000383;PRD000671;PRD000019;PXD001403;PXD001422	23					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.51	11	PRD000417;PRD000416;PXD000383;PRD000671;PRD000631;PRD000551;PRD000019;PXD000743;PXD000164;PXD001422;PXD001403	32					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH73	Immunoglobulin kappa variable 1-12	IGKV1-12	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.46	10	PRD000417;PXD000383;PRD000671;PRD000631;PRD000551;PRD000416;PXD001403;PXD001422;PRD000059;PRD000019	25					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P31997	Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)	CEACAM8	P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	0.51	2	PRD000684;PXD000164	16							
P20292	Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein)	ALOX5AP	P13688	Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a)	CEACAM1	0.44	2	PRD000684;PXD000164	16						integral component of membrane [GO:0016021];membrane [GO:0016020]	
A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	0.52	2	PXD000383;PXD001403	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A075B6J9	Immunoglobulin lambda variable 2-18	IGLV2-18	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.53	1	PXD000383	11					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	0.51	14	PRD000417;PXD000743;PXD000383;PRD000416;PRD000671;PRD000551;PRD000059;PRD000212;PRD000053;PXD001403;PXD000164;PRD000631;PRD000345;PXD001174	42				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886];blood microparticle [GO:0072562]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.54	16	PRD000417;PXD001324;PRD000416;PRD000671;PRD000631;PRD000551;PXD000383;PRD000019;PRD000212;PRD000053;PRD000059;PXD001403;PXD001422;PXD000164;PRD000269;PXD001174	48				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.5	16	PRD000417;PXD000743;PXD000383;PXD001324;PRD000416;PRD000631;PRD000671;PRD000019;PRD000551;PRD000212;PRD000053;PXD001403;PXD000164;PXD001422;PRD000269;PXD001174	48					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P06312	Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH)	IGKV4-1	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.46	15	PRD000417;PXD000743;PXD000383;PRD000631;PRD000671;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD000164;PXD001422;PXD001403;PRD000269;PXD001174	41					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P19013	Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)	KRT4	P19012	Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)	KRT15	0.45	49	PRD000069;PXD000743;PRD000123;PRD000092;PRD000443;PRD000597;PRD000345;PXD000529;PRD000373;PXD000387;PXD001328;PXD000164;PRD000154;PXD001422;PRD000796;PRD000164;PXD000047;PRD000711;PRD000172;PXD000746;PRD000594;PRD000059;PXD001323;PRD000607;PRD000680;PXD000997;PRD000212;PXD000593;PRD000151;PXD001402;PRD000565;PRD000020;PXD000218;PXD001174;PXD001324;PRD000551;PRD000146;PRD000234;PRD000444;PRD000113;PXD000383;PRD000600;PRD000053;PRD000733;PRD000362;PXD001572;PXD001447;PRD000407;PXD000964	153	EBI-18738483;EBI-18738496;EBI-10517220;EBI-10357565;EBI-10200251	1039450		R-HSA-6809371;R-HSA-6805567	cornification [GO:0070268];keratinization [GO:0031424]	intermediate filament [GO:0005882];nucleus [GO:0005634];cytosol [GO:0005829]	
P50914	60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14)	RPL14	P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	0.42	20	PRD000053;PRD000733;PXD001310;PRD000444;PRD000594;PXD001323;PXD000948;PRD000565;PRD000146;PXD000997;PXD001572;PRD000668;PXD001422;PRD000796;PXD000047;PXD000593;PRD000407;PRD000711;PRD000597;PXD000218	67		1269533;741963	3055;308;306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];extracellular exosome [GO:0070062];cytosol [GO:0005829];cytosolic large ribosomal subunit [GO:0022625]	cadherin binding [GO:0045296];structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P06727	Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4)	APOA4	P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	0.42	14	PRD000073;PRD000059;PRD000416;PRD000185;PXD000383;PRD000053;PXD000164;PRD000172;PXD001403;PRD000631;PXD001324;PRD000551;PRD000158;PRD000362	122						extracellular region [GO:0005576];extracellular space [GO:0005615];cytosol [GO:0005829];blood microparticle [GO:0072562];extracellular exosome [GO:0070062]	
P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	0.57	14	PRD000417;PRD000416;PRD000671;PRD000551;PXD000383;PXD000743;PRD000212;PXD001403;PRD000053;PRD000059;PRD000631;PXD000164;PXD001174;PRD000019	40				R-HSA-983695;R-HSA-977606;R-HSA-5690714;R-HSA-2871837;R-HSA-2871809;R-HSA-2871796;R-HSA-2730905;R-HSA-2454202;R-HSA-2168880;R-HSA-2029485;R-HSA-2029482;R-HSA-2029481;R-HSA-202733;R-HSA-198933;R-HSA-173623;R-HSA-166663	regulation of immune response [GO:0050776];receptor-mediated endocytosis [GO:0006898];complement activation, classical pathway [GO:0006958];immunoglobulin production [GO:0002377];regulation of complement activation [GO:0030449];Fc-epsilon receptor signaling pathway [GO:0038095];Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096];immune response [GO:0006955];complement activation [GO:0006956];leukocyte migration [GO:0050900]	extracellular region [GO:0005576];plasma membrane [GO:0005886]	antigen binding [GO:0003823];serine-type endopeptidase activity [GO:0004252]
P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.4	6	PRD000417;PRD000416;PRD000671;PXD000383;PXD001403;PXD001174	22					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.49	11	PRD000417;PXD000743;PXD000383;PRD000416;PRD000671;PRD000551;PXD001403;PRD000053;PXD000164;PRD000631;PXD001174	35					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01602	Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue)	IGKV1-5	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.51	14	PRD000417;PXD000743;PXD000383;PRD000671;PRD000059;PRD000551;PRD000416;PRD000212;PXD001403;PRD000053;PXD000164;PRD000631;PXD001174;PRD000019	32					immunoglobulin production [GO:0002377];immune response [GO:0006955]	plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.42	8	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PXD001174	25					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.55	14	PRD000417;PRD000551;PRD000416;PRD000671;PRD000631;PXD000383;PRD000019;PXD001324;PRD000053;PXD000743;PXD000164;PXD001422;PXD001403;PXD001174	42					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P01601	Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189)	IGKV1D-16	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.52	13	PRD000417;PRD000671;PRD000631;PXD000383;PRD000059;PRD000551;PRD000416;PRD000212;PRD000053;PXD001422;PXD001403;PXD001174;PRD000019	34					immunoglobulin production [GO:0002377];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P06899	Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r)	HIST1H2BJ	Q99877	Histone H2B type 1-N (Histone H2B.d) (H2B/d)	HIST1H2BN	0.44	20	PXD000529;PRD000684;PXD000743;PRD000594;PRD000123;PRD000269;PRD000164;PXD000746;PRD000565;PRD000680;PRD000733;PXD000314;PRD000020;PXD001572;PXD001422;PRD000796;PXD000050;PXD000217;PXD000948;PRD000597	51				R-HSA-977225;R-HSA-912446;R-HSA-9018519;R-HSA-8939236;R-HSA-8936459;R-HSA-8866654;R-HSA-73777;R-HSA-73728;R-HSA-69473;R-HSA-606279;R-HSA-5693607;R-HSA-5693571;R-HSA-5693565;R-HSA-5689880;R-HSA-5625886;R-HSA-5617472;R-HSA-5578749;R-HSA-5334118;R-HSA-5250924;R-HSA-427413;R-HSA-427389;R-HSA-427359;R-HSA-3214847;R-HSA-3214815;R-HSA-2559586;R-HSA-2559582;R-HSA-2559580;R-HSA-2299718;R-HSA-212300;R-HSA-201722;R-HSA-1912408;R-HSA-171306;R-HSA-1221632	protein ubiquitination [GO:0016567];nucleosome assembly [GO:0006334]	nucleus [GO:0005634];nucleosome [GO:0000786];nucleoplasm [GO:0005654];cytosol [GO:0005829]	protein heterodimerization activity [GO:0046982];DNA binding [GO:0003677]
P83731	60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24)	RPL24	P39019	40S ribosomal protein S19 (Small ribosomal subunit protein eS19)	RPS19	0.41	21	PRD000053;PXD001310;PRD000020;PRD000444;PRD000733;PRD000594;PRD000668;PRD000269;PRD000565;PXD000948;PRD000146;PXD000997;PXD001323;PXD001572;PXD001422;PXD000593;PRD000407;PRD000796;PRD000711;PRD000597;PXD000218	73		1270811;742871	306	R-HSA-975957;R-HSA-975956;R-HSA-9010553;R-HSA-72764;R-HSA-72706;R-HSA-72689;R-HSA-6791226;R-HSA-2408557;R-HSA-192823;R-HSA-1799339;R-HSA-156902;R-HSA-156827	translation [GO:0006412];translational initiation [GO:0006413];nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184];SRP-dependent cotranslational protein targeting to membrane [GO:0006614]	membrane [GO:0016020];cytoplasm [GO:0005737];cytosol [GO:0005829];extracellular exosome [GO:0070062]	structural constituent of ribosome [GO:0003735];RNA binding [GO:0003723]
P02774	Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf)	GC	P00734	Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain]	F2	0.51	14	PRD000073;PXD000383;PRD000059;PRD000185;PRD000053;PXD000164;PRD000711;PXD001403;PRD000631;PRD000172;PRD000551;PRD000158;PRD000362;PRD000416	126						extracellular region [GO:0005576];extracellular space [GO:0005615];extracellular exosome [GO:0070062];blood microparticle [GO:0072562]	
O60568	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3)	PLOD3	Q02809	Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)	PLOD1	0.45	8	PXD001328;PXD001323;PRD000345;PXD001572;PXD000529;PXD000533;PRD000146;PRD000053	12				R-HSA-1650814	hydroxylysine biosynthetic process [GO:0046947];peptidyl-lysine hydroxylation [GO:0017185]	rough endoplasmic reticulum membrane [GO:0030867];extracellular exosome [GO:0070062];endoplasmic reticulum membrane [GO:0005789]	procollagen-lysine 5-dioxygenase activity [GO:0008475];iron ion binding [GO:0005506];L-ascorbic acid binding [GO:0031418]
P60510	Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X)	PPP4C	P46109	Crk-like protein	CRKL	0.4	5	PRD000345;PRD000154;PXD001323;PXD001422;PXD000533	41						nucleoplasm [GO:0005654];cytosol [GO:0005829]	
P46109	Crk-like protein	CRKL	Q96DG6	Carboxymethylenebutenolidase homolog (EC 3.1.-.-)	CMBL	0.47	4	PRD000345;PXD000948;PXD000529;PXD001323	38						cytosol [GO:0005829]	
A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	0.45	3	PXD000383;PXD001403;PXD001422	14					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH69	Immunoglobulin kappa variable 1-9	IGKV1-9	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.43	3	PXD000383;PXD000743;PRD000345	13					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	0.46	10	PRD000417;PRD000416;PRD000671;PXD000383;PRD000019;PXD001403;PXD001422;PRD000269;PRD000185;PXD001174	28					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
A0A0C4DH68	Immunoglobulin kappa variable 2-24	IGKV2-24	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.41	7	PRD000417;PRD000671;PXD000383;PRD000416;PXD001403;PXD001422;PXD001174	22					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]
P08493	Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein)	MGP	A0A075B6K2	Immunoglobulin lambda variable 3-12	IGLV3-12	0.41	2	PXD000383;PXD000743	12							
A0A075B6K5	Immunoglobulin lambda variable 3-9	IGLV3-9	A0A075B6K4	Immunoglobulin lambda variable 3-10	IGLV3-10	0.45	11	PRD000417;PRD000631;PRD000671;PXD000383;PRD000416;PRD000212;PXD001403;PRD000053;PXD000164;PXD001422;PXD001174	32					immunoglobulin production [GO:0002377];adaptive immune response [GO:0002250];immune response [GO:0006955]	extracellular space [GO:0005615];plasma membrane [GO:0005886]	antigen binding [GO:0003823]